0001341004-11-001932.txt : 20111027 0001341004-11-001932.hdr.sgml : 20111027 20111027172723 ACCESSION NUMBER: 0001341004-11-001932 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 19 FILED AS OF DATE: 20111027 DATE AS OF CHANGE: 20111027 GROUP MEMBERS: EL VEDADO LLC GROUP MEMBERS: INVESCO PRIVATE CAPITAL INC. GROUP MEMBERS: INVESCO WLR IV ASSOCIATES LLC GROUP MEMBERS: WILBUR L. ROSS JR. GROUP MEMBERS: WL ROSS GROUP L.P. GROUP MEMBERS: WLR IV PARALLEL ESC L.P. GROUP MEMBERS: WLR MASTER CO-INVESTMENT GP LLC GROUP MEMBERS: WLR RECOVERY ASSOCIATES IV LLC GROUP MEMBERS: WLR RECOVERY ASSOCIATES V LLC GROUP MEMBERS: WLR RECOVERY FUND IV L.P. GROUP MEMBERS: WLR RECOVERY FUND V L.P. GROUP MEMBERS: WLR/GS MASTER CO-INVESTMENT L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GOVERNOR & CO OF THE BANK OF IRELAND CENTRAL INDEX KEY: 0001022575 STANDARD INDUSTRIAL CLASSIFICATION: COMMERCIAL BANKS, NEC [6029] IRS NUMBER: 132687269 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-86453 FILM NUMBER: 111162810 BUSINESS ADDRESS: STREET 1: LOWER BAGGOT ST CITY: DUBLIN 2 IRELAND STATE: L2 ZIP: 00000 BUSINESS PHONE: 35316043402 MAIL ADDRESS: STREET 1: LOWER BAGGOT ST CITY: DUBLIN IRLEND STATE: L2 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WL ROSS & CO LLC CENTRAL INDEX KEY: 0001202045 IRS NUMBER: 134106462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 600 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2128261100 MAIL ADDRESS: STREET 1: 600 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D 1 sc13d.htm sc13d.htm

 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
SCHEDULE 13D
 
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
THE GOVERNOR AND COMPANY OF THE BANK OF IRELAND
 
(Name of Issuer)
 
 
Ordinary Stock, Nominal Value €0.05 each
American Depository Shares, each representing forty units of Ordinary Stock, Par Value €0.05 each
 
(Title and Class of Securities)
 
46267Q202
(CUSIP Number)
 
 
WL Ross & Co. LLC
1166 Avenue of the Americas
New York, New York 10036
Attention: Michael J. Gibbons
Telephone Number: (212) 826-1100
Facsimile Number: (212) 278-9645
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
October 17, 2011
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box  .
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
*  The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
(Continued on following pages)

 
 

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WL Ross & Co. LLC (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
2,799,609,488 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
2,799,609,488 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,799,609,488 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
9.3%
14
TYPE OF REPORTING PERSON
 
OO

(1)
WL Ross & Co. LLC serves as the investment manager to WLR Recovery Fund IV, L.P. ("Fund IV"), WLR Recovery Fund V, L.P. ("Fund V") and WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund").  Fund IV owns 2,121,208,699 units of Ordinary Stock of the issuer, Fund V owns 489,713,102 units of Ordinary Stock of the issuer and the Co-Invest Fund owns 188,687,687 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC, WLR Recovery Associates V LLC and WLR Master Co-Investment GP, LLC.  WLR Recovery Associates IV LLC is the general partner of Fund IV, WLR Recovery Associates V LLC is the general partner of Fund V and WLR Master Co-Investment GP, LLC is the general partner of the Co-Invest Fund.


 
2

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
Accordingly, WL Ross & Co. LLC may be deemed to share voting and dispositive power with (i) Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates IV LLC over the units of Ordinary Stock owned by Fund IV; (ii) Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates V LLC over the units of Ordinary Stock owned by Fund V; and (iii) Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Master Co-Investment GP, LLC over the units of Ordinary Stock owned by the Co-Invest Fund.


 
3

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR Recovery Fund IV, L.P. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
2,121,208,699 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
2,121,208,699 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,121,208,699 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
7.0%
14
TYPE OF REPORTING PERSON
 
PN

(1)
WLR Recovery Fund IV, L.P. ("Fund IV") owns 2,121,208,699 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC and the managing member of El Vedado, LLC.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC.  WLR Recovery Associates IV LLC is the general partner of Fund IV.  WL Ross & Co. LLC serves as the investment manager to Fund IV.  Accordingly, WL Ross & Co. LLC, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates IV LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by Fund IV.


 
4

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR Recovery Fund V, L.P. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
489,713,102 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
489,713,102 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
489,713,102 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
1.6%
14
TYPE OF REPORTING PERSON
 
PN

(1)
WLR Recovery Fund V, L.P. ("Fund V") owns 489,713,102 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC and the managing member of El Vedado, LLC.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates V LLC.  WLR Recovery Associates V LLC is the general partner of Fund V.  WL Ross & Co. LLC serves as the investment manager to Fund V.  Accordingly, WL Ross & Co. LLC, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates V LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by Fund V.


 
5

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR/GS Master Co-Investment L.P. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
188,687,687 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
188,687,687 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
188,687,687 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
0.6%
14
TYPE OF REPORTING PERSON
 
PN

(1)
WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund") owns 188,687,687 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC and the managing member of El Vedado, LLC.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Master Co-Investment GP, LLC.  WLR Master Co-Investment GP, LLC is the general partner of the Co-Invest Fund.  WL Ross & Co. LLC serves as the investment manager to the Co-Invest Fund.  Accordingly, WL Ross & Co. LLC, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Master Co-Investment GP, LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by the Co-Invest Fund.


 
6

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR IV Parallel ESC, L.P. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
7,854,370 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
7,854,370 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,854,370 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
Less than 0.1%
14
TYPE OF REPORTING PERSON
 
PN

(1)
WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC.  WLR Recovery Associates IV LLC is the general partner of WLR Recovery Fund IV, L.P.  Invesco Private Capital, Inc. is the managing member of INVESCO WLR IV Associates LLC, which in turn is the general partner of the Parallel Fund.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P., WLR Recovery Associates


 
7

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
IV LLC, Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by the Parallel Fund.


 
8

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR Recovery Associates IV LLC (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
2,129,063,069 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
2,129,063,069 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,129,063,069 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
7.1%
14
TYPE OF REPORTING PERSON
 
OO

(1)
WLR Recovery Fund IV, L.P. ("Fund IV") owns 2,121,208,699 units of Ordinary Stock of the issuer.  WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC.  WLR Recovery Associates IV LLC is the general partner of Fund IV.  WL Ross & Co. LLC serves as the investment manager to Fund IV.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, WLR Recovery Associates IV LLC may be deemed to share voting

 
 
9

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
and dispositive power with (i) WL Ross & Co. LLC, Wilbur L. Ross, Jr., El Vedado, LLC and WL Ross Group L.P. over the units of Ordinary Stock owned by Fund IV, and (ii) Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group L.P., Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC over the units of Ordinary Stock owned by the Parallel Fund.


 
10

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR Recovery Associates V LLC (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
489,713,102 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
489,713,102 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
489,713,102 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
1.6%
14
TYPE OF REPORTING PERSON
 
OO

(1)
WLR Recovery Fund V, L.P. ("Fund V") owns 489,713,102 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC and the managing member of El Vedado, LLC.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates V LLC.  WLR Recovery Associates V LLC is the general partner of Fund V.  WL Ross & Co. LLC serves as the investment manager to Fund V.  Accordingly, WL Ross & Co. LLC, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates V LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by Fund V.


 
11

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WLR Master Co-Investment GP, LLC (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
188,687,687 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
188,687,687 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
188,687,687 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
0.6%
14
TYPE OF REPORTING PERSON
 
OO

(1)
WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund") owns 188,687,687 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC and the managing member of El Vedado, LLC.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Master Co-Investment GP, LLC.  WLR Master Co-Investment GP, LLC is the general partner of the Co-Invest Fund.  WL Ross & Co. LLC serves as the investment manager to the Co-Invest Fund.  Accordingly, WL Ross & Co. LLC, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P. and WLR Master Co-Investment GP, LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by the Co-Invest Fund.


 
12

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
INVESCO WLR IV Associates LLC (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
7,854,370 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
7,854,370 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,854,370 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
Less than 0.1%
14
TYPE OF REPORTING PERSON
 
OO

(1)
WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC.  WLR Recovery Associates IV LLC is the general partner of WLR Recovery Fund IV, L.P.  Invesco Private Capital, Inc. is the managing member of INVESCO WLR IV Associates LLC, which in turn is the general partner of the Parallel Fund.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P., WLR Recovery Associates


 
13

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
IV LLC, Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by the Parallel Fund.


 
14

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Invesco Private Capital, Inc. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
7,854,370 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
7,854,370 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,854,370 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
Less than 0.1%
14
TYPE OF REPORTING PERSON
 
CO

(1)
WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC.  WLR Recovery Associates IV LLC is the general partner of WLR Recovery Fund IV, L.P.  Invesco Private Capital, Inc. is the managing member of INVESCO WLR IV Associates LLC, which in turn is the general partner of the Parallel Fund.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, Wilbur L. Ross, Jr., El Vedado, LLC, WL Ross Group, L.P., WLR Recovery Associates


 
15

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
IV LLC, Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC may be deemed to share voting and dispositive power over the units of Ordinary Stock owned by the Parallel Fund.


 
16

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Wilbur L. Ross, Jr. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States of America
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
2,807,463,858 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
2,807,463,858 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,807,463,858 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
9.3%
14
TYPE OF REPORTING PERSON
 
IN

(1)
WLR Recovery Fund IV, L.P. ("Fund IV") owns 2,121,208,699 units of Ordinary Stock of the issuer, WLR Recovery Fund V, L.P. ("Fund V") owns 489,713,102 units of Ordinary Stock of the issuer, WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund") owns 188,687,687 units of Ordinary Stock of the issuer and WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC, WLR Recovery Associates V LLC and WLR Master Co-Investment GP, LLC.  WLR Recovery Associates IV LLC is the general partner of Fund IV, WLR Recovery Associates V LLC is the general partner of Fund V and WLR Master Co-Investment GP, LLC is the general partner of the Co-Invest Fund.  WL Ross & Co. LLC serves as the investment manager to Fund IV, Fund V and the Co-Invest Fund.  Invesco Private Capital, Inc. is the managing member of INVESCO WLR IV Associates LLC, which in turn is the general partner of the Parallel Fund.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV


 
17

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, Wilbur L. Ross, Jr. may be deemed to share voting and dispositive power with (i) WL Ross & Co. LLC, El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates IV LLC over the units of Ordinary Stock owned by Fund IV; (ii) WL Ross & Co. LLC, El Vedado, LLC, WL Ross Group, L.P. and WLR Recovery Associates V LLC over the units of Ordinary Stock owned by Fund V; (iii) WL Ross & Co. LLC, El Vedado, LLC, WL Ross Group, L.P. and WLR Master Co-Investment GP, LLC over the units of Ordinary Stock owned by the Co-Invest Fund; and (iv) El Vedado, LLC, WL Ross Group, L.P., WLR Recovery Associates IV LLC, Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC over the units of Ordinary Stock owned by the Parallel Fund.


 
18

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
El Vedado, LLC (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
New York
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
2,807,463,858 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
2,807,463,858 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,807,463,858 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
9.3%
14
TYPE OF REPORTING PERSON
 
OO

(1)
WLR Recovery Fund IV, L.P. ("Fund IV") owns 2,121,208,699 units of Ordinary Stock of the issuer, WLR Recovery Fund V, L.P. ("Fund V") owns 489,713,102 units of Ordinary Stock of the issuer, WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund") owns 188,687,687 units of Ordinary Stock of the issuer and WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC, WLR Recovery Associates V LLC and WLR Master Co-Investment GP, LLC.  WLR Recovery Associates IV LLC is the general partner of Fund IV, WLR Recovery Associates V LLC is the general partner of Fund V and WLR Master Co-Investment GP, LLC is the general partner of the Co-Invest Fund.  WL Ross & Co. LLC serves as the investment manager to Fund IV, Fund V and the Co-Invest Fund.  Invesco Private Capital, Inc. is the managing member of INVESCO WLR IV Associates LLC, which in turn is the general partner of the Parallel Fund.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV


 
19

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, El Vedado, LLC may be deemed to share voting and dispositive power with (i) Wilbur L. Ross, Jr., WL Ross & Co. LLC, WL Ross Group, L.P. and WLR Recovery Associates IV LLC over the units of Ordinary Stock owned by Fund IV; (ii) Wilbur L. Ross, Jr., WL Ross & Co. LLC, WL Ross Group, L.P. and WLR Recovery Associates V LLC over the units of Ordinary Stock owned by Fund V; (iii) Wilbur L. Ross, Jr., WL Ross & Co. LLC, WL Ross Group, L.P. and WLR Master Co-Investment GP, LLC over the units of Ordinary Stock owned by the Co-Invest Fund; and (iv) Wilbur L. Ross, Jr., WL Ross Group, L.P., WLR Recovery Associates IV LLC, Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC over the units of Ordinary Stock owned by the Parallel Fund.


 
20

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

1
NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
WL Ross Group, L.P. (1)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) c
(b) S
3
SEC USE ONLY
4
SOURCE OF FUNDS
 
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
New York
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
2,807,463,858 (1)
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
2,807,463,858 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,807,463,858 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
9.3%
14
TYPE OF REPORTING PERSON
 
PN

(1)
WLR Recovery Fund IV, L.P. ("Fund IV") owns 2,121,208,699 units of Ordinary Stock of the issuer, WLR Recovery Fund V, L.P. ("Fund V") owns 489,713,102 units of Ordinary Stock of the issuer, WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund") owns 188,687,687 units of Ordinary Stock of the issuer and WLR IV Parallel ESC, L.P. (the "Parallel Fund") owns 7,854,370 units of Ordinary Stock of the issuer.  Wilbur L. Ross, Jr. is the president and chief executive officer of WL Ross & Co. LLC, the managing member of El Vedado, LLC and the chairman and president of Invesco Private Capital, Inc.  El Vedado, LLC is the general partner of WL Ross Group, L.P., which in turn is the managing member of WLR Recovery Associates IV LLC, WLR Recovery Associates V LLC and WLR Master Co-Investment GP, LLC.  WLR Recovery Associates IV LLC is the general partner of Fund IV, WLR Recovery Associates V LLC is the general partner of Fund V and WLR Master Co-Investment GP, LLC is the general partner of the Co-Invest Fund.  WL Ross & Co. LLC serves as the investment manager to Fund IV, Fund V and the Co-Invest Fund.  Invesco Private Capital, Inc. is the managing member of INVESCO WLR IV Associates LLC, which in turn is the general partner of the Parallel Fund.  INVESCO WLR IV Associates LLC and WLR Recovery Associates IV


 
21

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
LLC have entered into a parallel investment agreement pursuant to which WLR Recovery Associates IV LLC has been appointed as representative and attorney of the Parallel Fund to, among other things, exercise all rights, powers and privileges with respect to the Ordinary Stock owned by the Parallel Fund and to take whatever action, including voting such Ordinary Stock, as WLR Recovery Associates IV LLC in its discretion deems fit.  Accordingly, WL Ross Group, L.P. may be deemed to share voting and dispositive power with (i) Wilbur L. Ross, Jr., WL Ross & Co. LLC, El Vedado, LLC and WLR Recovery Associates IV LLC over the units of Ordinary Stock owned by Fund IV; (ii) Wilbur L. Ross, Jr., WL Ross & Co. LLC, El Vedado, LLC and WLR Recovery Associates V LLC over the units of Ordinary Stock owned by Fund V; (iii) Wilbur L. Ross, Jr., WL Ross & Co. LLC, El Vedado, LLC and WLR Master Co-Investment GP, LLC over the units of Ordinary Stock owned by the Co-Invest Fund; and (iv) Wilbur L. Ross, Jr., El Vedado, LLC, WLR Recovery Associates IV LLC, Invesco Private Capital, Inc. and INVESCO WLR IV Associates LLC over the units of Ordinary Stock owned by the Parallel Fund.


 
22

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 
 
Item 1.                      Security and Issuer.
 
This Schedule 13D (this "Statement") relates to the ordinary stock, nominal value €0.05 per unit (the "Ordinary Stock"), of The Governor and Company of the Bank of Ireland, a chartered corporation registered in Ireland with registered no. C-1 (the "Company").  The Company's principal executive offices are located at 40 Mespil Road, Dublin 4, Ireland.
 
 
Item 2.                      Identity and Background.
 
The names of the persons filing this Statement (collectively, the "Reporting Persons") are:
 
 
·
WL Ross & Co. LLC, the investment manager of Fund IV, Fund V and the Co-Invest Fund (each as defined below)
     
 
·
WLR Recovery Fund IV, L.P. ("Fund IV")
     
 
·
WLR Recovery Fund V, L.P. ("Fund V")
     
 
·
WLR/GS Master Co-Investment L.P. (the "Co-Invest Fund")
     
 
·
WLR IV Parallel ESC, L.P. (the "Parallel Fund")
     
 
·
WLR Recovery Associates IV LLC, the general partner of Fund IV
     
 
·
WLR Recovery Associates V LLC, the general partner of Fund V
     
 
·
WLR Master Co-Investment GP, LLC, the general partner of the Co-Invest Fund
     
 
·
INVESCO WLR IV Associates LLC, the general partner of the Parallel Fund
     
 
·
Invesco Private Capital, Inc., the managing member of INVESCO WLR IV Associates LLC
     
 
·
WL Ross Group, L.P., the managing member of WLR Recovery Associates IV LLC, WLR Recovery Associates V LLC and WLR Master Co-Investment GP, LLC
     
 
·
El Vedado, LLC, the general partner of WL Ross Group, L.P.
     
 
·
Wilbur L. Ross, Jr., the managing member of El Vedado, LLC, president and chief executive officer of WL Ross & Co. LLC and chairman and president of Invesco Private Capital, Inc.

The information set forth in each of the inside cover pages to this Statement relating to each such Reporting Person is incorporated by reference herein.
 
The principal business office for each of the Reporting Persons other than Wilbur L. Ross, Jr. and El Vedado, LLC is c/o WL Ross Group, L.P., 1166 Avenue of the Americas, New York, New York 10036.  The principal business office of Mr. Ross and El Vedado, LLC is 319 Clematis Street, Room 1000 (10th Floor), West Palm Beach, Florida 33401.  The principal occupation of each of the Reporting Persons is investments.
 
Mr. Ross is a citizen of the United States of America.  WL Ross Group, L.P. and El Vedado, LLC are organized under the laws of the State of New York.  The Co-Invest Fund is organized under the laws of the Cayman Islands.  Each of the other Reporting Persons that is an entity is organized under the laws of the State of Delaware.
 
Michael J. Gibbons is the Chief Financial Officer of Invesco Private Capital, Inc.  The principal occupation for Mr. Gibbons is investment management.  The principal business office for Mr. Gibbons is 1166 Avenue of the Americas, New York, New York 10036.  In addition to Mr. Ross, Mr. G. Mark Armour and Mr. Roderick Ellis are
 

 
23

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

directors of Invesco Private Capital, Inc. The principal occupation for Mr. Armour is investment management.  The principal occupation for Mr. Ellis is finance.  The principal business office for Messrs. Armour and Ellis is 1555 Peachtree Street NE, Atlanta, Georgia 30309.  Mr. Gibbons is a citizen of the United States.  Mr. Armour is a citizen of Australia.  Mr. Ellis is a citizen of the United Kingdom.  Together, Messrs. Gibbons, Armour and Ellis are referred to herein as the "Additional Persons."
 
None of the Reporting Persons or the Additional Persons has, during the last five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) has been a party to a civil proceeding of a judical or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
 
Item 3.                      Source and Amount of Funds or Other Consideration.
 
On July 25, 2011, Fairfax Financial Holdings Limited ("Fairfax"), The Minister for Finance of Ireland (the "Minister") and The National Pensions Reserve Fund Commission ("NPRFC") entered into a securities purchase agreement (the "First SPA"), which was subsequently amended on July 29, 2011 by a supplemental agreement thereto (the "Supplemental Agreement to the First SPA"), pursuant to which Fairfax agreed to purchase approximately €238,153,233 of units of Ordinary Stock from NPRFC.  On July 29, 2011, each of Fund IV, Fund V, the Co-Invest Fund and the Parallel Fund (collectively, the "WL Ross Funds") entered into a deed of assignment (each, a "Deed of Assignment" and, collectively the "Deeds of Assignment") with Fairfax and provided the Minister, the Commission and Fairfax a deed of adherence (each, a "Deed of Adherence" and collectively, the "Deeds of Adherence"), pursuant to which Fairfax assigned its rights and obligations under the First SPA and the Supplemental Agreement to the First SPA to each of the WL Ross Funds as to the number of units of Ordinary Stock specified in the respective Deed of Adherence.  Pursuant to the Deeds of Adherence, the obligations of each of the WL Ross Funds under the First SPA and the Supplemental Agreement to the First SPA are several and not joint with any other party thereto.  The First SPA is filed as Exhibit 2 hereto, the Supplemental Agreement to the First SPA is filed as Exhibit 3 hereto and each of the Deeds of Assignment and Deeds of Adherence are filed as Exhibit 4 hereto.
 
On July 25, 2011, the WL Ross Funds, several other investors (collectively, the "Other Investors"), the Minister, NPRFC and the National Treasury Management Agency entered into a securities purchase agreement (the "Conditional SPA"), which was subsequently amended on July 29, 2011 by a supplemental agreement thereto (the "Supplemental Agreement to the Conditional SPA"), pursuant to which the WL Ross Funds agreed to purchase such additional units of Ordinary Stock from NPRFC as would (when taken together with the Ordinary Stock purchased by the WL Ross Funds pursuant to the First SPA, the Supplemental Agreement to the First SPA, and each of the Deeds of Assignment) bring the WL Ross Funds' collective aggregate holding of Ordinary Stock to a maximum of 3,000,000,000 units, conditioned on the closing of the First SPA and various other conditions.  The Conditional SPA is filed as Exhibit 5 hereto and the Supplemental Agreement to the Conditional SPA is filed as Exhibit 6 hereto.
 
On August 2, 2011, pursuant to the terms of the First SPA, the Supplemental Agreement to the First SPA and each of the Deeds of Assignment, the WL Ross Funds acquired, in the aggregate, 408,857,681 units of Ordinary Stock from NPRFC at a price of €0.10 per unit with cash consideration of €40,885,768.10.  The funding for the purchase price of the units of Ordinary Stock was obtained through equity contributions from the limited partners of the WL Ross Funds.
 
On October 17, 2011, pursuant to the terms of the Conditional SPA and the Supplemental Agreement to the Conditional SPA, the WL Ross Funds acquired, in the aggregate, 2,398,606,177 units of Ordinary Stock from NPRFC at a price of €0.10 per unit with cash consideration of €239,860,617.70.  The funding for the purchase price of the units of Ordinary Stock was obtained through equity contributions from the limited partners of the WL Ross Funds.  When added to the aggregate number of units of Ordinary Stock acquired on August 2, 2011, the WL Ross Funds owned, as of October 17, 2011, in the aggregate, 2,807,463,858 units of Ordinary Stock, which they acquired for aggregate cash consideration of €280,746,385.80.
 

 
24

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 
 
Item 4.                      Purpose of Transaction.
 
The Reporting Persons have acquired the issuer's Ordinary Stock for investment purposes.
 
The Reporting Persons may seek to have one director appointed to the Board of Directors of the Company.
 
The Reporting Persons intend to continually review their investment in the Company.  Pending the results of such review and other factors that the Reporting Persons deem relevant to an investment in the Company (but subject to applicable law, regulatory approvals and the limitations described in Item 6 of this Statement), the Reporting Persons may take or propose to take, alone or in conjunction with others, including the Company, other actions intended to increase or decrease the Reporting Persons' investments in the Company or the value of their investments in the Company, which could include one or more of the transactions or actions referred to in paragraphs (a) through (j) of the instructions to Item 4 of Schedule 13D.
 
Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change their intentions with respect to any or all of the matters referred to in this Statement.
 
 
Item 5.                      Interest in Securities of the Issuer.
 
The information set forth in each of the inside cover pages to this Statement relating to each such Reporting Person is incorporated by reference herein.
 
(a)–(b)  As of the date on which this Statement was initially filed, the Reporting Persons beneficially own, in the aggregate, a total of 2,807,463,858 units of Ordinary Stock, which represents approximately 9.3% of the issuer's outstanding Ordinary Stock.  Fund IV owns 2,121,208,699 units of Ordinary Stock, representing approximately 7.0% of the outstanding units of Ordinary Stock, Fund V owns 489,713,102 units of Ordinary Stock, representing approximately 1.6% of the outstanding units of Ordinary Stock, the Co-Invest Fund owns 188,687,687 units of Ordinary Stock, representing approximately 0.6% of the outstanding units of Ordinary Stock, and the Parallel Fund owns 7,854,370 units of Ordinary Stock, representing less than 0.1% of the outstanding units of Ordinary Stock.  As of the date on which this Statement was initially filed, the number of units of Ordinary Stock as to which each of the Reporting Persons has or shares voting or dispositive authority is set forth in rows 7 through 10 of each of the inside cover pages to this Statement relating to each such Reporting Person.  All percentages set forth in this paragraph are based on 30,132,505,842 units of Ordinary Stock outstanding as of October 17, 2011, as provided by the Company.
 
The Ordinary Stock owned by the WL Ross Funds is held in the name of Bank of New York Mellon.
 
Except for each of the WL Ross Funds, each of the Reporting Persons disclaims beneficial ownership of any of the units of Ordinary Stock referred to in this Statement, and the filing of this Statement should not be construed as an admission that any of the Reporting Persons is, for the purpose of Regulation 13D of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this statement.  Each WL Ross Fund disclaims beneficial ownership of the shares owned by each the other WL Ross Fund.
 
(c)  No Reporting Person has effected any transaction in the units of Ordinary Stock during the 60 days preceding the date of this Statement, other than the acquisition by Fund IV of 1,812,291,999 units of Ordinary Stock, Fund V of 418,395,011 units of Ordinary Stock, the Co-Invest Fund of 161,208,648 units of Ordinary Stock and the Parallel Fund of 6,710,519 units of Ordinary Stock, in each case on October 17, 2011.
 
(d)  Under certain circumstances, partners, members or managed accounts of a Reporting Person, as the case may be, could have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, units of Ordinary Stock owned by such Reporting Person.
 
(e)  Not applicable.
 
Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 

 
25

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

The information set forth in each of the inside cover pages to this Statement relating to each such Reporting Person and the information in Items 2, 3 and 4 is incorporated by reference herein.
 
The WL Ross Funds entered into a deed of undertaking (the "Deed of Undertaking"), dated as of July 24, 2011, with the Company and the Other Investors.  Pursuant to the Deed of Undertaking, the Company agreed to provide the WL Ross Funds and the Other Investors pro rata preemptive rights with respect to future equity issuances, subject to certain exceptions, until July 29, 2016.  The WL Ross Funds will no longer have those preemptive rights if they fail to own, in the aggregate, more than 1% of the Fully Diluted Ordinary Stock Capital (as defined in the Deed of Undertaking).  The Deed of Undertaking is filed as Exhibit 7 hereto.
 
The WL Ross Funds entered into a registration rights agreement (the "Registration Rights Agreement"), dated as of July 24, 2011, with the Company and the Other Investors.  The Registration Rights Agreement grants customary registration rights, including "demand" registration rights, "shelf" registration rights and "piggyback" registration rights under the Securities Act of 1933, as amended, with respect to the units of Ordinary Stock acquired by the WL Ross Funds and the Other Investors pursuant to the First SPA, the Supplemental Agreement to the First SPA, the Conditional SPA and the Supplemental Agreement to the Conditional SPA.  The Registration Rights Agreement is filed as Exhibit 8 hereto.
 
The WL Ross Funds entered into an offer agreement (the "Offer Agreement"), dated as of July 24, 2011, with the Minister and the Other Investors.  Pursuant to the terms of the Offer Agreement, the WL Ross Funds and the Other Investors will each have (1) the right to purchase Contingent Capital Tier 2 Notes due 2016 of the Company (the "CCNs") in proportion to each such WL Ross Fund's or Other Investor's pro rata share of the total units of Ordinary Stock outstanding if the Minister proposes to transfer CCNs to a third party, (2) the option to acquire from the Minister Ordinary Stock that is issued to the Minister if the CCNs have been converted into Ordinary Stock in proportion to each such WL Ross Fund's or Other Investor's pro rata share of the total units of Ordinary Stock outstanding, and (3) the option to acquire 2009 Bonus Stock (as defined in the Offer Agreement) from the Minister in proportion to each such WL Ross Fund's or Other Investor's pro rata share of the total units of Ordinary Stock outstanding if the Minister or any state entity becomes entitled to 2009 Bonus Stock.  The Offer Agreement is filed as Exhibit 9 hereto.
 
The WL Ross Funds entered into an issuer agreement (the "Issuer Agreement"), dated as of July 24, 2011, with the Company and the Other Investors, pursuant to which the Company will, prior to soliciting any third party investors in respect of the CCNs, notify the WL Ross Funds and the Other Investors of its intention to do so and will include the WL Ross Funds and the Other Investors in the negotiation process in relation to the price at which the CCNs might be sold.  The Issuer Agreement is filed as Exhibit 10 hereto.
 
In connection with the transaction, certain of the persons described herein and their affiliates made customary commitments to the Board of Governors of the Federal Reserve System to ensure that they will not, among other things, exercise or attempt to exercise a controlling influence over the management or policies of the issuer under the Bank Holding Company Act of 1956, as amended.
 
Item 7.  Material to be Filed as Exhibits.
 
 
Exhibit 1
 
Joint Filing Agreement
       
 
Exhibit 2
 
First SPA
       
 
Exhibit 3
 
Supplemental Agreement to the First SPA
       
 
Exhibit 4.1
 
Deed of Adherence for Fund IV
       
 
Exhibit 4.2
 
Deed of Adherence for Fund V
       
 
Exhibit 4.3  
 
Deed of Adherence for the Co-Invest Fund


 
26

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
Exhibit 4.4
 
Deed of Adherence for the Parallel Fund
       
 
Exhibit 4.5
 
Deed of Assignment for Fund IV
       
 
Exhibit 4.6
 
Deed of Assignment for Fund V
       
 
Exhibit 4.7
 
Deed of Assignment for the Co-Invest Fund
       
 
Exhibit 4.8  
 
Deed of Assignment for the Parallel Fund
       
 
Exhibit 5
 
Conditional SPA
       
 
Exhibit 6
 
Supplemental Agreement to the Conditional SPA
       
 
Exhibit 7
 
Deed of Undertaking
       
 
Exhibit 8
 
Registration Rights Agreement
       
 
Exhibit 9
 
Offer Agreement
       
 
Exhibit 10
 
Issuer Agreement
       
 
Exhibit 11
 
Parallel Investment Agreement


 
27

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
 
Dated:  October 27, 2011



 
WL ROSS & CO. LLC
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WLR RECOVERY FUND IV, L.P.
   
   
 
By:
WLR Recovery Associates IV LLC,
its General Partner
 
By:  
WL Ross Group, L.P.,
its Managing Member
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:
/s/ Michael Gibbons
   
Name:  
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WLR RECOVERY FUND V, L.P.
   
   
 
By:
WLR Recovery Associates V LLC,
its General Partner
 
By:
WL Ross Group, L.P.,
its Managing Member
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person


 
28

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
WLR/GS MASTER CO-INVESTMENT L.P.
   
   
 
By:
WLR Master Co-Investment GP, LLC,
its General Partner
 
By:  
WL Ross Group, L.P.,
its Managing Member
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:
/s/ Michael Gibbons
   
Name:  
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WLR IV PARALLEL ESC, L.P.
   
   
 
By:
INVESCO WLR IV Associates LLC,
its General Partner
 
By:
Invesco Private Capital, Inc.,
its Managing Member
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WLR RECOVERY ASSOCIATES IV LLC
   
   
 
By:
WL Ross Group, L.P.,
its Managing Member
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WLR RECOVERY ASSOCIATES V LLC
   
   
 
By:
WL Ross Group, L.P.,
its Managing Member
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:  
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:   
Authorized Person


 
29

 


CUSIP No. 46267Q202
 
Schedule 13D
 
 

 
WLR MASTER CO-INVESTMENT GP, LLC
   
   
 
By:  
WL Ross Group, L.P.,
its Managing Member
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
INVESCO WLR IV ASSOCIATES LLC
   
   
 
By:
Invesco Private Capital, Inc.,
its Managing Member
   
   
 
By:
/s/ Michael Gibbons
   
Name:  
Michael Gibbons
   
Title:
Authorized Person
   
   
 
INVESCO PRIVATE CAPITAL, INC.
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WL ROSS GROUP, L.P.
   
   
 
By:
El Vedado, LLC,
its General Partner
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
EL VEDADO, LLC
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
   
   
 
WILBUR L. ROSS, JR.
   
   
   
/s/ Wilbur L. Ross, Jr.
   
Wilbur L. Ross, Jr.
 
30
EX-99 2 ex1.htm EXHIBIT 1 Unassociated Document
Exhibit 1

Joint Filing Agreement
 
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13D and any further amendments thereto need to be filed with respect to the beneficial ownership by each of the undersigned of units of ordinary stock of The Governor and Company of the Bank of Ireland, and further agree that this Joint Filing Agreement be included as an exhibit to the Schedule 13D provided that, as contemplated by Section 13d-1(k)(1)(ii), no person shall be responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
 
Dated:  October 17, 2011
 
WL ROSS & CO. LLC
   
   
 
By: 
/s/ Michael Gibbons
   
Name: 
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WLR RECOVERY FUND IV, L.P.
   
   
 
By:
WLR Recovery Associates IV LLC,
   
its General Partner
 
By:
WL Ross Group, L.P.,
   
its Managing Member
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person

 
 

 
 
 
WLR RECOVERY FUND V, L.P.
   
   
 
By: 
WLR Recovery Associates V LLC,
   
its General Partner
 
By:
WL Ross Group, L.P.,
   
its Managing Member
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name: 
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WLR/GS MASTER CO-INVESTMENT L.P.
   
   
 
By:
WLR Master Co-Investment GP, LLC,
   
its General Partner
 
By:
WL Ross Group, L.P.,
   
its Managing Member
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WLR IV PARALLEL ESC, L.P.
   
   
 
By:
INVESCO WLR IV Associates LLC,
   
its General Partner
 
By:
Invesco Private Capital, Inc.,
   
its Managing Member
     
     
 
By:
/s/ Michael Gibbons
 
Name:
Michael Gibbons
   
Title:
Authorized Person

 
2

 
 
 
WLR RECOVERY ASSOCIATES IV LLC
   
   
 
By: 
WL Ross Group, L.P.,
   
its Managing Member
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name: 
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WLR RECOVERY ASSOCIATES V LLC
   
   
 
By:
WL Ross Group, L.P.,
   
its Managing Member
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WLR MASTER CO-INVESTMENT GP, LLC
   
   
 
By:
WL Ross Group, L.P.,
   
its Managing Member
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
       
       
 
INVESCO WLR IV ASSOCIATES LLC
   
   
 
By:
Invesco Private Capital, Inc.,
   
its Managing Member
     
     
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person

 
3

 
 
 
INVESCO PRIVATE CAPITAL, INC.
   
   
 
By: 
/s/ Michael Gibbons
   
Name: 
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WL ROSS GROUP, L.P.
   
   
 
By:
El Vedado, LLC,
   
its General Partner
     
     
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
       
       
 
EL VEDADO, LLC
   
   
 
By:
/s/ Michael Gibbons
   
Name:
Michael Gibbons
   
Title:
Authorized Person
       
       
 
WILBUR L. ROSS, JR.
   
   
   
/s/ Wilbur L. Ross, Jr.
   
Wilbur L. Ross, Jr.
 
4
 
EX-99 3 ex2.htm EXHIBIT 2 ex2.htm
Exhibit 2




THE MINISTER FOR FINANCE OF IRELAND


THE NATIONAL PENSIONS RESERVE FUND COMMISSION


FAIRFAX FINANCIAL HOLDINGS LIMITED







 







STOCK PURCHASE AGREEMENT

(Ordinary Stock in the capital stock of
The Governor and Company of the Bank of Ireland)








 



William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OOC/MDQ

 
 

 

THIS AGREEMENT is made on 25 July 2011

BETWEEN:

 
THE MINISTER FOR FINANCE OF IRELAND
 
of Upper Merrion Street, Dublin 2
 
(hereinafter called the "Minister")
   
 
THE NATIONAL PENSIONS RESERVE FUND
 
COMMISSION
 
acting in its capacity as controller and manager of
 
the assets of the National Pensions Reserve Fund
 
of Treasury Building, Grand Canal Street, Dublin 2
 
(hereinafter called the "Commission")
   
   
 
                        - and -
   
 
FAIRFAX FINANCIAL HOLDINGS LIMITED
 
having its registered office at
 
95 Wellington Street West, Suite 800,
 
Toronto, Ontario, Canada M5J 2N7
 
(hereinafter called the "Buyer")


RECITALS:
 
A.
The Commission is the owner of 1,909,810,044 units of BoI Ordinary Stock as at the date of this Agreement, and is entitled prior to Completion to take up rights (and will do so) over a further 6,875,316,158 units of Rights Issue Stock (together the “Commission Stock”).
 
B.
The Commission is agreeable to selling, and the Buyer is agreeable to purchasing, 2,413,352,900 units of BoI Ordinary Stock (comprising part of the Commission Stock, and hereinafter referred to as the “Sale Stock”) on the terms and subject to the conditions hereinafter appearing.
 
C.
The Commission and the Buyer have accordingly agreed to enter into this Agreement to provide for the sale and purchase of the Sale Stock.
 
D.
The Minister is party to this Agreement for the purposes expressly provided for in this Agreement.
 
THE PARTIES AGREE as follows:
 
1.
Interpretation
 
1.1
Definitions
 
In this Agreement the following terms shall have the following meanings:
 
"Agreement", this agreement;
 
Associated Entity”, in respect of a Relevant Person, any company or other entity controlled by that Relevant Person or which controls that Relevant Person or which is under common control with that Relevant Person and any fund or partnership managed by any such company or entity;
 
BoI”, The Governor and Company of the Bank of Ireland, a corporation established in Ireland by Royal Charter in 1783 and having limited liability, with registered number C-1 and having its registered office at 40 Mespil Road, Dublin 4;
 

 
2

 

"BoI Ordinary Stock", units of ordinary stock of €0.05 (five cent) each in the issued capital stock of BoI;
 
Buyers’ RRA”, the meaning given to that term in Clause 9.1;
 
CCN Agreement”, the agreement to be entered into on the date hereof between (amongst others) the Minister and the Buyer, providing for certain matters relating to the Contingent Convertible Notes;
 
Commission Stock”, the meaning given to that term in Recital A;
 
"Completion", completion of the sale and purchase of the Sale Stock pursuant to this Agreement;
 
 “Conditional Stock Purchase Agreement”, the agreement to be entered into on the date hereof between (amongst others) the Parties, providing (subject to certain conditions) for the purchase by the Buyer and others from the Commission of Commission Stock other than the Sale Stock;
 
Contingent Convertible Notes”, the €1,000,000,000 10% Contingent Capital Tier 2 Notes due 2016 of BoI, which shall be issued by BoI to the Minister in accordance with a Note Purchase Agreement dated 8 July 2011 between (1) BoI and (2) the Minister;
 
"CREST", the relevant system (as defined in the CREST Regulations) in respect of which Euroclear UK & Ireland Limited is the operator (as defined in the CREST Regulations);
 
"CREST Regulations", the Companies Act 1990 (Uncertified Securities) Regulations 1996 (SI No.  68/1996), as amended in 2003;
 
Deed of Undertaking”, the deed of undertaking to be entered into on the date hereof between (amongst others) the Buyer and BoI, providing (subject to certain conditions) for certain matters in connection with the transactions contemplated by this Agreement and the Conditional Stock Purchase Agreement;
 
Direction” a direction issued by the Minister to the Commission pursuant to the National Pensions Reserve Fund Act 2000, as amended;
 
Directors”, the directors from time to time of BoI;
 
"Encumbrance", any type of interest or equity of any person including any right to acquire,  option, right of pre-emption or right of first refusal, restriction on transfer or use or conversion, or any mortgage, charge, assignment, hypothecation, pledge, lien or security interest, encumbrance, claim, third party rights or other agreement or arrangement of any nature whatsoever having a similar effect;
 
First Completion”, shall have the meaning ascribed to such expression in the Conditional Stock Purchase Agreement;
 
Irish Takeover Rules”, the Irish Takeover Panel Act 1997 Takeover Rules 2007, as amended from time to time;
 
Issuer Agreement”, the agreement to be entered into on the date hereof between (amongst others) the Buyer and BoI, providing for certain matters relating to the Contingent Convertible Notes;
 
Listing Rules”, the Listing Rules of The Irish Stock Exchange Limited, as amended from time to time;
 

 
3

 

NAMA Bonds”, senior unsecured floating rate notes issued by National Asset Management Limited (“NAML”) ranking pari passu with NAML’s other unsecured and unsubordinated indebtedness;
 
Other Transaction Documents”, the Conditional Stock Purchase Agreement, the Deed of Undertaking, the CCN Agreement, the Issuer Agreement, the Buyers’ RRA and the Top-Up Letters;
 
"Party", a party to this Agreement, and "Parties" shall be construed accordingly;
 
Pre-Conditions”, the meaning given to that term in Clause 2.1;
 
Relevant Date”, the meaning given to that term in Clause 2.1.2;
 
Relevant Person”, the meaning given to that term in Clause 5.2;
 
"Rights Issue", the offer by BoI to the holders of BoI Ordinary Stock (by way of 18-for-5 rights issue) of the Rights Issue Stock, pursuant to a prospectus issued by BoI on 18 June 2011 as supplemented by a supplementary prospectus issued by BoI on 8 July 2011;
 
"Rights Issue Stock", the 19,077,889,032 units of new BoI Ordinary Stock to be allotted and issued by BoI pursuant to the Rights Issue;
 
RRA”, the meaning given to that term in Clause 9.1;
 
Sale Stock”, the meaning given to that term in Recital B;
 
Top-Up Letters”, letters written on or about the date hereof by BoI to the Buyer (amongst others) and the Commission respectively offering them certain rights in respect of the subscription for new BoI Ordinary Stock;
 
Underwriting Agreement”, the Transaction and Underwriting Agreement dated 18 June 2011 between the Minister, the Commission, NTMA, BoI and the Sponsors and Joint Bookrunners (as defined therein); and
 
Whitewash Date”, 5.00 p.m. on the date on which a meeting of the independent shareholders of BoI is held to consider a “whitewash” resolution to approve the waiver of Rule 9 of the Irish Takeover Rules and such resolution is voted on.
 
1.2
The headings in this Agreement do not affect its interpretation.
 
1.3
In this Agreement:
 
 
1.3.1
words denoting the singular shall include the plural and vice versa;
 
 
1.3.2
words denoting one gender shall include all genders;
 
 
1.3.3
except where otherwise stated, references to Clauses are references to Clauses of this Agreement;
 
 
1.3.4
references to the Parties include their respective successors in title; and
 
 
1.3.5
a reference to this Agreement or another instrument or agreement includes any variation, novation or replacement thereof.
 
2.
Conditions Precedent
 
2.1
Notwithstanding any other provision of this Agreement (save for Clause 2.2), Completion shall not occur unless:
 

 
4

 

 
2.1.1
on or prior to 25 July 2011 the Other Transaction Documents shall have been executed by all the respective parties thereto; and
 
 
2.1.2
on or prior to 29 July 2011 (or such later date as may be necessitated by the issue of a supplementary prospectus in respect of the Rights Issue) (the “Relevant Date”), the Rights Issue shall have completed and all Rights Issue Stock shall have been issued by BoI in accordance with the terms of the Underwriting Agreement;
 
(together, the “Pre-Conditions”).
 
2.2
The Pre-Conditions may be waived in whole or in part at their discretion by all Parties without prejudice to such rights (if any) which each Party may have against the other Parties arising out of the non-satisfaction of such Pre-Conditions.  Any such waiver shall be binding on the Parties only if it is in writing and signed by all the Parties.
 
2.3
If the Pre-Conditions shall not have been satisfied (or waived by all Parties in accordance with Clause 2.2) on or prior to the Relevant Date, then this Agreement shall thereupon lapse (but without prejudice to any rights of the Parties pursuant to this Clause 2).  In such event:
 
 
2.3.1
the accrued rights and obligations of the Parties up to the time of the lapse of this Agreement shall not be affected by such lapse; and
 
 
2.3.2
the provisions of Clauses 1 (Interpretation), 13 (Entire Agreement), 14 (Counterparts), 16 (Notices) and 17 (Governing Law and Jurisdiction) shall continue to apply notwithstanding such lapse.
 
3.
Sale and Purchase
 
Subject to the satisfaction (or waiver by the Parties in accordance with Clause 2.2) of the Pre-Conditions on or prior to the Relevant Date, the Commission agrees to sell and the Buyer agrees to purchase the Sale Stock with effect from Completion free from all Encumbrances and with the benefit of all rights and advantages attaching to the Sale Stock or accruing at Completion for the consideration specified in Clause 4.
 
4.
Consideration
 
The consideration for the sale and purchase of the Sale Stock shall be €241,335,290, payable in cash by the Buyer on Completion in accordance with Clause 5.2.
 
5.
Completion and Settlement
 
5.1
Subject to the satisfaction (or waiver by the Parties in accordance with Clause 2.2) of the Pre-Conditions on or prior to the Relevant Date, Completion shall occur on the Relevant Date immediately following the allotment and issue by BoI of the Rights Issue Stock.
 
5.2
Upon Completion, the Commission shall cause the Sale Stock to be transferred to the Buyer and/or such other Buyers (as that term is defined in the Conditional Stock Purchase Agreement) as the Buyer shall designate and have previously been approved in writing by the Minister (the Buyer together with all such other Buyers being hereinafter collectively referred to as “Relevant Persons”, and each a “Relevant Person”) by credit through the facilities of CREST of the Sale Stock to an account or accounts nominated by the Buyer (or the other Relevant Persons, as the case may be), against payment by or on behalf of the Buyer of the consideration referred to in Clause 4 in same day funds (subject to deduction pursuant to Clause 15 (Buyer’s Fee)).
 
5.3
Upon the date of this Agreement, the Buyer shall deliver to the Minister and the Commission a confirmation from its chief legal officer confirming that:
 
 
5.3.1
the Buyer is a company duly incorporated and validly existing under the laws of Canada;
 

 
5

 

 
5.3.2
the Buyer has the legal right and full power and authority to execute and deliver, and to perform its obligations under this Agreement;
 
 
5.3.3
all necessary corporate actions, conditions and things have been taken, fulfilled and done in order to enable the Buyer to enter into, perform and comply with its obligations hereunder, and the person who has executed this Agreement on behalf of the Buyer has the necessary authority to do so on behalf of the Buyer and to bind the Buyer accordingly; and
 
 
5.3.4
this Agreement constitutes valid and binding obligations of the Buyer enforceable in accordance with its terms.
 
Any Relevant Person which receives a transfer of some or all of the Sale Stock pursuant to Clause 5.2 shall, prior to and as a condition to receiving such a transfer, deliver to the Minister a confirmation mutatis mutandis to this Clause 5.3.
 
5.4
Upon the date of this Agreement, the Commission shall deliver to the Buyer a confirmation from the Head of Legal of the National Treasury Management Agency (which is the manager of the National Pensions Reserve Fund pursuant to the National Pensions Reserve Fund Act 2000 (as amended) (the “Act”)) confirming that:
 
 
5.4.1
the Commission is a body corporate established pursuant to the Act and validly existing under the laws of Ireland;
 
 
5.4.2
the Commission has the legal right and full power and authority to execute and deliver, and to perform its obligations under this Agreement;
 
 
5.4.3
all necessary actions, conditions and things have been taken, fulfilled and done in order to enable the Commission to enter into, perform and comply with its obligations hereunder, and the persons who have executed this Agreement on behalf of the Commission have the necessary authority to do so on behalf of the Commission and to bind the Commission accordingly; and
 
 
5.4.4
this Agreement constitutes valid and binding obligations of the Commission enforceable in accordance with its terms.
 
6.
Public Interest Matters
 
6.1
The Buyer undertakes and covenants that for a period commencing on First Completion and ending on 1 March 2016, it shall neither initiate nor support a refusal by BoI to agree a rollover of the NAMA Bonds or a demand for payment thereof, or make any attempt to induce BoI to make such a refusal or demand, in respect of either the NAMA Bonds now held by BoI or NAMA Bonds of similar or lesser aggregate nominal value issued annually in succession thereto.
 
6.2
The Buyer acknowledges that the Minister is relying on the undertaking and covenant set out in Clause 6.1 in entering into this Agreement.
 
7.
Warranties
 
7.1
The Commission hereby warrants to the Buyer that:
 
 
7.1.1
at Completion, the Commission will have full legal right, power and authority to transfer or procure the transfer of, in accordance with the terms and conditions of this Agreement, the Sale Stock, all of which will be fully paid up or credited as fully paid up and free of any Encumbrance (including for the avoidance of doubt any Encumbrance affecting any of the voting rights, dividend rights or other rights attaching to any Sale Stock) (other than this Agreement), and will be absolutely entitled to all rights thereon and in respect thereof and attaching thereto, and there
 

 
6

 

will be no agreement, arrangement or obligation to create any Encumbrance affecting any of the Sale Stock; and
 
 
7.1.2
so far as the Commission is aware, none of the Sale Stock is subject to any current or pending claim or litigation as to its title or ownership.
 
7.2
The Commission acknowledges that the Buyer is entering into this Agreement in reliance upon each of the warranties contained in Clause 7.1.
 
7.3
The aggregate liability of the Commission in respect of all or any claims under the warranties in this Clause 7 shall be subject to an overall maximum equal to the consideration payable pursuant to Clause 4 less any deductions or set-offs made pursuant to this Agreement.
 
7.4
Nothing herein shall or shall be deemed to relieve the Buyer of any common law duty to mitigate any loss or damage incurred by it.
 
8.
Lock-Up
 
8.1
The Buyer hereby undertakes to the Minister and the Commission on its own behalf and on behalf of all Associated Entities to which it may transfer Sale Stock pursuant to Clause 8.2.6, that for a period commencing on Completion and ending on (a) such date as is the 90th day thereafter and (b) the Whitewash Date, whichever is the first to occur, neither it nor any such Associated Entities shall sell, transfer, grant any option over or otherwise dispose of its legal, beneficial or any other interest held by it in any of the Sale Stock or any other rights arising from any of the Sale Stock.  For the avoidance of doubt, this Clause 8.1 shall not prohibit the sale, transfer, grant of options over or other disposal by the Buyer or its Associated Entities of BoI Ordinary Stock other than Sale Stock.
 
8.2
The restrictions set out in Clause 8.1 shall not apply to:
 
 
8.2.1
any disposal pursuant to acceptance of (or giving an irrevocable undertaking to accept) any offer or agreement by the Buyer to vote in favour of or to participate in a scheme of arrangement to acquire the whole or any part of the issued capital stock of BoI (other than any stock already held by the offeror or persons acting in concert with the offeror) to which the provisions of the Irish Takeover Rules apply;
 
 
8.2.2
any compromise or arrangement providing for the acquisition by any person (or group of persons acting in concert) of 50 per cent or more of the issued capital stock of BoI;
 
 
8.2.3
any disposal or agreement to dispose of BoI Ordinary Stock pursuant to an offer by BoI to purchase its own issued capital stock which is made on identical terms to all holders of BoI Ordinary Stock and otherwise complies with applicable legal requirements and otherwise complies with the Listing Rules;
 
 
8.2.4
any disposal made pursuant to a Court order or otherwise required by law;
 
 
8.2.5
any disposal made in accordance with Clause 10 (Assignment); or
 
 
8.2.6
any disposal by a Relevant Person to any Associated Entity of that Relevant Person and/or any subsequent disposals by any such Associated Entity of that Relevant Person to another Associated Entity of that Relevant Person.
 
9.
Consent to Registration Rights
 
9.1
Subject to the provisions of Clause 9.2, the Minister and the Commission hereby agree that the entry into and, performance of the registration rights agreement to be entered into on or around the date of this Agreement between BoI and the Buyers (as defined in the Conditional Stock Purchase Agreement) (the “Buyers’ RRA”) shall not be deemed to
 

 
7

 

 
constitute a breach of the registration rights agreement entered into by BoI, the Minister and the Commission dated 18 June 2011 (the “RRA”).
 
9.2
Without limitation to Clause 9.1:
 
 
9.2.1
Article 2.13 of the RRA shall not apply to the Buyers’ RRA, provided that in the event of any conflict between the registration rights granted pursuant to the RRA and any registration rights granted pursuant to the Buyers’ RRA, the respective registration rights shall rank pari passu;
 
 
9.2.2
Article 2.2(c) of the Buyers’ RRA shall apply in the event of a conflict between Articles 2.2(b), (c) or (d) of the RRA and Articles 2.2(b), (c) or (d) of the Buyers’ RRA, provided that the Minister and the Commission shall have equivalent rights (including equivalent information and consultation rights) to those afforded to the Buyers pursuant thereto; and
 
 
9.2.3
Article 2.3(b) of the Buyers’ RRA shall apply in the event of a conflict between Article 2.3(b) of the RRA and Article 2.3(b) of the Buyers’ RRA, provided that the Minister and the Commission shall have equivalent rights (including equivalent information and consultation rights) to those afforded to the Buyers pursuant thereto.
 
9.3
A copy of this Clause 9, certified by Arthur Cox (solicitors for the Minister and the Commission) as a true copy of the original, may be sent to BoI as conclusive evidence of the agreements set out in this Clause 9.
 
10.
Assignment
 
10.1
The Minister and the Commission may assign or transfer any of their respective rights and benefits under this Agreement to any entity wholly owned by the Irish State, but they may not transfer their obligations hereunder without the Buyer's prior written consent.
 
10.2
The Buyer may assign the benefit of this Agreement to any Relevant Person.
 
10.3
Any Relevant Person may assign the benefit of this Agreement to any person to whom any Sale Stock is transferred in accordance with the provisions of Clause 8.2.6.
 
11.
Further Assurance and Role of Minister
 
The Commission shall, upon receipt of a Direction from the Minister, execute all documents and do all acts and things as may reasonably be required after Completion by the Buyer or its successor(s) for assuring to or vesting in the Buyer (or its designees) the legal and beneficial ownership of the Sale Stock and generally to give effect to this Agreement.  The Minister agrees to give a Direction to the Commission as necessary to enable the Commission to comply with this Clause 11.
 
12.
Waiver
 
A waiver by any Party or Parties of any breach of any of the terms, provisions or covenants of this Agreement or the acquiescence of any Party or Parties in any act (whether of commission or omission) which, but for such acquiescence, would be a breach as aforesaid shall not constitute a general waiver of such term, provision or covenant or of any subsequent act contrary thereto.  Any liability to any Party under the provisions of this Agreement may be released, compounded or compromised by such Party in its absolute discretion as regards any Party or Parties under such liability without in any way prejudicing its rights against any other Party or Parties under the same or a like liability, whether joint and several or otherwise.
 

 
8

 

13.
Entire Agreement
 
This Agreement (together with the Conditional Stock Purchase Agreement and the CCN Agreement to the extent that a Party hereto is also a party thereto) contains the entire agreement between the Parties relating to the transactions provided for in this Agreement and supersedes all previous representations, arrangements, undertakings and agreements (if any) between the Parties in respect of such matters.  Each of the Parties acknowledges that in agreeing to enter into this Agreement it has not relied on any representation, warranty, undertaking, covenant, pre-contractual statement or understanding other than those contained in this Agreement and/or the Conditional Stock Purchase Agreement and/or the CCN Agreement.
 
14.
Counterparts
 
This Agreement may be executed in any number of counterparts and by the Parties on separate counterparts, each of which shall be an original and all of which, together, shall constitute one and the same instrument.  The expression "counterpart" shall include any executed copy of this Agreement transmitted by facsimile or transmitted electronically in Portable Document Format (PDF).
 
15.
Buyer’s Fee
 
In consideration of the Buyer dealing in the Sale Stock or effectively underwriting the issue of the Sale Stock (or as an agency service relating to them), the Commission shall pay to the Buyer the amount of €4,826,706 (the “Transaction Fee”).  The Parties consider that any service supplied to the Commission under this Agreement service falls within one of (A) paragraph 6(1)(a) (as a dealing in stocks or shares), (B) paragraph 6(1)(b) (as an underwriting of an issue of stocks or shares) or (C) paragraph 7 (as an agency service relating to an exempt supply) of the First Schedule to the Value Added Tax Consolidation Act 2010 and each of the Parties also agrees not to assert that any such service is other than an exempt service supply within the First Schedule to the Value Added Tax Consolidation Act 2010.  The Commission’s liability to pay the Transaction Fee shall arise immediately upon the execution of this Agreement or the satisfaction of the Pre-Conditions (whichever is later) and shall be discharged by way of set-off and deduction from the payment to be made by the Buyer at Completion pursuant to Clause 5.2.
 
16.
Notices
 
Any notice to be given to any Party under this Agreement shall be in writing and shall be sent to the address of such Party set out in this Agreement (or such other address as that Party may from time to time notify in writing to the other Parties in accordance with the provisions of this Clause 16).
 
17.
Governing Law and Jurisdiction
 
This Agreement shall be governed by and construed in accordance with Irish law and each of the Parties submit to the exclusive jurisdiction of the Irish Courts for all purposes in connection herewith.
 
18.
Process Agent
 
The Buyer agrees to appoint an agent for service of process in Ireland within fourteen (14) days of the Buyer receiving written notice of legal suit, action or proceedings and the request to appoint such agent for service from another Party.  If the Buyer does not appoint such an agent within fourteen (14) days of the notice requesting it to do so, such other Party may appoint a commercial agent for service for the Buyer on the Buyer's behalf and at the Buyer's expense and the Buyer agrees that subject to being notified of such appointment in writing, service upon such commercial agent will constitute service upon the Buyer.
 

 
9

 

IN WITNESS whereof the Parties have entered into this Agreement and delivered it as a deed on the date specified above.
 

 
10

 

(EXECUTION PAGE OF STOCK PURCHASE AGREEMENT)






SIGNED for and on behalf
of the MINISTER FOR FINANCE
by   John A. Moran                    

  /s/ John A. Moran
 
A person authorised by Section 15(4) of the Ministers and Secretaries Act 1924







 
 

 

(EXECUTION PAGE OF STOCK PURCHASE AGREEMENT)






The Seal of the
NATIONAL PENSIONS RESERVE
FUND COMMISSION
as authenticated by the Chairman
and a Commissioner
  /s/ Paul Carty
 
Chairman
   
   
   
  /s/ John C. Corrigan
 
Commissioner
 
 



 
 

 

(EXECUTION PAGE OF STOCK PURCHASE AGREEMENT)




 
 
 
SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ James Newman
 
Print name
Witness (Signature)
   
     
James Newman
   
Print name
   
     
Fitzwilton House, Wilton Place, Dublin 2
   
Print address
   

 
EX-99 4 ex3.htm EXHIBIT 3 ex3.htm
Exhibit 3

THIS SUPPLEMENTAL AGREEMENT is made on 29 July 2011

BETWEEN:

 
THE MINISTER FOR FINANCE OF IRELAND
 
of Upper Merrion Street, Dublin 2
 
(hereinafter called the "Minister")
   
 
THE NATIONAL PENSIONS RESERVE FUND
 
COMMISSION
 
acting in its capacity as controller and manager of
 
the assets of the National Pensions Reserve Fund
 
of Treasury Building, Grand Canal Street, Dublin 2
 
(hereinafter called the "Commission")
   
   
 
                      - and -
   
 
FAIRFAX FINANCIAL HOLDINGS LIMITED
 
having its registered office at
 
95 Wellington Street West, Suite 800,
 
Toronto, Ontario, Canada M5J 2N7
 
(hereinafter called the "Buyer")



IT IS HEREBY AGREED AS FOLLOWS:

1.           This Agreement is supplemental to a Stock Purchase Agreement made between the parties hereto on 25 July 2011 (the “SPA”). Words and expressions defined in the SPA shall have the same meanings herein unless it is otherwise expressly provided herein.
 
2.           The SPA is hereby amended as follows:
 
 
2.1
The Sale Stock as agreed to be purchased and sold and as defined in the SPA shall mean 2,381,532,330 units of BoI Ordinary Stock. Recital B of the SPA is amended accordingly.
 
 
2.2
The definition of “Agreement” shall be deemed amended to include reference to this Supplemental Agreement. Clause 1.1 of the SPA is amended accordingly.
 
 
2.3
The consideration for the sale and purchase of the Sale Stock shall be €238,153,233. Clause 4 of the SPA is amended accordingly.
 
 
2.4
The Transaction Fee shall be €4,763,065. Clause 15 of the SPA is amended accordingly.
 
 
2.5
Clause 13 of the SPA shall be deemed amended to refer to this Supplemental Agreement as forming part of the entire agreement between the Parties relating to the transactions provided for in the SPA.
 

 
 

 

3.
In all other respects, the SPA is hereby confirmed.
 
4.
Clauses 12, 14, 16, 17 and 18 of the SPA shall be deemed incorporated herein.
 
IN WITNESS whereof the Parties have entered into this Agreement and delivered it as a deed on the date specified above.
 

 

 

 
2

 

(EXECUTION PAGE OF STOCK PURCHASE AGREEMENT)






SIGNED for and on behalf
of the MINISTER FOR FINANCE
by   John A. Moran                    

 
/s/ John A. Moran
 
A person authorised by Section 15(4) of the Ministers and Secretaries Act 1924







 
 

 

(EXECUTION PAGE OF STOCK PURCHASE AGREEMENT)






The Seal of the
NATIONAL PENSIONS RESERVE
FUND COMMISSION
as authenticated by the Chairman
and a Commissioner
 
/s/ Paul Carty
 
Chairman
   
   
   
 
/s/
 
Commissioner



 
 

 
 
(EXECUTION PAGE OF STOCK PURCHASE AGREEMENT)




 
 
 
SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
    Paul Rivett
/s/ Beth O'Hanlon
 
Print name
Witness (Signature)
   
     
Beth O'Hanlon    
Print name
   
     
95 Wellington St. W., Toronto, Ontario M5J 2N7
   
Print address
   

 
 
5
EX-99 5 ex4-1.htm EXHIBIT 4.1 ex4-1.htm
Exhibit 4.1

DEED OF ADHERENCE

To:
Minister for Finance of Ireland (the “Minister”)
 
 Pensions Reserve Fund Commission (the “Commission”)
 
Fairfax Financial Holdings Limited (“Fairfax”)

THIS DEED OF ADHERENCE is made on 29 July 2011 by WLR RECOVERY FUND IV, L.P. (the Covenantor”).

WHEREAS this Deed is supplemental to a stock purchase agreement entered into on 25 July 2011 between the Minister, the Commission and Fairfax as amended by a supplemental agreement dated 29 July 2011 between the same parties (together, the “Stock Purchase Agreement”).
 
THIS DEED WITNESSES AS FOLLOWS:

1.
The Covenantor confirms that it has been supplied with a copy of the Stock Purchase Agreement and has been designated by Fairfax as a Relevant Person in respect of 308,916,700 units of Sale Stock pursuant to Clause 5.2 thereof. The Covenantor undertakes in favour of the Minister, the Commission and Fairfax that it will severally observe, perform and be bound by such of the terms of the Stock Purchase Agreement which are (a) capable of applying to the Covenantor and (b) apply to the Sale Stock in respect of which it has been designated a Relevant Person and (c) have not been performed as of the later of (i) the execution and delivery of this Deed and (ii) the time at which Covenantor’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the Stock Purchase (the “Effective Time”), to the intent and effect that the Covenantor shall be deemed with effect from the Effective Time to be a party to the Stock Purchase Agreement as if named therein as a party and on the basis that references therein to a “party” and the “parties” include a reference to the Covenantor.
   
2.
All of the obligations of the Covenantor under the Stock Purchase Agreement shall be its several obligations, and shall not be joint obligations with any other party thereto.
   
3.
The Covenantor’s notice details for the purposes of the Stock Purchase Agreement are as follows:
   
 
Address
Attention
     
 
c/o WL Ross & Co. LLC   
James B. Lockhart III
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
   
 
with a copy to Benjamin Gruder (BenGruder@invesco.com).
   
4.
This Deed shall be governed by and construed in accordance with the laws of Ireland.
   
5.
The courts of Ireland are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Deed and, for such purposes, each party hereto irrevocably submits to the exclusive jurisdiction of such courts. Any proceeding, suit or action arising out of or in connection with this Deed (the “Proceedings”) shall therefore be brought in the courts of Ireland.
   
IN WITNESS of which this document has been executed and delivered as a deed on the date which first appears above.

 
 

 

(EXECUTION PAGE OF DEED OF ADHERENCE)




SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
  /s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton    
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 6 ex4-2.htm EXHIBIT 4.2 ex4-2.htm
Exhibit 4.2

DEED OF ADHERENCE

To: 
Minister for Finance of Ireland (the “Minister”)
 
National Pensions Reserve Fund Commission (the “Commission”)
 
Fairfax Financial Holdings Limited (“Fairfax”)

THIS DEED OF ADHERENCE is made on 29 July 2011 by WLR RECOVERY FUND V, L.P. (the Covenantor”).

WHEREAS this Deed is supplemental to a stock purchase agreement entered into on 25 July 2011 between the Minister, the Commission and Fairfax as amended by a supplemental agreement dated 29 July 2011 between the same parties (together, the “Stock Purchase Agreement”).
 
THIS DEED WITNESSES AS FOLLOWS:

1. 
The Covenantor confirms that it has been supplied with a copy of the Stock Purchase Agreement and has been designated by Fairfax as a Relevant Person in respect of 71,318,091 units of Sale Stock pursuant to Clause 5.2 thereof. The Covenantor undertakes in favour of the Minister, the Commission and Fairfax that it will severally observe, perform and be bound by such of the terms of the Stock Purchase Agreement which are (a) capable of applying to the Covenantor and (b) apply to the Sale Stock in respect of which it has been designated a Relevant Person and (c) have not been performed as of the later of (i) the execution and delivery of this Deed and (ii) the time at which Covenantor’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the Stock Purchase (the “Effective Time”), to the intent and effect that the Covenantor shall be deemed with effect from the Effective Time to be a party to the Stock Purchase Agreement as if named therein as a party and on the basis that references therein to a “party” and the “parties” include a reference to the Covenantor.
   
2.
All of the obligations of the Covenantor under the Stock Purchase Agreement shall be its several obligations, and shall not be joint obligations with any other party thereto.
   
3. 
The Covenantor’s notice details for the purposes of the Stock Purchase Agreement are as follows:
   
 
Address
Attention
     
 
c/o WL Ross & Co. LLC     
James B. Lockhart III
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
   
 
with a copy to Benjamin Gruder (BenGruder@invesco.com).
   
4.
This Deed shall be governed by and construed in accordance with the laws of Ireland.
   
5.
The courts of Ireland are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Deed and, for such purposes, each party hereto irrevocably submits to the exclusive jurisdiction of such courts. Any proceeding, suit or action arising out of or in connection with this Deed (the “Proceedings”) shall therefore be brought in the courts of Ireland.
 
IN WITNESS of which this document has been executed and delivered as a deed on the date which first appears above.

 
 

 

(EXECUTION PAGE OF DEED OF ADHERENCE)



 

SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   
EX-99 7 ex4-3.htm EXHIBIT 4.3 ex4-3.htm
Exhibit 4.3

DEED OF ADHERENCE

To: 
Minister for Finance of Ireland (the “Minister”)
 
National Pensions Reserve Fund Commission (the “Commission”)
 
Fairfax Financial Holdings Limited (“Fairfax”)

THIS DEED OF ADHERENCE is made on 29 July 2011 by WLR/GS MASTER CO-INVESTMENT L.P. the Covenantor”).

WHEREAS this Deed is supplemental to a stock purchase agreement entered into on 25 July 2011 between the Minister, the Commission and Fairfax as amended by a supplemental agreement dated 29 July 2011 between the same parties (together, the “Stock Purchase Agreement”).
 
THIS DEED WITNESSES AS FOLLOWS:

1. 
The Covenantor confirms that it has been supplied with a copy of the Stock Purchase Agreement and has been designated by Fairfax as a Relevant Person in respect of 27,479,039 units of Sale Stock pursuant to Clause 5.2 thereof. The Covenantor undertakes in favour of the Minister, the Commission and Fairfax that it will severally observe, perform and be bound by such of the terms of the Stock Purchase Agreement which are (a) capable of applying to the Covenantor and (b) apply to the Sale Stock in respect of which it has been designated a Relevant Person and (c) have not been performed as of the later of (i) the execution and delivery of this Deed and (ii) the time at which Covenantor’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the Stock Purchase (the “Effective Time”), to the intent and effect that the Covenantor shall be deemed with effect from the Effective Time to be a party to the Stock Purchase Agreement as if named therein as a party and on the basis that references therein to a “party” and the “parties” include a reference to the Covenantor.
   
2.
All of the obligations of the Covenantor under the Stock Purchase Agreement shall be its several obligations, and shall not be joint obligations with any other party thereto.
   
3.
The Covenantor’s notice details for the purposes of the Stock Purchase Agreement are as follows:
   
 
Address
Attention
     
 
c/o WL Ross & Co. LLC
James B. Lockhart III
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
   
 
with a copy to Benjamin Gruder (BenGruder@invesco.com).
   
4.
This Deed shall be governed by and construed in accordance with the laws of Ireland.
   
5.
The courts of Ireland are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Deed and, for such purposes, each party hereto irrevocably submits to the exclusive jurisdiction of such courts. Any proceeding, suit or action arising out of or in connection with this Deed (the “Proceedings”) shall therefore be brought in the courts of Ireland.
   
IN WITNESS of which this document has been executed and delivered as a deed on the date which first appears above.

 
 

 

(EXECUTION PAGE OF DEED OF ADHERENCE)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS MASTER CO-INVESTMENT, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 8 ex4-4.htm EXHIBIT 4.4 ex4-4.htm
Exhibit 4.4

DEED OF ADHERENCE

To: 
Minister for Finance of Ireland (the “Minister”)
 
National Pensions Reserve Fund Commission (the “Commission”)
 
Fairfax Financial Holdings Limited (“Fairfax”)

THIS DEED OF ADHERENCE is made on 29 July 2011 by WLR IV PARALLEL ESC, L.P. (the Covenantor”).

WHEREAS this Deed is supplemental to a stock purchase agreement entered into on 25 July 2011 between the Minister, the Commission and Fairfax as amended by a supplemental agreement dated 29 July 2011 between the same parties (together, the “Stock Purchase Agreement”).
 
THIS DEED WITNESSES AS FOLLOWS:

1. 
The Covenantor confirms that it has been supplied with a copy of the Stock Purchase Agreement and has been designated by Fairfax as a Relevant Person in respect of 1,143,851 units of Sale Stock pursuant to Clause 5.2 thereof. The Covenantor undertakes in favour of the Minister, the Commission and Fairfax that it will severally observe, perform and be bound by such of the terms of the Stock Purchase Agreement which are (a) capable of applying to the Covenantor and (b) apply to the Sale Stock in respect of which it has been designated a Relevant Person and (c) have not been performed as of the later of (i) the execution and delivery of this Deed and (ii) the time at which Covenantor’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the Stock Purchase (the “Effective Time”), to the intent and effect that the Covenantor shall be deemed with effect from the Effective Time to be a party to the Stock Purchase Agreement as if named therein as a party and on the basis that references therein to a “party” and the “parties” include a reference to the Covenantor.
   
2.
All of the obligations of the Covenantor under the Stock Purchase Agreement shall be its several obligations, and shall not be joint obligations with any other party thereto.
   
3.
The Covenantor’s notice details for the purposes of the Stock Purchase Agreement are as follows:
   
 
Address
Attention
     
 
c/o WL Ross & Co. LLC    
James B. Lockhart III
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
   
 
with a copy to Benjamin Gruder (BenGruder@invesco.com).
   
4.
This Deed shall be governed by and construed in accordance with the laws of Ireland.
   
5.
The courts of Ireland are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Deed and, for such purposes, each party hereto irrevocably submits to the exclusive jurisdiction of such courts. Any proceeding, suit or action arising out of or in connection with this Deed (the “Proceedings”) shall therefore be brought in the courts of Ireland.
   
IN WITNESS of which this document has been executed and delivered as a deed on the date which first appears above.

 
 

 

(EXECUTION PAGE OF DEED OF ADHERENCE)





SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 9 ex4-5.htm EXHIBIT 4.5 ex4-5.htm
Exhibit 4.5



FAIRFAX FINANCIAL HOLDINGS LIMITED


WLR RECOVERY FUND IV, L.P.




 









DEED OF ASSIGNMENT
(STOCK PURCHASE AGREEMENT)






 









William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OOC

 
 

 

THIS DEED is made on 29 July 2011

BETWEEN:

 
FAIRFAX FINANCIAL HOLDINGS LIMITED
 
of 95 Wellington Street West,
 
Suite 800, Toronto, Ontario,
 
Canada, M5J 2N7
 
(hereinafter called "Fairfax")
   
   
 
               - and -
   
   
 
WLR RECOVERY FUND IV, L.P.
 
c/o WL Ross & Co. LLC
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
 
(hereinafter called the "Assignee")

RECITALS:
 
A.
Fairfax is party as the Buyer to a Stock Purchase Agreement made on 25 July 2011 between the Minister for Finance of Ireland, the National Pensions Reserve Fund Commission and Fairfax, as amended by a Supplemental Agreement dated 29 July 2011 between the same parties (together, the “SPA”).
 
B.
Fairfax has the power pursuant to Clause 5.2 of the SPA to designate certain other persons (one of whom is the Assignee) to purchase Sale Stock pursuant to the SPA and has designated the Assignee in respect of the Designated Sale Stock, which designation is subject to the approval in writing of the Minister in accordance with Clause 5.2 of the SPA. Fairfax has further agreed, with effect from the later of (i) the execution and delivery of a Deed of Adherence whereby the Assignee will become party to the SPA and (ii) the time at which the Assignee’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the SPA (the “Effective Time”), to assign to the Assignee the benefit of the SPA in respect of the Designated Sale Stock.
 
 
THIS DEED WITNESSES AS FOLLOW:
 
1.
Words and expressions defined in the SPA shall have the same meanings herein. The expression “Designated Sale Stock” shall mean the 308,916,700 units of Sale Stock in respect of which the Assignee has been designated pursuant to the SPA by Fairfax.
 
2.
With effect from the Effective Time, Fairfax hereby assigns and transfers to the Assignee absolutely (and not by way of security) the benefit of the SPA in respect of every unit of the Designated Sale Stock (including, without limitation, the benefit of the Warranties and the Transaction Fee under Clauses 7 and 15, respectively, of the SPA, in respect of the Designated Sale Stock) and the Assignee hereby undertakes, as several obligations, the obligations of Fairfax pursuant to the SPA in respect of the Designated Sale Stock which fall to be performed from the Effective Time.
 
3.
The provisions of Clauses 12, 14, 16 and 17 of the SPA shall have effect as if incorporated herein.
 
4.
Fairfax hereby agrees and undertakes to the Assignee, as soon as reasonably practicable after execution and delivery of this Deed, to provide written notice of the assignments contained herein to all parties to the SPA on the date of this Deed and to use all reasonable endeavours to obtain written acknowledgements of such notices from all such parties.
 

 
2

 

IN WITNESS WHEREOF the parties have executed and delivered this Deed as a deed on the date specified above.
 

 
3

 

(EXECUTION PAGE OF DEED OF ASSIGNMENT)

SIGNED AND DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
  /s/ Paul Rivett
   
Authorised Signatory (Signature)
     
    Paul Rivett
/s/ Beth O'Hanlon  
Print name
Witness (Signature)
   
     
Beth O'Hanlon    
Print name
   
     
95 Wellington St. W., Toronto, Ontario M5J 2N7    
Print address
   





 
 

 


(EXECUTION PAGE OF DEED OF ASSIGNMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 10 ex4-6.htm EXHIBIT 4.6 ex4-6.htm
Exhibit 4.6



FAIRFAX FINANCIAL HOLDINGS LIMITED


WLR RECOVERY FUND V, L.P.















DEED OF ASSIGNMENT
(STOCK PURCHASE AGREEMENT)
















William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OOC

 
 

 

THIS DEED is made on 29 July 2011

BETWEEN:

 
FAIRFAX FINANCIAL HOLDINGS LIMITED
 
of 95 Wellington Street West,
 
Suite 800, Toronto, Ontario,
 
Canada, M5J 2N7
 
(hereinafter called "Fairfax")
   
   
 
               - and -
   
   
 
WLR RECOVERY FUND V, L.P.
 
c/o WL Ross & Co. LLC
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
 
(hereinafter called the "Assignee")

RECITALS:
 
A.
Fairfax is party as the Buyer to a Stock Purchase Agreement made on 25 July 2011 between the Minister for Finance of Ireland, the National Pensions Reserve Fund Commission and Fairfax, as amended by a Supplemental Agreement dated 29 July 2011 between the same parties (together, the “SPA”).
 
B.
Fairfax has the power pursuant to Clause 5.2 of the SPA to designate certain other persons (one of whom is the Assignee) to purchase Sale Stock pursuant to the SPA and has designated the Assignee in respect of the Designated Sale Stock, which designation is subject to the approval in writing of the Minister in accordance with Clause 5.2 of the SPA. Fairfax has further agreed, with effect from the later of (i) the execution and delivery of a Deed of Adherence whereby the Assignee will become party to the SPA and (ii) the time at which the Assignee’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the SPA (the “Effective Time”), to assign to the Assignee the benefit of the SPA in respect of the Designated Sale Stock.
 
 
THIS DEED WITNESSES AS FOLLOW:
 
1.
Words and expressions defined in the SPA shall have the same meanings herein. The expression “Designated Sale Stock” shall mean the 71,318,091 units of Sale Stock in respect of which the Assignee has been designated pursuant to the SPA by Fairfax.
 
2.
With effect from the Effective Time, Fairfax hereby assigns and transfers to the Assignee absolutely (and not by way of security) the benefit of the SPA in respect of every unit of the Designated Sale Stock (including, without limitation, the benefit of the Warranties and the Transaction Fee under Clauses 7 and 15, respectively, of the SPA, in respect of the Designated Sale Stock) and the Assignee hereby undertakes, as several obligations, the obligations of Fairfax pursuant to the SPA in respect of the Designated Sale Stock which fall to be performed from the Effective Time.
 
3.
The provisions of Clauses 12, 14, 16 and 17 of the SPA shall have effect as if incorporated herein.
 
4.
Fairfax hereby agrees and undertakes to the Assignee, as soon as reasonably practicable after execution and delivery of this Deed, to provide written notice of the assignments contained herein to all parties to the SPA on the date of this Deed and to use all reasonable endeavours to obtain written acknowledgements of such notices from all such parties.
 

 
2

 

IN WITNESS WHEREOF the parties have executed and delivered this Deed as a deed on the date specified above.
 

 
3

 

(EXECUTION PAGE OF DEED OF ASSIGNMENT)

SIGNED AND DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
  /s/ Paul Rivett
   
Authorised Signatory (Signature)
     
/s/ Beth O'Hanlon   Paul Rivett
   
Print name
Witness (Signature)
   
     
/s/ Beth O'Hanlon    
Print name
   
     
95 Wellington St. W., Toronto, Ontario M5J 2N7    
Print address
   

 
 

 

(EXECUTION PAGE OF DEED OF ASSIGNMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 11 ex4-7.htm EXHIBIT 4.7 ex4-7.htm
Exhibit 4.7



FAIRFAX FINANCIAL HOLDINGS LIMITED


WLR/GS MASTER CO-INVESTMENT L.P.















DEED OF ASSIGNMENT
(STOCK PURCHASE AGREEMENT)

















William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OOC

 
 

 

THIS DEED is made on 29 July 2011

BETWEEN:

 
FAIRFAX FINANCIAL HOLDINGS LIMITED
 
of 95 Wellington Street West,
 
Suite 800, Toronto, Ontario,
 
Canada, M5J 2N7
 
(hereinafter called "Fairfax")
   
   
 
                - and -
   
   
 
WLR/GS MASTER CO-INVESTMENT L.P.
 
c/o WL Ross & Co. LLC
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
 
(hereinafter called the "Assignee")

RECITALS:
 
A.
Fairfax is party as the Buyer to a Stock Purchase Agreement made on 25 July 2011 between the Minister for Finance of Ireland, the National Pensions Reserve Fund Commission and Fairfax, as amended by a Supplemental Agreement dated 29 July 2011 between the same parties (together, the “SPA”).
 
B.
Fairfax has the power pursuant to Clause 5.2 of the SPA to designate certain other persons (one of whom is the Assignee) to purchase Sale Stock pursuant to the SPA and has designated the Assignee in respect of the Designated Sale Stock, which designation is subject to the approval in writing of the Minister in accordance with Clause 5.2 of the SPA. Fairfax has further agreed, with effect from the later of (i) the execution and delivery of a Deed of Adherence whereby the Assignee will become party to the SPA and (ii) the time at which the Assignee’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the SPA (the “Effective Time”), to assign to the Assignee the benefit of the SPA in respect of the Designated Sale Stock.
 
 
THIS DEED WITNESSES AS FOLLOW:
 
1.
Words and expressions defined in the SPA shall have the same meanings herein. The expression “Designated Sale Stock” shall mean the 27,479,039 units of Sale Stock in respect of which the Assignee has been designated pursuant to the SPA by Fairfax.
 
2.
With effect from the Effective Time, Fairfax hereby assigns and transfers to the Assignee absolutely (and not by way of security) the benefit of the SPA in respect of every unit of the Designated Sale Stock (including, without limitation, the benefit of the Warranties and the Transaction Fee under Clauses 7 and 15, respectively, of the SPA, in respect of the Designated Sale Stock) and the Assignee hereby undertakes, as several obligations, the obligations of Fairfax pursuant to the SPA in respect of the Designated Sale Stock which fall to be performed from the Effective Time.
 
3.
The provisions of Clauses 12, 14, 16 and 17 of the SPA shall have effect as if incorporated herein.
 
4.
Fairfax hereby agrees and undertakes to the Assignee, as soon as reasonably practicable after execution and delivery of this Deed, to provide written notice of the assignments contained herein to all parties to the SPA on the date of this Deed and to use all reasonable endeavours to obtain written acknowledgements of such notices from all such parties.
 

 
2

 

IN WITNESS WHEREOF the parties have executed and delivered this Deed as a deed on the date specified above.
 

 
3

 

(EXECUTION PAGE OF DEED OF ASSIGNMENT)

SIGNED AND DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
  /s/ Paul Rivett
   
Authorised Signatory (Signature)
     
    Paul Rivett
/s/ Beth O'Hanlon  
Print name
Witness (Signature)
   
     
Beth O'Hanlon    
Print name
   
     
95 Wellington St. W., Toronto, Ontario M5J 2N7    
Print address
   



 
 

 


(EXECUTION PAGE OF DEED OF ASSIGNMENT)





SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS MASTER CO-INVESTMENT, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
  /s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton    
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 12 ex4-8.htm EXHIBIT 4.8 ex4-8.htm
Exhibit 4.8



FAIRFAX FINANCIAL HOLDINGS LIMITED


WLR IV PARALLEL ESC, L.P.














DEED OF ASSIGNMENT
(STOCK PURCHASE AGREEMENT)















William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OOC

 
 

 

THIS DEED is made on 29 July 2011

BETWEEN:

 
FAIRFAX FINANCIAL HOLDINGS LIMITED
 
of 95 Wellington Street West,
 
Suite 800, Toronto, Ontario,
 
Canada, M5J 2N7
 
(hereinafter called "Fairfax")
   
   
 
              - and -
   
   
 
WLR IV PARALLEL ESC, L.P.
 
c/o WL Ross & Co. LLC
 
1166 Avenue of the Americas
 
25th Floor
 
New York 10036
 
USA
 
(hereinafter called the "Assignee")

RECITALS:
 
A.
Fairfax is party as the Buyer to a Stock Purchase Agreement made on 25 July 2011 between the Minister for Finance of Ireland, the National Pensions Reserve Fund Commission and Fairfax, as amended by a Supplemental Agreement dated 29 July 2011 between the same parties (together, the “SPA”).
 
B.
Fairfax has the power pursuant to Clause 5.2 of the SPA to designate certain other persons (one of whom is the Assignee) to purchase Sale Stock pursuant to the SPA and has designated the Assignee in respect of the Designated Sale Stock, which designation is subject to the approval in writing of the Minister in accordance with Clause 5.2 of the SPA. Fairfax has further agreed, with effect from the later of (i) the execution and delivery of a Deed of Adherence whereby the Assignee will become party to the SPA and (ii) the time at which the Assignee’s designation aforesaid is effective by virtue of the Minister’s written approval thereof pursuant to Clause 5.2 of the SPA (the “Effective Time”), to assign to the Assignee the benefit of the SPA in respect of the Designated Sale Stock.
 
 
THIS DEED WITNESSES AS FOLLOW:
 
1.
Words and expressions defined in the SPA shall have the same meanings herein. The expression “Designated Sale Stock” shall mean the 1,143,851 units of Sale Stock in respect of which the Assignee has been designated pursuant to the SPA by Fairfax.
 
2.
With effect from the Effective Time, Fairfax hereby assigns and transfers to the Assignee absolutely (and not by way of security) the benefit of the SPA in respect of every unit of the Designated Sale Stock (including, without limitation, the benefit of the Warranties and the Transaction Fee under Clauses 7 and 15, respectively, of the SPA, in respect of the Designated Sale Stock) and the Assignee hereby undertakes, as several obligations, the obligations of Fairfax pursuant to the SPA in respect of the Designated Sale Stock which fall to be performed from the Effective Time.
 
3.
The provisions of Clauses 12, 14, 16 and 17 of the SPA shall have effect as if incorporated herein.
 
4.
Fairfax hereby agrees and undertakes to the Assignee, as soon as reasonably practicable after execution and delivery of this Deed, to provide written notice of the assignments contained herein to all parties to the SPA on the date of this Deed and to use all reasonable endeavours to obtain written acknowledgements of such notices from all such parties.
 

 
2

 

IN WITNESS WHEREOF the parties have executed and delivered this Deed as a deed on the date specified above.
 

 
3

 

(EXECUTION PAGE OF DEED OF ASSIGNMENT)

SIGNED AND DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
  /s/ Paul Rivett
   
Authorised Signatory (Signature)
     
    Paul Rivett
/s/ Beth O'Hanlon  
Print name
Witness (Signature)
   
     
Beth O'Hanlon    
Print name
   
     
95 Wellington St. W., Toronto, Ontario M5J 2N7    
Print address
   




 
 

 


(EXECUTION PAGE OF DEED OF ASSIGNMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
  /s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

EX-99 13 ex5.htm EXHIBIT 5 ex5.htm
Exhibit 5





THE MINISTER FOR FINANCE OF IRELAND


THE NATIONAL PENSIONS RESERVE FUND COMMISSION


THE NATIONAL TREASURY MANAGEMENT AGENCY


THE PERSONS WHOSE NAMES ARE SET OUT IN SCHEDULE 1











CONDITIONAL STOCK PURCHASE AGREEMENT

(Ordinary Stock in the capital stock of
The Governor and Company of the Bank of Ireland)













William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OOC/KC

 
 

 

THIS AGREEMENT is made on 25 July 2011

BETWEEN:

 
THE MINISTER FOR FINANCE OF IRELAND
of Upper Merrion Street, Dublin 2
(hereinafter called the "Minister")
   
 
THE NATIONAL PENSIONS RESERVE FUND
COMMISSION
acting in its capacity as controller and manager of
the assets of the National Pensions Reserve Fund
of Treasury Building, Grand Canal Street,
Dublin 2, Ireland
(hereinafter called the "Commission")
   
 
THE NATIONAL TREASURY MANAGEMENT
AGENCY
of Treasury Building, Grand Canal Street,
Dublin 2, Ireland
(hereinafter called the “NTMA”)
   
   
 
                      - and -
 
   
   
 
THE PERSONS WHOSE NAMES ARE SET OUT
IN SCHEDULE 1
(hereinafter called the "Buyers")


RECITALS:
 
A.
BoI is carrying out the Debt for Equity Offers, the Rights Issue, the Renominalisation and the Contingent Capital Notes Issue (as all described in the Offer Documents), in order to meet its current and expected long term capital requirements.
   
B.
Following the Rights Issue, the issued Ordinary Stock of BoI will comprise 24,377,302,652 (twenty four billion three hundred and seventy seven million three hundred and two thousand six hundred and fifty two) units of €0.05 each, all of which will be fully paid and the Commission will, subject to it obtaining sufficient BoI Ordinary Stock in its capacity as Underwriter to the Rights Issue, be the owner of sufficient BoI Ordinary Stock to comply with the terms of this Agreement.
   
C.
The Commission has agreed to sell, and Fairfax agreed to purchase, 2,413,352,900 (two billion four hundred and thirteen million three hundred and fifty two thousand nine hundred) units of BoI Ordinary Stock (comprising part of the Commission Stock, and hereinafter referred to as the “Purchased Sale Stock”) on the terms and subject to the conditions of the Stock Purchase Agreement.
   
D.
The Commission proposes to retain 15% of the issued Ordinary Stock of BoI and, subject to that, has, in addition to the Purchased Sale Stock, agreed to sell and the Buyers have agreed to purchase further BoI Ordinary Stock and the Minister, the Commission and the NTMA have agreed to assign to the Buyers the benefit of the Commission Warranties and the Indemnity in respect thereof.
   
E.
The Commission and each of the Buyers have accordingly entered into this Agreement in order to provide for the said sale and purchase of the Sale Stock and the assignment of the Commission Warranties and the Indemnity in respect thereof to the Buyers.


 
2

 


F.
The Minister is Party to this Agreement for the purpose appearing in Clause 11 and for the purpose of assigning the Commission Warranties and the Indemnity in respect of the Sale Stock to the Buyers.
   
G.
The NTMA is Party to this Agreement for the purposes expressly provided for in this Agreement.

THE PARTIES AGREE as follows:

1.
Interpretation
   
1.1
Definitions
   
 
Save as otherwise defined in this Agreement, terms and expressions defined in the Underwriting Agreement shall have the same meanings where such terms and/or expressions are used in this Agreement.  In this Agreement the following expressions shall, unless the context otherwise requires, have the following meanings:
   
 
"Agreement", this Agreement and the Schedule;
   
 
"Arrangements", all of the transactions and arrangements provided for, contemplated by or referred to in this Agreement;
   
 
Associated Entity”, in respect of a Relevant Person, any company or other entity controlled by that Relevant Person or which controls that Relevant Person or which is under common control with that Relevant Person and any fund or partnership managed by any such company or entity;
   
 
BoI”, The Governor and Company of the Bank of Ireland, a corporation established in Ireland by Royal Charter in 1783 and having limited liability, with registered number C-1 and having its registered office at 40 Mespil Road, Dublin 4;
   
 
BoI Capital”, the number of units of stock comprised in the entire issued equity share capital of BoI as at any date upon which the same is required to be determined;
   
 
"BoI Ordinary Stock", units of ordinary stock of €0.05 (five cent) each in the issued capital of BoI;
   
 
"Buyer Commitment", the several obligation of each Buyer hereunder to purchase up to the total number of units of Ordinary Stock set out opposite its name in Schedule 1 (which number shall include any units of Purchased Sale Stock acquired by such Buyer on or immediately following completion of the Stock Purchase Agreement);
   
 
Buyer Stock”, the First Sale Stock, the Second Sale Stock and the Third Sale Stock;
   
 
Buyer Transactions”, the purchase by each of the Buyers of the Buyer Stock under the terms of this Agreement, the purchase by Fairfax of the Purchased Sale Stock pursuant to the Stock Purchase Agreement and the acquisition by any Buyer from another Buyer of any Purchased Sale Stock;
   
 
CCN Agreement”, the agreement to be entered into on the date hereof between the Minister and the Buyers, providing for certain matters relating to the Contingent Capital Notes;
   
 
Commission Stock”, all of the BoI Ordinary Stock owned by the Commission immediately after the Rights Issue;
   
 
Completion”, completion of the purchase and sale of the First Sale Stock, the Second Sale Stock and the Third Sale Stock or of any of such purchases and sales and “First


 
3

 


 
Completion”, “Second Completion” and “Third Completion” shall be construed accordingly;
   
 
Completion Dates”, the First Completion Date, the Second Completion Date and the Third Completion Date or any of them;
   
 
Conditions”, the First Conditions, the Second Conditions and the Third Conditions;
   
 
Deed of Undertaking”, the deed of undertaking entered into on the date hereof between BoI and each of the Buyers, providing (subject to certain conditions) for certain matters in connection with the transactions contemplated by this Agreement and the Stock Purchase Agreement;
   
 
Direction”, a direction issued by the Minister to the Commission pursuant to Section 19(B), as appropriate, of the National Pensions Reserve Fund Act 2000, as amended;
   
 
Directors”, the directors from time to time of BoI;
   
 
"Encumbrance", any type of interest or equity of any person including any right to acquire,  option, right of pre-emption or right of first refusal, restriction on transfer or use or conversion, or any mortgage, charge, assignment, hypothecation, pledge, lien or security interest, encumbrance, claim, third party rights or other agreement or arrangement of any nature whatsoever having a similar effect;
   
 
"Fairfax", Fairfax Financial Holdings Limited, having its registered office at 95 Wellington Street, Suite 800, Toronto, Ontario, M5J 2N7, Canada, one of the Buyers;
   
 
First Completion Date”, the date upon which each of the Buyers shall purchase its Specified Proportion of the First Sale Stock, being 29 July 2011 or, if later, the second Business Day after satisfaction (or waiver) of the last to be satisfied (or waived) of the First Conditions;
   
 
"First Conditions", the conditions listed in Clause 2.1;
   
 
First Longstop Date”, 150 days after the date hereof, or in respect of any Buyer, such later date or dates as that Buyer may agree with the Commission;
   
 
First Sale Stock”, subject to Clause 3.4, such number of units of BoI Ordinary Stock held by the Commission which may on the First Completion Date represent up to 29.5% of the voting rights comprised in the BoI Capital, less the Purchased Sale Stock, purchased pursuant to Clause 3.1;
   
 
Government Parties”, the Minister, the Commission and the NTMA;
   
 
Indemnity”, the indemnity provided to the Government Parties pursuant to Clause 17.1(b) of the Underwriting Agreement in respect of the Commission Warranties;
   
 
Issuer Agreement”, the agreement to be entered into on the date hereof between the Buyers and BoI, providing for certain matters relating to the Contingent Capital Notes;
   
 
Listing Rules”, the Listing Rules of The Irish Stock Exchange Limited, as amended from time to time:
   
 
"Losses", any and all losses, damages, costs, liabilities, demands, charges, duties or expenses (including legal fees) and Taxation, in each case whether joint or several, which any person may suffer or incur (including, but not limited to all losses suffered or incurred in investigating, preparing for or disputing or defending or providing evidence) in connection with, or settling any Claim and/or in establishing its right to be indemnified pursuant to the Indemnity and/or in seeking advice regarding any Claim and "Loss" will be construed accordingly;


 
4

 


 
NAMA Bonds”, senior unsecured floating rate notes issued by National Asset Management Limited (“NAML”) ranking pari passu with NAML’s other unsecured and unsubordinated indebtedness;
   
 
New Registration Rights Agreement”, means the registration rights agreement, in the agreed form, between BoI and the Buyers to be entered into on the date of this Agreement;
   
 
Other Transaction Documents”, the Stock Purchase Agreement, the Deed of Undertaking, the CCN Agreement, the New Registration Rights Agreement, the Issuer Agreement and the Top-Up Letters;
   
 
"Party", a Party to this Agreement, and "Parties" shall be construed accordingly;
   
 
Purchased Sale Stock”, the meaning given to that term in Recital C;
   
 
Regulatory Approvals”, all consents, determinations, authorisations, permits, waivers, approvals and licences reasonably determined by any of the Buyers to be necessary for the acquisition by it of the Sale Stock, of all Government, EU, United States of America and other regulatory and self-regulatory bodies having jurisdiction over that Buyer or BoI, including without limitation, the Central Bank of Ireland, the Financial Services Authority of the United Kingdom, the Irish Takeover Panel, the Irish Competition Authority, the EU Commission, the Board of Governors of the Federal Reserve System, and any consent, determination, waiver or approval needed pursuant to any competition or anti-trust restrictions and for the avoidance of doubt, including such derogations, determinations, waivers and resolutions as each Buyer shall reasonably determine to be necessary to ensure that they shall not be required by virtue of any or all of the Buyer Transactions to make a mandatory bid for BoI pursuant to Rule 9 of the Takeover Rules;
   
 
Relevant Person”, the meaning given to that term in Clause 5.2 of the Stock Purchase Agreement;
   
 
"Rights Issue", the offer by BoI to the holders of BoI Ordinary Stock (by way of 18-for-5 rights issue) of the Rights Issue Stock, pursuant to a prospectus issued by BoI on 18 June 2011 as supplemented by a supplementary prospectus issued by BoI on 8 July 2011;
   
 
"Rights Issue Stock" the 19,077,889,032 units of new Ordinary Stock to be allotted and issued by BoI pursuant to the Rights Issue;
   
 
Sale Stock”, the First Sale Stock, the Second Sale Stock and the Third Sale Stock;
   
 
Second Completion Date”, the date upon which each of the Buyers shall purchase its Specified Proportion of the Second Sale Stock, being 17 August 2011 or, if later, the second Business Day after satisfaction (or waiver) of the last to be satisfied (or waived) of the Second Conditions;
   
 
Second Conditions”, the conditions referred to and set out in Clause 2.6;
   
 
Second Longstop Date”, 150 days after the date hereof, or in respect of any Buyer, such later date or dates as that Buyer may agree with the Commission;
   
 
Second Sale Stock”, subject to Clause 3.4, such number of units of BoI Ordinary Stock held by the Commission which may on the Second Completion Date represent up to 29.5 per cent of the voting rights comprised in the BoI Capital after the issue of the Debt for Equity Stock, less the aggregate of the Purchased Sale Stock and the First Sale Stock, purchased by each of the Buyers pursuant to Clause 3.2;
   
 
"Specified Proportion”, in respect of each Buyer, a proportion equal to the proportion which its Buyer Commitment bears to the aggregate of all of the Buyer Commitments as set out in Column 4 of Schedule 1;


 
5

 


 
"State Title Warranties”, the warranties contained in Clause 6.1, each a "State Title Warranty” and given by the Commission to the Buyers;
   
 
Stock Purchase Agreement”, the agreement entered into contemporaneously with this Agreement between the Minister, the Commission and Fairfax for the purchase and sale of the Purchased Sale Stock;
   
 
"Takeover Act and Rules", the Irish Takeover Panel Act 1997 (as amended) and all regulations made thereunder and the European Communities (Takeover Bids (Directive 2004/25/EC)) Regulations 2006 (SI No 255 of 2006), the Irish Takeover Panel Act 1997 Takeover Rules 2007 (as amended) and the “Takeover Rules” shall mean the said Rules and “Takeover Panel” or “Panel” shall have the meaning given to the term the “Panel” in the Takeover Rules; ;
   
 
Third Completion Date”, the date upon which each of the Buyers shall purchase its Specified Proportion of the Third Sale Stock held by the Commission, being 31 August 2011 or, if later, the second Business Day after the satisfaction (or waiver) of the last to be satisfied (or waived) of the Third Conditions;
   
 
Third Conditions”, the conditions referred to and set out in Clauses 2.9 and 2.11;
   
 
Third Longstop Date”, 150 days after the date hereof, or, in respect of any Buyer, such later date or dates as that Buyer may agree with the Commission;
   
 
Third Sale Stock”, subject to Clause 3.4, such number of units of BoI Ordinary Stock as shall be determined in accordance with the following formula:
   
 
T =
C – (P+F+S)
   
 
Where:
   
 
T =
the number of units of BoI Ordinary Stock as shall comprise the Third Sale Stock,
     
 
C =
the aggregate of all of the Buyer Commitments expressed in numbers of units of BoI Ordinary Stock;
     
 
P =
the Purchased Sale Stock;
     
 
F =
the First Sale Stock; and
     
 
S =  
the Second Sale Stock;
   
 
Top-Up Letters”, letters written on or about the date hereof by BoI to the Buyers and the Commission respectively offering them certain rights in respect of the subscription for new BoI Ordinary Stock
   
 
Transaction Fee”, the meaning ascribed thereto in Clause 15;
   
 
Whitewash Date”, 5pm on the date on which a meeting of the independent shareholders of BoI is held to consider a “whitewash” resolution to approve the waiver of Rule 9 of the Irish Takeover Rules and such resolution is voted on; and
   
 
Underwriting Agreement”, the Transaction and Underwriting Agreement dated 18 June 2011 between the Minister, the Commission, the NTMA, BoI and the Sponsors and Joint Bookrunners (as defined therein).


 
6

 


1.2  
In this Agreement, unless the context otherwise requires:
   
 
1.2.1
a reference to:
     
   
(a)
any Party includes its successors in title and permitted assigns;
       
   
(b)
a "person" includes any individual, firm, body corporate, association or partnership, government or state or agency of a state, local authority or government body or any joint venture association or partnership (whether or not having a separate legal personality) and that person's personal representatives, successors or permitted assigns;
       
   
(c)  
a "company" will be construed so as to include any company, corporation or body corporate, wherever and however incorporated or established;
       
   
(d)
a recital, clause, paragraph, or schedule, unless otherwise specified, is a reference to a recital, clause, paragraph of or schedule to this Agreement;
       
   
(e)
writing or similar expressions includes, unless otherwise specified, transmission by facsimile but excludes e-mail;
       
   
(f)
the singular includes the plural and vice versa and references to one gender includes all genders;
       
   
(g)
"day" or a "Business Day" will mean a period of 24 (twenty-four) hours running from midnight to midnight;
       
   
(h)
a "month" will mean a calendar month;
       
   
(i)
time is to time in Ireland;
       
   
(j)
a "subsidiary undertaking" or "parent undertaking" is to be construed in accordance with the European Communities (Companies: Group Accounts) Regulations 1992 of Ireland and a "subsidiary" or "holding company" is to be construed in accordance with Section 155 of the Companies Act 1963 of Ireland; and
       
   
(k)
any other document referred to in this Agreement is a reference to that document as amended, varied, novated or supplemented at any time;
     
 
1.2.2
a reference to a statute or statutory provision will be construed as a reference to the laws of Ireland unless otherwise specified and includes:
     
   
(a)
any subordinate legislation made under it including all regulations, by-laws, orders and codes made thereunder;
       
   
(b)
any repealed statute or statutory provision which it re-enacts (with or without modification); and
       
   
(c)
any statute or statutory provision which modifies, consolidates, re- enacts or supersedes it, and
     
   
in each case, prior to the date of this Agreement;
     
 
1.2.3  
any phrase introduced by the terms "including", "include" and "in particular" or any similar expression will be construed as illustrative and will not limit the sense of the words preceding those terms; and


 
7

 


 
1.2.4
expressions defined or used in the CREST Regulations shall have the same meanings in this Agreement (except where the context otherwise requires).
   
1.3
The table of contents and headings in this Agreement are inserted for convenience only, and they are to be ignored in the interpretation of this Agreement.
   
1.4
For the avoidance of doubt any reference in this Agreement to the agreement or consent of, or any notice or waiver by, the Minister, the Commission or the NTMA will be construed as the agreement or consent of, or any notice or waiver by (as the case may be), each of them, except where expressly provided to the contrary.
   
1.5
Notwithstanding any other provisions of this Agreement, all obligations of each of the Buyers are several and not joint.
   
2.
Conditions Precedent
   
2.1
Notwithstanding any other provision of this Agreement, Completion by each Buyer on a several basis of the purchase and sale of the First Sale Stock shall not occur until and unless the following conditions set forth in this Clause 2.1 (the “First Conditions”) shall have been satisfied (and/or waived by that Buyer in accordance with Clause 2.3) on or prior to the First Completion Date:
   
 
2.1.1
the Other Transaction Documents shall have been executed by all of the parties thereto;
     
 
2.1.2
the Rights Issue shall have completed and all of the Rights Issue Stock shall have been allotted fully paid pursuant thereto and to the Underwriting Agreement;
     
 
2.1.3
each of the State Title Warranties shall continue to be true and accurate in all respects and not misleading;
     
 
2.1.4
all Regulatory Approvals shall have been obtained in terms to the reasonable satisfaction of each of the Buyers, all waiting and objection periods applicable thereto shall have expired and each of them shall be in full force and effect;
     
 
2.1.5
the Stock Purchase Agreement shall have been completed in accordance with its terms; and
     
 
2.1.6  
the Panel shall have confirmed that in its view none of the Buyers is acting in concert with any other Buyer or Buyers.
   
2.2  
The Commission and each of the Buyers will use all reasonable endeavours to procure the fulfilment of the First Conditions on 29 July 2011 (or such later date as may be necessitated by the issue of a supplementary prospectus in respect of the Rights Issue), and, in any event, by not later than 5.30 pm on the First Longstop Date; provided that each Buyer and its Associated Entities may in its absolute discretion decline to provide some or all documentation requested.
   
2.3
Each of the Buyers may agree for itself, to the extent permitted by law and upon such terms as it considers fit, to waive fulfilment of all or any of the conditions set out in Clause 2.1 or to extend the time provided for fulfilment of any of the conditions set out in Clause 2.1 in respect of all or any part of the performance thereof (provided that no such extension of time shall be capable of continuing beyond the First Longstop Date without the consent of the Commission).
   
2.4
If any condition or conditions set out in Clause 2.1 is not fulfilled in relation to any Buyer or Buyers or, if capable of waiver, not waived in accordance with Clause 2.3 in each case by the First Longstop Date or if it becomes clear prior to the First Longstop Date that any of the conditions(s) are incapable of fulfilment and will not be waived, then this Agreement will automatically cease and terminate with immediate effect in respect of such Buyer(s) (the


 
8

 


 
“Terminated Buyer”) and no Party to this Agreement will have any claim against any other Party to this Agreement for costs, damages, compensation or otherwise in respect of the Terminated Buyer except as provided in Clause 2.5.1.
   
2.5
Where this Agreement has terminated pursuant to Clause 2.4:
   
 
2.5.1
such termination will be without prejudice to any accrued rights or obligations under this Agreement;
     
 
2.5.2
the provisions of this Clause 2.5 and Clauses 1, 13, 14, 16, 17 and 18 will remain in full force and effect.
   
2.6
Completion of the purchase and sale of the Second Sale Stock shall not occur until and unless:
   
 
2.6.1
the Debt for Equity Stock shall have been allotted credited as fully paid;
     
 
2.6.2
First Completion shall have occurred;
     
 
2.6.3
the First Conditions in Clauses 2.1.3 and 2.1.4 shall remain fulfilled as at the Second Completion Date; and
     
 
2.6.4  
the Panel shall have confirmed that in its view none of the Buyers is acting in concert with any other Buyer or Buyers.
   
 
The Commission and each of the Buyers will use all reasonable endeavours to procure the fulfilment of the Second Condition as soon as is reasonably practicable after the date hereof and, in any event, by not later than 5.30 pm on the Second Longstop Date.  In particular and without prejudice to the generality of the foregoing, it is acknowledged by each of the Parties that additional Regulatory Approvals may be required prior to Second Completion and/or that the Regulatory Approvals obtained for First Completion may have to be renewed, extended or amended, and accordingly, the purchase and sale of the Second Sale Stock shall be conditional upon the Regulatory Approvals referred to in Clause 2.1.4 being or remaining valid in respect of the Second Sale Stock and upon the additional Regulatory Approvals and/or such renewals, extensions or amendments aforesaid, having been obtained in terms to the reasonable satisfaction of any of the Buyers proceeding to Completion, all waiting and objection periods applicable thereto shall have expired and each of them shall be in full force and effect; provided that each Buyer and its Associated Entities may in its absolute discretion decline to provide some or all documentation requested for the purpose of Clause 2.1.4 and Clause 2.6.
   
2.7  
Each of the Buyers may agree, for itself, to the extent permitted by law and upon such terms as it considers fit, to waive fulfilment of all or any of the conditions set out in Clause 2.6 or to extend the time provided for fulfilment of any of the conditions set out in Clause 2.6 in respect of all or any part of the performance thereof (provided that no such extension of time shall be capable of continuing beyond the Second Longstop Date without the consent of the Commission).
   
2.8
If any condition or conditions set out in Clause 2.6 is not fulfilled in relation to any Buyer or Buyers or, if capable of waiver, not waived in accordance with Clause 2.7 by the Second Longstop Date or if it becomes clear prior to the Second Longstop Date that any of the condition(s) are incapable of fulfilment or will not be waived, the obligations of any such Buyer(s) and the Government Parties in respect of the purchase and sale of the Second Sale Stock shall lapse (without prejudice to any accrued rights of the Parties in respect thereof), but this Agreement shall continue in force in all other respects.
   
2.9
Completion of the purchase and sale of the Third Sale Stock shall not occur until and unless:
   
 
2.9.1
First Completion and Second Completion shall have occurred;


 
9

 


 
2.9.2
the First Conditions in Clauses 2.1.3 and 2.1.4 shall remain fulfilled as at the Third Completion Date;
     
 
2.9.3
the requirements of Clause 2.12 shall have been met; and
     
 
2.9.4
the Panel shall have confirmed that in its view none of the Buyers is acting in concert with any other Buyer or Buyers.
   
 
The Commission and each of the Buyers will use all reasonable endeavours to procure fulfilment of the Third Conditions as soon as is reasonably practicable after the date hereof and, in any event, by not later than 5.30 pm on the Third Longstop Date. In particular and without prejudice to the generality of the foregoing, it is acknowledged by the Parties that additional Regulatory Approvals may be required prior to Third Completion and/or that the Regulatory Approvals obtained for First Completion and/or Second Completion may have to be renewed, extended or amended, and accordingly, the purchase and sale of the Third Sale Stock shall be conditional upon the Regulatory Approvals referred to in Clause 2.1.4 and Clause 2.6 being or remaining valid in respect of the Third Sale Stock and upon the additional Regulatory Approvals and or such renewals, extensions or amendments aforesaid provided that each Buyer and its Associated Entities may in its absolute discretion decline to provide some or all documentation requested for the purpose of Clause 2.1.4, Clause 2.6 and Clause 2.9.
   
2.10
Each of the Buyers may agree, for itself, to the extent permitted by law and upon such terms as it considers fit, to waive fulfilment of all or any of the conditions set out in Clause 2.9 or to extend the time provided for fulfilment of any of the conditions set out in Clause 2.9 in respect of all or any part of the performance thereof (provided that no such extension of time shall be capable of continuing beyond the Third Longstop Date unless without the consent of the Commission).
   
2.11
If any condition or conditions set out in Clause 2.9 is not fulfilled in relation to any Buyer or Buyers or, if capable of waiver, not waived in accordance with Clause 2.10 by the Third Longstop Date or if it becomes clear prior to the Third Longstop Date that any of the condition(s) are incapable of fulfilment or will not be waived, the obligations of any such Buyer(s) and the Government Parties in respect of the purchase and sale of the Third Sale Stock shall lapse (without prejudice to any accrued rights of the Parties in respect thereof), but this Agreement shall continue in force in all other respects.
   
2.12  
The provisions of this Agreement concerning the purchase and sale of the Third Sale Stock shall not be effective nor shall Third Completion occur in respect of any Buyer unless each of the Buyers who is proceeding to Third Completion is satisfied (acting reasonably) (and so declare by notice in writing to the Commission):
   
 
2.12.1  
that the Irish Takeover Panel has granted to them all such waivers, derogations, consents, clarifications and confirmations that they deem necessary or desirable pursuant to the Takeover Act and Rules, including pursuant to Rules 5 and 9;
     
 
2.12.2
that all conditions thereto (including, if required, the approval of a “whitewash” resolution of the independent shareholders of BoI) have been fulfilled;
     
 
2.12.3
that such consents, waivers, derogations, clarifications and confirmations are in full force and effect and that none of the Buyers will consequently be obliged to extend a mandatory offer to the shareholders of BoI pursuant to the said Rule 9; and
     
 
2.12.4
that they are not deemed by the Takeover Panel to be acting in concert with the Government Parties for the purposes of the Takeover Rules.
   
 
Copies of all waivers, derogations, consents, clarifications and confirmations received hereunder will be provided to the Government Parties.


 
10

 


2.13
Each of the Buyers hereby confirms to the other Buyers that it has concluded that the Buyer Transactions do not require to be notified under the EU Merger Regulation.
   
2.14
For the purposes of Clause 2.1.4, 2.2, 2.6 and 2.9, if one or more, but not all, of the Buyers declines to provide documentation to the detriment of the process for the fulfilment of the Conditions, the remaining Buyers will nevertheless continue to use all reasonable endeavours to procure fulfilment of the Conditions so as to permit Completion pursuant to Clause 5.3.
   
3.
Sales and Purchases
   
3.1
Subject to:
   
 
3.1.1
the satisfaction in respect of each of the Buyers proceeding to Completion (and/or waiver by each such Buyer in accordance with Clause 2.3) of the First Conditions; and
     
 
3.1.2
the provisions of Clause 3.4;
   
 
the Commission agrees to sell or procure the sale of the First Sale Stock and each such Buyer agrees on a several basis to purchase such number of units of Ordinary Stock as is equal to its Specified Proportion of the First Sale Stock with effect from the First Completion Date free from all Encumbrances and with the benefit of all rights and advantages attaching to the First Sale Stock or accruing at the First Completion for the consideration specified in Clause 4.1.
   
3.2  
Subject to:
   
 
3.2.1
the satisfaction in respect of each of the Buyers proceeding to Completion (and/or waiver by each such Buyer in accordance with Clause 2.7) of the Second Conditions; and
     
 
3.2.2  
the provisions of Clause 3.4;
   
 
the Commission agrees to sell or procure the sale of the Second Sale Stock and each such Buyer agrees on a several basis to purchase such number of units of Ordinary Stock as is equal to its Specified Proportion of the Second Sale Stock with effect from the Second Completion Date free from all Encumbrances and with the benefit of all rights and advantages attaching to the Second Sale Stock or accruing at the Second Completion Date for the Consideration specified in Clause 4.1.
   
3.3
Subject to:
   
 
3.3.1
the satisfaction in respect of each of the Buyers proceeding to Completion (and/or waiver by each such Buyer pursuant to Clause 2.10) of the Third Conditions; and
     
 
3.3.2
the provisions of Clause 3.4;
   
 
the Commission agrees to sell or procure the sale of the Third Sale Stock and each such Buyer agrees on a several basis to purchase such number of units of Ordinary Stock as is equal to its Specified Proportion of the Third Sale Stock with effect from the Third Completion Date free from all Encumbrances and with the benefit of all rights and advantages attaching to the Third Sale Stock or accruing at the Third Completion Date for the consideration calculated in accordance with Clause 4.1.
   
3.4
The Commission shall not be obliged to sell or to procure the sale of any units of Ordinary Stock pursuant to Clauses 3.1, 3.2 or 3.3 to the extent that such sale would reduce the Commission’s holding of BoI Ordinary Stock to less than 4,558,025,000 (four billion, five hundred and fifty-eight million and twenty-five thousand) units of BoI Ordinary Stock, (provided that there shall be deemed to be added back to the Commission’s holding of BoI


 
11

 


 
Ordinary Stock for the purpose of such calculation, all units of Ordinary Stock sold or transferred by it after the date hereof and prior to the relevant Completion Date, other than units of BoI Ordinary Stock previously sold by it hereunder or under the Stock Purchase Agreement).  To the extent that any such sale would cause a shortfall in the Commission’s holding of BoI Ordinary Stock to less than 4,558,025,000 units of BoI Ordinary Stock, the First Sale Stock, the Second Sale Stock and/or the Third Sale Stock (as applicable) shall be reduced to the number at which the aggregate holding of the Commission shall be maintained at 4,558,025,000 units of BoI Ordinary Shares notwithstanding that in the case of the First Sale Stock and/or the Second Sale Stock this provision may result in the aggregate holding of BoI Stock acquired by the Buyers after the First Completion Date and/or the Second Completion Date (as the case may be) representing less than 29.5% of the voting rights comprised in the BoI Capital upon such date.
   
3.5
No Buyer, together with its Associated Entities, shall be obliged to purchase:
   
 
3.5.1  
more Sale Stock than is comprised in its Buyer Commitment; or
     
 
3.5.2
Sale Stock such that its aggregate holding of BoI Ordinary Stock acquired hereunder, under the Stock Purchase Agreement and/or as Purchased Sale Stock acquired by that Buyer on or immediately following completion of the Stock Purchase Agreement, would exceed 9.9% of the entire issued share capital of BoI.
   
4.
Consideration
   
4.1
The consideration for every sale and purchase of the Sale Stock hereunder shall be €0.10 per unit of Sale Stock, payable in cash in accordance with Clause 5.4.
   
5.
Completion and Settlement
   
5.1
Subject to the satisfaction in respect of each of the Buyers (and/or waiver by each of the Buyers in accordance with Clause 2.3) of the First Conditions on or prior to the First Longstop Date, Completion of the purchase and sale of the First Sale Stock shall occur on the First Completion Date.
   
5.2
Subject to the satisfaction in respect of each of the Buyers (and/or waiver by each of the Buyers in accordance with Clause 2.7) of the Second Conditions on or prior to the Second Longstop Date, Completion of the purchase and sale of the Second Sale Stock shall occur on the Second Completion Date.
   
5.3
Subject to the satisfaction in respect of each of the Buyers (and/or waiver by each of the Buyers in accordance with Clause 2.10) of the Third Conditions on or prior to the Third Longstop Date, Completion of the purchase and sale of the Third Sale Stock shall occur on the Third Completion Date.  For the avoidance of doubt, if the Conditions have been satisfied or waived on any Completion Date by one or more, but not all, of the Buyers, the Buyers that have satisfied the Conditions or in respect of whom waivers have been given (“Compliant Buyers”) may proceed to Completion.  Each Compliant Buyer will in good faith enter into discussions with the Government Parties with a view to determining whether and on what terms Completion of the Buyer Transactions may be achieved, subject to such amendments as each of the Compliant Buyers and the Commission may agree.
   
5.4
Upon each Completion, each Buyer shall, simultaneously with the Sale Stock transfer pursuant to Clause 5.5, transfer through the facilities of CREST, to an account designated prior to the relevant Completion Date by the Commission, in cleared funds, the amount of the consideration due for the Sale Stock being purchased by it, less the appropriate proportion of the Transaction Fee due to such Buyer on such Completion pursuant to Clause 15.
   
5.5  
Upon each Completion Date, simultaneously with the funds transfers provided for in Clause 5.4,  the Commission shall cause such of the Sale Stock to be transferred to each of the Buyers as is equal to its Specified Proportion of the Sale Stock to be sold on that Completion Date by credit through the facilities of CREST of the Sale Stock to an account or


 
12

 


 
accounts nominated by each Buyer, against payment by or on behalf of such Buyer of the consideration referred to in Clause 4.1 in same day funds (subject to deduction pursuant to Clause 15);
   
5.6
Upon the date hereof, each Buyer shall deliver to the Commission a confirmation from its general counsel or chief legal officer or secretary, substantially confirming that:
   
 
5.6.1
it is a company duly incorporated and validly existing under the laws of its jurisdiction of incorporation;
     
 
5.6.2
it has the legal right and full power and authority to execute and deliver, and to perform its obligations under this Agreement;
     
 
5.6.3
all necessary corporate actions, conditions and things have been taken, fulfilled and done in order to enable such Buyer to enter into, perform and comply with its obligations hereunder, and the person who has executed this Agreement on behalf of such Buyer has the necessary authority to do so on behalf of that Buyer and to bind such Buyer accordingly; and
     
 
5.6.4
this Agreement constitutes valid and binding agreement of the relevant Buyer enforceable in accordance with its terms.
   
5.7
Upon the date of this Agreement, the Commission shall deliver to each of the Buyers a confirmation from the Head of Legal of the NTMA (which is the manager of the National Pensions Reserve Fund pursuant to the National Pensions Reserve Fund Act 2000 (as amended) (the “Act”)) confirming that:
   
 
5.7.1
the Commission is a body corporate established pursuant to the Act and validly existing under the laws of Ireland;
     
 
5.7.2
the Commission has the legal right and full power and authority to execute and deliver, and to perform its obligations under this Agreement;
     
 
5.7.3
all necessary actions, conditions and things have been taken, fulfilled and done in order to enable the Commission to enter into, perform and comply with its obligations hereunder, and the persons who have executed this Agreement on behalf of the Commission have the necessary authority to do so on behalf of the Commission and to bind the Commission accordingly; and
     
 
5.7.4
this Agreement constitutes valid and binding obligations of the Commission enforceable in accordance with its terms.
   
6.
Warranties
   
6.1  
The Commission hereby warrants to the each of the Buyers that upon each Completion Date:
   
 
6.1.1  
the Commission will at such Completion Date have full legal right, power and authority to transfer or procure the transfer of, in accordance with the terms and conditions of this Agreement, the Sale Stock being sold on that date, all of which will at such Completion Date be fully paid up or credited as fully paid up and free of any Encumbrance (including for the avoidance of doubt any Encumbrance affecting any of the voting rights, dividend rights or other rights attaching to any Sale Stock), and will at such Completion Date be absolutely entitled to all rights thereon and in respect thereof and attaching thereto, and (save as provided in this Agreement) there will at such Completion Date be no agreement, arrangement or obligation to create any Encumbrance affecting any of the Sale Stock and no claim will have been made by any person to be entitled to any such Encumbrance;


 
13

 


 
6.1.2
so far as the Commission is aware none of the Sale Stock will at such Completion Date be subject to any current or pending claim or litigation as to its title or ownership.
   
6.2
The Commission, the Minister and the NTMA hereby assign and transfer to each of the Buyers the benefit of the Commission Warranties in respect of every unit of the Sale Stock and acknowledge that they shall have no Claim pursuant to the Commission Warranties for any Losses suffered by any of them for any breach of the Commission Warranties in respect of any units of Sale Stock, to the intent that all Claims available and arising pursuant to every breach of the Commission Warranties in respect of every unit of the Sale Stock shall be the property and entitlement of the Buyer having purchased such unit and may be pursued, settled or waived by such Buyer at its absolute discretion and without competition from any of the Minister, the Commission or NTMA.
   
6.3
The Minister, the Commission and the NTMA hereby assign to each of the Buyers the benefit of the Indemnity in respect of every unit of the Sale Stock.
   
6.4
In the event that there is a legal impediment to the enforcement by any of the Buyers of any Claim pursuant to the Commission Warranties by virtue only of the fact that the Commission Warranties were assigned to each of the Buyers rather than being given directly to each of the Buyers by BoI, the Minister, the Commission (upon receipt of a Direction from the Minister) and the NTMA undertake to provide reasonable co-operation, information and assistance to each of the Buyers and to execute and deliver any necessary documents and consents in relation to such legal impediment, provided that:
   
 
6.4.1
any such assistance and co-operation shall not give rise to any obligation on the Minister, the Commission or the NTMA to make any payment;
     
 
6.4.2
any action taken by the Minister, the Commission and the NTMA at the request of the Buyers shall be at the cost of the Buyer making the request;
     
 
6.4.3
the Minister, the Commission and the NTMA will be under no obligation to do anything which would create a legal obligation for, give rise to a claim from any third party against or result in any liability for the Minister, the Commission or the NTMA;
     
 
6.4.4
the Minister, the Commission or the NTMA shall not be required to take any action which would be against public policy or detrimental to the financial stability of BoI or the stability of the financial system of the Irish State as a whole.
   
6.5
The Minister, the Commission and the NTMA accept no liability to the Buyers in respect of the Commission Warranties or the Indemnity.  For the avoidance of doubt nothing in this Agreement or any of the Other Transaction Documents shall affect in any way the rights and Claims of the Commission, the Minister and the NTMA under the Commission Warranties or the Indemnity as they relate to Ordinary Stock other than the Sale Stock.
   
6.6
The Commission acknowledges that each of the Buyers are entering into this Agreement in reliance upon each of the warranties contained in Clause 6.1 and on the assignment and undertakings provided for in Clause 6.2.
   
6.7  
Each of:
   
 
6.7.1  
the State Title Warranties will be construed separately and will not be limited by reference (express or implied) to the terms of any other representation, warranty or undertaking or any other term of this Agreement;
     
 
6.7.2
the warranties given and the warranties, undertakings, representations and Indemnity assigned under this Agreement will remain in full force and effect notwithstanding Completion and all other matters and arrangements referred to in or contemplated by this Agreement.


 
14

 


6.8
The aggregate liability of the Commission under the State Title Warranties in respect of all claims shall be subject to an overall maximum equal to the aggregate of the consideration for Sale Stock payable hereunder, less any deductions or set-offs made pursuant to this Agreement.
   
6.9
Nothing herein shall or shall be deemed to relieve any of the Buyers of any common law duty to mitigate any loss or damage incurred by it.
   
7.
Public Interest Undertaking
   
7.1
Each Buyer undertakes and covenants that for a period commencing on First Completion and ending on 1 March 2016, it shall neither initiate nor support a refusal by BoI to agree a rollover of the NAMA Bonds or a demand for payment thereof, or any attempt to induce BoI to make such a refusal or demand, in respect of either the NAMA Bonds now held by BoI or NAMA Bonds of similar or lesser aggregate nominal value issued annually in succession thereto.
   
7.2
Each Buyer acknowledges that the State Entities are relying on the undertaking and covenant set out in Clause 7.1 in entering into this Agreement.
   
8.
Lock Up
   
8.1
Subject to Clause 8.3, each of the Buyers hereby severally undertakes to the Minister and the Commission on its own behalf and on behalf of all Associated Entities to which it may transfer Sale Stock pursuant to Clause 8.2.6 that for a period commencing on the First Completion Date and ending on the 90th day thereafter or the Whitewash Date, whichever is the first to occur, neither such Buyer nor its Associated Entities as aforesaid will sell, transfer, grant any option over or otherwise dispose of its legal, beneficial or any other interest held by it in any of the Sale Stock acquired by it upon such Completion Date.  For the avoidance of doubt, this Clause shall not prohibit the sale, transfer, grant of option over or other disposal by any Buyer or its Associated Entities of BoI Ordinary Stock other than Sale Stock.
   
8.2 
The restrictions set out in Clause 8.1 shall not apply to:
   
 
8.2.1
any disposal pursuant to acceptance of (or giving an irrevocable undertaking to accept) any offer or agreement by the Buyer to vote in favour of or participate in a scheme of arrangement to acquire the whole or any part of the issued stock capital of BoI (other than any stock already held by the offeror or persons acting in concert with the offeror) to which the provisions of the Takeover Act and Rules apply; or
     
 
8.2.2  
any compromise or arrangement providing for the acquisition by any person (or group of persons acting in concert) of 50 per cent of more of the issued capital stock of BoI;
     
 
8.2.3
any disposal or agreement to dispose of BoI Ordinary Stock pursuant to an offer by BoI to purchase its own issued capital stock which is made on identical terms to all holders of BoI Ordinary Stock and otherwise complies with applicable legal requirements and otherwise complies with the Listing Rules;
     
 
8.2.4
any disposal made pursuant to a Court order or otherwise required by law;
     
 
8.2.5
any disposal made in accordance with Clause 9 (Assignment); or
     
 
8.2.6
any disposal by a Relevant Person to an Associated Entity of that Relevant Person and/or any subsequent disposals by any such Associated Entity of that Relevant Person to another Associated Entity of that Relevant Person.
   
8.3
The restrictions in Clause 8.1 shall expire on the Whitewash Date.


 
15

 


9.
Assignment
   
9.1
The Minister, the NTMA and the Commission may assign or transfer any of their respective rights or benefits under this Agreement to any entity wholly-owned by the Irish State, but they may not transfer their obligations hereunder without each of the Buyers’ prior written consent.
   
9.2
Any Relevant Person may assign the benefit of this Agreement to any person to whom any Sale Stock is transferred in accordance with the provisions of Clause 8.2.6.
   
10.
Covenant
   
 
The Commission covenants with each Buyer that the Commission shall take up in full all of its rights under the Rights Issue.
   
11.
Further Assurance and Role of Minister
   
 
The Commission shall, upon receipt of a Direction from the Minister, execute all documents and do all acts and things as may reasonably be required after Completion by any Buyer or its successor(s) for assuring to or vesting in such Buyer (or its designees) the legal and beneficial ownership of the Sale Stock acquired by it hereunder and generally to give effect to this Agreement.  The Minister agrees to give a Direction to the Commission as necessary to enable the Commission to comply with this Clause 11.
   
12.
Waiver
   
 
A waiver by any Party or Parties of any breach of any of the terms, provisions or covenants of this Agreement or the acquiescence of any Party or Parties in any act (whether of commission or omission) which, but for such acquiescence, would be a breach as aforesaid shall not constitute a general waiver of such term, provision or covenant or of any subsequent act contrary thereto.  Any liability to any Party under the provisions of this Agreement may be released, compounded or compromised by such Party in its absolute discretion as regards any Party or Parties under such liability without in any way prejudicing its rights against any other Party or Parties under the same or a like liability, whether joint and several or otherwise.
   
13.
References to the Buyers
   
13.1 
The prior consent of each Buyer will be required prior to the release or publication of any document or announcement to be executed, published or filed in connection with the Buyer Transactions that refers to that Buyer, or refers to any actions that are contemplated or have been or will be taken by that Buyer ("Relevant Documents").
   
13.2
Prior to seeking the consent of each Buyer pursuant to Clause 13.1, each of the Government Parties agrees and undertakes that it will, subject to applicable law and regulation:
   
 
13.2.1  
afford the Buyers such time as they may reasonably require to consider the Relevant Documents to give such consent; and
     
 
13.2.2
submit drafts and revised drafts of the Relevant Documents for review and comment by each Buyer, and having afforded each Buyer appropriate time pursuant to Clause 13.2.1 to consider such drafts, discuss such comments with the Buyers for the purposes of preparing revised drafts.
   
14.
Entire Agreement
   
 
This Agreement (together with the Stock Purchase Agreement and the CCN Agreement to the extent that the Parties hereto are party thereto) contains the entire agreement between the Parties relating to the transactions provided for in this Agreement and supersedes all previous representations, arrangements, undertakings and agreements (if any) between the


 
16

 


 
Parties in respect of such matters.  Each of the Parties acknowledges that in agreeing to enter into this Agreement it has not relied on any representation, warranty, undertaking, covenant, pre-contractual statement or understanding other than those contained in this Agreement and/or the Stock Purchase Agreement and/or the CCN Agreement.
   
15.
Transaction Fee
   
 
In consideration of the Buyers dealing in the Sale Stock or effectively underwriting the issue of the Sale Stock (or as an agency service relating to them), the Commission shall pay to the Buyers a transaction fee in the Specified Proportions an amount equal to 2% of the first €181,374,852 of the consideration payable by it hereunder and 4% of all remaining consideration payable by it hereunder for the Sale Stock purchased by it (the “Transaction Fee”).  The Parties consider that any service supplied to the Commission under this Agreement falls within one of (A) paragraph 6(1)(a) (as a dealing in stocks or shares), (B) paragraph 6(1)(b) (as an underwriting of an issue of stocks or shares), (C) as an agency service relating to an exempt service supply within paragraph 7 of the First Schedule to the Value Added Tax Consolidation Act 2010 and each of the Parties also agrees not to assert that any such service is other than an exempt service supply within the First Schedule to the Value Added Tax Consolidation Act 2010.
   
 
The Commission’s liability to pay the Transaction Fee shall arise immediately upon each Completion Date, whereupon a part of the Transaction Fee determined according to the aggregate amount of the consideration payable by the Buyers upon such Completion Date shall be due.  The relevant part of the Transaction Fee shall be payable in every case by deduction by the Buyer entitled thereto of the amount thereof from the consideration payable by it upon such Completion..
   
16.
General
   
16.1
Any liability to any Party under this Agreement may in whole or in part be released, compounded or compromised and time or indulgence may be given by any Party in its absolute discretion as regards any other person under such liability without in any way prejudicing or affecting the first Party's rights against such other person under the same or a similar liability, whether joint and several or otherwise.
   
16.2
The rights, powers and remedies provided in this Agreement are cumulative and not exclusive of and rights, powers and remedies provided by law.
   
16.3
Except to the extent already performed, all the provisions of this Agreement will, so far as they are capable of being performed or observed, continue in full force and effect notwithstanding the conclusion of any or all of the constituent parts of this Agreement.
   
16.4
This Agreement may be entered into in any number of counterparts and by any one or more of the parties to it on separate counterparts but will not be effective until each Party has executed at least one counterpart.  Each counterpart when executed and delivered will be an original, but all the counterparts will together constitute one and the same instrument.  Delivery of a counterpart of this Agreement by email attachment or telecopy shall be an effective mode of delivery.
   
16.5
No variation of this Agreement will be effective unless in writing (not including e-mail) and signed by or on behalf of each of the parties.
   
16.6 
If at any time any provision of this Agreement is or becomes illegal, invalid or unenforceable in any respect under the law of any jurisdiction, that will not affect or impair:
   
 
16.6.1  
the legality, validity or enforceability in that jurisdiction of any other provision of this Agreement; or
     
 
16.6.2
the legality, validity or enforceability under the law of any other jurisdiction of that or any other provision of this Agreement.


 
17

 


 
If any invalid, unenforceable or illegal provision of this Agreement would be valid, enforceable and legal if some part of it were deleted, the parties will negotiate in good faith to amend such provision such that, as amended, it is legal, valid and enforceable, and, to the greatest extent possible, achieves the parties original commercial intention.
   
17.
Notices
   
17.1
Subject to Clause 17.2, any notice or other communication under this Agreement will only be effective if it is in writing.
   
17.2
Communication by e-mail will not be effective under this Agreement.
   
17.3 
Any notice or other communication given or made under this Agreement will be addressed as provided in Clause 17.5 and, if so addressed, will, in the absence of earlier receipt, be deemed to have been duly given or made as follows:
   
 
17.3.1
if sent by personal delivery, on delivery at the address of the relevant Party;
     
 
17.3.2
if sent by pre-paid post, two (2) clear Business Days after the date of posting.
   
17.4
Any notice or other communication given or made, or deemed to have been given or made, outside Working Hours will be deemed not to have been given or made until the start of the next period of Working Hours.
   
17.5
The relevant notice details for the parties hereto are:
   
 
17.5.1
if to the Minister:
     
   
Address:
Upper Merrion Street
       
     
Dublin 2
       
   
Fax no.:
+353 1 678 9936
       
   
Attention:  
The Secretary General, Department of Finance
     
 
17.5.2
if to the Commission:
     
   
Address:
Treasury Building
       
     
Grand Canal Street
       
     
Dublin 2
       
   
Fax no.:
+353 1 676 6639
       
   
Attention:
Chief Executive, National Treasury Management Agency
       
   
With copy to:  
Head of Control, National Treasury Management Agency
       
     
Treasury Building
       
     
Grand Canal Street
       
     
Dublin 2
       
   
Fax no.:
+353 1 676 6639
     
 
17.5.3  
if to the NTMA:  


 
18

 


   
Address:
Treasury Building
       
     
Grand Canal Street
       
     
Dublin 2
       
   
Fax no.:
+353 1 676 6639
       
   
Attention:
Head of Banking, National Treasury Management Agency
     
 
17.5.4
if to any of the Buyers, to the address and fax number (if any) set out in respect of that Buyer in the second column of Schedule 1, with copy to the person(s) (if any) specified in the second column of Schedule 1.
   
17.6
A Party may notify the other parties of a change to its notice details.  That notification will only be effective on:
   
 
17.6.1
any effective date specified in the notification; or
     
 
17.6.2
if no effective date is specified or the effective date specified is less than five (5) clear Business Days after the date when notice is received, the date falling five (5) clear Business Days after the notification has been received.
   
18.
Governing Law and Submission to Jurisdiction
   
 
This Agreement shall be governed by and construed in accordance with Irish law and each of the Parties submits to the exclusive jurisdiction of the Irish Courts for all purposes in connection herewith.
   
19.
Process Agent
   
 
Each Buyer agrees to appoint an agent for service of process in Ireland within fourteen (14) days of the Buyer receiving written notice of legal suit, action or proceedings and the request to appoint such agent for service from another Party to this agreement. In the event that a Buyer does not appoint such an agent within fourteen (14) days of the notice requesting it to so, such other Party to this agreement may appoint a commercial agent for service for the relevant Buyer on the relevant Buyer's behalf and at relevant Buyer's expense and each Buyer agrees that subject to being notified of such appointment in writing, service upon such commercial agent will constitute service upon that Buyer.

IN WITNESS whereof the Parties have entered into this Agreement and delivered it as a deed on the date specified above.
 

 
19

 

SCHEDULE 1
 
Buyers and Buyer Commitments
 
Name
Address and Contact
 
Buyer Commitment
Specified Proportion
Fairfax Financial Holdings Limited
95 Wellington Street West
Suite 800
Toronto
Ontario
Canada M5J 2N7
For the attention of:
Paul Rivett
Vice President and Chief Legal Officer
 
With copy to:
William Fry
Fitzwilton House
Wilton Place
Dublin 2
For the attention of:
Owen O’Connell
 
3,000,000,000 units of Sale Stock at an aggregate Sale Price not exceeding €300,000,000
26.70987%
Fidelity Contrafund: Fidelity Advisor New Insights Fund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
360,189,300 units of Sale Stock at an aggregate Sale Price not exceeding €36,018,930
3.20687%
Fidelity Contrafund: Fidelity Contrafund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
1,502,949,000 units of Sale Stock at an aggregate Sale Price not exceeding €150,294,900
 
13.38119%
Variable Insurance Products Fund III: Balanced Portfolio
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
26,320,100 units of Sale Stock at an aggregate Sale Price not exceeding €2,632,010
 
0.2343%
Fidelity Advisor Series I: Fidelity Advisor Dividend Growth Fund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
19,207,600 units of Sale Stock at an aggregate Sale Price not exceeding €1,920,760
0.17101%
Fidelity Securities Fund: Fidelity Dividend Growth Fund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
202,472,200 units of Sale Stock at an aggregate Sale Price not exceeding €20,247,220
1.80267%


 
20

 


Name
Address and Contact
 
Buyer Commitment
Specified Proportion
Fidelity Capital Trust: Fidelity Value Fund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
155,671,500 units of Sale Stock at an aggregate Sale Price not exceeding €15,567,150
1.38599%
Fidelity Advisor Series I: Fidelity Advisor Value Fund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
1,409,100 units of Sale Stock at an aggregate Sale Price not exceeding €140,910
0.01255%
Fidelity Puritan Trust: Fidelity Low-Priced Stock Fund
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
713,584,900 units of Sale Stock at an aggregate Sale Price not exceeding €71,358,490
 
6.35325%
Kennedy-Wilson Investments, LLC
Kennedy-Wilson Investments LLC
c/o Matt Windisch
9701 Wilshire Boulevard, Suite 700
Beverly Hills
CA 90212
USA
 
With a copy to:
William McMorrow
(wmcmorrow@kennedywilson.com) or
Mary Ricks
(mricks@kennedywilson.com)
 
250,000,000 units of Sale Stock at an aggregate Sale Price not exceeding €25,000,000
2.22582%
WLR/GS Master Co-Investment L.P.
 
WLR Recovery Fund IV, L.P.
 
WLR Recovery Fund V, L.P.
 
WLR IV Parallel Esc, L.P
 
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
With a copy to:
Benjamin Gruder (BenGruder@invesco.com)
 
3,000,000,000 units of Sale Stock at an aggregate Sale Price not exceeding €300,000,000
26.70987%
Capital Research and Management Company
333 South Hope St
Los Angeles
CA 90071
SA
For the attention of:
Michael Downer
 
2,000,000,000 units of Sale Stock at an aggregate Sale Price not exceeding €200,000,000
17.80658%
       


 
21

 


Name
Address and Contact
 
Buyer Commitment
Specified Proportion
TOTAL
 
11,231,803,700 units of Sale Stock at an aggregate Sale Price not exceeding €1,123,180,370
100.00000%
       


 
22

 



(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)





SIGNED for and on behalf
of the MINISTER FOR FINANCE
   
by 
  John A. Moran
   
       
       
     
  /s/ John A. Moran
     
A person authorised by Section 15(4) of the Ministers and Secretaries Act 1924


 
 

 

 (EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)







The Seal of the
NATIONAL PENSIONS RESERVE
FUND COMMISSION
as authenticated by the Chairman
and a Commissioner
 
  /s/ Paul Carty
 
Chairman
   
   
   
 
  /s/ John C. Corrigan
 
Commissioner


 
 

 

 (EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)





The Seal of the
NATIONAL TREASURY MANAGEMENT
AGENCY
was affixed in the presence of:
 
  /s/ John C. Corrigan
 
Chief Executive


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)







SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ James Newman
 
Print name
Witness (Signature)
   
     
James Newman
   
Print name
   
     
Fitzwilton House, Wilton Place, Dublin 2
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY CONTRAFUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
VARIABLE INSURANCE PRODUCTS FUND III: BALANCED PORTFOLIO
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY SECURITIES FUND: FIDELITY DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CAPITAL TRUST: FIDELITY VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISER SERIES I: FIDELITY ADVISOR VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY PURITAN TRUST: FIDELITY LOW-PRICED STOCK FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
83 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
KENNEDY-WILSON INVESTMENTS, LLC
by its authorised signatory
in the presence of:
 
/s/ Matthew Windisch
   
Authorised Signatory (Signature)
     
   
Matthew Windisch
/s/ Mark Martin
 
Print name
Witness (Signature)
   
     
Mark Martin
   
Print name
   
     
9701 Wilshire Blvd., Beverly Hills, CA 90212
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)






SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS Master Co-Investment, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   


 
 

 

 (EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
CAPITAL RESEARCH AND MANAGEMENT COMPANY
by its authorised signatory
in the presence of:
 
/s/ Michael J. Downer
   
Authorised Signatory (Signature)
     
   
Michael J. Downer, SVP and Secretary
/s/ Walt R. Burkley
 
Print name
Witness (Signature)
   
     
Walt R. Burkley
   
Print name
   
     
c/o 333 S. Hope Street, Los Angeles, CA 90071
   
Print address
   

EX-99 14 ex6.htm EXHIBIT 6 ex6.htm
Exhibit 6

THIS SUPPLEMENTAL AGREEMENT is made on 29 July 2011

BETWEEN:

 
THE MINISTER FOR FINANCE OF IRELAND
of Upper Merrion Street, Dublin 2
(hereinafter called the "Minister")
   
 
THE NATIONAL PENSIONS RESERVE FUND
COMMISSION
acting in its capacity as controller and manager of
the assets of the National Pensions Reserve Fund
of Treasury Building, Grand Canal Street, Dublin 2
(hereinafter called the "Commission")
   
 
THE NATIONAL TREASURY MANAGEMENT
AGENCY
of Treasury Building, Grand Canal Street, Dublin 2
(hereinafter called the "NTMA")
   
   
   
 
                       - and -
   
 
THE PERSONS WHOSE NAMES ARE SET OUT IN SCHEDULE 1 TO THE CONDITIONAL STOCK PURCHASE AGREEMENT REFERRED TO HEREIN (hereinafter called the "Buyers")



IT IS HEREBY AGREED AS FOLLOWS:

1.
This Agreement is supplemental to a Conditional Stock Purchase Agreement made between the parties hereto on 25 July 2011 (the “CSPA”).  Words and expressions defined in the CSPA shall have the same meanings herein unless it is otherwise expressly provided herein. The expression “SPA” shall mean a Stock Purchase Agreement made on 25 July 2011 between the Minister, the Commission and Fairfax Financial Holdings Limited, as amended by a Supplemental Agreement made on 29 July 2011 between the same parties.
   
2.  
The CSPA is hereby amended as follows:
   
 
2.1  
The Purchased Sale Stock shall mean the BoI Ordinary Stock sold and purchased pursuant to the SPA and Recital C and Clause 1.1 of the CSPA are amended accordingly, such that Recital C shall be deemed to read as follows:
     
   
“C. The Commission has agreed to sell, and Fairfax agreed to purchase, certain units of BoI Ordinary Stock (comprising part of the Commission Stock and such BoI Ordinary Stock as is sold and purchased pursuant to the Stock Purchase Agreement is hereinafter referred to as the “Purchased Sale Stock”) on the terms and subject to the conditions of the Stock Purchase Agreement.”


 
 

 


 
2.2
The definition of “Agreement” shall be deemed amended to include this Supplemental Agreement. Clause 1.1 of the CSPA is amended accordingly.
     
 
2.3
There shall be inserted a new definition at the appropriate (alphabetically determined) location in Clause 1.1 of the CSPA , as follows:
     
   
““Aggregate Sale Stock”, in respect of any Completion, the total number of units of BoI Ordinary Stock comprised in that Completion, in all preceding Completions which have occurred hereunder and any Completion as defined in the Stock Purchase Agreement;”.
     
 
2.4  
Clauses 3.1, 3.2 and 3.3 of the CSPA shall be deemed amended to read as follows:
     
   
“3.1
Subject to:
       
   
3.1.1  
the satisfaction in respect of each of the Buyers proceeding to Completion (and/or waiver by each such Buyer in accordance with Clause 2.3) of the First Conditions; and
       
   
3.1.2
the provisions of Clause 3.4;
     
   
the Commission agrees to sell or procure the sale of the First Sale Stock and each such Buyer agrees on a several basis to purchase such number of units of BoI Ordinary Stock as will cause the aggregate number of units of BoI Ordinary Stock purchased by such Buyer pursuant to the Stock Purchase Agreement and upon First Completion to be equal to its Specified Proportion of the Aggregate Sale Stock, with effect from the First Completion Date free from all Encumbrances and with the benefit of all rights and advantages attaching to the First Sale Stock or accruing at the First Completion for the consideration specified in Clause 4.1.
     
   
3.2
Subject to:
       
   
3.2.1
the satisfaction in respect of each of the Buyers proceeding to Completion (and/or waiver by each such Buyer in accordance with Clause 2.7) of the Second Conditions; and
       
   
3.2.2
the provisions of Clause 3.4;
     
   
the Commission agrees to sell or procure the sale of the Second Sale Stock and each such Buyer agrees on a several basis to purchase such number of units of BoI Ordinary Stock as will cause the aggregate number of units of BoI Ordinary Stock purchased by such Buyer pursuant to the Stock Purchase Agreement and upon First Completion and Second Completion to be equal to its Specified


 
2

 


   
Proportion of the Aggregate Sale Stock, with effect from the Second Completion Date free from all Encumbrances and with the benefit of all rights and advantages attaching to the Second Sale Stock or accruing at the Second Completion Date for the Consideration specified in Clause 4.1.
     
   
3.3
Subject to:
       
   
3.3.1
the satisfaction in respect of each of the Buyers proceeding to Completion (and/or waiver by each such Buyer pursuant to Clause 2.10) of the Third Conditions; and
       
   
3.3.2  
the provisions of Clause 3.4;
     
   
the Commission agrees to sell or procure the sale of the Third Sale Stock and each such Buyer agrees on a several basis to purchase such number of units of BoI Ordinary Stock as will cause the aggregate number of units of BoI Ordinary Stock purchased by such Buyer pursuant to the Stock Purchase Agreement and upon First Completion, Second Completion and Third Completion to be equal to its Specified Proportion of the Aggregate Sale Stock, with effect from the Third Completion Date free from all Encumbrances and with the benefit of all rights and advantages attaching to the Third Sale Stock or accruing at the Third Completion Date for the consideration calculated in accordance with Clause 4.1.”.
     
 
2.5  
Clause 14 of the CSPA shall be deemed amended to refer to this Supplemental Agreement as forming part of the entire agreement between the Parties relating to the transactions provided for in the CSPA.
   
3.  
In all other respects, the CSPA is hereby confirmed.
   
4.
Clauses 12, 16, 17, 18 and 19 of the CSPA shall be deemed incorporated herein.

IN WITNESS whereof the Parties have entered into this Agreement and delivered it as a deed on the date specified above.
 

 
3

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)






SIGNED for and on behalf
of the MINISTER FOR FINANCE
   
by 
  John A. Moran
   
       
       
     
  /s/ John A. Moran
     
A person authorised by Section 15(4) of the Ministers and Secretaries Act 1924



 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)






The Seal of the
NATIONAL PENSIONS RESERVE
FUND COMMISSION
as authenticated by the Chairman
and a Commissioner
 
  /s/ Paul Carty
 
Chairman
   
   
   
 
  /s/
 
Commissioner


 
 

 



 
(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)





The Seal of the
NATIONAL TREASURY MANAGEMENT
AGENCY
was affixed in the presence of:
   
 
Director
   
   
   
 
  /s/ Eugene O'Gallagher
 
Director


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)







SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ Beth O'Hanlon
 
Print name
Witness (Signature)
   
     
Beth O'Hanlon
   
Print name
   
     
95 Wellington St. W., Toronto, Ontario M5J 2N7
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY CONTRAFUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
VARIABLE INSURANCE PRODUCTS FUND III: BALANCED PORTFOLIO
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY SECURITIES FUND: FIDELITY DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CAPITAL TRUST: FIDELITY VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISER SERIES I: FIDELITY ADVISOR VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY PURITAN TRUST: FIDELITY LOW-PRICED STOCK FUND
by its authorised signatory
in the presence of:
 
/s/ Gary Ryan
   
Authorised Signatory (Signature)
     
   
Gary Ryan, Assistant Treasurer
/s/ Daniel Chisholm
 
Print name
Witness (Signature)
   
     
Daniel Chisholm
   
Print name
   
     
82 Devonshire St., Boston, MA
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
KENNEDY-WILSON INVESTMENTS, LLC
by its authorised signatory
in the presence of:
 
/s/ Matthew Windisch
   
Authorised Signatory (Signature)
     
   
Matthew Windisch
/s/ Brigitte Boudress
 
Print name
Witness (Signature)
   
     
Brigitte Boudress
   
Print name
   
     
9701 Wilshire Blvd., Beverly Hills, CA
   
Print address
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   


 
 

 

(EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS Master Co-Investment, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   


 
 

 

 (EXECUTION PAGE OF CONDITIONAL STOCK PURCHASE AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
CAPITAL RESEARCH AND MANAGEMENT COMPANY
by its authorised signatory
in the presence of:
 
/s/ Mark G. Denning
   
Authorised Signatory (Signature)
     
   
Mark G. Denning
/s/ James Browning
 
Print name
Witness (Signature)
   
     
James Browning
   
Print name
   
     
c/o Capital International Limited
   
40 Grosvenor Place
   
London
   
SW1X 7GG
   
Print address
   

EX-99 15 ex7.htm EXHIBIT 7 ex7.htm
Exhibit 7





THE GOVERNOR AND COMPANY OF THE BANK OF IRELAND


THE BUYERS
















DEED OF UNDERTAKING
















William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.IOS

 
 

 

CONTENTS

 
1.
INTERPRETATION
 
3
         
 
2.
COMMENCEMENT
 
7
         
 
3.
UNDERTAKINGS RE CONDITIONS
 
7
         
 
4.
CONDUCT DURING RELEVANT PERIOD
 
8
         
 
5.
BUYER PURCHASES
 
8
         
 
6.
BOI CONFIRMATIONS
 
9
         
 
7.
FEES
 
10
         
 
8.
REPRESENTATIONS, WARRANTIES AND UNDERTAKINGS
 
10
         
 
9.
THE BUYER TRANSACTIONS
 
10
         
 
10.
NOTIFICATION OF CERTAIN EVENTS
 
12
         
 
11.
PRE-EMPTION
 
12
         
 
12.
EXPIRY
 
13
         
 
13.
GENERAL
 
13
         
 
14.
ASSIGNMENT, NOVATION
 
14
         
 
15.
NOTICES
 
15
         
 
16.  
GOVERNING LAW AND SUBMISSION TO JURISDICTION
 
16
         
 
SCHEDULE 1
 
17


 
 

 


THIS DEED is made on                          July 2011

BETWEEN:
IT IS AGREED as follows:
 
 
THE GOVERNOR AND COMPANY OF THE
 
BANK OF IRELAND
 
a chartered corporation registered in Ireland
 
with registered no C-1
 
whose registered office is at
 
40 Mespil Road, Dublin 4, Ireland
 
(hereinafter called "BoI")
   
   
 
                       - and -
   
   
 
THE PERSONS WHOSE NAMES ARE SET OUT
 
IN SCHEDULE 1
 
(hereinafter called the “Buyers” and each a “Buyer”)
 
1.
Interpretation
 
1.1
Definitions
 
Terms and expressions defined in the Underwriting Agreement shall have the same meanings where such terms and/or expressions are used in this Deed, unless otherwise defined in this Deed.
 
In this Deed the following expressions shall, unless the context otherwise requires, have the following meanings:
 
2009 Preference Stock”, the 3,500,000,000 units of Perpetual Non-Cumulative Redeemable Preference Stock of €0.01 each issued on 31 March 2009 by BoI to the Commission for a subscription price of €1.00 per unit, 1,837,041,304 units of which remain in issue;
 
ACSM Hybrids”, the €600 million Guaranteed Step-up Callable Perpetual Preferred Securities issued by Bank of Ireland UK Holdings plc in March 2001 and the £350 million 6.25% Guaranteed Callable Perpetual Preferred Securities issued by Bank of Ireland UK Holdings plc in March 2003;
 
Associated Entity”, in respect of each Buyer, any company or other entity controlled by that Buyer or which controls or is under common control with that Buyer and any fund or partnership managed by any such company or entity;
 
BoI Group”, BoI and its subsidiaries and subsidiary undertakings from time to time;
 
BoI Ordinary Stock”, units of ordinary stock of €0.05 (five cent) each in the issued stock of BoI;
 
Business Plan”, the BoI Group Fortress 2 Investment Case, Updated 5 Year Plan, dated 18 May 2011;
 
Buyer Commitments”, the several obligations of each Buyer to purchase up to a specified number of units of BoI Ordinary Stock pursuant to the Stock Purchase Agreements;
 

 
 

 

Buyer Transactions”, the purchase by the Buyers of the Sale Stock under the Stock Purchase Agreements and other agreements, letters and arrangements contemplated and/or provided therein;
 
Buyers’ Group”, in respect of each Buyer means that Buyer, any company or entity controlled by that Buyer or which controls that Buyer or which is under common control with that Buyer and any fund or partnership managed by that Buyer or any such company or entity;
 
CCN Agreement”, the agreement to be entered into on the date hereof between (amongst others) the Minister and the Buyers, providing for certain matters relating to the Contingent Convertible Notes;
 
Commission”, the National Pensions Reserve Fund Commission;
 
Commission Indemnity”, the indemnity given to the Commission (as well others) pursuant to Clause 17.1(b) of the Underwriting Agreement;
 
Completion Dates”, the dates on which the Buyers complete acquisitions of BoI Ordinary Stock pursuant to the Stock Purchase Agreements and each a “Completion Date”;
 
Conditional Stock Purchase Agreement”, the agreement entered into on the date of this Deed between the Minister, the Commission, the NTMA and the Buyers pursuant to which the Buyers will purchase BoI Ordinary Stock from the Commission;
 
"Conditions", the conditions listed in Clause 2 of the Stock Purchase Agreement and in Clause 2 of the Conditional Stock Purchase Agreement;
 
Contingent Capital Instrument”, shall have the meaning given to that term in the Prospectus;
 
Contingent Convertible Notes”, the €1,000,000,000 10% Contingent Capital Tier 2 Notes due 2016 of BoI, which shall be issued by BoI to the Minister in accordance with a Note Purchase Agreement dated 8 July 2011 between BoI and the Minister;
 
Debt for Equity Offers”, shall have the meaning given to that term in the Prospectus;
 
"Deed", this Deed and the schedule(s);
 
Disclosure Letter”, the disclosure letter dated 18 June 2011 from BoI to the Minister, the Commission and the NTMA;
 
Equity Securities”, the ordinary stock of BoI and any other securities convertible into, exchangeable for or conferring a right to subscribe for, ordinary stock of BoI, other than such Contingent Convertible Notes as are issued pursuant to the Note Purchase Agreement dated 8 July 2011;
 
"Fairfax", Fairfax Financial Holdings Limited, having its registered office at 95 Wellington Street, Suite 800, Toronto, Ontario, M5J 2N7, Canada;
 
"First Completion Date", the first of the Completion Dates pursuant to the Conditional Stock Purchase Agreement;
 
Fully Diluted Ordinary Stock Capital”, the aggregate issued Equity Securities of BoI from time to time;
 
Initial Proportion”, in respect of each Buyer, the proportion of the Fully Diluted Ordinary Stock Capital held by it and its Associated Entities from time to time which is Sale Stock  (including for the avoidance of doubt, BoI Ordinary Stock acquired by way of rights issues,
 

 
 

 

bonus issues and issues in lieu of dividends declared upon the Sale Stock and subsequently upon BoI Ordinary Stock so acquired), expressed as a percentage;
 
Issuer Agreement”, the agreement to be entered into on the date hereof between the Buyers and BoI, providing for certain matters relating to the Contingent Capital Notes;
 
New Registration Rights Agreement”, means the registration rights agreement, in the agreed form, between BoI and the Buyers to be entered into on the date of this Deed;
 
PIBs”, BoI 13.375% unsecured perpetual subordinated Bonds (ISIN: GB 0000510312) issued by BoI (in substitution for Bristol and West plc);
 
Pre-emptive Basis”, in respect of each of the Buyers, an offer or issuance of Equity Securities in relation to which such Buyer has been afforded an opportunity to participate at the same offer or issue price per unit of the Equity Securities as generally offered pursuant to that offer or issuance on a pro-rata basis, meaning on a basis which would enable such Buyer to maintain that Buyer’s Initial Proportion of the Fully Diluted Ordinary Stock Capital immediately following such offer or issuance at the same level as that existing immediately prior to such offer or issuance;
 
Prospectus”, the prospectus issued by BoI dated 18 June 2011;
 
Relevant Period”, the date of this Deed up to and including the Third Completion Date pursuant to the Conditional Stock Purchase Agreement;
 
"Rights Issue", the offer of €1,757,788,903 (one billion, seven hundred and fifty-seven million, seven hundred and eighty eight thousand nine hundred and three euro) plus expenses (estimated to be €150,000,000 (one hundred and fifty million euro)), by way of rights to Qualifying Stockholders, where eligible to participate, to acquire Rights Issue Stock on the terms and subject to the conditions in the Prospectus and also, where relevant, the Provisional Allotment Letters;
 
"Rights Issue Stock", 19,077,889,032 (nineteen billion, seventy-seven million, eight hundred and eight-nine thousand and thirty two) units of new BoI Ordinary Stock to be allotted and issued by BoI pursuant to the Rights Issue;
 
Sale Stock”, all units of BoI Ordinary Stock sold pursuant to the Stock Purchase Agreements;
 
SPA Completion Date”, the date on which the purchase of BoI Ordinary Stock from the Commission pursuant to the Stock Purchase Agreement is completed;
 
Stock Purchase Agreement”, the agreement entered into on the date of this Deed between inter alia the Commission and Fairfax (one of the Buyers) pursuant to which certain of the Buyers will purchase 2,413,352,900 units of BoI Ordinary Stock from the Commission;
 
Stock Purchase Agreements”, the Stock Purchase Agreement and the Conditional Stock Purchase Agreement;
 
"Takeover Act and Rules", the Irish Takeover Panel Act 1997 (as amended) and the Irish Takeover Panel Act 1997, Takeover Rules 2007 (as amended);
 
Third Completion Date”, the third of the Closing Dates pursuant to the Conditional Stock Purchase Agreement;
 
Transaction Agreements”, the Stock Purchase Agreements, the CNN Agreement, the Issuer Agreement, the New Registration Rights Agreement, this Deed and all agreements and arrangements thereby contemplated or provided for;
 

 
 

 

Underwriting Agreement”, the agreement dated 18 June 2011 between the Minister, the Commission, the NTMA, BoI, the Sponsors and the Joint Bookrunners, pursuant to and subject to the terms of which the Minister has directed the Commission to underwrite the Rights Issue.
 
1.2
In this Deed, unless the context otherwise requires:
 
 
1.2.1
any reference to a document being "in the agreed form" or "agreed form" means in the form of the draft or proof thereof signed or initialled for the purpose of identification by, the solicitors for the parties thereto, or as otherwise evidenced as being in the agreed form by communications between the parties to this Deed or their legal advisers.  No such initialling shall imply approval for all or any part of its contents by or on behalf of the person initialling it or any of the parties to this Deed;
 
 
1.2.2
a reference to:
 
 
(a)
any party includes its successors in title and permitted assigns;
 
 
(b)
a "person" includes any individual, firm, body corporate, association or partnership, government or state or agency of a state, local authority or government body or any joint venture association or partnership (whether or not having a separate legal personality) and that person's personal representatives, successors or permitted assigns;
 
 
(c)
a "company" will be construed so as to include any company, corporation or body corporate, wherever and however incorporated or established;
 
 
(d)
a recital, Clause, paragraph, or Schedule, unless otherwise specified, is a reference to a recital, Clause, paragraph of or Schedule to this Deed;
 
 
(e)
writing or similar expressions includes, unless otherwise specified, transmission by facsimile but excludes e-mail;
 
 
(f)
the singular includes the plural and vice versa and references to one gender includes all genders;
 
 
(g)
"day" or a "Business Day" will mean a period of 24 (twenty-four) hours running from midnight to midnight;
 
 
(h)
a "month" will mean a calendar month;
 
 
(i)
times are to time in Ireland;
 
 
(j)
a reference to a "subsidiary undertaking" or "parent undertaking" is to be construed in accordance with the European Communities (Companies: Group Accounts) Regulations 1992 of Ireland and a "subsidiary" or "holding company" is to be construed in accordance with Section 155 of the Companies Act 1963 of Ireland; and
 
 
(k)
any other document referred to in this Deed is a reference to that document as amended, varied, novated or supplemented at any time.
 
 
1.2.3
a reference to a statute or statutory provision will be construed as a reference to the laws of Ireland unless otherwise specified and includes:
 
 
(a)
any subordinate legislation made under it including all regulations, by-laws, orders and codes made thereunder;
 
 
(b)
any repealed statute or statutory provision which it re-enacts (with or without modification); and
 

 
 

 

 
(c)
any statute or statutory provision which modifies, consolidates, re-enacts or supersedes it,
 
in each case, prior to the date of this Deed; and
 
 
1.2.4
any phrase introduced by the terms "including", "include" and "in particular" or any similar expression will be construed as illustrative and will not limit the sense of the words preceding those terms.
 
1.3
The table of contents and headings in this Deed are inserted for convenience only, and they are to be ignored in the interpretation of this Deed.
 
2.
Commencement
 
The respective Buyer Commitments of each of the Buyers under the Stock Purchase Agreements are conditional upon the fulfilment or waiver of the Conditions in accordance with the terms of the Stock Purchase Agreements.  BoI, having determined that it is in its best interests and the interests of its stockholders, has entered into this Deed in consideration of the Buyers entering into the Stock Purchase Agreement (as appropriate) and BoI’s obligations pursuant to or as contemplated by this Deed will commence on the date of this Agreement.
 
3.
Undertakings re Conditions
 
3.1
BoI hereby undertakes as a separate covenant with each of the Buyers to :
 
 
3.1.1
request and, to the extent reasonably within its power to do so, obtain such approvals, authorisations, permits, consents and waivers as may be required in relation to the Buyer Transactions from the BoI Stockholders and/or from any government, state or other regulatory body;
 
 
3.1.2
without prejudice to the provisions of Clause 3.1.1, assist in the application for and the obtaining of the grant of such waivers, consents, confirmations, clarifications and derogations under the Takeover Act and Rules as each of the Buyers deem necessary or desirable, including any derogation from and/or waiver of Rules 5 and  9 of the said Rules, to convene any requisite general meeting(s) of its shareholders or independent shareholders in relation thereto and generally to do all acts and things requisite therefor, and for any supporting independent shareholders’ whitewash approval;
 
 
3.1.3
to the extent reasonably within its power to do so, execute or cause to be executed all such documents and provide or cause to be provided all such information, and do or cause to be done all such things as may be required by or necessary to comply with the requirements of the Central Bank, the UK Listing Authority, the Irish Stock Exchange, the London Stock Exchange, the New York Stock Exchange, Euroclear and all other applicable legislation and regulation, in each case in connection with the applications referred to in Clause 3.1.1 and 3.1.2, the Buyer Transactions and the Transaction Agreements;
 
 
3.1.4
to carry out an analysis of the law and regulation in those jurisdictions where it conducts banking, insurance and/or other regulated operations to determine if there are or might be any restrictions (including the requirement to seek regulatory approvals or consents) or prohibitions on the acquisition or potential acquisition of the Sale Stock by the Buyers (the "Regulatory Analysis") and to inform the Buyers of the results of that analysis provided that such analysis is provided to the Buyers for information purposes only and on a non-recourse basis and compliance with any applicable law or regulation by the Buyers shall be solely the responsibility of the Buyers.  To the extent that the Regulatory Analysis identifies any jurisdiction where regulatory approvals or consents may be required in connection with the acquisition or potential acquisition of the Sale Stock by the Buyers, BoI undertakes
 

 
 

 

to take all such steps reasonably within its power in order to obtain or to assist the Buyers in obtaining such regulatory approvals or consents;
 
 
3.1.5
enter into the New Registration Rights Agreement with each of the Buyers;
 
 
3.1.6
enter into the Issuer Agreement; and
 
 
3.1.7
prepare and post a circular to BoI’s stockholders to convene the extraordinary general court of BoI (“EGC”) at which a resolution will be proposed for independent stockholders for the purposes of obtaining the Takeover Panel’s waiver of the application of Rule 9 of the Irish Takeover Rules to the purchase by the Buyers of the Third Sale Stock (pursuant to and as that term is defined in the Conditional Purchase Agreement),  such EGC to be convened for as soon as reasonably possible and in any event not later that seven weeks after the date of this Agreement.
 
3.2
Provided that each Buyer and its Associated Entities may in its absolute discretion decline to provide some or all documentation requested for the purpose of obtaining the approvals, authorisations, permits, consents and waivers referred to in Clause 3.1.1, each of the Buyers undertakes on a several basis with BoI to assist it in its application for, and obtaining of, the approvals, authorisations, permits, consents and waivers referred to in Clause 3.1.1.
 
4.
Conduct during Relevant Period
 
BoI shall procure that during the Relevant Period the business of BoI shall be carried out in its ordinary and usual course and in a reasonable and prudent manner, provided that the taking of any action or occurrence of any matter disclosed in the Prospectus or the Business Plan shall not be deemed to be a breach of or restricted by this Clause 4.
 
5.
Buyer Purchases
 
5.1
As soon as practicable after 11.00 am on the Acceptance Date and, in any event, by not later than 5.00 pm on the Acceptance Date, BoI will (or will procure that the Receiving Agent will) notify the Buyers in writing of the number of units of Rights Issue Stock which have not been taken up.  Whether or not any units of Rights Issue Stock have been taken up shall be determined in accordance with the provisions of Schedule 7 of the Underwriting Agreement.
 
5.2
BoI shall by not later than 7.00 p.m. on the first Dealing Day after the Acceptance Date inform the Buyers of the number of units of Residual Stock.
 
5.3
On each Completion Date, BoI shall register the transfers provided for in the Stock Purchase Agreements and enter each of the Buyers in its register of members as a stockholder of BoI in respect of the BoI Ordinary Stock transferred to such Buyer and (if required) issue an appropriate share certificate to each Buyer.
 
5.4
On each Completion Date, BoI shall certify to each Buyer:
 
 
5.4.1
the percentage which the Sale Stock being transferred represents:
 
 
(a)
of BoI’s Fully Diluted Ordinary Stock Capital;
 
 
(b)
of BoI Ordinary Stock then in issue; and
 
 
5.4.2
the BoI Ordinary Stock then held by the Government Parties.
 

 
 

 

6.
BoI Confirmations
 
6.1
Subject to Clause 6.2, BoI hereby confirms to each of the Buyers that:
 
 
6.1.1
execution or performance of the Buyer Transaction and the Transaction Agreements (each as disclosed to BoI) and/or the publication, execution or performance of any documents relating thereto (each as disclosed to BoI) does not:
 
 
(a)
conflict with or result in the material breach of or constitute a material default under any of the terms, conditions or other provisions of any material contract, permit, authorisation, consent, requirement, instrument or arrangement to which any member of the BoI Group is a party or by which any member of the BoI Group is bound and which is necessary for any member or members of the BoI Group for the purposes of carrying on its/their business in the ordinary course as heretofore or the loss of which would have a material adverse effect on the BoI Group or any member of the BoI Group; or
 
 
(b)
relieve any person from any material obligation to any member of the BoI Group or enable any person to determine or avoid any such obligation or any material right or benefit enjoyed by any member of the BoI Group or enable any person to exercise any right under any of the terms, conditions or other provisions of any material contract, permit, authorisation, consent, requirement, instrument or arrangement to which any member of the BoI Group is a party or which any member of the BoI Group is bound by; or
 
 
(c)
vary or accelerate the rights of any person, or enable any person to exercise any right, under any Incentive Scheme; or
 
 
(d)
constitute a change of control or any other event provided for in any correspondence, contract, permit, authorisation, consent, requirement, instrument or arrangement to which any member of the BoI Group is a party or by which any member of the BoI Group is bound so as to enable or entitle any Director, Senior Executive or employee of any member of the BoI Group to receive any form of financial compensation, cash payment or severance arrangement.
 
 
6.1.2
execution or performance of its obligations in respect of the Transaction Agreements and/or the publication, execution or performance of any documents relating thereto complies or will comply (as applicable) in all respects with all agreements to which any member of the BoI Group is a party or by which any such member of the BoI Group is bound, the charter and bye-laws and other constitutional documentation of BoI or any member of the BoI Group, and all applicable laws and regulations in Ireland and elsewhere; and
 
 
6.1.3
all units of the Sale Stock to be purchased by the Buyers pursuant to the Stock Purchase Agreements have been properly and validly issued and are fully paid.
 
6.2
Without limitation to BoI’s obligations under Clause 3.1, BoI makes no confirmation, representation, warranty or confirmation pursuant to Clauses 6.1.1 or 6.1.2 as to whether any of the Buyer Transactions or the Transaction Agreements require any consent, authorisation, circular or stockholder approval pursuant to the Listing Rules or the Takeover Act and Rules and BoI shall not be liable for any loss, expenses or damages arising from or in connection with the purported execution, completion or implementation of any of the Buyer Transactions or Transaction Agreements prior to the obtaining or issuing of any such required authorisation, consent circular or stockholder approval.
 

 
 

 

7.
Fees
 
BoI shall pay to each of the Buyers a fee of 0.5% of the consideration paid by it for Sale Stock upon every Completion Date, plus VAT to the extent applicable.  In addition, BoI will bear all vouched costs and expenses of the Buyers in connection with or incidental to the Transaction Agreements and all agreements and documents ancillary thereto (whether or not the obligations of the Buyers under any or all of the said Agreements become unconditional or are terminated), such expenses including, without limitation, the fees and expenses of the professional advisers of the Buyers, due diligence costs, the costs of preparation of all documents connected with the said Agreements and any charges by CREST, all totalling in aggregate not more than €4,000,000 (four million euro) plus any irrecoverable VAT upon such fees and expenses.  The costs and expenses of the Buyers payable hereunder shall accrue and be payable upon the First Completion Date or, if later, at the date(s) upon which they are incurred by or invoiced to the Buyers and BoI will forthwith upon demand by the Buyers (accompanied by the relevant invoice or receipt therefor) pay to or reimburse the full amount of any such costs and expenses up to the aforesaid amount (together with VAT thereon if payable and invoiced accordingly).
 
8.
Representations, Warranties and Undertakings
 
8.1
Pursuant to the Conditional Stock Purchase Agreement, the Minister, the Commission and the NTMA have agreed with the Buyers to assign and transfer to the Buyers the benefit of the Commission Warranties and the Commission Indemnity in respect of every unit of Sale Stock acquired by the Buyers. BoI hereby consents and agrees to such assignment and transfer, acknowledges that the Buyers shall be entitled to rely upon the Commission Warranties and the Commission Indemnity in respect of every unit of Sale Stock acquired by them and confirms that, upon their assignment to the Buyers, the Commission Warranties and the Commission Indemnity shall be enforceable by the Buyers against BoI as if the Commission Warranties had been made and the Commission Indemnity had been given directly by BoI to the Buyers in respect of any Losses incurred by the Buyers in connection with any unit of Sale Stock acquired by them.  BoI acknowledges that each of the Buyers is entering into the Transaction Agreements in reliance on the Commission Warranties and each such Commission Warranty will be construed separately and will not be limited by reference (express or implied) to the terms of any other representation, warranty or undertaking or any other term of the Transaction Agreements (or any of them), subject in each case to the terms of the Underwriting Agreement.  The Buyers acknowledge that the assignment of the Commission Warranties is subject to the matters fairly disclosed in the Disclosure Letter.
 
8.2
Each of the provisions of Clause 16 of the Underwriting Agreement and any other provisions of the Underwriting Agreement dealing with the Commission Warranties shall apply mutatis mutandis to the parties to, and as if re-stated in, this Deed as if each reference therein to any Government Party was to the Buyers.
 
9.
The Buyer Transactions
 
9.1
References to Buyers
 
 
9.1.1
Subject to BoI’s obligations to comply with applicable law and regulation, the prior consent of each of the Buyers should be obtained prior to the release or publication of any document or announcement to be executed, published or filed in connection with the Buyer Transactions or the Transaction Agreements that refers to any Buyer, or refers to any actions that are contemplated or have been or will be taken by any of the Buyers ("Relevant Documents").  (For the avoidance of doubt, the parties agree that the consent of the Buyers will not be required in respect of the release or publication of documents or announcements relating to the Rights Issue, unless such documents or announcements refer to any Buyer or any actions taken or contemplated to be taken by any of the Buyers.)
 

 
 

 

 
9.1.2
Prior to seeking the consent of the Buyers pursuant to Clause 9.1.1, BoI agrees and undertakes that it will subject to BoI’s obligations to comply with applicable law and regulation:
 
 
(a)
afford the Buyers such time as they may reasonably require to consider the Relevant Documents to give such consent; and
 
 
(b)
submit drafts and revised drafts of the Relevant Documents for review and comment by the Buyers, having afforded the Buyers appropriate time pursuant to Clause 9.1.2(a) to consider such drafts and discuss such comments with the Buyers for the purposes of preparing revised drafts.
 
9.2
Co-operation, Consultation and Consent
 
Where any proposed amendment, addition or revision to the timing or structure of the Proposals would, or could be reasonably expected to, vary the rights or obligations or actual or potential liabilities of the Buyers pursuant to or in connection with the Buyer Transactions and/or the Transaction Agreements, BoI will promptly update the Buyers in relation to the same, and will immediately supply any documents or information that the Buyers reasonably require. Furthermore, BoI will not implement any such proposed amendment, addition or revision to the timing or structure of the Proposals without the prior written consent of each of the Buyers.
 
9.3
Clearances and Consents
 
Where clearance or consent from any third party (each a "Consent Party") is required to be obtained by BoI for the Buyer Transactions or the Transaction Agreements, BoI agrees to:
 
 
9.3.1
promptly update the Buyers on its discussions and negotiations with any Consent Parties, and to immediately supply any documents or information that the Buyers reasonably require to assist in their consideration of the implications of such discussions and negotiations; and
 
 
9.3.2
if requested by the Buyers and where it is possible to so do, to arrange for persons nominated by the Buyers to observe or participate in BoI's discussions with Consent Parties.
 
9.4
Information
 
Subject to BoI’s obligations to comply with applicable law and regulation, BoI will provide, and procure that each member of the BoI Group will provide, the Buyers with:
 
 
9.4.1
any publications, reports and other information with respect to any member of the BoI Group and/or their businesses; and
 
 
9.4.2
access to the books and records and management and other employees of any member of the BoI Group and/or their businesses
 
as may reasonably be required in order to allow the Buyers (including any agent or adviser of the foregoing parties) to obtain clearance or consent from a Consent Party or to comply fully with all legal and regulatory and other requirements under any applicable laws and regulations of any jurisdiction applicable to the Buyers as a direct or indirect consequence of their actual stockholdings in BoI or their proposed stockholdings pursuant to the Stock Purchase Agreements or in furtherance of any of the matters referred to in Clause 3.1.
 
9.5
Expiry
 
BoI’s obligations under Clause 9 shall expire at the end of the Relevant Period.
 

 
 

 

10.
Notification of Certain Events
 
10.1
If following the date of this Deed but any time on or before the end the Relevant Period:
 
 
10.1.1
any of the Commission Warranties has become or been discovered to be untrue, inaccurate or misleading in any material respect;
 
 
10.1.2
matters have arisen or have been discovered which would, if any of the Offer Documents (or any amendment or supplement thereto) were to be issued at that time, constitute a material omission therefrom or which would render any such Offer Documents (or any amendment or supplement thereto) to be misleading in any material respect;
 
 
10.1.3
trading in any securities of BoI has been suspended or materially limited by the Irish Stock Exchange, the London Stock Exchange or the New York Stock Exchange on any exchange or over-the-counter market, or if trading generally on the New York Stock Exchange, the NASDAQ Stock Market, the Irish Stock Exchange or the London Stock Exchange has been suspended or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices of securities have been required, by any of the said exchanges or by such system or by order of any governmental authority, or a material disruption has occurred in commercial banking or securities settlement or clearance services in Ireland, in the United States, or in the United Kingdom or in a member or associated member of the European Union; or
 
 
10.1.4
one or more downgradings has occurred, resulting in an aggregate reduction of three or more notches in the senior long-term rating accorded to debt securities of BoI by Standard and Poor's Rating Services or by Fitch Ratings Limited (or, in each case, its successor rating business) compared to the rating accorded by the relevant rating organisation as at the date of this Deed;
 
then BoI will notify the Buyers immediately.
 
11.
Pre-emption
 
11.1
Subject to Clauses 11.2 and 11.3, BoI undertakes to each of the Buyers that it will issue Equity Securities prior to 29 July 2016 only on a Pre-emptive Basis unless such Buyer shall, in its absolute discretion, otherwise agree. This covenant shall confer rights upon each of the Buyers in respect of the issue of Equity Securities to that Buyer on a Pre-emptive Basis and may be enforced or waived by each Buyer without prejudice to the rights of the other Buyers.
 
11.2
Permitted Exceptions
 
Clause 11.1 shall not prevent or otherwise restrict BoI from issuing any Equity Securities on a non-Pre-emptive Basis:
 
 
11.2.1
to the extent it is required to do so to comply with applicable law or pursuant to a court order to do so in any applicable jurisdiction;
 
 
11.2.2
to the extent it is required to do so to comply with the obligations of the BoI Group with respect to the Contingent Capital Instrument, the 2009 Preference Stock and the ACSM Hybrids;
 
 
11.2.3
pursuant to the Rights Issue and the Debt for Equity Offers;
 
 
11.2.4
pursuant to the offer it may make to holders of the PIBs provided that not more than 300,000,000 units of BoI Ordinary Stock shall be issued pursuant to any offer to holders of the PIBs; and
 

 
 

 

 
11.2.5
pursuant to any existing or future authority granted by BoI's Stockholders to permit BoI to issue Equity Securities on a non-Pre-emptive Basis for cash provided that BoI shall not pursuant to any such authority in any calendar year (i) issue more than 5% of its Fully Diluted Ordinary Stock Capital as at 1 January of that year and/or (ii) issue any BoI Ordinary Stock at a discount of greater than 5% to the average closing price of BoI Ordinary Stock for the five immediately preceding dealing days on the Irish Stock Exchange.
 
11.3
Minimum Shareholding
 
Clause 11.1 shall only operate for the benefit of a Buyer and be capable of enforcement by such Buyer in each case in circumstances where at the relevant time:
 
 
11.3.1
In the case of Kennedy-Wilson Investments, LLC such Buyer (and/or members of the Buyer’s Group) holds more than 0.5% of the Fully Diluted Ordinary Stock Capital; and
 
 
11.3.2
In the case of each of the other Buyers (and/or Members of its Buyer’s Group) holds more than 1% of the Fully Diluted Ordinary Stock Capital.
 
12.
Expiry
 
Save where an earlier expiry date is provided for in respect of specific Clauses under this Deed, this Deed shall expire on 29 July 2016, provided always that such expiry shall not in any respect extinguish or affect (or constitute a waiver by any of the Buyers of) any rights that the Buyers (or any of them) may have in respect of any breach of the terms of this Deed or failure by BoI to comply with its obligations hereunder prior to such date of expiry.
 
13.
General
 
13.1
All of the undertakings and commitments given to the Buyers by BoI under this Deed shall confer rights upon each of the Buyers and any of such rights or commitments of a Buyer may be enforced or waived by such Buyer without prejudice to the rights of the other Buyers.
 
13.2
Any liability to any party under this Deed may in whole or in part be released, compounded or compromised and time or indulgence may be given by any party in its absolute discretion as regards any other person under such liability without in any way prejudicing or affecting the first party's rights against such other person under the same or a similar liability.
 
13.3
No failure of any party to exercise, and no delay by it in exercising, any right, power or remedy in connection with this Deed will operate as a waiver thereof, nor will any single or partial exercise of any such right preclude any other or further exercise of such right or the exercise of any other right.  Any express waiver of any breach of this Deed will not be deemed a waiver of any subsequent breach.
 
13.4
The rights, powers and remedies provided in this Deed are cumulative and not exclusive of and rights, powers and remedies provided by law; in particular, Bol agrees that damages would not be an adequate remedy for any breach by it of this Deed and that accordingly the Buyers will be entitled, without proof of special damages, to the remedies of injunction, specific performance or other equitable relief for any threatened or actual breach of this Deed.
 
13.5
Subject to Clause 12 (Expiry) and, except to the extent already performed, all the provisions of this Deed will, so far as they are capable of being performed or observed, continue in full force and effect notwithstanding the conclusion of any or all of the constituent parts of the Buyer Transactions.
 
13.6
With regard to the obligations of BoI, time will be of the essence in this Deed, both as regards any dates, times or periods mentioned and as regards any dates, times or periods which may be substituted for them in accordance with this Deed or by agreement in writing
 

 
 

 

between the parties.  For the avoidance of doubt, time will not be of the essence in relation to the obligations of any other party to this Deed.
 
13.7
This Deed may be entered into in any number of counterparts and by any one or more of the parties to it on separate counterparts but will not be effective until each party has executed at least one counterpart.  Each counterpart when executed and delivered will be an original, but all the counterparts will together constitute one and the same instrument.  Delivery of a counterpart of this Deed by email attachment or telecopy shall be an effective mode of delivery.
 
13.8
The Transaction Agreements and any other documents referred to therein constitute the whole agreement and understanding between the parties in relation to the Buyer Transactions.  All previous agreements, understandings, undertakings, representations, warranties and arrangements of any nature whatsoever between the parties or any of them with any bearing on the Buyer Transactions are superseded and extinguished (and all rights and liabilities arising by reason of them, whether accrued or not at the date of this Deed, are cancelled) to the extent they have such a bearing.
 
13.9
No variation of this Deed will be effective unless in writing (not including e-mail) and signed by or on behalf of each of the parties.
 
13.10
All parties will, from time to time on request and at their own expense, do and execute or procure to be done and executed (including by any member of the BoI Group) all necessary acts, deeds, documents and things (as are reasonably within its power) in a form satisfactory to the other parties that the other parties reasonably consider necessary to:
 
 
13.10.1
give full effect to this Deed;
 
 
13.10.2
secure to all parties the full benefit of the rights, powers and remedies conferred upon the parties in or by this Deed; and
 
 
13.10.3
remedy any breach of this Deed which is related to any absence of authority or the existence of any impediment in regard to the performance of the obligations of BoI pursuant to this Deed and pursuant to the terms of the Bye-Laws.
 
13.11
If at any time any provision of this Deed is or becomes illegal, invalid or unenforceable in any respect under the law of any jurisdiction, that will not affect or impair:
 
 
13.11.1
the legality, validity or enforceability in that jurisdiction of any other provision of this Deed; or
 
 
13.11.2
the legality, validity or enforceability under the law of any other jurisdiction of that or any other provision of this Deed.
 
If any invalid, unenforceable or illegal provision of this Deed would be valid, enforceable and legal if some part of it were deleted, the parties will negotiate in good faith to amend such provision such that, as amended, it is legal, valid and enforceable, and, to the greatest extent possible, achieves the parties original commercial intention.
 
14.
Assignment, Novation
 
14.1
No Buyer will be permitted to assign, novate, transfer or otherwise alienate in any way whatsoever, wholly or partially, all or any of its rights, interests and/or obligations under this Deed without the prior written consent of BoI PROVIDED ALWAYS that each Buyer may transfer, wholly or partially, its rights and/or obligations under this Deed, including by way of assignment and/or novation and/or contribution, to any entity within that Buyer’s Group and the other parties hereby:
 
 
14.1.1
consent to any such assignment and/or novation and/or contribution;
 

 
 

 

 
14.1.2
agree to do and execute or procure to be done and executed all necessary acts, deeds, documents and things in a form satisfactory to the Buyers which the Buyers may reasonably consider necessary for giving full effect to this Deed and securing to the Buyers or any person to whom the Buyers have transferred or proposes to transfer its rights and obligations under this Deed in accordance with this Clause 14.1 the full benefit of the rights, powers and remedies conferred upon that Buyer in or by this Deed.
 
14.2
BoI will not be permitted to assign, novate, transfer or otherwise alienate in any way whatsoever, wholly or partially, all or any of its rights, interests and/or obligations under this Deed without the prior written consent of the other parties.
 
15.
Notices
 
15.1
Subject to Clause 15.2, any notice or other communication under this Deed will only be effective if it is in writing.
 
15.2
Communication by e-mail will not be effective under this Deed.
 
15.3
Any notice or other communication given or made under this Deed will be addressed as provided in Clause 15.5 and, if so addressed, will, in the absence of earlier receipt, be deemed to have been duly given or made as follows:
 
 
15.3.1
if sent by personal delivery, on delivery at the address of the relevant party;
 
 
15.3.2
if sent by pre-paid post, two (2) clear Business Days after the date of posting; or
 
 
15.3.3
if sent by facsimile, when transmitted.
 
15.4
Any notice or other communication given or made, or deemed to have been given or made, outside Working Hours will be deemed not to have been given or made until the start of the next period of Working Hours.
 
15.5
The relevant notice details for the parties hereto are:
 
 
15.5.1
if to BoI:
 
 
Address:
Head Office
40 Mespil Road
Dublin 4
 
 
Fax no.
+353 1 661 5671
 
 
Attention:
The Group Secretary
 
 
15.5.2
if to any of the Buyers, to the address and fax number (if any) set out opposite that Buyer’s name in Schedule 1, with copy to the person(s) if any specified in Schedule 1.
 
15.6
A party may notify the other parties of a change to its notice details.  That notification will only be effective on:
 
 
15.6.1
any effective date specified in the notification; or
 
 
15.6.2
if no effective date is specified or the effective date specified is less than five (5) clear Business Days after the date when notice is received, the date falling five (5) clear Business Days after the notification has been received.
 

 
 

 

16.
Governing Law and Submission to Jurisdiction
 
16.1
This Deed and any dispute arising out of or in connection with it or its subject matter or formation (including non-contractual obligations, disputes or claims) will be governed by and construed in accordance with the laws of Ireland.
 
16.2
Subject to Clause 16.4, each of the parties to this Deed irrevocably agrees that the courts of Ireland are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Deed and, for such purposes, irrevocably submits to the exclusive jurisdiction of such courts.  Subject to Clause 16.4 any proceeding, suit or action arising out of or in connection with this Deed (the "Proceedings") will therefore be brought in the courts of Ireland.
 
16.3
Notwithstanding the provisions of Clause 16.2, in the event that any Indemnified Person becomes subject to proceedings brought by a third party (the "Foreign Proceedings") in the courts of any country other than Ireland (including, without prejudice to the generality of the foregoing, in any court of competent jurisdiction in the United States) (the "Foreign Jurisdiction"), such Indemnified Person will be entitled, without objection by BoI, to take such steps as are available in the Foreign Jurisdiction, in the circumstances of the Foreign Proceedings, including (if reasonably necessary) the issuing of separate proceedings, to ensure that, any issues between any such Indemnified Person and Bol are determined in the Foreign Jurisdiction as part of, or as closely connected (as the procedure of the Foreign Jurisdiction will permit) with, the Foreign Proceedings and BoI hereby submits to the Jurisdiction of the Foreign Jurisdiction for this purpose.
 
16.4
Each of the parties to this Deed irrevocably waives any objection to Proceedings or Foreign Proceedings in the courts referred to in Clause 16.2 or 16.3 on the grounds of venue or on the grounds of forum non conveniens.
 
16.5
BoI agrees to appoint an agent for service of process in any Foreign Jurisdiction other than Ireland in which any other party is subject to legal suit, action or proceedings based on or arising under this Deed within fourteen (14) days of receiving written notice of such legal suit, action or proceedings and the request to appoint such agent for service.  In the event that BoI does not appoint such an agent within fourteen (14) days of the notice requesting it to so, such other party may appoint a commercial agent for service for BoI on BoI's behalf and at Bol's expense and BoI agrees that subject to being notified of such appointment in writing, service upon such commercial agent will constitute service upon Bol.
 
16.6
Each of the Buyers agrees to appoint an agent for service of process in Ireland within fourteen (14) days of receiving written notice of any legal suit, action or proceedings based on or arising under this Deed and the request to appoint such agent for service.  In the event that any Buyer does not appoint such an agent within fourteen (14) days of the notice requesting it to so, BoI may appoint a commercial agent for service for that Buyer on its behalf and at its expense and each Buyer agrees that, subject to being notified of such appointment in writing, service upon such commercial agent will constitute service upon that Buyer.
 
IN WITNESS whereof the parties have entered into this Deed and delivered it as a deed on the date specified above.
 


 
 

 

SCHEDULE 1
 
The Buyers
 
Party
 
Address
 
Fax No.
Fairfax Financial Holdings Limited
 
 
95 Wellington Street West
Suite 800
Toronto
Ontario
Canada M5J 2N7
For the attention of:
Paul Rivett
Vice President and Chief Legal Officer
 
 
+1 416 367 4946
With a copy to:
 
 
 
William Fry
Fitzwilton House.
Wilton Place
Dublin 2
For the attention of:
Owen O’Connell
 
 
+353 1 639 5333
Fidelity Contrafund: Fidelity Advisor New Insights Fund
 
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Contrafund: Fidelity Contrafund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Variable Insurance Products Fund III: Balanced Portfolio
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 
Fidelity Advisor Series I: Fidelity Advisor Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Securities Fund: Fidelity Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Capital Trust: Fidelity Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 


 
 

 


Party
 
Address
 
Fax No.
Fidelity Advisor Series I: Fidelity Advisor Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Puritan Trust: Fidelity Low-Priced Stock Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 
Kennedy-Wilson Investments, LLC
 
 
 
Kennedy-Wilson Investments LLC
c/o Matt Windisch
9701 Wilshire Boulevard, Suite 700
Beverly Hills
CA 90212
USA
 
 
+ 001 310 887 6459
With a copy to:
 
 
William McMorrow
(wmcmorrow@kennedywilson.com) or Mary Ricks
(mricks@kennedywilson.com)
 
   
WLR/GS Master Co-Investment L.P.
 
 
 
 
 
WLR Master Co-Investment GP, LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
 
+ 001 212 278 9821
 
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR Recovery Fund IV, L.P.
 
 
WLR Recovery Associates IV LLC
c c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
+ 001 212 278 9821
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR Recovery Fund V, L.P.
 
 
WLR Recovery Associates V LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+001 212 278 9769
 
 
 
 
+ 001 212 278 9821


 
 

 


Party
 
Address
 
Fax No.
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR IV Parallel Esc, L.P
 
 
WLR Recovery Associates IV LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001  212 278 9769
 
 
 
 
+ 001 212 278 9821
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
Capital Research and Management Company
 
333 South Hope St
Los Angeles
CA 90071
SA
For the attention of:
Michael Downer
 
 
+ 001 213 486 9041
 
 
 
 


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)



The Seal of
THE GOVERNOR AND COMPANY
OF THE BANK OF IRELAND
was affixed in the presence of:

  /s/ John O'Donovan
 
Director/Secretary/Authorised Signatory
   
   
  /s/ Richie Boucher
 
Director/Secretary/Authorised Signatory


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)







SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ James Newman
 
Print name
Witness (Signature)
   
     
James Newman
   
Print name
   
     
Fitzwilton House, Wilton Place, Dublin 2
   
Print address
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY CONTRAFUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
VARIABLE INSURANCE PRODUCTS FUND III: BALANCED PORTFOLIO
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY SECURITIES FUND: FIDELITY DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CAPITAL TRUST: FIDELITY VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY PURITAN TRUST: FIDELITY LOW-PRICED STOCK FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)



SIGNED and DELIVERED AS A DEED
on behalf of
KENNEDY-WILSON INVESTMENTS, LLC
by its authorised signatory
in the presence of:
 
/s/ Matthew Windisch
   
Authorised Signatory (Signature)
     
   
Matthew Windisch
/s/ Mark Martin
 
Print name
Witness (Signature)
   
     
Mark Martin
   
Print name
   
     
9701 Wilshire Blvd., Beverly Hills, CA 90212
   
Print address
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS Master Co-Investment, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
   
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
   


 
 

 

(EXECUTION PAGE OF DEED OF UNDERTAKING)



SIGNED and DELIVERED AS A DEED
on behalf of
CAPITAL RESEARCH AND MANAGEMENT COMPANY
by its authorised signatory
in the presence of:
 
/s/ Michael J. Downer
   
Authorised Signatory (Signature)
     
   
Michael J. Downer, SVP and Secretary
/s/ Walt R. Burkley
 
Print name
Witness (Signature)
   
     
Walt R. Burkley
   
Print name
   
     
c/o 333 S. Hope Street, Los Angeles, CA 90071
   
Print address
   
EX-99 16 ex8.htm EXHIBIT 8 ex8.htm
Exhibit 8
 

 
REGISTRATION RIGHTS AGREEMENT, dated as            July 2011 (this “Agreement”), between The Governor and Company of the Bank of Ireland , a chartered corporation registered in Ireland with registered  no. C-1 (the “Company) and the parties set out in Schedule 1 (the “Holders” and any one a “Holder”).
 
RECITAL
 
A. Acquisition of Securities. The Holders comprise investors who have acquired a significant stockholding in the Company from the NPRFC.
 
B. Registration Rights. The parties desire to enter into this Agreement in order to grant certain registration rights to the Holders as set forth below.
 
NOW, THEREFORE, in consideration of the premises and of the representations, warranties, covenants and agreements set forth herein, the parties agree as follows:
 
ARTICLE I
 
GENERAL
 
1.1.       Definitions. As used in this Agreement, the following terms shall have the following respective meanings:
 
Amended Shelf Registration Statement” has the meaning ascribed to it in Section 2.1(d).
 
ADSs” means American Depositary Shares of the Company, each representing  four (4) shares of Ordinary Stock.
 
“Associated Entity”, in respect of any Holder, any company or other entity controlled by that Holder or which controls that Holder and any fund or partnership managed by any such company or entity.
 
Board of Directors” has the meaning ascribed to it in Section 2.2(b).
 
Close Period” means any close period, as defined in Annex I to Chapter 9 of the Listing Rules made by the UK Financial Services Authority pursuant to Part VI of the Financial Services and Markets Act 2000 and Appendix 1 to Chapter 6 of the Irish Listing Rules, in relation to the Company or equivalent or analogous securities exchange or national market rule applying in relation to the Company from time to time.
 
“Debt for Equity Holders” means holders of Debt for Equity Securities to whom the Debt for Equity Offers have been made;
 
“Debt for Equity Offers” means the offer by the Company made by the Company on 10 June 2011to the Debt for Equity Holders giving them the right to exchange their Debt for Equity Securities for cash or, subject to shareholder approval or units of new ordinary stock of the Company on the terms of the Debt for Equity Offer Document;
 
“Debt for Equity Offer Document” means the consent and exchange offer memorandum (and related annexes) published on 8 June 2011 in connection with the Debt for Equity Offers;
 

 
1

 

“Debt for Equity Securities” means those securities which are the subject of the Debt for Equity Offers;
 
Exchange Act” means the Securities Exchange Act of 1934, as amended, or similar federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.
 
Holder” has the meaning given to it in Recital A to this Agreement.
 
Holders’ Counsel” means one counsel for the Holders together chosen by (i) Holders holding a majority interest in the Registrable Securities being registered or (ii) agreement between them.
 
Holder Stock” means (i) the Securities acquired, subscribed for or held by a Holder pursuant to the Stock Purchase Agreements and (ii) any Securities issued or issuable with respect to, or in exchange or replacement for, any such Securities.
 
Initiating Holder” has the meaning ascribed to it in Section 2.1(a).
 
Minister” means the Minister for Finance of Ireland.
 
NPRFC” means the National Pensions Reserve Fund Commission.
 
NPRFC Holders” means the NPRFC and/or the Minister and/or any “Holder” as defined in the NPRFC Registration Rights Agreement.
 
NPRFC Registrable Securities” means “Registrable Securities” as defined in the NPRFC Registration Rights Agreement.
 
NPRFC Registration Rights Agreement” means the registration rights agreement between the Company, the Minister and the NPRFC dated 18 June 2011.
 
Notice of Demand” has the meaning ascribed to it in Section 2.1(a).
 
Other Stockholder” has the meaning ascribed to it in Section 2.2(c).
 
Ordinary Stockmeans ordinary stock of €0.05 each (or such other nominal amount resulting from any merger, consolidation, stock exchange, sub-division, reorganization, recapitalization or similar transaction resulting in a change in the nominal amount of the ordinary stock) in the capital of the Company, and includes ADSs.
 
Person” means any individual, corporation, partnership, joint venture, limited liability company, business trust, joint stock company, trust or unincorporated organization or any government or any agency or political subdivision thereof.
 
Permitted Registration Rights” means any registration rights granted to or exercisable by an NPRFC Holder pursuant to the NPRFC Registration Rights Agreement..
 
Qualifying Holder” means a Holder and its Associated Entities holding 5% or more of the total issued Ordinary Stock in the capital of the Company from time to time.
 
Piggyback Registration” has the meaning ascribed to it in Section 2.2(a).
 

 
2

 

Register,” “registered,” and “registration” shall refer to a registration effected by preparing and (a) filing a registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or (b) filing a prospectus and/or prospectus supplement in respect of an appropriate effective registration statement on Form F-3 (or any successor form).
 
Registrable Securities” means any Holder Stock, including any Holder Stock required to be registered in connection with an offering or sale of Related Securities by any Holder.  As to any particular Registrable Securities, once issued, such securities shall cease to be Registrable Securities when (i) they shall have ceased to be outstanding or (ii) they have been sold, distributed or otherwise transferred in a transaction (including without, limitation, a sale over the Irish Stock Exchange, the London Stock Exchange, the New York Stock Exchange or any other stock exchange on which the Company’s Securities are listed) in which the transferor’s rights under this Agreement are not assigned, transferred or novated to the transferee of such Registrable Securities in accordance with the terms of this Agreement.  No Registrable Securities may be registered under more than one registration statement at any one time.
 
Registration Expenses” means all expenses incurred by the Company in effecting any registration pursuant to this Agreement, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, blue sky fees and expenses, fees and disbursements of Holders’ Counsel, and expenses of the Company’s independent accountants in connection with any regular or special reviews or audits incidental to or required by any such registration, but shall not include (a) Selling Expenses and (b) the compensation of regular employees of the Company, each of which shall be paid in any event by the Company.
 
Related Securities” means any securities of any description called by a Holder to be issued by any Person from time to time and which are exchangeable for, convertible into, give rights over or otherwise reference any Holder Stock.
 
Stock Purchase Agreements” means the stock purchase agreement and the conditional stock purchase agreement entered into on the date of this Agreement between the Minister, the NPRFC, the NTMA and the Holders, pursuant to each of which the Holders will purchase Securities from the NPRFC.
 
SEC” or “Commission” means the U.S. Securities and Exchange Commission and any successor agency.
 
Securities” means the Ordinary Stock in the capital of the Company issued by the Company from time to time.
 
Securities Act” shall mean the Securities Act of 1933, as amended, or similar federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.
 
Selling Expenses” means all underwriting discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities and the fees and expenses of any Holder’s financial advisers.
 
Third Party Transferee” has the meaning ascribed to in Section 2.10(a).
 

 
3

 

Transferring Parties” has the meaning ascribed to it in Section 2.10(b).
 
Underwriting Agreement” means the transaction and underwriting agreement, dated as of 18 June 2011 between the Company, the NPRFC and the Minister
 
ARTICLE II
 
REGISTRATION
 
2.1.       Demand Registration.
 
(a)        Subject to the conditions of this Section 2.1, if at any time the Company shall receive a written request from one or more Qualifying Holder (the “Initiating Holder”) that the Company register under the Securities Act Registrable Securities, which request shall include confirmation that the amount of Registrable Securities proposed to be sold under such registration would cause the condition in Section 2.1(c)(ii) to be satisfied and the intended method of distribution thereof (a “Notice of Demand”), then the Company shall, subject to the limitations of this Section 2.1, effect, as promptly as reasonably practicable, the registration under the Securities Act of all Registrable Securities that the Initiating Holder requests to be registered.
 
(b)        If the Initiating Holder intends to distribute the Registrable Securities covered by its Notice of Demand by means of an underwritten offering, (1) it shall so advise the Company as part of its Notice of Demand made pursuant to this Section 2.1 and (2) it shall have the right, following consultation with the Company, to appoint a managing underwriter or underwriters and/or bookrunners of recognized international standing.
 
(c)         The Company shall not be required to effect a registration pursuant to this Section 2.1:
 
(i)           within six months from the date of this Agreement or such other period as shall be required so as not to affect the exemption from registration of the Securities under the Securities Act. For the avoidance of doubt, the provisions of this Section 2.1(c)(i) shall in no way interfere with or restrict the Debt for Equity Offers or the transfer by the Transferring Parties of the Securities to an investor or investors which has approached the Company or the Minister prior to the date of this Agreement.
 
(ii)           unless (A) the anticipated aggregate offering price to the public in the United States exceeds $50,000,000 or (B) the anticipated aggregate offering price to the public (aggregated to include sales within the United States and outside the United States) exceeds $100,000,000;
 
(iii)          more than three (3) times in any twelve (12) month period; provided that for the purposes of complying with this Section 2.1(c)(iii), (A) each of such registrations shall have been declared or ordered effective and kept effective by the Company as required by Section 2.5(a) of this Agreement, (B) any registrations declared or ordered effective contemporaneously shall be deemed to be the same registration;
 
(iv)          subject to Section 2.2, with respect to a registration of Registrable Securities during the period starting with the date thirty (30) calendar days prior to the Company’s good faith estimate of the launch date of, and ending on a date ninety (90)
 

 
4

 

calendar days after the closing date of, a Company-initiated registered offering of Securities; provided that (a) the Company is actively employing in good faith all reasonable best efforts to launch such registered offering and (b) the Company notifies the Initiating Holder of any proposed Company-initiated registered offering of Securities within such timescale as soon as possible following its receipt of the relevant Notice of Demand;
 
(vi)          during any Close Period, in which event the Company shall have the right to defer the filing of a registration statement (but not the preparation of any registration statement or the provision of assistance with customary confirmatory due diligence in relation to any registration) until the earlier of the end of such Close Period and the date falling forty-five (45) calendar days after receipt of the relevant Notice of Demand; or
 
(vii)         if the Company notifies the Initiating Holder that it anticipates, in good faith and in its reasonable business judgment, announcing a corporate transaction or event or state of affairs within thirty (30) calendar days of the date of the Notice of Demand, which announcement, in the reasonable good faith business judgment of the Company, is or would be material in the context of the Company and does or would interfere with the registration referred to in the Notice of Demand, in which case the Company shall have the right to defer the filing of a registration statement (but not the preparation of any registration statement or the provision of assistance with customary confirmatory due diligence in relation to any registration) for a period of not more than thirty (30) calendar days after receipt of the relevant Notice of Demand; provided that (A) the Company is actively employing in good faith all reasonable best efforts to make such announcement as soon as practicable, (B) the Company notifies the Initiating Holder of any such anticipated announcement as soon as practicable following its receipt of the relevant Notice of Demand, (C) the Company keeps the Initiating Holder regularly updated as to the date on which such announcement is anticipated to be made and, in particular, informs the Initiating Holder without delay if the Company no longer proposes to make the anticipated announcement (in which case the restrictions in this Section 2.1(c)(vi) shall cease to apply) and (D) such right to defer a filing may not be exercised by the Company more than two (2) times in any twelve (12) month period and in any case for not more than thirty (30) calendar days in the aggregate in any twelve (12) month period.
 
(d)        One registration pursuant to this Section 2.1 may be required by one or more Holders to be effected by means of a shelf registration statement on Form F-3 or any successor thereto (a “Shelf Registration Statement”) relating to any or all of the Registrable Securities in accordance with the methods and distribution set forth in the Shelf Registration Statement and Rule 415 under the Securities Act. The Company shall use its reasonable best efforts to cause any Shelf Registration Statement to remain effective, except during the periods described in Section 2.6, including by filing extensions of the Shelf Registration Statement; provided that (i) no provision of this Agreement shall prevent the Company from fulfilling its obligations under this Section 2.1(d) by amending any previously filed and declared effective shelf registration statement on Form F-3 of the Company to allow the offer and sale of Registrable Securities (an “Amended Shelf Registration Statement”) and (ii) during any time when a Shelf Registration Statement (including an Amended Shelf Registration Statement) is effective, the Company’s obligations to effect the registration of Registrable Securities pursuant to Section 2.1(a) shall be deemed satisfied, and any underwritten offering of securities carried out pursuant to this Section 2.1 shall be effected by way of an offering under the Shelf Registration Statement (including an Amended Shelf Registration Statement) and otherwise in accordance with the terms, requirements and limitations set forth in this Agreement.
 

 
5

 

(e)         The Company acknowledges and accepts that a Notice of Demand does not indicate or give rise to any commitment on the part of any Holder to proceed with an offering or sale of Registrable Securities, nor is it intended to give any binding indication of the number of Registrable Securities which may be offered or sold or the terms, pricing or timing of any offering or sale of Registrable Securities.
 
2.2.       Right to Piggyback.
 
(a)        Whenever the Company proposes to register any of its Securities under the Securities Act (except (i) in the case of a routine offering or sale by the Company of a class of debt securities not previously issued to any Holder under the terms of a customary debt issuance program (including pursuant to a registration statement on Form F-3 or any successor thereto), (ii) for any registration of Securities for offering and sale to employees or directors of the Company pursuant to any employee stock plan or other employee benefit plan arrangement (including pursuant to a registration statement on Form S-8 or any successor thereto) (iii) pursuant to a demand registration effected in accordance with Section 2.1 or (iv) for any registration of Securities on Form F-4 or any successor thereto and other than solely pursuant to a registration statement on Form F-6), the Company shall (A) as soon as practicable (but in no event less than thirty (30) calendar days prior to the proposed date of filing of the related registration statement), give written notice to the Holders of its intention to effect such a registration and (B) register under such registration statement (x) all Registrable Securities of the same class as the Securities the Company proposes to register and (y) any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities the Company proposes to register (in accordance with the priorities set forth in subsections (b) and (c) below) with respect to which the Company shall have received written requests therefor within fifteen (15) calendar days after delivery of the Company’s notice (each such registration, a “Piggyback Registration”).
 
(b)        If a Piggyback Registration is an underwritten primary registration on behalf of the Company and the managing underwriters advise the Board of Directors of the Company (the “Board of Directors”) in writing that in their opinion the total number of Securities (including the Registrable Securities of the same class as the Securities the Company proposes to register and any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities the Company proposes to register) requested to be included in the registration would prevent the underwriters from completing such offering, then the Company shall promptly provide the Holders with a copy of such advice and consult with the Holders with respect to such advice, and after such consultation shall include in such registration only such number of Securities (including the Registrable Securities of the same class as the Securities the Company proposes to register and any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities the Company proposes to register), if any, which the managing underwriters determine can be sold in such offering without preventing the underwriters from completing such offering.  The Company shall include in such Piggyback Registration (i) first, 100% of the Securities that the Company proposes to sell as part of its initial registration, (ii) second, if any Holders participates in such registration pursuant to this Agreement, 100% of the Registrable Securities (which are of the same class as the Securities the Company proposes to register and any Related Securities in respect of which the Holder Shares are Securities of the same class as the Securities the Company proposes to register) that the Holders propose to sell, or such lesser amount determined by the managing underwriters pursuant to the preceding sentence, which shall be allocated pro rata between the participating Holders on
 

 
6

 

the basis of the number of such Registrable Securities owned by each such Person or as otherwise agreed between the Holders.
 
(c)        If a Piggyback Registration is an underwritten secondary registration on behalf of any Person other than a Holder (the “Other Stockholder”) who has Permitted Registration Rights and the managing underwriters advise the Board of Directors in writing that in their opinion the total number of Securities (including the Registrable Securities of the same class as the Securities such Other Stockholder proposes to register and any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities such Other Stockholder proposes to register) requested to be included in the registration would prevent the underwriters from completing such offering, then the Company shall promptly provide the Holders with a copy of such advice and consult with the Holders with respect to such advice, and after such consultation shall include in such registration only such number of Securities (including the Registrable Securities of the same class as the Securities such Other Stockholder proposes to register and any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities such Other Stockholder proposes to register) which the managing underwriters determine can be sold in such offering without preventing the underwriters from completing such offering.  The Company shall include in such Piggyback Registration (i) first, 100% of the Registrable Securities (of the same class as the Securities such Other Stockholder proposes to register and any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities such Other Stockholder proposes to register) that the Holders propose to sell and 100% of the Securities that such Other Stockholder proposes to sell, or such lesser amount determined by the managing underwriters pursuant to the preceding sentence, which shall be allocated pro rata between the participating Holders and such Other Stockholder on the basis of the number of Securities owned by each such Person or such other allocation amongst the Holders as agreed between the Holders and (ii) second, only if all of the Securities referred to in clause (i) have been included in the registration, any other Securities requested to be included therein that the managing underwriters have determined can be included pursuant to the preceding sentence.
 
(d)        If a Piggyback Registration involves an underwritten primary registration on behalf of the Company or an underwritten secondary registration on behalf of any Other Stockholder with Permitted Registration Rights, the managing underwriter or underwriters thereof shall be selected by the Company; provided, however, that (i) such managing underwriter or underwriters shall be of recognized international standing, (ii) the Company shall consult with the Holders (or any Person nominated by the Holders) prior to agreeing upon any fees, discounts or other amounts payable to such managing underwriter or underwriters and (iii) if the aggregate amount of Registrable Securities included by participating Holders in the underwritten offering for such Piggyback Registration exceeds 15% of the total amount of Securities to be included in such underwritten primary offering by the Company or such underwritten secondary offering by the Other Stockholder, as applicable, such Holders shall be entitled to select an additional managing underwriter to act as a joint bookrunner that is reasonably acceptable to the Company, which acceptance cannot be unreasonably withheld or delayed.
 
(e)        The Company will use its reasonable best efforts not to register any of its Securities for sale for its own account (other than Securities issued to employees of the Company under an employee benefit plan or Securities issued to effect a business combination pursuant to Rule 145 promulgated under the Securities Act) except as a firm commitment underwriting.
 

 
7

 

(f)         No registration or designation of Registrable Securities effected pursuant to a request under this Section 2.2 shall be deemed to have been effected pursuant to Section 2.1 or shall relieve the Company of its obligations under Section 2.1.
 
2.3.       Piggyback Rights in Respect of a Demand Registration.
 
(a)        If an Initiating Holder has made a Notice of Demand pursuant to Section 2.1, the Company shall give written notice to each Holder (other than the Initiating Holder) at least thirty (30) calendar days prior to the initial filing of a demand registration statement filed pursuant to Section 2.1 informing such Holder of its intent to file such demand registration statement and of such Holder’s rights under this Section 2.3 to request, as part of such demand registration, the registration of the Registrable Securities held by such Holder.  Upon written request of any Holder made within fifteen (15) calendar days after any such notice is given (which request must include the amount of Registrable Securities proposed to be sold by such Holder), then the Company shall effect, as promptly as reasonably practicable, the registration under the Securities Act of all Registrable Securities (of the same class as the Securities such Initiating Holder proposes to register and any Related Securities in respect of which the Holder Stock are Securities of the same class as the Securities such Initiating Holder proposes to register) that such Holder requests to be registered (in accordance with the priorities set forth in subsection (b) below).
 
(b)        If a demand registration made pursuant to Section 2.1 is (i) an underwritten registration initiated by an Initiating Holder or is an underwritten registration in which the Holders shall participate by exercise of its rights under Section 2.3(a) and (ii), other Holders shall have given notice of the exercise of their rights pursuant to Section 2.3(a) in respect of such underwritten registration, and the managing underwriters advise representatives of the Initiating Holder in writing that in their opinion the total number of stock of such Registrable Securities requested to be included in the registration would prevent the underwriters from completing such offering, then the Initiating Holder shall promptly provide the other Holders with a copy of such advice and consult with the other Holders with respect to such advice, and after such consultation shall communicate such advice to the Company.  If any other Holder and/or any NPRFC Holder participate in such registration, the Company shall include in such registration 100% of the Registrable Securities that the Holders propose to sell as part of their initial registration and/or any applicable NPRFC Registrable Securities that the NPRFC Holders are entitled to propose to sell as part of their initial registration or such lesser amount determined by the managing underwriters pursuant to the preceding sentence, which shall be allocated pro rata between the Holders and/or the NPRFC Holders on the basis of the number of such Registrable Securities and/or NPRFC Registrable Securities (as the case may be) respectively owned by each such Person or as otherwise agreed between the Holders and/or the NPRFC Holders.
 
2.4.       Expenses of Registration.
 
(a)        Except as specifically provided herein, all Registration Expenses incurred in connection with any registration, qualification or compliance hereunder shall be borne by the Company.  All Selling Expenses incurred in connection with any underwritten offering made in accordance with the terms set forth herein shall be borne by the Company and the Holders and the NPRFC Holders (if any) pro rata on the basis of the number of Registrable Securities of each party to be registered and sold under the applicable registration statement.
 

 
8

 

(b)        The Company shall not, however, be required to pay for expenses of any registration proceeding begun pursuant to Section 2.1, the request of which has been subsequently withdrawn by the requesting Holder(s) unless (i) the withdrawal is based upon (A) any fact, circumstance, event, change, effect or occurrence that individually or in the aggregate with all other facts or circumstances, events, changes, effects or occurrences has a material adverse effect on the Company, or (B) material adverse information concerning the Company that the Company had not publicly disclosed at least forty-eight (48) hours prior to the request or that the Company had not otherwise notified to the requesting Holder(s) at the time of such request or (C) any undue delay caused by the Company or any breach by the Company of this Agreement or (ii) with the Company’s agreement, the Holders of a majority of Registrable Securities subject to the proposed registration, as the case may be, agree to forfeit their right to one requested registration pursuant to Section 2.1, as applicable, in which event such right shall be forfeited by all Holders. 
 
(c)        If the Holders are required to pay Registration Expenses pursuant to terms hereof, such expenses shall be borne by the Holders in proportion to the number of Registrable Securities for which registration was requested by each such Person.  If the Company is required to pay the Registration Expenses of a withdrawn offering pursuant to Section 2.4(b)(i) above, then the Holders shall not forfeit their rights pursuant to Section 2.1.
 
2.5.       Obligations of the Company. Whenever required to effect the registration of any Registrable Securities, the Company shall, as promptly as reasonably practicable:
 
(a)        Prepare and file with the SEC not later than forty-five (45) calendar days after the request (i) a registration statement with respect to such Registrable Securities and use its reasonable best efforts to cause such registration statement to become effective or (ii) a prospectus supplement with respect to such Registrable Securities pursuant to an effective registration statement and, upon the request of Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective or such prospectus supplement current for up to one hundred and twenty (120) calendar days, other than a registration statement required by a Holder to be effected by means of a Shelf Registration Statement or an Amended Shelf Registration Statement pursuant to Section 2.1(d) or, if earlier, until the Holder or Holders have completed the distribution related thereto;  provided, however, that within a reasonable time before filing a registration statement or prospectus, or filing any amendment thereof or supplement thereto, the Company shall furnish copies of all such documents proposed to be filed to Holders’ Counsel and provide reasonable opportunity for Holders’ Counsel to comment thereon.
 
(b)        Prepare and file with the SEC such amendments and supplements to the applicable registration statement and the prospectus or prospectus supplement used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all Securities covered by such registration statement for the period set forth in paragraph (a) above.
 
(c)        Furnish to the Holders such number of copies of the applicable registration statement and each such amendment and supplement thereto (including in each case all exhibits) and a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them.
 

 
9

 

(d)        Use its reasonable best efforts to register and qualify the Securities covered by such registration statement under such other securities or blue sky laws of such jurisdictions as shall be reasonably requested by the Holders, to keep such registration or qualification in effect for so long as such registration statement remains in effect, and to take any other action which may be reasonably necessary to enable such Holders to consummate the disposition in such jurisdictions of the Securities owned by such Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions.
 
(e)        Enter into customary agreements (including, if the method of distribution is by means of an underwriting and/or if a bookrunner or bookrunners are to be appointed by a Holder in relation to any Registrable Securities, a customary underwriting and/or bookrunners’ agreement in form and substance reasonably satisfactory to the Holders with the managing underwriter or underwriters and/or bookrunners (as the case may be) of such offering; provided that such underwriting and/or bookrunners’ agreement shall incorporate customary protections given to underwriters and/or bookrunners (as the case may be) by issuers for the type of securities offering contemplated, including customary warranties and covenants given in favor of, and indemnification of, such underwriters and/or bookrunners (as the case may be) by the Company in form and substance satisfactory to the Company, acting reasonably; and provided, further, that the Company shall consult with the Holders prior to agreeing upon any fees, discounts or other amounts payable to such managing underwriter or underwriters and/or bookrunners (as the case may be) and take such other actions (including participating in and making documents available for the due diligence review of underwriters and/or bookrunners if the method of distribution is by means of an underwriting and/or if a bookrunner or bookrunners are to be appointed by a Holder in relation to any Registrable Securities) in accordance with customary market practice and make available appropriate members of management of the Company for assistance reasonably required in the selling effort relating to the Registrable Securities, including, but not limited to, participation in “road shows” to the extent customary in order to facilitate the disposition of such Registrable Securities. Each Holder participating in such distribution shall also enter into and perform its obligations under such underwriting and/or bookrunners’ agreement; provided, however, that no Holder shall be required to make any representations or warranties to, or agreements with, the Company or any underwriters and/or bookrunners (as the case may be) in connection with any registration statement, other than such customary representations, warranties or agreements of a selling stockholder regarding such Holder, such Holder’s title to the Registrable Securities, such Holder’s intended method or methods of distribution and any other representation, warranty or agreement required by law.
 
(f)         Notify each Holder of Registrable Securities at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event or the existence of any facts or circumstances as a result of which the applicable prospectus, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing.
 
(g)        Furnish, on the date that such Registrable Securities are delivered to the underwriters for sale, if such securities are being sold through underwriters, (i) an opinion, dated as of such date, of outside legal counsel representing the Company for the purposes of such registration, in form and substance as is customarily given by issuer’s counsel to underwriters in an underwritten public offering, addressed to the underwriters, (ii) a letter
 

 
10

 

dated as of such date, from the independent registered public accountants of the Company, in form and substance as is customarily given by independent registered public accountants to underwriters in an underwritten public offering, addressed to the underwriters and (iii) such other customary documents, certificates, resolutions or agreements as may reasonably be required by the underwriters.
 
(h)        Give written notice to the Holders:
 
(i)     
when any registration statement filed at the request of a Holder or in respect of which a Holder has exercised piggyback rights pursuant to Article II or any amendment thereto has been filed with the SEC (except any amendment effected by the filing of a document with the SEC pursuant to the Exchange Act) and when such registration statement or any post-effective amendment thereto has become effective;
 
(ii)     
of  any request by the SEC for amendments or supplements to any registration statement filed at the request of a Holder or in respect of which a Holder has exercised piggyback rights pursuant to Article II or the prospectus included therein or for additional information;
 
(iii)     
of the issuance by the SEC of any stop order suspending the effectiveness of any registration statement filed at the request of a Holder or in respect of which a Holder has exercised piggyback rights pursuant to Article II or the initiation of any proceedings for that purpose;
 
(iv)     
of the receipt by the Company or its legal counsel of any notification with respect to the suspension of the qualification of the Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and
 
(v)     
of the happening of any event or the existence of any facts or circumstances that requires the Company to make changes in any effective registration statement filed at the request of a Holder or in respect of which a Holder has exercised piggyback rights pursuant to Article II, or to the prospectus or prospectus supplement related to such registration statement, in order to correct any untrue statement of a material fact or any omission to state a material fact required to be stated therein or necessary to make the statements therein in light of the circumstances then existing not misleading (which notice shall be accompanied by an instruction to suspend the use of the prospectus until the requisite changes have been made).
 
(i)         Use its reasonable best efforts to prevent the issuance or obtain the withdrawal of any order suspending the effectiveness of any registration statement referred to in Section 2.5(h)(iii) at the earliest practicable time.
 

 
11

 

(j)         Upon the occurrence of any event contemplated by Section 2.5(h)(v) above, promptly prepare a post-effective amendment to such registration statement or a supplement to the related prospectus or file any other required document so that, as thereafter delivered to the Holders, the prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holders in accordance with Section 2.5(h)(v) above to suspend the use of the prospectus until the requisite changes to the prospectus have been made, then the Holders shall suspend use of such prospectus and use their reasonable best efforts to return to the Company all copies of such prospectus (at the Company’s expense) other than permanent file copies then in such Holder’s possession, and the period of effectiveness of such registration statement provided for above shall be extended by the number of days from and including the date of the giving of such notice to the date Holders shall have received such amended or supplemented prospectus pursuant to this Section 2.5(j).
 
(k)        Provide a transfer agent and registrar for purposes of settling any offering or sale of Registrable Securities, including with respect to the transfer of physical stock certificates into book-entry form in accordance with any procedures reasonably requested by the Holders or the underwriters.
 
(l)         Use its reasonable best efforts to cause all Registrable Securities to be listed, on or prior to the effective date of any registration statement, on each securities exchange or national market on which similar Securities issued by the Company are then listed.
 
(m)       On or prior to the effective date of any registration statement, to take all steps reasonably necessary to permit the deposit of all Registrable Securities that are not then held in the form of ADSs into such depositary receipt facility as the Company may then sponsor, and to prepare and file with the SEC any amendment to an existing registration statement on Form F-6, if necessary, to cover any ADSs held by any Holder or that will be held by any purchaser of Registrable Securities to be sold under any registration statement, it being understood that any customary fees, charges and taxes payable in connection with any deposit of Registrable Securities into a deposit agreement then sponsored by the Company shall be borne by the Holders pro rata on the basis of the number of Registrable Securities of each Holder to be deposited in accordance with this Section 2.5(m).
 
(n)        Cooperate as reasonably required with each Holder and each underwriter and their counsel, if Registrable Securities are being sold through underwriters, in connection with any filings required to made with the Financial Industry Regulatory Authority.
 
2.6.       Suspension of Sales; Effectiveness of Registration Statements.
 
(a)        Upon receipt of written notice from the Company that a registration statement, prospectus or prospectus supplement contains or may contain an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or that circumstances exist that make to inadvisable use such registration statement, prospectus or prospectus supplement, each Holder shall forthwith discontinue disposition of Registrable Securities until such Holder has received copies of a supplemented or amended prospectus or prospectus supplement or until such Holder is advised in writing by the Company that the use of the prospectus and, if applicable, prospectus supplement may be resumed, and, if so directed by the Company, such Holder shall use its reasonable best efforts to deliver to the Company (at the
 

 
12

 

Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the prospectus and, if applicable, prospectus supplement covering such Registrable Securities current at the time of receipt of such notice.  The total number of days that any such suspension may be in effect in any twelve (12) month period shall not exceed forty-five (45) calendar days.
 
(b)        A registration statement filed pursuant to this Article II shall be deemed not to have become effective (and the related registration shall be deemed not to have been effected) unless it has been declared effective by the SEC; provided, however, that if, after it has been declared effective, the offering of any Registrable Securities pursuant to such registration statement is interfered with by any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court (other than any such stop order or injunction issued as a result of the inclusion in such registration statement of any information supplied to the Company for inclusion therein by the Holders) that is not subsequently remedied, such registration statement shall be deemed not to have become effective; provided, further, however, if any such stop order, injunction or other order or requirement of the SEC or any other governmental agency or court is subsequently remedied, such registration statement shall be deemed not to have been effective during the period of such interference.
 
2.7.       Termination of Registration Rights. The registration rights granted under this Article II shall terminate with respect to any Holder as of the last day of the first calendar month in which the sum of the Registrable Securities held by such Holder (including any Registrable Securities issuable upon exchange of other securities held by such Holder) may be sold in a single transaction without registration pursuant to Rule 144K under the Securities Act without volume limitation or other restrictions on transfer thereunder.
 
2.8.       Furnishing Information
 
(a)        No Holder shall use any “free writing prospectus” (as defined in Rule 405 under the Securities Act) in connection with the sale of Registrable Securities without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed.
(b)         The Holders agree to furnish to the Company such customary information regarding themselves, the Registrable Securities held by them and the intended method of disposition of such securities as shall be required to effect the registration of their Registrable Securities.
 
2.9.       Indemnification.
 
(a)         The Company agrees to indemnify and hold harmless each Holder and, if a Holder is a Person other than an individual, such Holder’s officers, directors, commissioners, employees, agents, representatives and affiliates, and each person or entity, if any, that controls a Holder within the meaning of the Securities Act (each, an “Indemnitee”), against any and all losses, claims, penalties, damages, actions, liabilities, costs and expenses (including without limitation reasonable fees, expenses and disbursements of attorneys and other professionals), joint or several, arising out of or based upon any untrue or alleged untrue statement of material fact contained in any registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto or contained in any “free writing prospectus” (as such term is defined in
 

 
13

 

Rule 405 under the Securities Act) prepared by the Company or authorized by it in writing for use by such Holder (or any amendment or supplement thereto); or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that the Company shall not be liable to such Indemnitee in any such case to the extent that any such loss, claim, penalty, damage, liability (or action or proceeding in respect thereof), cost or expense arises out of or is (i) based upon an untrue statement or alleged untrue statement or omission or alleged omission made in such registration statement, including any such preliminary prospectus or final prospectus contained therein or any such amendments or supplements thereto or contained in any “free writing prospectus” (as such term is defined in Rule 405 under the Securities Act) prepared by the Company or authorized by it in writing for use by such Holder (or any amendment or supplement thereto), in reliance upon and in conformity with information regarding such Indemnitee or its plan of distribution or ownership interests which was furnished in writing to the Company by such Indemnitee for use in connection with such registration statement, including any such preliminary prospectus or final prospectus contained therein or any such amendments or supplements thereto or (ii) based upon offers or sales effected by or on behalf such Indemnitee “by means of” (as defined in Rule 159A under the Securities Act) a “free writing prospectus” (as defined in Rule 405 under the Securities Act) that was not authorized in writing by the Company.
 
(b)       If the indemnification provided for in Section 2.9(a) is unavailable to an Indemnitee with respect to any losses, claims, damages, actions, liabilities, costs or expenses referred to therein or is insufficient to hold the Indemnitee harmless as contemplated therein, then the Company, in lieu of indemnifying such Indemnitee, shall contribute to the amount paid or payable by such Indemnitee as a result of such losses, claims, damages, actions, liabilities, costs or expenses in such proportion as is appropriate to reflect the relative fault of the Indemnitee, on the one hand, and the Company, on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages, actions, liabilities, costs or expenses as well as any other relevant equitable considerations. The relative fault of the Company, on the one hand, and of the Indemnitee, on the other hand, shall be determined by reference to, among other factors, whether the untrue or alleged untrue statement of a material fact or omission to state a material fact relates to information supplied by the Company or by the Indemnitee and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.  The Company and each Holder hereby agree that it would not be just and equitable if contribution pursuant to this Section 2.9(b) were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in Section 2.9(a). Notwithstanding the provisions of this Section 2.9, in connection with any registration statement filed by the Company, no Indemnitee shall be required to contribute any amount in excess of the net proceeds received by such Indemnitee from the sale of Registrable Securities registered under such registration statement.  No Indemnitee guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from the Company if the Company was not guilty of such fraudulent misrepresentation.
 
(c)        Each Indemnitee shall:
 
 
(i)
give notice as promptly as reasonably practicable to the Company of any action commenced against it after receipt of a written notice of any claim or the commencement of any action, claim, suit, investigation or
 

 
14

 

 
proceeding in respect of which a claim for indemnification may be sought under this Section 2.9; and
 
 
(ii)
as promptly as reasonably practicable notify the Company after any such action is formally commenced (by way of service with a summons or other legal process giving information as to the nature and basis of the claim),
 
and shall keep the Company informed of, and, to the extent reasonably practicable, consult with the Company in relation to, all material developments in respect thereof, but in each case, only insofar as may be consistent with the terms of any relevant insurance policy and provided (in each case) that to do so would not, in such Indemnitee’s view (acting in good faith), be prejudicial to it (or to any Indemnitee connected to it) or to any obligation of confidentiality or other legal or regulatory obligation which that Indemnitee owes to any third party or to any regulatory request that has been made of it.  However, the failure to so notify the Company and keep the Company informed shall not relieve the Company from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve the Company from any liability which it may have otherwise than on account of the indemnity set out in this Section 2.9.
 
(d)        Legal advisers for Indemnitees shall be selected by the Company in consultation with the Indemnitees.
 
(e)        In no event shall the Company be liable for fees and expenses of more than one legal adviser (in addition to any local legal advisers) separate from its own legal advisers for the Holders in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances.
 
(f)         The Company shall have the sole right to conduct and settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 2.9 (whether or not the Indemnitees are actual or potential parties thereto), provided that (i) such rights are exercised in good faith; (ii) that no settlement, compromise or consent shall be entered into without reasonable consultation with the relevant Indemnitee; (iii) it shall obtain the consent of an Indemnitee in respect of any such settlement, compromise or consent that includes a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any Indemnitee (provided such consent shall not be unreasonably delayed or withheld).
 
2.10.     No Assignment or Novation of Registration Rights. No Holder shall be permitted to assign, novate, transfer or otherwise alienate in any way whatsoever, wholly or partially, all or any of its rights, interests and/or obligations under this Agreement without the prior written consent of the Company, save that such rights and interests (i) may be assigned once (only) upon the first transfer of a Holder’s Registrable Securities to which this Agreement relates to the transferee of such Registrable Securities and (ii) may be assigned by a Holder to an Associated Entity of that Holder.
 
2.11.     “Market Stand-Off’.  In connection with any registered sale of Securities by the Company in which the Holders shall participate by exercise of the rights provided hereunder,
 

 
15

 

such Holders hereby agree to discuss with the managing underwriter or underwriters of such registered sale entry by such Holders into market stand-off or similar agreements in connection with such Holders’ participation in such registered sale; provided that (i) no provision of this Agreement shall in any way be construed so at to require such Holders to enter into any such market stand-off or similar agreement and (ii)  such Holders shall in any case not enter into any such market stand-off or similar agreement unless all executive officers and directors of the Company enter into similar agreements and only if such Persons remain subject thereto (and are not released from such agreements) for at least the same period as may be applicable to such Holders.
 
2.12.     Rule 144 Reporting. With a view to making available to Holders the benefits of certain rules and regulations of the SEC which may permit the sale of the Registrable Securities to the public without registration, the Company agrees to use its reasonable best efforts to:
 
(a)        make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act or any similar or analogous rule promulgated under the Securities Act, at all times after the effective date of this Agreement;
 
(b)        file with the SEC, in a timely manner, all reports and other documents required of the Company under the Exchange Act; and
 
(c)        so long as a Holder owns any Registrable Securities, furnish to such Holder forthwith upon request (i) a written statement by the Company as to its compliance with the reporting requirements of Rule 144 under the Securities Act and of the Exchange Act, (ii) a copy of the most recent annual report of the Company and (iii) such other reports and documents as the Holder may reasonably request in availing itself of any rule or regulation of the SEC allowing it to sell any such Registrable Securities without registration.
 
2.13.    Other Registration Rights.  This agreement is subject to the terms of the NPRFC Registration Rights Agreement, in particular (without limitation) article 2.13 of the NPRFC Registration Right Agreement, and in the event that the Minister and the NPRFC grant any consent or waiver or agreement to the terms of this Agreement, any rights granted to the Holders pursuant to this Agreement shall rank pari passu with any rights granted to the NPRFC and/or the Minister pursuant to the NPRFC Registration Rights Agreement.
 
2.14.     Exercise of Holder Consent.  Where any provision of this Agreement provides for consultation with or the consent of the Holders or a representative of the Holders, such consultation or consent shall be deemed to be given, as the case may be, where the Company has consulted with or obtained the consent of either (i) a representative of the Holders nominated by a majority of the Holders of the Registrable Securities in the relevant registration undertaken pursuant to this Agreement or which would reasonably be expected to adversely affect the marketability of such Registrable Securities in any such registration; or (ii) in the absence of such a representative being appointed, the Initiating Holder or a representative of the Initiating Holder.
 

 
16

 

ARTICLE III
 
MISCELLANEOUS
 
3.1.       No Inconsistent Agreements.  The Company shall not hereafter enter into any agreement with respect to its Securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.
 
3.2.       Authority; Enforceability.  Each entity that is a party hereto has the corporate power and each has the authority to enter into this Agreement and to carry out its obligations hereunder. Each entity that is a party hereto is duly organized and validly existing under the laws of its jurisdiction of organization, and the execution of this Agreement and the consummation of the transactions contemplated herein have been duly authorized by all necessary action, and no other act or proceeding, corporate or otherwise, on its part is necessary to authorize the execution of this Agreement or the consummation of any of the transactions contemplated hereby. This Agreement has been duly executed and delivered by each party.
 
3.3.       Adjustments Affecting Registrable Securities.  The Company shall not amend, or permit any amendment of, its articles of association, by-laws or similar organizational documents which would reasonably be expected to adversely affect the ability of Holders to include Registrable Securities in a registration undertaken pursuant to this Agreement or which would reasonably be expected to adversely affect the marketability of such Registrable Securities in any such registration.
 
3.4.       No Assignment.  The rights, interests and powers granted to the Holders under this Agreement are personal to the Holders and do not attach to any securities or units of stock held by them (including without limitation any Securities or Registrable Securities) or in which they have an interest (at any time and whether acquired from the NPRFC or otherwise) and shall not be transferrable upon the transfer, disposal, grant or alienation by them of any interests whatsoever in such securities or units of stock, save pursuant to an assignment permitted under Section 2.10.  No right, interest or power granted under this Agreement shall be capable of being exercised by any successor of any Holder. No Holder shall be permitted to assign, novate, transfer or otherwise alienate in any way whatsoever, wholly or partially, all or any of its rights, interests and/or obligations under this Agreement without the prior written consent of the Company, save pursuant to an assignment permitted under Section 2.10.
 
3.5.       Applicable Law and Submission to Jurisdiction.
 
(a)         This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York, regardless of the law that might be applied under principles of conflicts of laws.
 
(b)         The Holders irrevocably submits to the nonexclusive jurisdiction of any New York State or United States Federal court sitting in the State of New York over any suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated thereby. Each Holder irrevocably waive, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any such suit, action or proceeding brought in such a court and any claim that any such suit, action or proceeding brought in such a court has been brought in an inconvenient forum. EACH
 

 
17

 

PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 3.5(b).
 
3.6.       Counterparts and Facsimile.  For the convenience of the parties hereto, this Agreement may be executed in any number of separate counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts will together constitute the same agreement. Executed signature pages to this Agreement may be delivered by facsimile and such facsimiles will be deemed as sufficient as if actual signature pages had been delivered.
 
3.7.       Titles and Subtitles.  The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.
 
3.8.       Notices.  Except as otherwise provided in this Agreement, all notices, requests, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier service, or when received by facsimile transmission if promptly confirmed, as follows:
 
(a)         if to the Company, to:
 
 
The Governor and Company of the Bank of Ireland
 
Head Office
 
40 Mespil Road,
 
Dublin 4, Ireland.
 
Attention: The Group Secretary
 
Fax: +353 (1)  661 56 71
   
 
with copies to:
   
 
Sullivan & Cromwell LLP
 
1 New Fetter Lane
 
London
 
EC4A 1AN
 
England
 
Attention: John O’Connor, Esq,
 
Fax: +44-20-7959-8950

 
18

 

if to a Holders, to the address and fax number (if any) se out opposite that Holder’s name in Schedule 1, with a copy to the person(s) (if any) specified in Schedule 1 or to such other address, facsimile number or telephone as either party may, from time to time, designate in a written notice given in a like manner. 

3.9.       Amendments and Waivers.  Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Holders of a majority of the Registrable Securities then outstanding. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each Holder of any Registrable Securities then outstanding, each future Holder of all such Registrable Securities, and the Company.
 
3.10.     Severability.  If any provision of this Agreement or the application thereof to any person or circumstance is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision to persons or circumstances other than those as to which it has been held invalid or unenforceable, will remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties
 
3.11.    [Deleted]
 
3.12.    Entire Agreement, Etc.  This Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, between the parties, with respect to the subject matter hereof.
 
3.13.     Remedies.  Any Person having rights under any provision of this Agreement shall be entitled to enforce such rights specifically, to recover damages caused by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law.
 
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as a deed as of the date first stated above.
 

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]
 

 
19

 

SCHEDULE 1

The Holders


Party
 
Address
 
Fax No.
Fairfax Financial Holdings Limited
 
 
95 Wellington Street West
Suite 800
Toronto
Ontario
Canada M5J 2N7
For the attention of:
Paul Rivett
Vice President and Chief Legal Officer
 
 
+1 416 367 4946
With a copy to:
 
 
 
William Fry
Fitzwilton House.
Wilton Place
Dublin 2
For the attention of:
Owen O’Connell
 
 
+353 1 639 5333
Fidelity Contrafund: Fidelity Advisor New Insights Fund
 
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Contrafund: Fidelity Contrafund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Variable Insurance Products Fund III: Balanced Portfolio
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 


 
20

 


Party
 
Address
 
Fax No.
Fidelity Advisor Series I: Fidelity Advisor Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Securities Fund: Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Capital Trust: Fidelity Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
Fidelity Advisor Series I: Fidelity Advisor Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Puritan Trust: Fidelity Low-Priced Stock Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 
Kennedy-Wilson Investments, LLC
 
 
 
Kennedy-Wilson Investments LLC
c/o Matt Windisch
9701 Wilshire Boulevard, Suite 700
Beverly Hills
CA 90212
USA
 
 
+ 001 310 887 6459
With a copy to:
 
 
William McMorrow
(wmcmorrow@kennedywilson.com) or Mary Ricks
(mricks@kennedywilson.com)
 
   


 
21

 


Party
 
Address
 
Fax No.
WLR/GS Master Co-Investment L.P.
 
 
 
 
 
WLR Master Co-Investment GP, LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
 
 
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
 
+ 001 212 278 9821
 
WLR Recovery Fund IV, L.P.
 
 
WLR Recovery Associates IV LLC
c c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
 
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
 
+ 001 212 278 9821
WLR Recovery Fund V, L.P.
 
 
WLR Recovery Associates V LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+001 212 278 9769
 
 
 
 
 
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
 
+ 001 212 278 9821
WLR IV Parallel Esc, L.P
 
 
WLR IV Parallel Esc, L.P.
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001  212 278 9769
 
 
 
 
 


 
22

 


Party
 
Address
 
Fax No.
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
 
+ 001 212 278 9821
Capital Research and Management Company
 
333 South Hope St
Los Angeles
CA 90071
SA
For the attention of:
Michael Downer
 
 
+ 001 213 486 9041
 
 
 
 





 

 

 
23

 


 
The Seal of
THE GOVERNOR & COMPANY
OF THE BANK OF IRELAND
was affixed in the presence of:
  /s/ John O'Donovan
 
Director/Secretary/Authorised Signatory
   
   
 
/s/ Richie Boucher
 
Director/Secretary/Authorised Signatory


 
24

 


SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ James Newman
 
Print name
Witness (Signature)
   
     
James Newman
   
Print name
   
     
Fitzwilton House, Wilton Place, Dublin 2
   
Print address
   


 
25

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY CONTRAFUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
26

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
VARIABLE INSURANCE PRODUCTS FUND III: BALANCED PORTFOLIO
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   



 
27

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY SECURITIES FUND: FIDELITY DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
28

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CAPITAL TRUST: FIDELITY VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   



 
29

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY PURITAN TRUST: FIDELITY LOW-PRICED STOCK FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   




 
30

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
KENNEDY-WILSON INVESTMENTS, LLC
by its authorised signatory
in the presence of:
 
/s/ Matthew Windisch
   
Authorised Signatory (Signature)
     
   
Matthew Windisch
/s/ Mark Martin
 
Print name
Witness (Signature)
   
     
Mark Martin
   
Print name
   
     
9701 Wilshire Blvd., Beverly Hills, CA 90212
   
Print address
   


 
31

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
 
   


SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
 
   




 
32

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS Master Co-Investment, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
 
   


SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
Wilbur L. Ross, Jr.
     
     
/s/ Stephen J. Naughton
   
Witness (Signature)
Stephen J. Naughton
1166 Avenue of the Americas, 25th Floor
New York, New York 10036
 
   



 
33

 

(EXECUTION PAGE OF REGISTRATION RIGHTS AGREEMENT)



 
 
SIGNED and DELIVERED AS A DEED
on behalf of
CAPITAL RESEARCH AND MANAGEMENT COMPANY
by its authorised signatory
in the presence of:
 
/s/ Michael J. Downer
   
Authorised Signatory (Signature)
     
   
Michael J. Downer, SVP and Secretary
/s/ Walt R. Burkley
 
Print name
Witness (Signature)
   
     
Walt R. Burkley
   
Print name
   
     
c/o 333 S. Hope Street, Los Angeles, CA 90071
   
Print address
   


34
EX-99 17 ex9.htm EXHIBIT 9 ex9.htm
Exhibit 9





THE MINISTER FOR FINANCE OF IRELAND


THE INVESTORS
















OFFER AGREEMENT

relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016
















William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

William Fry 2011

021444.0001.OMB

 
 

 

CONTENTS

1.
INTERPRETATION
 
4
       
2.
OFFER PROVISIONS
 
7
       
3.
INVESTORS’ REPRESENTATIONS AND WARRANTIES
 
10
       
4.
UNDERTAKINGS BY THE MINISTER
 
10
       
5.
SURVIVAL OF REPRESENTATIONS AND OBLIGATIONS
 
10
       
6.
NOTICES
 
10
       
7.
ASSIGNMENT
 
11
       
8.
WAIVER
 
11
       
9.
ENTIRE AGREEMENT
 
12
       
10.
COUNTERPARTS
 
12
       
11. 
GOVERNING LAW AND JURISDICTION
 
12
     
SCHEDULE 1
 
13
     
SCHEDULE 2
 
17
     
SCHEDULE 3
 
53
     
PART 1
 
53
     
SCHEDULE 3
 
54
     
PART 2
 
54
     
SCHEDULE 4
 
55
     
PART 1
 
55
     
SCHEDULE 4
 
56
     
PART 2
 
56
     
SCHEDULE 5
 
57
     
PART 1
 
57
     
SCHEDULE 5
 
58
     
PART 2
 
58
 
 
2

 

This Agreement is made on                                     2011
 
BETWEEN:

 
THE MINISTER FOR FINANCE OF IRELAND
of Upper Merrion Street, Dublin 2, Ireland
(hereinafter called the "Minister")
   
   
 
                      - and -
   
   
 
THE PERSONS WHOSE NAMES ARE SET OUT
IN SCHEDULE 1
(hereinafter called the “Investors”)


RECITALS:
 
A.
Under the note purchase agreement dated 8 July 2011 (the “Note Purchase Agreement”), the Issuer and the Minister have recorded certain arrangements agreed between them in relation to the issue of €1,000,000,000 (one billion euro) 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 by the Issuer (the “CCNs”).
 
B.
The CCNs shall be issued in registered form by a definitive certificate or certificates pursuant to the Agency Deed.
 
C.
Each of the Investors has agreed to acquire units of Ordinary Stock in the capital of the Issuer under the terms of the Stock Purchase Agreement and the Conditional Stock Purchase Agreement, as applicable.
 
D.
The Minister and each of the Investors have agreed that if:
 
 
(a)
it is proposed that any of the CCNs will be transferred by the Minister or any other State Entity to a Third Party, then each of the Investors shall have a right to purchase its Pro Rata Share of the CCNs subject to the conditions herein; or
 
 
(b)
a Conversion Event occurs, then each of the Investors shall have an option to acquire its Pro Rata Share of Ordinary Stock that is issued following the Conversion Event pursuant to the Conditions (the “Converted Ordinary Stock”);
 
 
(c)
if any State Entity becomes entitled to 2009 Bonus Stock then each of the Investors shall have an option to acquire its Pro Rata Share of the 2009 Bonus Stock subject to the conditions herein.
 
E.
Condition 3(g)(iii) of the Conditions provides (among other things) that in certain circumstances the Issuer can solicit third party investors in respect of the CCNs.  The Issuer has agreed with each of the Investors that prior to soliciting any such third party investors, it will notify each of the Investors of its intention to do so.  Under the terms of the Issuer Agreement, the Issuer has agreed (among other things) to notify each of the Investors prior to soliciting any such third party investors to purchase the CCNs from the Minister and to include each of the Investors in the negotiations to agree the price at which the CCNs might be sold by the Minister in accordance with Condition 3(g).
 
F.
The Minister and each of the Investors have entered into this Agreement to set out the arrangements between them in relation to the CCNs.
 

 
3

 

1.
Interpretation
 
1.1
In this Agreement, unless the context otherwise requires all terms defined in the Conditions shall have the same meanings when used herein. In this Agreement, the following words and expressions shall have the following meanings:
 
2009 Bonus Stock”, shall have the meaning given to that term in the Issuer’s Bye-Laws;
 
2009 Bonus Stock Sale Price”, in respect of each unit of 2009 Bonus Stock issued is an amount equal to 100 per cent of the Average Stock Price (as defined in the Issuer’s Bye-Laws) at which such unit is deemed to have been issued under the Issuer’s Bye-Laws;
 
Agency Deed”, the agency deed to be entered into prior to or on the Issue Date by the Issuer with Citibank, N.A., London Branch as fiscal agent, calculation agent and registrar;
 
Associated Entity”, in respect of an Investor, any company or other entity controlled by that Investor or which controls that Investor or which is under common control with the Investor and any fund or partnership managed by any such company or entity and “Associated Entities” shall be construed accordingly;
 
Authority”, means and includes (whether having a distinct legal personality or not) any supra-national, national or local government authority, central bank, financial services regulator, board, commission, department, division, organ, instrumentality, court or agency and any association, organisation or institution of which any of the foregoing is a member or to whose jurisdiction any of the foregoing is subject or in whose activities any of the foregoing in a participant including, without limitation, the Central Bank of Ireland, the Board of Governors of the Federal Reserve System, the Connecticut Department of Banking, the New York Department of Banking, the U.S. Securities and Exchange Commission, the Financial Services Authority of the United Kingdom, the Financial Supervision Commission of the Isle of Man, the Irish Revenue Commissioners, the Irish Takeover Panel, the Competition Authority of Ireland, the European Union or any federation, community, association or organisation of which Ireland shall be a member;
 
"Business Day", a day (excluding Saturdays, Sundays and public holidays) on which banks are generally open for business in the City of Dublin and London;
 
CCN Sale Price”, the sale price for each CCN, being the price which the Minister has demonstrated that a Third Party institutional purchaser is prepared to pay for the CCNs (by way of written evidence from such purchaser or written evidence from a third party financial intermediary which is an unconflicted internationally recognised leading investment bank with expertise in valuation);
 
"Central Bank", the Central Bank of Ireland;
 
Conditional Stock Purchase Agreement”, the agreement to be entered into on the date hereof between (among others) the Minister, the National Pensions Reserve Fund Commission and each of the Investors, providing (subject to certain conditions) for the purchase from the National Pensions Reserve Fund Commission of further Commission Stock (as defined therein);
 
"Conditions", the terms and conditions of the CCNs (as scheduled to the Agency Deed and as modified from time to time in accordance with their terms), being materially in the form of the draft terms and conditions set out in Schedule 2 to this Agreement, and any reference to a numbered "Condition" is to the corresponding numbered provision thereof;
 
Contracts”, the Note Purchase Agreement and the Agency Deed;
 
Deed of Adherence”, a deed of adherence in a form reasonably satisfactory to each of the Investors;
 

 
4

 

Deed of Undertaking”, the deed to be entered into on the date hereof between each of the Investors and the Issuer, providing (subject to certain conditions) for certain matters in connection with the transactions contemplated by the Stock Purchase Agreements;
 
Encumbrance”, any type of interest or equity of any person including any right to acquire, option, right of pre-emption or right of first refusal, restriction on transfer or use or conversion, or any mortgage, charge, assignment, hypothecation, pledge, lien or security interest, encumbrance, claim, third party rights or other agreement or arrangement of any nature whatsoever having a similar effect;
 
Fairfax”, Fairfax Financial Holdings Limited having its registered office at 95 Wellington Street West, Suite 800, Toronto, Ontario, Canada M5J 2N7;
 
Fully Diluted Ordinary Stock Capital”, shall have the meaning given to that term in the Deed of Undertaking;
 
Initial Proportion”, in respect of each Investor, the proportion of the Fully Diluted Ordinary Stock Capital held by it and its Associated Entities from time to time which is Sale Stock (as defined in the Stock Purchase Agreements) (including, for the avoidance of doubt, BoI Ordinary Stock acquired by way of rights issues, bonus issues and issues in lieu of dividend declared upon the Sale Stock (as defined in the Stock Purchase Agreements) and subsequently upon BoI Ordinary Stock so acquired, expressed as a percentage;
 
Investor’s Group”, in respect of each Investor means that Investor, any company or entity controlled by that Investor or which controls that Investor or which is under common control with that Investor and any fund or partnership managed by that Investor or any such company or entity;
 
Irish Takeover Act and Rules”, the Irish Takeover Panel Act 1997 (as amended) and all regulations made thereunder and the European Communities (Takeover Bids (Directive 2004/25/EC) Regulations 2006 (SI No 255 of 2006), the Irish Takeover Panel Act 1997 Takeover Rules 2007 (as amended).
 
Issuer”, The Governor and Company of the Bank of Ireland, a chartered corporation registered in Ireland with registered number C-1 whose registered office is at 40 Mespil Road, Dublin 4, Ireland;
 
Issuer Agreement”, the agreement dated on the date of this Agreement between the Issuer and each of the Investors in relation to the CCNs;
 
"Issue Date", such date as the Issuer and the Minister may agree, being not later than 29 July 2011;
 
Legal Reservations”:
 
 
(a)
the principle that equitable remedies are remedies which may be granted or refused at the discretion of the court, the limitation of enforcement by laws relating to bankruptcy, insolvency, court protection, liquidation, reorganisation, court scheme, moratoria, administration and other laws generally affecting the rights of creditors, the time barring of claims, the possibility that an undertaking to assume liability or to indemnify a person against non-payment of stamp duty may be void, defences of set-off or counterclaim and similar principles, rights and defences under the laws of any jurisdiction in which relevant obligations may have to be performed; and
 
 
(b)
any principles of the law limiting the obligations of any Investor;
 
Other Transaction Documents”, the Conditional Stock Purchase Agreement and the Stock Purchase Agreement;
 
Party”, a party to this Agreement and “Parties” shall be construed accordingly;
 

 
5

 

Pro Rata Share”, in respect of an Investor on any date, is a proportion equal to that Investor’s Initial Proportion on that date;
 
"Prospectus", the prospectus to be prepared in connection with the listing of the CCNs on the Stock Exchange;
 
"Prospectus Regulations", the Prospectus (Directive 2003/71/EC) Regulations 2005;
 
 “Specified Period”, the period commencing on the Issue Date and ending on the date on which a State Entity ceases to hold any of the CCNs;
 
"Stock Exchange", the Irish Stock Exchange;
 
Stock Purchase Agreement”, the stock purchase agreement to be entered into on the date of this Agreement between the Minister, the National Pensions Reserve Fund Commission and Fairfax;
 
Stock Purchase Agreements”, shall have the meaning given to that term in the Deed of Undertaking;
 
Stock Sale Price”, in respect of each unit of Ordinary Stock sold pursuant to Clause 2, shall be 100% of the price at which the unit of Ordinary Stock was issued to the Initial Holder;
 
Third Party”, any person who is not a State Entity;
 
"Working Hours", 9.00 am to 5.00 pm on a Business Day.
 
1.2
In this Agreement, unless the context otherwise requires:
 
 
1.2.1
a reference to:
 
 
(a)
any party includes its successors in title and permitted assigns;
 
 
(b)
a "person" includes any individual, firm, body corporate, association or partnership, government or state or agency of a state, local authority or government body or any joint venture association or partnership (whether or not having a separate legal personality) and that person's personal representatives, successors or permitted assigns;
 
 
(c)
a "company" will be construed so as to include any company, corporation or body corporate, wherever and however incorporated or established;
 
 
(d)
a Clause, paragraph, or Schedule, unless otherwise specified, is a reference to a Clause, paragraph of or Schedule to this Agreement;
 
 
(e)
writing or similar expressions includes, unless otherwise specified, transmission by facsimile but excludes email;
 
 
(f)
the singular includes the plural and vice versa and references to one gender includes all genders;
 
 
(g)
"day" or a "Business Day" will mean a period of 24 (twenty-four) hours running from midnight to midnight;
 
 
(h)
a "month" will mean a calendar month;
 
 
(i)
times are to time in Ireland;
 

 
6

 

 
(j)
a reference to a "subsidiary undertaking" is to be construed in accordance with the European Communities (Companies: Group Accounts) Regulations 1992 of Ireland and a "subsidiary" or "holding company" is to be construed in accordance with Section 155 of the Companies Act 1963 of Ireland; and
 
 
(k)
any other document referred to in this Agreement is a reference to that document as amended, varied, novated or supplemented at any time.
 
 
1.2.2
a reference to a statute or statutory provision will be construed as a reference to the laws of Ireland unless otherwise specified and includes:
 
 
(a)
any subordinate legislation made under it including all regulations, by-laws, orders and codes made thereunder;
 
 
(b)
any repealed statute or statutory provision which it re-enacts (with or without modification); and
 
 
(c)
any statute or statutory provision which modifies, consolidates, re-enacts or supersedes it;
 
in each case, prior to the date of this Agreement.
 
 
1.2.3
any phrase introduced by the terms "including", "include" and "in particular" or any similar expression will be construed as illustrative and will not limit the sense of the words preceding those terms.
 
1.3
The table of contents and headings in this Agreement are inserted for convenience only, and they are to be ignored in the interpretation of this Agreement.
 
1.4
References in this Agreement to CCNs being or to be "listed on the Stock Exchange" shall be to CCNs being or to be listed on the official list (the "Official List") of the Stock Exchange, having obtained approval from the Central Bank in its capacity as competent authority for admission of the CCNs to trading on the Stock Exchange's regulated market for listed securities.
 
1.5
References in this Agreement to the "Prospectus Directive" are to Directive 2003/7l/EC of the European Parliament and of the Council and shall include the Prospectus (Directive 2003/7l/EC) Regulations 2005 and any other relevant implementing measures of Ireland as well as Commission Regulation (EC) No. 809/2004.
 
2.
Offer Provisions
 
Offer of CCNs
 
2.1
On each occasion that the Minister proposes to sell or transfer any of the CCNs to a Third Party, the Minister shall forthwith by notice in writing to each Investor in the form set out in Part 1 of Schedule 3 (a “CCN Sale Notice”) offer to sell to each Investor that Investor’s Pro Rata Share of the CCNs at the CCN Sale Price.  Following receipt of the CCN Sale Notice, each Investor may apply in writing to the Minister by sending to the Minister a notice in the form set out in Part 2 of Schedule 3 (the “CCN Sale Acceptance Notice”) within 5 or, as the case may be, 2 Business Day(s) after the date of receipt of the CCN Sale Notice by the relevant Investor to acquire its Pro Rata Share of the CCNs provided that if the Minister proposes to sell or transfer any of the CCNs at the end of the solicitation period under Condition 3(g)(iii), the number of Business Days shall be reduced to 2.  Such CCN Sale Acceptance Notice shall include confirmation of such Investor’s Pro Rata Share and the Minister may rely on this confirmation for all purposes under this Agreement.
 
2.2
Following receipt of the CCN Sale Acceptance Notice by the Minister within the said period of 5 or, as the case may be, 2 Business Day(s), the relevant Investor shall purchase and the
 

 
7

 

Minister shall allocate to that Investor, its Pro Rata Share of the CCNs on the date (which shall not be less than 10 Business Days after the date of the relevant CCN Sale Notice) and at the price specified in the CCN Sale Notice.
 
2.3
The Minister shall be bound to transfer to the relevant Investor (or its nominee) and the relevant Investor shall be bound to purchase the CCNs comprised in a CCN Acceptance Notice on the date specified in the CCN Sale Notice against payment by such Investor to the Minister of the applicable CCN Sale Price for each relevant CCN.
 
Conversion Event -Converted Ordinary Stock
 
2.4
If a Conversion Event occurs and the CCNs have been converted into Ordinary Stock (the “Converted Ordinary Stock”) the Minister shall forthwith by notice in writing to each Investor in the form set out in Part 1 of Schedule 4 (a “Stock Sale Notice”) offer to sell to each Investor that Investor’s Pro Rata Share of the Converted Ordinary Stock at the Stock Sale Price.  Following receipt of a Stock Sale Notice, each Investor may apply in writing to the Minister by sending to the Minister a notice in the form set out in Part 2 of Schedule 4 (the “Stock Sale Acceptance Notice”) within 5 Business Days after the date of receipt of the Stock Sale Notice by the relevant Investor to acquire the Investor’s Pro Rata Share of the Converted Ordinary Stock or Approved Entity Shares, as the case may be.  Such Stock Sale Acceptance Notice shall include written confirmation of the Investor’s Pro Rata Share and the Minister may rely on such confirmation for all purposes under this Agreement.
 
2.5
Following receipt of the Stock Sale Acceptance Notice by the Minister within the said period of 5 Business Days, the relevant Investor shall purchase and the Minister shall allocate to that Investor, its Pro Rata Share of the Converted Ordinary Stock (or Approved Entity Shares, as the case may be) on the date (which shall not be less than 10 Business Days after the date of the Stock Sale Notice) and at the price specified in the Stock Sale Notice.
 
2.6
The Minister shall be bound to transfer to the relevant Investor (or its nominee) and the relevant Investor shall be bound to purchase the Converted Ordinary Stock (or Approved Entity Shares, if applicable) comprised in a Stock Sale Acceptance Notice on the date specified in the Stock Sale Notice against payment by such Investor to the Minister of the Stock Sale Price in respect of each such unit of Converted Ordinary Stock or Approved Entity Shares, as the case may be.
 
2009 Bonus Stock
 
2.7
If any State Entity becomes entitled to any units of 2009 Bonus Stock, the Minister shall forthwith by notice in writing to each Investor in the form set out in Part 1 of Schedule 5 (a “Bonus Stock Sale Notice”) offer to sell to each Investor that Investor’s Pro Rata Share of the 2009 Bonus Stock at the 2009 Bonus Stock Sale Price.  Following receipt of a Bonus Stock Sale Notice, each Investor may apply in writing to the Minister by sending to the Minister a notice in the form set out in Part 2 of Schedule 5 (the “Bonus Stock Sale Acceptance Notice”) within 5 Business Days after the date of receipt of the Bonus Stock Sale Notice by the relevant Investor to acquire the Investor’s Pro Rata Share of the 2009 Bonus Stock.  Such Bonus Stock Sale Acceptance shall include a written confirmation of the Investor’s Pro Rata Share and the Minister may rely on such confirmation for all purposes under this Agreement.
 
2.8
Following receipt of the Bonus Stock Sale Acceptance Notice by the Minister within the said period of 5 Business Days, the relevant Investor shall purchase and the Minister shall allocate to that Investor, its Pro Rata Share of the 2009 Bonus Stock on the date (which shall not be less than 10 Business Days after the date of the Bonus Stock Sale Notice) and at the price specified in the Bonus Stock Sale Notice.
 
2.9
The Minister shall be bound to transfer to the relevant Investor (or its nominee) and the relevant Investor shall be bound to purchase the 2009 Bonus Stock comprised in a Bonus Stock Sale Acceptance Notice on the date specified in the Bonus Stock Sale Notice against
 

 
8

 

payment by such Investor to the Minister of the 2009 Bonus Stock Sale Price in respect of each such unit of 2009 Bonus Stock.
 
Title
 
2.10
The Minister represents and warrants that each CCN, unit of 2009 Bonus Stock and/or unit of Ordinary Stock (or Approved Entity Shares, if applicable) which is sold to an Investor in accordance with the terms of this Agreement shall be sold by the Holder thereof as legal and beneficial owner free from Encumbrances.
 
Approved Entity Shares
 
2.11
In relation to any Conversion in respect of which the Conversion Date falls on or after a Takeover Date, where the Takeover Event is a Qualifying Takeover Event, references in this Agreement to Ordinary Stock shall be deemed to be references to Approved Entity Shares.
 
Irish Takeover Rules
 
2.12
Notwithstanding the date specified in a Stock Sale Notice or Bonus Stock Sale Notice, no purchase of Converted Ordinary Stock (or Approved Entity Shares, if applicable) or 2009 Bonus Stock shall occur unless and until each of the Investors is satisfied (and so declares by notice in writing to the Minister) that the Irish Takeover Panel has granted to them all such consents, waivers, derogations, clarifications and confirmations as are necessary pursuant to the Takeover Act and Rules (including pursuant to Rules 5 and 9), that all conditions thereto (including, if required, the approval by a “whitewash” resolution of the independent shareholders of the Issuer) have been fulfilled, that such consents, waivers or derogations are in full force and effect and that consequently none of the Investors will be restricted or prohibited from purchasing the Converted Ordinary Stock (or Approved Entity Shares, if applicable) or 2009 Bonus Stock (as the case may be) and that they (or any of them) will not be obliged to extend a mandatory offer to the shareholders of Issuer pursuant to the Irish Takeover Rules provided that, unless otherwise agreed by the Parties in writing, the number of applicable days shall not be more than 150 days from the date of relevant sale notice.
 
Authority Notifications/Approvals
 
2.13
Notwithstanding the number of Business Days specified in any of the provisions of this Clause 2, if a notification must be made to, or an authorisation obtained from, any Authority in respect of, or as a consequence of, any of the transactions contemplated by this Agreement the applicable number of Business Days shall be extended to permit the making of such notification to, or to obtain the required consent from, any relevant Authority provided that, unless otherwise agreed by the Parties in writing, the number of applicable days shall not be more than 150 days from the date of relevant sale notice.
 
Role of Minister
 
2.14
If the Minister is not the Holder of any CCNs, Converted Ordinary Stock (or Approved Entity Shares, if applicable) or 2009 Bonus Stock which are to be sold from time to time in accordance with the terms and conditions set out in this Clause 2 and the relevant CCNs, units of Converted Ordinary Stock (or Approved Entity Shares, if applicable) or 2009 Bonus Stock are held by another State Entity, the Minister shall exercise all powers and rights available to him and take such further actions (including procuring the taking of actions by any relevant State Entity) as may be required to transfer the full legal and beneficial title free from Encumbrances in any such CCNs, Converted Ordinary Stock (or Approved Entity Shares, if applicable) or 2009 Bonus Stock to the relevant Investor.
 
Conditionality
 
2.15
The rights and obligations of the Parties under this Agreement are conditional upon the Completion (as defined therein) of the transactions under the Stock Purchase Agreement.
 

 
9

 

Minimum Shareholding
 
2.16
Clause 2 shall only operate for the benefit of an Investor and be capable of enforcement by that Investor in each case in circumstances where such Investor (and/or members of the Investor’s Group) holds more than 0.5% of the Fully Diluted Ordinary Stock Capital.
 
3.
Investors’ Representations and Warranties
 
3.1
Investors’ Representations and Warranties:
 
Each of the Investors represents in respect of itself only that this Agreement has been duly authorised, executed and delivered by it and constitutes its valid, legally binding and enforceable obligations of each Investor subject to the Legal Reservations.
 
4.
Undertakings by the Minister
 
The Minister undertakes with the Investors that:
 
 
4.1
Contracts
 
During the Specified Period it will not, and will procure that no relevant State Entity, will (unless required to do so by an Authority), agree to amend or modify the terms of the Conditions or vote in favour of any resolution to do so if, as a result of such amendments or modifications any Investor’s Pro Rata Share would be altered, without obtaining the prior written consent of each of the Investors (such consent not to be unreasonably withheld) and in all other cases the Minster will notify each of the Investors prior to agreeing to amend or modify the terms of the Contracts (including the Conditions).
 
 
4.2
Remarketing Option
 
If any Initial Holder serves notice in writing on the Issuer under Condition 3(g)(iii) of any proposed Third Party Sale, the Minister will on the date of such service notify the Investors in writing of such service.
 
 
4.3
Deed of Adherence
 
The Minister will not transfer any of the CCNs, Converted Ordinary Stock  (or Approved Entity Shares, if applicable) or 2009 Bonus Stock to any State Entity which is not a party to this Agreement unless that State Entity shall, prior to such transfer, have entered into and delivered to each of the Investors, a Deed of Adherence.  On receipt of such Deed of Adherence by each of the Investors and upon completion of the transfer of CCNs, Converted Ordinary Stock (or Approved Entity Shares, if applicable) or 2009 Bonus Stock, as the case may be, such State Entity shall be deemed for all purposes to be a party to this Agreement and to be bound by the provisions and have the benefit of all covenants and undertakings contained herein as if such party was a party to this Agreement.
 
5.
Survival of Representations and Obligations
 
The representations, warranties, agreements, undertakings and indemnities in this Agreement shall continue in full force and effect despite completion of the transfers of any CCNs, 2009 Bonus Stock or Converted Ordinary Stock (or Approved Entity Shares, if applicable), as the case may be, in accordance with the terms of this Agreement.
 
6.
Notices
 
6.1
Subject to Clause 6.2, any notice or other communication under this Agreement will only be effective if it is in writing.
 

 
10

 

6.2
Communication by email will not be effective under this Agreement.
 
6.3
Any notice or other communication given or made under this Agreement will be addressed as provided in Clause 6.5 and, if so addressed, will, in the absence of earlier receipt, be deemed to have been duly given or made as follows:
 
 
6.3.1
if sent by personal delivery, on delivery at the address of the relevant party;
 
 
6.3.2
if sent by pre-paid post, two (2) clear Business Days after the date of posting; or
 
 
6.3.3
if sent by facsimile, when transmitted.
 
6.4
Any notice or other communication given or made, or deemed to have been given or made, outside Working Hours will be deemed not to have been given or made until the start of the next period of Working Hours.
 
6.5
The relevant notice details for the parties hereto are:
 
 
6.5.1
if to the Minister:
 
 
Address:
Upper Merrion Street
Dublin 2
 
 
Fax no.: 
+353 1 678 9936
 
 
Attention:
The Secretary General
Department of Finance
 
 
6.5.2
if to any of the Investors, to the address and fax number (if any) set out opposite that Investor’s name in Schedule 1, with copy to the person(s) if any specified in Schedule 1.
 
6.6
A party may notify the other parties of a change to its notice details. That notification will only be effective on:
 
 
6.6.1
any effective date specified in the notification; or
 
 
6.6.2
if no effective date is specified or the effective date specified is less than five (5) clear Business Days after the date when notice is received, the date falling five (5) clear Business Days after the notification has been received.
 
7.
Assignment
 
7.1
The Minister may not assign or transfer any of his rights, benefits or obligations under this Agreement without each of the Investor’s prior written consent provided that the Minister may assign and/or transfer any of his rights or benefits under this Agreement to any State Entity without consent.
 
7.2
Each Investor may assign the benefit of this Agreement to any Associated Entity and any Associated Entity may assign the benefit of this Agreement to any other Associated Entity but no Investor or Associated Entity may otherwise assign or transfer any of its rights or benefits under this Agreement.
 
8.
Waiver
 
A waiver by any Party or Parties of any breach of any of the terms, provisions or covenants of this Agreement or the acquiescence of any Party or Parties in any act (whether of commission or omission) which, but for such acquiescence, would be a breach as aforesaid shall not constitute a general waiver of such term, provision or covenant or of any subsequent act contrary thereto.  Any liability to any Party under the provisions of this
 

 
11

 

Agreement may be released, compounded or compromised by such Party in its absolute discretion as regards any Party or Parties under such liability without in any way prejudicing its rights against any other Party or Parties under the same or a like liability, whether joint and several or otherwise.
 
9.
Entire Agreement
 
This Agreement (together with the Other Transaction Documents) contains the entire agreement between the Parties relating to the transactions provided for in this Agreement and supersedes all previous representations, arrangements, undertakings and agreements (if any) between the Parties in respect of such matters.  Each of the Parties acknowledges that in agreeing to enter into this Agreement it has not relied on any representation, warranty, undertaking, covenant, pre-contractual statement or understanding other than those contained in this Agreement and/or the Other Transaction Documents.
 
10.
Counterparts
 
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same document and any party to this Agreement may enter into this Agreement by executing a counterpart.
 
11.
Governing Law and Jurisdiction
 
11.1
This Agreement, and all non-contractual obligations arising in connection therewith, shall be governed by and construed in accordance with Irish law.
 
11.2
The courts of Ireland are to have jurisdiction to settle any disputes which may arise out of or in connection with this Agreement and accordingly any legal action or proceedings arising out of or in connection with this Agreement ("Proceedings") may be brought in such courts. The Issuer irrevocably submits to the jurisdiction of such courts and waives any objection to Proceedings in such courts whether on the ground of venue or on the ground that the Proceedings have been brought in an inconvenient forum. These submissions are made for the benefit of the Minister and shall not limit the right of any of them to take Proceedings in any other court of competent jurisdiction nor shall the taking of Proceedings in one or more jurisdictions preclude the taking of Proceedings in any other jurisdiction (whether concurrently or not).
 
IN WITNESS WHEREOF this Agreement has been executed as a deed on the date of this Agreement.
 

 
12

 

SCHEDULE 1
 
The Investors
 
The relevant notice details are:
 
Party
 
Address
 
Fax No.
         
Fairfax Financial Holdings Limited
 
 
95 Wellington Street West
Suite 800
Toronto
Ontario
Canada M5J 2N7
For the attention of:
Paul Rivett
Vice President and Chief Legal Officer
 
 
+1 416 367 4946
With a copy to:
 
 
 
William Fry
Fitzwilton House.
Wilton Place
Dublin 2
For the attention of:
Owen O’Connell
 
 
+353 1 639 5333
Fidelity Contrafund: Fidelity Advisor New Insights Fund
 
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Contrafund: Fidelity Contrafund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Variable Insurance Products Fund III: Balanced Portfolio
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 


 
13

 


Party
 
Address
 
Fax No.
         
Fidelity Advisor Series I: Fidelity Advisor Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Securities Fund: Fidelity Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Capital Trust: Fidelity Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
Fidelity Advisor Series I: Fidelity Advisor Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Puritan Trust: Fidelity Low-Priced Stock Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 
Kennedy-Wilson Investments, LLC
 
 
 
Kennedy-Wilson Investments LLC
c/o Matt Windisch
9701 Wilshire Boulevard, Suite 700
Beverly Hills
CA 90212
USA
 
 
+ 001 310 887 6459


 
14

 


Party
 
Address
 
Fax No.
         
With a copy to:
 
 
William McMorrow
(wmcmorrow@kennedywilson.com) or Mary Ricks
(mricks@kennedywilson.com)
 
   
WLR/GS Master Co-Investment L.P.
 
 
 
 
 
WLR Master Co-Investment GP, LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
 
+ 001 212 278 9821
 
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR Recovery Fund IV, L.P.
 
 
WLR Recovery Associates IV LLC
c c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
+ 001 212 278 9821
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR Recovery Fund V, L.P.
 
 
WLR Recovery Associates V LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+001 212 278 9769
 
 
 
 
+ 001 212 278 9821


 
15

 


Party
 
Address
 
Fax No.
         
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR IV Parallel Esc, L.P.
 
 
WLR Recovery Associates IV LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001  212 278 9769
 
 
 
 
+ 001 212 278 9821
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
Capital Research and Management Company
 
333 South Hope St
Los Angeles
CA 90071
SA
For the attention of:
Michael Downer
 
 
+ 001 213 486 9041
 
 
 
 
 

 
16

 

SCHEDULE 2
 
Terms and Conditions
 
THE GOVERNOR AND COMPANY OF THE BANK OF IRELAND
 
TERMS AND CONDITIONS OF THE CONTINGENT CAPITAL TIER 2 NOTES
 
The following (excluding this paragraph) is the text of the terms and conditions (the “Conditions”) of the CCNs which (subject to modification) shall be endorsed on the Certificates relating to the CCNs.
 
The €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due [30] July 20161 (“CCNs”) issued by The Governor and Company of the Bank of Ireland (the “Issuer”), which expression shall in these Conditions include any further CCNs issued pursuant to Condition 10 and forming a single series with the CCNs, are subject to these Conditions and are issued pursuant to an agency deed dated on or about the Issue Date (the “Agency Deed”) made between the Issuer and [Citibank N.A., London Branch] as fiscal agent (the “Fiscal Agent”), calculation agent (the “Calculation Agent”) and registrar (the “Registrar”) (together with any other agent or agents appointed from time to time with respect to the CCNs, the “CCN Agents” and each a “CCN Agent”). Copies of the Agency Deed will be available during usual business hours at the specified offices of the Fiscal Agent.
 
The Holders are entitled to the benefit of, are bound by, and are deemed to have notice of those provisions applicable to them of the Agency Deed.
 
1.
Form, Denomination and Title
 
The CCNs are issued in definitive registered form, serially numbered, in denominations of €100,000 and integral multiples of €1,000 in excess thereof.
 
The CCNs are represented by a definitive registered certificate or, as the case may be, definitive registered certificates (each, a “Certificate”) and, save as provided in these Conditions, each Certificate shall represent the entire holding of CCNs by the same Holder.
 
Title to the CCNs shall pass by registration in the register that the Issuer shall procure to be kept by the Registrar in accordance with the provisions of the Agency Deed (the “Register”).
 
2.
Status and Subordination of the CCNs
 
 
(a)
Status
 
The CCNs constitute direct, unsecured and subordinated obligations of the Issuer and rank pari passu and without any preference among themselves. The rights and claims of the Holders are subordinated as described in Condition 2(b).
 
 
(b)
Subordination
 
Subject as provided below, in the event of an order being made, or an effective resolution being passed, for the liquidation, dissolution or winding-up of the Issuer by reason of insolvency, bankruptcy or otherwise, the rights and claims of the Holders against the Issuer in respect of or arising under (including any damages awarded for breach of any obligation under) the CCNs shall, subject to any obligations which are mandatorily preferred by law, rank (A) junior to the claims of all holders of unsubordinated obligations of the Issuer, (B) pari passu with the claims of holders of all other dated subordinated obligations of the Issuer which qualify as consolidated
 

 
17

 

Tier 2 Capital of the Group for regulatory capital purposes, and (C) senior to the claims of holders of all other subordinated obligations of the Issuer expressed to rank junior to the subordinated obligations of the Issuer including any subordinated obligations of the Issuer which qualify as Tier 1 Capital of the Group for regulatory purposes or which are expressed to rank junior to the CCNs.
 
3.
Interest
 
 
(a)
Interest Payment Dates
 
Each CCN bears interest on its principal amount from time to time from (and including) the Issue Date (the “Interest Commencement Date”) and interest will be payable in arrears at the Rate of Interest (as defined below) on [29] July in each year (each an “Interest Payment Date”) up to (but excluding) the Maturity Date in accordance with Condition 7.
 
If any Interest Payment Date falls on a day which is not a Business Day, such Interest Payment Date shall be postponed to the next day which is a Business Day unless it would then fall into the next calendar month, in which event the Interest Payment Date shall be brought forward to the immediately preceding Business Day.
 
The period from and including the Interest Commencement Date to (but excluding) the first Interest Payment Date, and each successive period from and including an Interest Payment Date to (but excluding) the next succeeding Interest Payment Date, or if earlier, the Maturity Date or the Conversion Date is called an “Interest Period”.
 
 
(b)
Interest Accrual
 
Interest accrues on each CCN from day to day from (and including) the Interest Commencement Date to (but excluding) the date on which such CCN has been redeemed in full. Each CCN will cease to bear interest from and including the due date for redemption unless, upon due presentation of the relevant Certificate, payment of the principal in respect of such CCN is improperly withheld or refused or unless default is otherwise made in respect of payment. In such event, interest will continue to accrue until whichever is the earlier of:
 
 
(i)
the date upon which all amounts due in respect of such CCN has been paid;
 
 
(ii)
five days after the date on which the full amount of the moneys in respect of such CCN has been received by the Fiscal Agent and notice to that effect has been given to the Holders; and
 
 
(iii)
in the case of a Conversion (as defined below), the Conversion Date.
 
 
(c)
Fixed Rate of Interest
 
Subject to Condition 3(g), interest is payable on each Interest Payment Date at a rate of 10.00 per cent. per annum (the “Rate of Interest”) and shall be calculated by the Calculation Agent in accordance with the Agency Deed on each Interest Payment Date in respect of each CCN.
 
 
(d)
Calculations
 
If interest is required to be calculated for a period other than a complete Interest Period, the day count fraction used will be the actual number of days in the relevant
 

 
18

 

period divided by the actual number of days in the Interest Period in which such payment falls (including the first such day but excluding the last).
 
 
(e)
Notifications to be Final
 
All notifications, opinions, determinations, certificates, calculations, quotations and decisions given, expressed, made or obtained for the purposes of the provisions of these Conditions by the Calculation Agent will, in the absence of wilful default, bad faith or manifest error, be binding on the Issuer, the Fiscal Agent and the Holders and in the absence of wilful default, bad faith or manifest error, no liability to the Issuer, the Fiscal Agent or the Holders shall attach to the Calculation Agent in connection with  exercise or non-exercise by it of its powers, duties and discretions under these Conditions.
 
 
(f)
No Deferral
 
The Issuer shall not be entitled to defer or cancel any payments of interest or any other amounts payable in respect of the CCNs.
 
 
(g)
Remarketing Option
 
 
(i)
For as long as the Initial Holder is Holder of 100 per cent. of the CCNs, the Initial Holder may, at any time, increase the Rate of Interest on the CCNs (such increased rate, the “New Interest Rate”) as determined by an independent investment bank appointed by the Initial Holder (the “Remarketing Agent”) but with effect only from the date that the CCNs are sold by the Initial Holder to any other person other than any State Entity (a “Third Party Sale”).
 
 
(ii)
For the purposes of this Condition 3(g), the New Interest Rate will not exceed 18.00 per cent. per annum.
 
 
(iii)
The Initial Holder will provide at least 15 Business Days notice in writing to the Issuer of any proposed Third Party Sale or such longer period as may be approved in writing by the Initial Holder. During such period, the Issuer may solicit other third party investors, at a potentially lower interest rate than the rate described in Condition 3(g)(ii), to whom the entire principal amount of the CCNs may be sold at an equivalent or higher price than the Initial Holder would receive for any proposed Third Party Sale.
 
 
(iv)
Notwithstanding any other provision of these Conditions or the Agency Deed to the contrary, the Initial Holder shall have absolute discretion as to whether to sell the CCNs, to whom it may sell the CCNs and the terms of any such sale.
 
 
(v)
The Issuer shall, if required by the Initial Holder: (a) disclose to the Initial Holder the identity of any third party investors solicited or to be solicited by the Issuer pursuant to Condition 3(g)(iii) and (b) provide and/or disclose all such information necessary, as determined by the Initial Holder in its absolute discretion, to facilitate the effecting of a Third Party Sale.
 
 
(h)
Maintenance of Agents
 
The Issuer shall ensure that, so long as any of the CCNs remain outstanding, there shall at all times be a Calculation Agent and a Fiscal Agent having its office in a
 

 
19

 

European city (other than Ireland) and not operating through a branch in Ireland, and that, if the Issuer or the Fiscal Agent would be required to withhold or deduct tax in respect of payments on the CCNs, the Issuer undertakes that it will ensure that it maintains a Fiscal Agent in a member state of the European Union (other than Ireland) that will not be obliged to withhold or deduct tax pursuant to European Council Directive 2003/48/EC on the taxation of savings or any law implementing or complying with, or introduced in order to confirm to, such Directive.
 
4.
Conversion
 
 
(a)
Conversion upon a Conversion Event
 
 
(i)
If a Conversion Event shall occur at any time while the CCNs are outstanding, each CCN shall, subject to and as provided in this Condition 4, be immediately and mandatorily redeemed as of the Conversion Date and settled (such redemption and settlement being the “Conversion” and the term “converted” shall be construed accordingly) by the allotment, issue and delivery by the Issuer of fully paid Ordinary Stock to the Holders on the date specified in the Conversion Notice (as defined below), which date shall be no later than 20 Business Days following the Conversion Date (the “Conversion Settlement Date”).  Subject to Condition 4(c), receipt by the Holders of the Ordinary Stock and Accrued Conversion Interest (if any) shall be a good and complete discharge of the Issuer’s obligations in respect of the CCNs.
 
 
(ii)
As soon as reasonably practicable following the occurrence of the Conversion Event, the Issuer shall give notice thereof to Holders (the “Conversion Notice”) in accordance with Condition 13. The Conversion Notice shall specify the circumstances giving rise to the Conversion Event, the Conversion Price and the Conversion Settlement Date.
 
 
(iii)
If a Conversion Event occurs, the CCNs will be converted in whole and not in part as provided in accordance with this Condition 4(a). CCNs so converted shall be automatically cancelled by the Issuer and may not be held, reissued or resold.
 
 
(iv)
Except on the occurrence of a Conversion Event, the CCNs are not convertible into Ordinary Stock at the option of Holders at any time and are not redeemable in cash as a result of a Conversion Event.
 
 
(v)
No Conversion Notice shall be given and no Conversion shall occur following a Capital Deficiency Event if, notwithstanding the Capital Ratio being below the Trigger Ratio, the Competent Authority, at the request of the Issuer, has agreed, in its absolute discretion, that a Conversion shall not occur because it is satisfied that actions, circumstances or events have had, or imminently will have during the next 90 days following such Capital Deficiency Event, the effect of restoring the Capital Ratio to a level above the Trigger Ratio that the Competent Authority deems to be adequate at such time.
 
 
(vi)
Notwithstanding Condition 4(a)(v), a Conversion Event will immediately occur if the Competent Authority determines, in its absolute discretion, that at any time after agreeing under Condition 4(a)(v) that no Conversion Event shall occur, the Issuer will not be able to restore the Capital Ratio to a level above the Trigger Ratio that the Competent Authority deems to be adequate at such time.
 

 
20

 

 
(b)
Accrued Conversion Interest
 
 
(i)
Upon Conversion, Accrued Conversion Interest shall become due and payable on the Conversion Date and the Issuer shall pay to the Holders the Accrued Conversion Interest (if any) in respect of the CCNs on the Conversion Settlement Date.
 
 
(ii)
Payment of any Accrued Conversion Interest will be made in cash by transfer to an account with a bank in a city in which banks have access to the TARGET System, as specified by the relevant Holder.
 
 
(c)
Conversion Price
 
 
(i)
Upon Conversion, each Holder shall be deemed to have accepted the conversion of its holding of CCNs into Ordinary Stock at the Conversion Price and that the Issuer shall effect such conversion on behalf of such Holder. Such Ordinary Stock will be deemed to be credited as fully paid up and allotted, issued and delivered as of the Conversion Date, whereupon each Holder shall cease as a matter of Irish law to be treated for all purposes under Irish law as a Holder and shall instead as of such date be treated for all purposes under Irish law as a Stockholder.
 
 
(ii)
The Issuer shall, not later than the Conversion Settlement Date, allot and issue or deliver such number of units of Ordinary Stock to the Holders in respect of each CCN as is determined by dividing the principal amount of such CCN by the Conversion Price in effect on the Conversion Date.
 
 
(iii)
The Conversion Price shall be subject to adjustment in the circumstances provided in Condition 4(e) for the adjustment of the Floor Price (with such modifications and amendments as an Independent Financial Adviser acting in good faith shall determine to be appropriate) and the Issuer shall give notice to Holders of the New Floor Price and of any such modifications and amendments thereafter.
 
 
(d)
Conversion on a Takeover Event
 
 
(i)
If a Qualifying Takeover Event shall occur then the CCNs shall, where the Conversion Date falls on or after the Takeover Event Date, be convertible into Approved Entity Shares upon the occurrence of a Conversion Event, mutatis mutandis as provided in accordance with this Condition 4, at a Conversion Price that shall be the New Conversion Price.
 
 
(ii)
The New Conversion Price shall be subject to adjustment in the circumstances provided in Condition 4(e) for the adjustment of the Floor Price (if necessary with such modifications and amendments as an Independent Financial Adviser acting in good faith shall determine to be appropriate) and the Issuer shall give notice to Holders of the New Conversion Price and of any such modifications and amendments thereafter.
 
 
(iii)
If a Non-Qualifying Takeover Event shall occur then, with effect from the occurrence of such Takeover Event and unless a Conversion Event shall have occurred prior to such date, any outstanding CCNs shall remain the obligation of the Issuer and shall, upon the occurrence of a Conversion Event, be convertible into Ordinary Stock in accordance with this Condition 4 but shall
 

 
21

 

not be convertible into Approved Entity Shares at any time notwithstanding that a Conversion Event may occur subsequently.
 
 
(iv)
In the case of a Qualifying Takeover Event:
 
 
(1)
the Issuer shall, on or prior to the Takeover Event Date, enter into such agreements and arrangements, (which may include deeds supplemental to these Conditions and amendments and modifications to these Conditions) as may be required to ensure that, with effect from the Takeover Event Date, the CCNs will be convertible into Approved Entity Shares of the Approved Entity, mutatis mutandis in accordance with, and subject to, this Condition 4 (as may be so supplemented, amended or modified) at a price equal to the New Conversion Price and that subject to such Conversion the CCNs shall remain the obligations of the Issuer; and
 
 
(2)
the Issuer shall, where the Conversion Date falls on or after the Takeover Event Date, procure the allotment and issue and/or delivery of the relevant number of Approved Entity Shares in the manner provided in this Condition 4, as may be amended or modified as provided above.
 
 
(v)
Within 10 Business Days following the occurrence of a Takeover Event, the Issuer shall give notice thereof in accordance with Condition 13 to the Holders (a “Takeover Event Notice”), which shall specify.
 
(1)           the identity of the Acquirer;
 
 
(2)
whether the Takeover Event is a Qualifying Takeover Event or a Non-Qualifying Takeover Event;
 
 
(3)
in the case of a Qualifying Takeover Event, if determined at such time, the New Conversion Price; and
 
 
(4)
in the case of a Qualifying Takeover Event, the Takeover Event Date.
 
 
(e)
Adjustments to the Floor Price
 
Upon the happening of any of the events described below, the Floor Price shall be adjusted, unless, for as long as the Initial Holder is a holder of 100 per cent. of the CCNs, the Initial Holder within six months of the Issue Date agrees that no adjustment is required, as follows:
 
 
(i)
Increase of share capital by means of capitalisation of reserves, profits or premia by distribution of Ordinary Stock, or division or consolidation of Ordinary Stock
 
Subject to Condition 4(f), in the event of a change in the Issuer’s share capital as a result of the capitalisation of reserves, profits or premia by means of the distribution of Ordinary Stock or as a result of the division or consolidation of the Ordinary Stock, the Floor Price shall be adjusted by multiplying the Floor Price in force immediately prior to such change by the result of the following formula:
 
Nold / Nnew
 

 
22

 

where:
 
 
Nold
is the number of units of Ordinary Stock existing before the change in share capital; and
 
 
Nnew
is the number of units of Ordinary Stock existing after the change in share capital;
 
provided, however, that no such adjustment shall be made if Ordinary Stock are issued in lieu of the whole or any part of a Cash Dividend, or another cash distribution made in lieu of a dividend, which the Stockholders concerned would or could otherwise have received. Such adjustment shall become effective on the date on which such Ordinary Stock are traded ex-the relevant entitlement on the Primary Stock Exchange.
 
 
(ii)
Issues of Ordinary Stock or Other Securities to Stockholders by way of conferring subscription or purchase rights
 
Subject to Condition 4(f), if (a) the Issuer issues or grants to Stockholders any rights or options, warrants or other rights to subscribe for or acquire Ordinary Stock, Other Securities or securities convertible or exchangeable into Ordinary Stock or Other Securities or (b) any third party, with the agreement of the Issuer, issues to holders of Ordinary Stock any rights, options or warrants to purchase any Ordinary Stock, Other Securities or securities convertible or exchangeable into Ordinary Stock or Other Securities (the rights referred to in (a) and (b) collectively and individually being the “Purchase Rights”), the Floor Price shall be adjusted by multiplying the Floor Price in force immediately prior to such issue or grant by the result of the following formula:
 
(Pcum – R) / Pcum
 
where:
 
 
Pcum
is the VWAP of one unit of Ordinary Stock on whichever is the later of (x) the last dealing day immediately preceding the first date on which the Ordinary Stock is first traded ex-the relevant Purchase Rights on the Primary Stock Exchange or (y) the dealing day when the price for the relevant Purchase Rights is announced, or if the day the subscription or purchase price is announced is not a dealing day, the next following dealing day; and
 
 
R
is the value of the relevant Purchase Rights relating to one unit of Ordinary Stock or Other Security, such value to be calculated as follows:
 
(1)        if the Purchase Rights relate to Ordinary Stock
 
R = Pcum – TERP
 
where:
 
TERP           = (Nold x Pcum + Nnew x (Prights + Div)) / (Nold + Nnew)
 
and:
 

 
23

 

TERP   is the theoretical ex-rights price; and
 
 
Nold
is the number of units of Ordinary Stock existing before the change in share capital; and
 
 
Nnew
is the number of units of Ordinary Stock being newly issued; and
 
 
Prights
is the price at which one new unit of Ordinary Stock can be subscribed, exercised or purchased for; and
 
 
Div
is the amount (in euro) by which the dividend entitlement per unit of Ordinary Stock exceeds the dividend entitlement per new unit of Ordinary Stock, (x) if dividends have already been proposed to the general meeting of shareholders but not yet paid, based on the proposed dividend amount, or (y) if dividends have not yet been proposed based on the last paid dividend;
 
provided, however, that no such adjustment shall be made if the subscription or purchase price at which one new unit of Ordinary Stock can be subscribed or purchased is at least 95 per cent. of Pcum (as defined above);
 
 
(2)
if the Purchase Rights relate to Other Securities or to securities convertible or exchangeable into Ordinary Stock or Other Securities and where such Purchase Rights, or Other Securities are traded on a regulated stock exchange in the European Union, the United States of America, Canada or Japan:
 
R = Nrights x Prights
 
where:
 
 
Nrights
is the number of Purchase Rights granted per unit of Ordinary Stock; and
 
 
Prights
is the average of the last paid prices on the Primary Stock Exchange (in euro) (or, if no dealing is recorded, the arithmetic mean of the bid and offered prices) on a spot basis of one Purchase Right on each dealing day during the period the Purchase Rights are traded or, if such period is longer than ten dealing days, the arithmetic average of the last paid prices (or, if no dealing is recorded, the arithmetic mean of the bid and offered prices) on a spot basis on the first ten such dealing days; or
 
 
(3)
in all other cases where neither of the previous paragraphs (1) or (2) is applicable:
 
R will be determined by an Independent Financial Adviser.
 
Such adjustment shall become effective:
 

 
24

 

 
(i)
where the provisions of Condition 4(e)(ii)(1) apply, on the date on which the Ordinary Stock are traded ex-Purchase Rights on the Primary Stock Exchange or, if the subscription or exercise price is announced only at a later time, one dealing day after the announcement of the price of the Purchase Right;
 
 
(ii)
where the provisions of Condition 4(e)(ii)(2) apply, five dealing days after (x) the end of the subscription or purchase period or (y) the tenth day of the subscription or purchase period, whichever is the sooner; and
 
 
(iii)
where the provisions of Condition 4(e)(ii)(3) apply, on the date determined by an Independent Financial Adviser.
 
 
(iii)
Capital Distributions
 
Subject to Condition 4(f), if and whenever any Capital Distribution shall be made or paid to Stockholders, the Floor Price shall be adjusted by multiplying the Floor Price in force immediately prior to the Effective Date by the following fraction:
 
(Pcum – D) / Pcum
 
where:
 
 
Pcum
is the VWAP of one unit of Ordinary Stock on whichever is the later of (x) the last dealing day immediately preceding the Effective Date or (y) the dealing day when the relevant Dividend is announced (or, if the day on which the amount of the relevant Dividend is announced is not a dealing day, the next following dealing day); and
 
 
D
is the portion of the Fair Market Value of the aggregate Capital Distribution attributable to one unit of Ordinary Stock, with such portion being determined by dividing the Fair Market Value of the aggregate Capital Distribution on the Effective Date by the number of units of Ordinary Stock entitled to receive the relevant Dividend (or, in the case of a purchase, redemption or buy back of Ordinary Stock (or any depositary or other receipts or certificates representing Ordinary Stock) by or on behalf of the Issuer or any Subsidiary of the Issuer, by the number of units of Ordinary Stock in issue immediately following such purchase, redemption or buy back, and treating as not being in issue any Ordinary Stock (or any Ordinary Stock represented by depositary or other receipts or certificates) so purchased, redeemed or bought back).
 
Such adjustment shall become effective on the Effective Date or, if later, the first date upon which the Fair Market Value of the relevant Capital Distribution is capable of being determined as provided herein.
 
 
(iv)
Non-Cash Dividends
 
Subject to Condition 4(f), in respect of a Non-Cash Dividend, the Floor Price shall be adjusted as follows:
 

 
25

 

 
(1)
where the Non-Cash Dividend in question (x) consists of securities that are traded on a regulated stock exchange in the European Union, the United States of America, Canada or Japan or (y) has otherwise a value which is determinable by reference to a stock exchange quotation or otherwise, by multiplying the Floor Price in force immediately prior to such Non-Cash Dividend by the result of the following formula:
 
(Pcum – D) / Pcum
 
where:
 
 
Pcum
is the VWAP of one unit of Ordinary Stock on whichever is the later of (x) the last dealing day preceding the date on which the Ordinary Stock is first traded ex-the relevant Non-Cash Dividend on the Primary Stock Exchange or (y) the dealing day when the amount of the relevant Non-Cash Dividend is announced (or, if the day on which the amount of the relevant Non-Cash Dividend is announced is not a dealing day, the next following dealing day); and
 
 
D
is the portion of the Fair Market Value of the relevant Non-Cash Dividend (in euro) on the dealing day immediately following the date in respect of which Pcum (as defined above) has been determined; and
 
 
(2)
in all other cases, by multiplying the Floor Price in force immediately prior to such issue or distribution by the result of the following formula:
 
Pafter / Pbefore
 
where:
 
 
Pafter
is the arithmetic average of the VWAP of a unit of Ordinary Stock on the first five consecutive dealing days starting on the dealing day immediately following the first dealing day on which the Ordinary Stock are traded ex-the relevant Non-Cash Dividend (the “Distribution Date”); and
 
 
Pbefore
is arithmetic average of the VWAP of a unit of Ordinary Stock on the five consecutive dealing days ending on the dealing day immediately preceding the Distribution Date,
 
as determined by an Independent Financial Adviser.
 
Such adjustment shall become effective:
 
 
(i)
where the provisions of Condition 4(e)(iv)(1) apply, on the date on which the relevant Non-Cash Dividend is made; and
 
 
(ii)
where the provisions of Condition 4(e)(iv)(2) apply, five dealing days after the Distribution Date.
 

 
26

 

 
(v)
Other Events
 
If the Issuer determines that, notwithstanding paragraphs (i) to (iv) of this Condition 4(e), an adjustment should be made to the Floor Price as a result of one or more of the events or circumstances not referred to in this Condition 4(e) or circumstances have arisen which might have an adverse effect on the right of the Holders upon Conversion of the CCNs and no adjustment of the Floor Price under this Condition 4(e) would otherwise arise, the Issuer shall engage the advice or services of an Independent Financial Adviser to determine as soon as practicable what adjustment, if any, to the Floor Price or amendment, if any, to the terms of this Condition 4 is fair and reasonable to take into account thereof and the date on which such adjustment should take effect.  The Independent Financial Adviser shall have no responsibility to make any enquiries as to whether or not any event has occurred which might require an adjustment to the Floor Price or amendment, if any, to the terms of this Condition 4.
 
Notwithstanding the foregoing provisions of this Condition 4(e)(v):
 
 
(1)
where the events or circumstances giving rise to any adjustment pursuant to this Condition 4(e) have already resulted or will result in an adjustment to the Floor Price or where the events or circumstances giving rise to any adjustment arise by virtue of any other events or circumstances which have already given or will give rise to an adjustment to the Floor Price or where more than one event which gives rise to an adjustment to the Floor Price occurs within such a short period of time that, in the opinion of the Issuer, a modification to the operation of the adjustment provisions is required to give the intended result, such modification shall be made to the operation of the adjustment provisions as may be determined in good faith by an Independent Financial Adviser to be in its opinion appropriate to give the intended result;
 
 
(2)
such modification shall be made to the operation of the CCNs as may be determined in good faith by an Independent Financial Adviser to be in its opinion appropriate (i) to ensure that an adjustment to the Floor Price or the economic effect thereof shall not be taken into account more than once and (ii) to ensure that the economic effect of a Dividend is not taken into account more than once;
 
 
(3)
for the avoidance of doubt, the issue of Ordinary Stock upon a Conversion or upon any conversion or exchange in respect of any Other Securities or the exercise of any other options, warrants or other rights shall not result in an adjustment to the Floor Price; and
 
 
(4)
at any time when the Ordinary Stock are not admitted to trading on a Recognised Stock Exchange, the Floor Price shall be adjusted as provided above save that for the purposes thereof the Current Market Price, the VWAP of a unit of Ordinary Stock and the date upon which any adjustment becomes effective shall be determined in good faith by an Independent Financial Adviser in such manner as it considers appropriate to ensure that an adjustment to the Floor Price is made which gives the intended same result as if the Ordinary Stock we so admitted to trading.
 

 
27

 

Notice of any adjustments to the Floor Price pursuant to this Condition 4(e)(v) shall be given by the Issuer in accordance with Condition 13 to Holders promptly after the determination thereof.
 
The Floor Price shall not in any event be reduced to below the prevailing nominal value of the Ordinary Stock at the effective date of such adjustment. The Issuer shall not take any action, and procure that no action is taken, that would otherwise result in an adjustment to the Floor Price to an amount below such nominal value.
 
 
(f)
Events not Giving Rise to Adjustments
 
Notwithstanding the provisions of Condition 4(e), no adjustment to the Floor Price will be made:
 
 
(i)
as a result of any issue or distribution of new Ordinary Stock or Other Securities if the pre-emptive right in respect thereof has been validly excluded by a non-routine resolution of the general meeting of Stockholders unless a pre-emptive right in respect thereof is granted indirectly to the Stockholders by a third party with the agreement of the Issuer. For the purpose of these Conditions, the annual disapplication of pre-emption rights conferred by way of special resolution proposed at each annual general meeting of the Issuer shall not constitute a non-routine resolution; or
 
 
(ii)
as a result of any public issue of bonds convertible into Ordinary Stock or bonds with options to subscribe for Ordinary Stock, such issue being in connection with a conditional increase of the share capital of the Issuer, irrespective of whether in respect of such issue the advance subscription rights to acquire such bonds have been excluded or not, unless advance subscription rights have been granted and are traded on the Primary Stock Exchange; or
 
 
(iii)
if, as a result of any Non-Cash Dividend by the Issuer, the Issuer sells any share, right, warrant or other security representing the same (an “Interest”) in any of its subsidiaries to holders of the Ordinary Stock at fair value, and for this purpose:
 
 
(1)
where such Interest is listed on, traded on, or dealt in any stock exchange, the fair value of such Interest shall be at least 95 per cent. of the average of the last paid prices therefor on such stock exchange (or, if more than one, the principal such stock exchange) on each of the ten dealing days commencing on the twentieth dealing day before the day on which the Issuer officially announces the terms and conditions for such sale, as determined by an Independent Financial Adviser; and
 
 
(2)
where such Interest is not so listed, traded or dealt in, the fair value of such Interest shall be at least 95 per cent. of the Fair Market Value thereof; or
 
 
(iv)
if an increase in the Floor Price would result from such adjustment, except in case of an exchange of the Ordinary Stock for Other Securities or a consolidation of Ordinary Stock.
 

 
28

 

 
(g)
Decision of an Independent Financial Adviser
 
 
(i)
If any doubt shall arise as to whether an adjustment falls to be made to the Floor Price or the Conversion Price or as to the appropriate adjustment to the Floor Price, and following consultation between the Issuer and an Independent Financial Adviser, a written opinion of such Independent Financial Adviser in respect thereof shall be conclusive and binding on the Issuer and the Holders, save in the case of manifest error.
 
 
(ii)
If the Independent Financial Adviser does not at any time for any reason make any determination or calculate any adjustment in the circumstances provided for in this Condition 4 then the Holders shall, at the expense of the Issuer, be entitled to appoint an agent to do so, and such determination or calculation shall be deemed to have been made by the Independent Financial Adviser. In doing so, the Holders’ agent shall apply the foregoing provisions of Condition 4, with any necessary consequential amendments, to the extent that, in its opinion, it can do so, and in all other respects it shall do so in such manner as it shall deem fair and reasonable in all the circumstances.
 
 
(h)
Share Option Schemes
 
No adjustment will be made to the Floor Price if Ordinary Stock or Other Securities (including pre-emptive rights, options or warrants in relation to Ordinary Stock or Other Securities) are issued, offered or granted to, or for the benefit of, directors or employees, or former directors or employees, of the Issuer or any of its Subsidiaries or any associated company or to trustees to be held for the benefit of any such person in any such case pursuant to any employee share or option scheme which, if required, has been approved by Stockholders.
 
 
(i)
Rounding Down
 
On any adjustment, the resultant Floor Price, if a number that is of more decimal places than the initial Floor Price, shall be rounded to such decimal place. No adjustment shall be made to the Floor Price where such adjustment (rounded down if applicable) would be less than one per cent. of the Floor Price then in effect. Any adjustment not required to be made, and/or any amount by which the Floor Price has been rounded down, shall be carried forward and taken into account in any subsequent adjustment, and such subsequent adjustment shall be made on the basis that the adjustment not required to be made had been made at the relevant time and/or, as the case may be, that the relevant rounding down had not been made.
 
 
(j)
No other Conversion Events
 
Other than a Conversion in accordance with this Condition 4, the CCNs are not subject to any other conversion event. In particular, the CCNs are not convertible into Ordinary Stock at the option of the Holders.
 
 
(k)
Procedure for Settlement and Delivery of Ordinary Stock on Conversion
 
Ordinary Stock to be issued upon a Conversion in respect of the CCNs shall be allotted, issued and delivered subject to and as provided in these Conditions and in the Agency Deed.
 

 
29

 

 
(l)
Fractions
 
Fractions of Ordinary Stock will not be issued or delivered pursuant to the Conditions upon a Conversion and no cash payment will be made in lieu thereof.
 
 
(m)
Delivery of Ordinary Stock
 
 
(i)
The Issuer shall, on or prior to the Conversion Settlement Date, allot and issue or deliver to the Holders such number of units of Ordinary Stock as is required to satisfy in full the Issuer’s obligation to deliver Ordinary Stock in respect of the Conversion of the aggregate amount of CCNs as at the Conversion Date. Receipt by the Holders of such Ordinary Stock and Accrued Conversion Interest (if any) shall be a good and complete discharge of the Issuer’s obligations in respect of the CCNs.
 
 
(ii)
In order to obtain delivery of the relevant Ordinary Stock upon a Conversion, the relevant Holder must deliver the relevant Certificates representing the CCNs held by it to the specified office of the Registrar prior to the Conversion Settlement Date.
 
 
(iii)
The Issuer shall procure that Ordinary Stock to be created, issued and delivered following a Conversion Event will be delivered to the Holders in uncertificated form through CREST, unless at the relevant time the Ordinary Stock are not a participating security in CREST or the relevant holder elects to receive the Ordinary Stock in certificated registered form.  Where the Ordinary Stock are to be delivered through CREST, they will be delivered to an account specified by the relevant Holder prior to the Conversion Settlement Date. Where the Ordinary Stock are to be delivered in certificated form, a certificate in respect thereof will be dispatched by mail free of charge (but uninsured and at the risk of the recipient) to the relevant Holder or prior to the Conversion Settlement Date.
 
 
(n)
Taxes and Duties
 
 
(i)
A Holder must pay any taxes and capital, stamp, issue and registration and transfer taxes or duties arising on Conversion (other than any taxes and capital, stamp, issue and registration and transfer taxes or other duties payable in Ireland in respect of the issue and delivery of the Ordinary Stock delivered pursuant to these Conditions which shall be paid by the Issuer) and such Holder must pay all, if any, taxes arising by reference to any disposal or deemed disposal of a CCN or interest therein.
 
 
(ii)
If the Issuer shall fail to pay any taxes or capital, stamp, issue, registration and transfer taxes or other duties payable in Ireland for which it is responsible as provided in Condition 4(n)(i) above, any Holder shall be entitled (but shall not be obliged) to tender and pay the same and the Issuer, as a separate and independent stipulation, covenants to reimburse and indemnify on an after tax basis such Holder in respect of any payment thereof and any penalties payable in respect thereof.
 
 
(o)
Ordinary Stock
 
The Ordinary Stock issued or delivered on Conversion will be fully paid and non-assessable, free from any Encumbrance and will in all respects rank pari passu with the fully paid Ordinary Stock in issue on the Conversion Settlement Date except in
 

 
30

 

any such case for any right excluded by mandatory provisions of applicable law, and except that the Ordinary Stock so issued or delivered will not rank for (or, as the case may be, the relevant Holder shall not be entitled to receive) any rights, distributions or payments the record date or other due date for the establishment of entitlement for which falls prior to the Conversion Settlement Date.
 
5.
Covenants
 
For so long as any CCN remains outstanding, the Issuer shall (in each case save with the prior written approval of the Holders):
 
 
(a)
not make any issue, grant, reorganisation, capitalisation or distribution or take or omit to take any other action if the effect thereof would be (or is reasonably foreseeable to be) that a unit of Ordinary Stock cannot be legally issued as fully paid and free from any Encumbrance on the Conversion of each CCN;
 
 
(b)
(other than in connection with a Reorganisation or a Liability Management Exercise) not issue or pay up any Ordinary Stock or Other Securities, in either case by way of capitalisation of profits or reserves, other than:
 
 
(i)
by the issue of fully paid Ordinary Stock or Other Securities to Stockholders and other holders of shares in the capital of the Issuer which, by their terms, entitle the holders thereof to receive Ordinary Stock or Other Securities on a capitalisation of profits or reserves; or
 
 
(ii)
by the issue of Ordinary Stock paid up in full (in accordance with applicable law) and issued wholly, ignoring fractional entitlements, in lieu of the whole or part of a Dividend in cash (excluding, for the avoidance of doubt, the issue of Ordinary Stock in respect of hybrid capital instruments where there is an alternative coupon settlement mechanism); or
 
 
(iii)
by the issue of fully paid Other Securities to the holders of Ordinary Stock or Other Securities which, by their terms, entitle the holders thereof to receive Other Securities (excluding, for the avoidance of doubt, the issue of Ordinary Stock in respect of hybrid capital instruments where there is an alternative coupon settlement mechanism); or
 
 
(iv)
by the issue of Ordinary Stock or Other Securities to, or for the benefit of, any employee or former employee, director or executive holding or formerly holding executive office of Issuer or any of its Subsidiaries or any associated company or to trustees or nominees to be held for the benefit of any such person, in any such case pursuant to an employee, director or executive share or option scheme whether for all employees, directors, or executives or any one or more of them,
 
unless, in any such case, the same constitutes a Dividend or otherwise gives rise (or would, but for the provisions of Condition 4(i) relating to roundings and minimum adjustments or the carry forward of adjustments, give rise) to an adjustment to the Floor Price and unless, if the Floor Price would otherwise be reduced to below the prevailing nominal value of the Ordinary Stock at the effective date of such adjustment, gives rise to an adjustment to the nominal value of the Ordinary Stock to reflect the Floor Price so reduced;
 
 
(c)
not modify the rights attaching to the Ordinary Stock with respect to voting, dividends or liquidation but so that nothing in this Condition 5(b) shall prevent:
 

 
31

 

 
(i)
any consolidation, reclassification or subdivision of the Ordinary Stock; or
 
 
(ii)
any modification of such rights which is not materially prejudicial to the interests of the Holders as determined in good faith by an Independent Financial Adviser;
 
 
(d)
procure that no Ordinary Stock or Other Securities issued without rights to convert into, or exchange or subscribe for, Ordinary Stock shall subsequently be granted such rights and that at no time shall there be in issue Ordinary Stock of differing nominal values unless the same gives rise (or would, but for the provisions of Condition 4(i) relating to roundings and minimum adjustments or the carry forward of adjustments, give rise) to an adjustment to the Floor Price and that at no time shall there be in issue Ordinary Stock or Other Securities of differing nominal values, save where such Ordinary Stock or Other Securities have the same economic rights;
 
 
(e)
not reduce its issued ordinary share capital, share premium account, capital redemption reserve, or any uncalled liability in respect thereof, or any non-distributable reserves, except where the reduction is permitted by applicable law and results in (or would, but for the provisions of Condition 4(i) relating to roundings or the carry forward of adjustments, result in) an adjustment to the Floor Price or is otherwise taken into account for the purposes of determining whether or not such an adjustment should be made, provided that, for the avoidance of doubt, this Condition 5(e) shall not operate to restrict the Issuer from reducing its preference share capital and share premium amounts in respect of its preference share capital;
 
 
(f)
issue, allot and/or deliver Ordinary Stock upon Conversion subject to and as provided in Condition 4;
 
 
(g)
use all reasonable endeavours to ensure that any Ordinary Stock issued upon a Conversion Event will, as soon as is practicable, be admitted to the Official List of the Irish Stock Exchange and trading on its regulated market or will be listed, quoted or dealt in, as soon as is practicable, on any other stock exchange or securities market on which the Ordinary Stock are then listed or quoted or dealt in;
 
 
(h)
use all reasonable endeavours to ensure that its issued and outstanding Ordinary Stock continue to be admitted to the Official List of the Irish Stock Exchange and trading on its regulated market, or listed, admitted to trading, quoted or dealt in on such other principal stock exchange or securities market on which the Ordinary Stock are currently listed, admitted to trading or quoted or dealt in;
 
 
(i)
in the event of a Reorganisation, take (or shall procure that there is taken) all necessary action to ensure that, immediately after completion of the relevant proceedings, such amendments are made to these Conditions as are necessary to ensure that the CCNs may be converted into or exchanged for ordinary shares or stock or units or the equivalent in Newco mutatis mutandis in accordance with and subject to these Conditions and the ordinary shares or stock or units or the equivalent of Newco are listed and admitted to trading on a Recognised Stock Exchange;
 
 
(j)
if an offer is made to all (or a majority) of the holders of the Ordinary Stock other than the offeror and/or any associates of the offeror to acquire all or a majority of the issued ordinary share capital of the Issuer, or if a scheme (other than a Reorganisation) or merger is proposed with regard to such acquisition or merger with the undertaking of the Issuer, give notice in writing of such offer or scheme or merger to the Holders, in their capacity as the Holders, as soon as practicable upon becoming aware of such offer;
 

 
32

 

 
(k)
give notice in writing to the Holders, in their capacity as the Holders, if an offer is made to all (or a majority) of the holders of the Ordinary Stock other than the offeror and/or any associate of the offeror to acquire all or a majority of the issued ordinary share capital of the Issuer or if any person proposes a scheme or merger with regard to such acquisition or merger with the undertaking of the Issuer and such offer or scheme or merger having become or been declared unconditional in all respects, the right to cast more than 50 per cent. of the votes which may ordinarily be cast on a poll at a general meeting of the Issuer has or will become unconditionally vested in the offeror and/or an associate. Such notice shall specify all information relevant to Holders concerning such offer or scheme or merger;
 
 
(l)
notwithstanding that no voting rights shall attach to the CCNs in respect of the Ordinary Stock, provide to the Holders, in their capacity as Holders, notice of every general meeting of the Stockholders of the Issuer and a copy of every circular or like document sent out by the Issuer to the Stockholders;
 
 
(m)
for so long as the CCNs are listed and freely transferable, from time to time on request and at its own expense, do and execute or procure to be done and executed all necessary acts, deeds, documents and things in a form satisfactory to a Holder that such Holder reasonably considers necessary to effect and/or facilitate the transfer of any of the CCNs and their registration in the name of the transferee in the Register;
 
 
(n)
where the provisions of Condition 4 require or provide for a determination by an Independent Financial Adviser, use all reasonable endeavours promptly to appoint such person for such purpose;
 
 
(o)
at all times keep available for issue, free from pre-emptive or other preferential rights, a sufficient number of units of Ordinary Stock to enable the conversion of the CCNs, and any other rights of subscription and exchange for Ordinary Stock arising pursuant to the CCNs, to be satisfied in full;
 
 
(p)
not take any action, and procure that no action is taken, that would result in an adjustment to the Floor Price to below the prevailing nominal value of the Ordinary Stock at the effective date of such adjustment;
 
 
(q)
provide to the Competent Authority the Core Tier 1 Ratio and CET1 Ratio, as applicable, on an ad hoc or ongoing basis as requested by the Competent Authority and the Issuer will publish the Core Tier 1 Ratio and CET1 Ratio, as applicable, in respect of any Semi-Annual Reporting Period or as otherwise required to be publically disclosed by the Issuer;
 
 
(r)
obtain prior written approval from the Competent Authority for any distributions proposed by the Issuer in respect of any profit generated or other fair value movements as a consequence of the accounting treatment of the CCNs in the Issuer’s shareholder funds;
 
 
(s)
maintain a listing of the CCNs on the Irish Stock Exchange, or failing that, any other Recognised Stock Exchange; and
 
 
(t)
immediately give notice in writing to the Holders of the occurrence of any Conversion Event or Takeover Event or any Event of Default or any matter it concludes is likely to give rise to a Conversion Event or Takeover Event or Event of Default immediately upon becoming aware thereof and without waiting for the Holders to take any further action.
 

 
33

 

6.
Redemption and Cancellation
 
 
(a)
Redemption at Maturity
 
Unless previously converted as provided in these Conditions, each CCN will only be redeemed at its principal amount, together with accrued interest, on the Maturity Date.
 
 
(b)
No other redemption, purchase, or buy back
 
None of the Issuer nor any of its Subsidiaries nor any other Group Company shall purchase, redeem, buy back or otherwise acquire any of the CCNs prior to the Maturity Date.
 
 
(c)
Cancellation
 
All CCNs redeemed by the Issuer pursuant to this Condition 6 will forthwith be cancelled.
 
7.
Payments
 
 
(a)
Payments in respect of CCNs
 
 
(i)
Payments of principal to be made to Holders in respect of CCNs and payments of accrued interest payable on a redemption of CCNs (other than on an Interest Payment Date) and payment of any Accrued Conversion Interest that is to be paid in accordance with this Condition 7 shall, in each case, be made against presentation and surrender of the relevant Certificates at the specified office of any of the CCN Agents or of the Registrar.
 
 
(ii)
Payments of interest to be made to Holders in respect of CCNs due on an Interest Payment Date shall be paid to the person shown on the Register at the close of business on the fifteenth day before the Relevant Date for payment thereof (the “Record Date”).
 
 
(iii)
Payments of any other amounts in respect of CCNs other than as referred to in (i) and (ii) will be made as provided in these Conditions.
 
 
(b)
Payments subject to Fiscal Laws
 
All payments are subject in all cases to any applicable fiscal or other laws, regulations and directives in the place of payment, but without prejudice to the provisions of Condition 8. No commission or expenses shall be charged to the Holders in respect of such payments.
 
 
(c)
Method of Payment
 
Payments of principal and interest will be made by credit or transfer in euro to the account specified in the Register.
 
 
(d)
Non-Business Days
 
If any date for payment in respect of any CCNs is not a Business Day, the Holder shall not be entitled to payment until the next following Business Day nor to any interest or other sum in respect of such postponed payment.
 

 
34

 

8.
Taxation
 
All payments of principal, premium (if any) and/or interest to the Holders by or on behalf of the Issuer in respect of the CCNs shall be made without withholding or deduction for or on account of any present or future tax, duty, assessment or governmental charge of whatsoever nature imposed, levied, collected, withheld or assessed by or on behalf of Ireland or any authority thereof or therein having power to tax, unless such withholding or deduction is required by law. In that event, the Issuer shall pay such additional amounts (“Additional Amounts”) as will result (after such withholding or deduction) in receipt by the Holders of the sums which would have been receivable (in the absence of such withholding or deduction) from it in respect of their CCNs; except that no such Additional Amounts shall be payable with respect to any CCN:
 
 
(a)
to, or to a third party on behalf of, a Holder if such withholding or deduction may be avoided by complying with any statutory requirement or by making a declaration of non-residence or other similar claim for exemption to any authority of or in Ireland, unless such Holder proves that he is not entitled so to comply or to make such declaration or claim; or
 
 
(b)
to, or to a third party on behalf of, a Holder that is a partnership, or a holder that is not the sole beneficial owner of the CCN, or which holds the CCN in a fiduciary capacity, to the extent that any of the members of the partnership, the beneficial owner or the settlor or beneficiary with respect to the fiduciary would not have been entitled to the payment of an additional amount had each of the members of the partnership, the beneficial owner, settlor or beneficiary (as the case may be) received directly his beneficial or distributive share of the payment; or
 
 
(c)
(where presentation and surrender is required pursuant to these Conditions) presented for payment more than 30 days after the Relevant Date except to the extent that the Holder thereof would have been entitled to such Additional Amounts on presenting the same for payment at the expiry of such period of 30 days; or
 
 
(d)
where such withholding or deduction is imposed on a payment to an individual and is required to be made pursuant to European Council Directive 2003/48/EC on the taxation of savings income or any law implementing or complying with, or introduced in order to conform to, such Directive; or
 
 
(e)
(where presentation and surrender is required pursuant to these Conditions) in respect of any CCN presented for payment by or on behalf of a Holder who would have been able to avoid such withholding or deduction by presenting the relevant CCN to another Fiscal Agent in a member state of the European Union; or
 
 
(f)
where such withholding or deduction arises by reason of the Holder having some connection with Ireland other than the mere holding or ownership of the CCNs.
 
9.
Variation following Tax Event
 
 
(a)
Tax Event
 
If a Tax Event has occurred and is continuing, the Issuer may, subject to Condition 9(b), at any time upon not less than 30 nor more than 60 days’ notice to the Holders in accordance with Condition 13, without any requirement for the consent of approval of the Holders, vary the terms of the CCNs so that they remain or, as appropriate, become, Qualifying CCNs.  In connection with any variation in accordance with this Condition 9, the Issuer shall comply with the rules of any stock exchange on which
 

 
35

 

the CCNs are for the time being listed or admitted to trading.  For the avoidance of doubt, a variation under this Condition 9 may include a substitution of the Issuer.
 
 
(b)
Conditions to Variation
 
Any variation of the terms of the CCNs in accordance with this Condition 9 shall be solely for the purposes of curing a Tax Event and shall be subject to (i) the provisions of Condition 14(b) and (ii) for so long as the Initial Holder is a holder of 100 per cent of the CCNs, such variation being approved in writing by the Initial Holder.
 
10.
Replacement of Certificates
 
If a Certificate is lost, stolen, mutilated, defaced or destroyed, it may be replaced, subject to applicable laws, regulations and stock exchange or other relevant authority regulations, at the specified office of the Registrar, or such other CCN Agent as may from time to time be designated by the Issuer for the purpose and notice of whose designation is given to Holders, on payment by the claimant of the fees and costs incurred in connection therewith and on such terms as to evidence, security and indemnity (which may provide, inter alia, that if the allegedly lost, stolen or destroyed Certificate is subsequently presented for payment there shall be paid to the Issuer on demand the amount payable by the Issuer in respect of such Certificates) and otherwise as the Issuer and/or CCN Agent may reasonably require. Mutilated or defaced CCNs or Certificates must be surrendered before replacements will be issued.
 
11.
Further Issues
 
The Issuer may, from time to time, without the consent of the Holders, create and issue further securities either having the same terms and conditions as the CCNs in all respects (or in all respects except for the first payment of interest on them) and so that such further issue shall be consolidated and form a single series with the outstanding securities of any series (including the CCNs) or upon such terms as the Issuer may determine at the time of their issue. References in these Conditions to the CCNs include (unless the context requires otherwise) any other securities issued pursuant to these Conditions and forming a single series with the CCNs.
 
12.
Event of Default
 
If, for so long as the CCNs have not converted, (a) there is default for more than 7 days in the payment of any principal or for more than 14 days in the payment of any interest in respect of the CCNs or any of them when and as the same are due for payment or (b) if proceedings have been instituted for the winding up or liquidation of the Issuer (each an “Event of Default”), the Holders of 25 per cent of the aggregate principal amount of the CCNs for the time being outstanding may, in their absolute discretion, institute proceedings for the winding-up or liquidation of the Issuer (in the case of (a) above) and each Holder may prove and/or claim in the winding up or liquidation of the Issuer for such payment but may not take any other action with respect to such default.
 
13.
Notices
 
A notice may be given by the Issuer to any Holder of CCNs by sending it by post to such Holder at its address in the Register. Service of such notice shall be deemed to have been effected by properly addressing, prepaying and posting a letter by post containing the notice and shall be deemed to have been given on the second Business Day after the date of posting.
 
A notice may be given by the Issuer to joint holders of the CCNs by giving notice to the joint holder first named in the Register.
 

 
36

 

A notice may be given by the Issuer, to the extent permitted by the Irish Stock Exchange (if and for so long as the CCNs are listed on the Irish Stock Exchange) and by law, by electronic communication if so requested or authorised by the Holders, the Holders having notified the Issuer of an e-mail address to which the Issuer may send electronic communications and having agreed to receive notices and other documents from the Issuer by electronic communication. If a Holder notifies the Issuer of an e-mail address, the Issuer may send the Holder the notice or other document by publishing the notice or other document on a website and notifying the Holder by e-mail that the notice or other document has been published on the website.  The Issuer must also specify the address of the website on which it has been published, the place on the website where the notice may be accessed and how it may be accessed, and where the notice in question is a notice of a meeting, the notice must continue to be published on that website throughout the period beginning with the date of that notification and ending on the conclusion of that meeting, save that if the notice is published for part only of that period the failure to publish the notice throughout that period shall not invalidate the proceedings of a meeting where such failure is wholly attributable to circumstances which it would not be reasonable to have expected the Issuer to prevent or avoid.
 
In addition, if and for so long as the CCNs are listed on the Irish Stock Exchange or any other Recognised Stock Exchange, notices shall be given in accordance with any requirement of such exchange.
 
Any notice or notification (however expressed) to be given to the Issuer by any Holder shall be effected by properly addressing, prepaying and posting a letter by registered post containing the notice and shall be deemed to have been given on the second Business Day after the date of posting.
 
14.
Meetings of Holders, Modification and Consent
 
 
(a)
Meetings of Holders
 
The Agency Deed contains provisions for convening meetings of Holders to consider any matter affecting their interests, including the sanctioning by Extraordinary Resolution of a modification of any of these Conditions or any provisions of the Agency Deed. Such a meeting may be convened by Holders holding not less than 10 per cent. in aggregate principal amount of the CCNs for the time being outstanding. The quorum for any meeting convened to consider an Extraordinary Resolution shall be one or more persons holding or representing a clear majority in aggregate principal amount of the CCNs for the time being outstanding, or at any adjourned meeting one or more persons being or representing Holders whatever the aggregate principal amount of the CCNs held or represented, unless the business of such meeting includes consideration of proposals, inter alia, (i) to amend the provisions for redemption of the CCNs or any date for payment of interest on the CCNs, (ii) to reduce or cancel the principal amount of the CCNs, (iii) to reduce the rate of interest in respect of the CCNs or to vary the method or basis of calculating the rate or amount of interest or the basis for calculating the amounts of any interest in respect of the CCNs, (iv) to vary any method of, or basis for, calculating the amounts payable on redemption of the CCNs, (v) to vary the currency of payment or denomination of the CCNs, (vi) to modify the provisions concerning the quorum required at any meeting of Holders or the majority required to pass the Extraordinary Resolution, or (vii) to amend or modify the provisions relating to the Conversion Event, in which case the necessary quorum shall be such person or persons holding or representing not less than 75 per cent., or at any adjourned meeting not less than 25 per cent., in aggregate principal amount of the CCNs for the time being outstanding. Any Extraordinary Resolution duly passed shall be binding on Holders (whether or not they were present at the meeting at which such resolution was passed).
 

 
37

 

A resolution in writing signed by or on behalf of the Holder or Holders of not less than 75 per cent. in aggregate principal amount of the CCNs outstanding shall for all purposes be as valid and effective as an Extraordinary Resolution passed at a meeting of Holders duly convened and held. Such a resolution in writing may be contained in one document or several documents in the same form, each signed by or on behalf of one or more Holders.
 
 
(b)
Modification
 
No modification to these Conditions or any other provisions of the Agency Deed (whether pursuant to this Condition 14 or otherwise) shall become effective unless the Issuer shall have received written approval from the Competent Authority (provided that, at the relevant time, there is a requirement to obtain such approval).
 
The Issuer may, in accordance with Condition 9, without the consent or approval of the Holders, make such modifications or variations to the terms of the CCNs and Agency Deed as it considers necessary or desirable to give effect to the provisions of Condition 9, provided that such modifications or variations are not materially prejudicial to the interests of the Holders, as determined in good faith by an Independent Financial Adviser, and provided that such modifications or variations do not modify or vary any of the terms of the CCNs as contemplated by Condition 14(a)(i) to (vii) above.
 
 
(c)
Consent
 
Where these Conditions require the prior consent or approval of the Holders, such consent or approval shall for all purposes be deemed to be valid and effective if in writing signed by or on behalf of the Holder or Holders of in excess of 50.00 per cent. in aggregate principal amount of the CCNs outstanding or if given by way of an Extraordinary Resolution.
 
15.
Transfers of CCNs
 
 
(a)
Transfer of CCNs
 
One or more CCNs may be transferred upon the surrender (at the specified office of the Registrar) of the Certificate representing such CCNs to be transferred, together with the form of transfer endorsed on such Certificate (or another form of transfer substantially in the same form and containing the same representations and certifications (if any), unless otherwise agreed by the Issuer), duly completed and executed and any other evidence as the Registrar may reasonably require. A new Certificate shall be issued to the transferee in respect of the CCNs the subject of the relevant transfer and, in the case of a transfer of part only of a holding of CCNs represented by one Certificate, a new Certificate in respect of the balance of the CCNs not transferred shall be issued to the transferor. In the case of a transfer of CCNs to a person who is already a Holder, a new Certificate representing the enlarged holding may be issued but only against surrender of the Certificate representing the existing holding of such person. All transfers of CCNs and entries on the Register will be made subject to the detailed regulations concerning transfers of CCNs scheduled to the Agency Deed. The regulations may be changed by the Issuer, with the prior written approval of the Registrar. A copy of the current regulations will be made available by the Registrar to any Holder upon request.
 

 
38

 

 
(b)
Delivery of New Certificates
 
Each new Certificate to be issued pursuant to Condition 15(a) shall be available for delivery within three Business Days of receipt of the form of transfer and surrender of the relevant Certificate.  Delivery of new Certificate(s) shall be made at the specified office of the Registrar to whom delivery and surrender of such form of transfer and Certificate or, as the case may be, surrender of such Certificate, shall have been made or, at the option of the relevant Holder and as specified in the relevant form of transfer or otherwise in writing, be mailed by uninsured post at the risk of the Holder entitled to the new Certificate to such address as may be so specified, unless such Holder requests otherwise and pays in advance to the relevant Registrar the costs of such other method of delivery and/or such insurance as it may specify.
 
 
(c)
Transfers Free of Charge
 
Transfers of CCNs and the issue of new Certificates on transfer shall be effected without charge by or on behalf of the Issuer or the Registrar, but upon payment by the transferee of any tax or other governmental charges that may be imposed in relation to it (or the giving of such indemnity as the Registrar may require).
 
16.
Definitions and Interpretation
 
 
16.1
The following capitalised terms shall have the following meanings:
 
Accrued Conversion Interest” means, upon Conversion of the CCNs, interest accrued on the CCNs, if any, from (and including) the Interest Payment Date immediately preceding the Conversion Date (or, if none, from the Issue Date) to (but excluding) the Conversion Date;
 
Acquirer” means the person which, following a Takeover Event, controls the Issuer;
 
Additional Amounts” has the meaning given to it in Condition 8;
 
Approved Entity” means a body corporate (other than a State Entity) which: (i) for so long as the Initial Holder is a holder of 100 per cent. of the CCNs is (a) approved in writing by the Initial Holder and (b) on the occurrence of the Takeover Event, has in issue Approved Entity Shares; or (ii) where the Initial Holder is not the sole holder of 100 per cent. of the CCNs, on the occurrence of the Takeover Event, has in issue Approved Entity Shares. On and after the date of a Takeover Event, references herein to “Ordinary Stock” shall be read as references to “Approved Entity Shares”;
 
Approved Entity Shares” means ordinary shares or stock in the capital of the Approved Entity which constitute equity share capital or the equivalent which, unless otherwise agreed in writing by the Holders at such time, is listed and admitted to trading on a Recognised Stock Exchange. In relation to any Conversion in respect of which the Conversion Date falls on or after the Takeover Event Date, where the Takeover Event is a Qualifying Takeover Event, references herein to “Ordinary Stock” shall be deemed to be references to “Approved Entity Shares”;
 
Business Day” means a day on which the TARGET system is operating;
 
Capital Deficiency Event” means the occurrence of (i) the Issuer giving notice to the Holders that the relevant Capital Ratio is below the Trigger Ratio, or (ii) the Competent Authority notifying the Issuer that it has determined, in its absolute discretion, that the Group’s financial and solvency condition is deteriorating in such a
 

 
39

 

way that the relevant Capital Ratio is likely to be below the Trigger Ratio in the short term;
 
Capital Distribution” means:
 
 
(i)
any Dividend which is expressed by the Issuer or declared by the board of directors of the Issuer to be a capital distribution, extraordinary dividend, extraordinary distribution, special dividend or return of value to Stockholders or any analogous or similar term, in which case the Capital Distribution for the purpose of these Conditions shall be the Fair Market Value of such Dividend; or
 
 
(ii)
any Cash Dividend (the “Relevant Dividend”) paid or made in respect of a fiscal year of the Issuer (the “Relevant Fiscal Year”) if the sum of:
 
 
(a)
the Fair Market Value of the Relevant Dividend per unit of Ordinary Stock; and
 
 
(b)
the aggregate of the Fair Market Value per unit of Ordinary Stock of any other Cash Dividend or Cash Dividends per unit of Ordinary Stock paid or made in respect of the Relevant Fiscal Year (disregarding for such purposes any amount previously determined to be a Capital Distribution in respect of the Relevant Fiscal Year),
 
such sum being the “Current Year’s Dividend”, exceeds the Reference Amount, and in such case the amount of the relevant Capital Distribution shall be the lesser of (i) the amount by which the Current Year’s Dividend exceeds the Reference Amount and (ii) the Fair Market Value of the Relevant Dividend;
 
Capital Ratio” means, prior to the CRD IV Implementation Date, the Core Tier 1 Ratio and, on or after the CRD IV Implementation Date, the CET1 Ratio;
 
Cash Dividend” means (i) any Dividend which is to be paid or made in cash (in whatever currency) and (ii) any Dividend determined to be a Cash Dividend pursuant to paragraph (i) of the definition of Dividend:
 
CET1 Amount” means, at any time, as calculated by the Issuer on a consolidated basis and expressed in the Group’s reporting currency, the sum of all amounts (whether positive or negative) of Common Equity Tier 1 Capital of the Group as at such time. For the avoidance of doubt, CET1 Amount includes any capital instruments injected at any time by the Initial Holder or any other State Entity to strengthen the capital base of the Group and deemed by the Competent Authority to be eligible to count previously towards Core Tier 1 Amount;
 
CET1 Ratio” means, in respect of any Semi-Annual Reporting Period, the ratio (expressed as a percentage) of the CET1 Amount divided by the RWA Amount, as at the date of the financial statements contained in the relevant Semi-Annual Financial Report, as calculated by the Issuer and appearing in its relevant Semi-Annual Financial Report;
 
Common Equity Tier 1 Capital” means all items that constitute common equity tier 1 capital, or deductions from and any other adjustments to common equity tier 1 capital, in each case within the meaning of these terms or equivalent in the CRD IV and as implemented, where necessary, in Ireland through legislation.  For the
 

 
40

 

avoidance of doubt the Common Equity Tier 1 Capital will be calculated taking into account the phase-in of deductions and other adjustments pursuant to CRD IV;
 
Competent Authority” means the Central Bank of Ireland or any subsequent entity acting in that capacity as the lead regulator of the Issuer;
 
Conversion” and “converted” shall have the meaning given to such terms in Condition 4(a);
 
Conversion Date” means the date upon which a Conversion Event occurs;
 
Conversion Event” means the occurrence of a Capital Deficiency Event or Non-Viability Event;
 
Conversion Notice” has the meaning given to it in Condition 4(a)(ii);
 
Conversion Price” means: (i) at any time when the Ordinary Stock are admitted to trading on a Recognised Stock Exchange, in respect of any Conversion Date, the greater of:
 
 
(a)
the VWAP of a unit of Ordinary Stock of the Issuer over the 30 Business Days prior to the date of the relevant Conversion Event, and
 
 
(b)
the Floor Price of unit of Ordinary Stock on the date of the relevant Conversion Event (being, at the Issue Date, €[ l ]),
 
or (ii) at any time when the Ordinary Stock are not admitted to trading on a Recognised Stock Exchange, the Floor Price;
 
Conversion Settlement Date” shall have the meaning given to such terms in Condition 4(a)(i);
 
Core Tier 1 Amount” means, if at any time, as calculated by the Issuer on a consolidated basis and expressed in the Group’s reporting currency, the aggregate amount of capital elements prescribed by the European Banking Authority in the “Supporting Document 2: Capital Definition Criteria” published on the 8 April 2011 and released to be the benchmark to be used in the 2011 EU-wide stress test for the purpose of computing the “Core Tier 1 including existing government support measures (CT1)” as at such time. For the avoidance of doubt, Core Tier 1 Amount includes any capital instruments injected at any time by the Initial Holder or any other State Entity to strengthen the capital base of the Group and deemed by the Competent Authority to be eligible to count towards Core Tier 1 Amount;
 
Core Tier 1 Ratio” means, in respect of any Semi-Annual Reporting Period, the ratio (expressed as a percentage) of the Core Tier 1 Amount divided by the RWA Amount, as at the date of the financial statements contained in the Semi-Annual Reporting Period, as calculated by the Issuer and appearing in its relevant Semi-Annual Financial Report as “Core Tier 1 Ratio” or such other term having the same meaning;
 
CRD IV” means a proposal for a Directive of the European Parliament and of the Council which will amend Directives 2006/48/EC and 2006/49/EC, principally in order to implement in the EU, the reforms agreed by the Basel Committee on Banking Supervision in December 2010 (Basel III), including reforms to the definition of capital and counterparty credit risk and the introduction of a leverage ratio and liquidity requirements;
 

 
41

 

CRD IV Implementation Date” means the first date on which the Group is required to comply with the capital adequacy standards adopted and implemented in the European Union through the CRD IV as amended and as implemented, where necessary, in Ireland through legislation. Such date can be when the Minister chooses to transpose the requirements of CRD IV into Irish law or when the deadline for transposition has been reached, whichever is earlier;
 
Current Market Price” means, in respect of unit of Ordinary Stock  at a particular date, the average of the daily VWAP of a unit of Ordinary Stock on each of the five consecutive dealing days ending on the dealing day immediately preceding such date; provided that, if the VWAP of a unit of Ordinary Stock is not available on one or more of the said five dealing days (disregarding for this purpose the proviso to the definition of VWAP), then the average of such VWAPs which are available in that five-dealing-day period shall be used (subject to there being a daily VWAP available for a minimum of two such days) and if only one, or no, such VWAP is available in the relevant period, the Current Market Price shall be determined in good faith by an Independent Financial Adviser;
 
dealing day” means a day on which the Primary Stock Exchange or relevant stock exchange or securities market is open for business and on which Ordinary Stock or Other Securities may be dealt in (other than a day on which the Primary Stock Exchange or relevant stock exchange or securities market is scheduled to or does close prior to its regular weekday closing time);
 
Dividend” means any dividend or distribution in respect of the Ordinary Stock to Stockholders whether of cash, assets or other property, and however described and whether payable out of share premium account, profits, retained earnings or any other capital or revenue reserve or account, and including a distribution or payment to holders upon or in connection with a reduction of capital, provided that:
 
 
(i)
where a Dividend in cash is announced which is to be, or may at the election of a Stockholder or Stockholders be, satisfied by the issue or delivery of Ordinary Stock or other property or assets, then the Dividend in question shall be treated as a Cash Dividend of an amount equal to the greater of (i) the Fair Market Value of such cash amount and (ii) the Current Market Price of such Ordinary Stock as at the first date on which the Ordinary Stock are traded ex-the relevant Dividend on the Primary Stock Exchange or, as the case may be, the Fair Market Value of such other property or assets as at the date of the first public announcement of such Dividend on the Primary Stock Exchange or, if later, the date on which the number of units of Ordinary Stock (or amount of such other property or assets, as the case may be) which may be issued or delivered is determined;
 
 
(ii)
any issue of Ordinary Stock falling within Condition 4(e)(i) or Condition 4(e)(ii) shall be disregarded;
 
 
(iii)
a purchase or redemption or buy back of share capital of the Issuer by or on behalf of the Issuer or any of its Subsidiaries shall not constitute a Dividend unless, in the case of a purchase or redemption or buy back of Ordinary Stock by or on behalf of the Issuer or any of its Subsidiaries, the VWAP per unit of Ordinary Stock (before expenses) on any one day (a “Specified Share Day”) in respect of such purchases or redemptions or buy backs exceeds by more than 5 per cent. the average of the daily VWAP of a unit of Ordinary Stock on the five dealing days immediately preceding the Specified Share Day or, where an announcement (excluding, for the avoidance of doubt for these
 

 
42

 

purposes, any general authority for such purchases, redemptions or buy backs approved by a general meeting of Stockholders or any notice convening such a meeting of Stockholders) has been made of the intention to purchase, redeem or buy back Ordinary Stock at some future date at a specified price or where a tender offer is made, on the five dealing days immediately preceding the date of such announcement or the date of first public announcement of such tender offer (and regardless of whether or not a price per unit of Ordinary Stock, a minimum price per unit of Ordinary Stock or a price range or formula for the determination thereof is or is not announced at such time), as the case may be, in which case such purchase, redemption or buy back shall be deemed to constitute a Dividend in euro in an amount equal to the amount by which the aggregate price paid (before expenses) in respect of such Ordinary Stock purchased, redeemed or bought back by the Issuer or, as the case may be, any of its Subsidiaries exceeds the product of (i) 105 per cent. of the daily VWAP of a unit of Ordinary Stock determined as aforesaid and (ii) the number of units of Ordinary Stock so purchased, redeemed or bought back;
 
 
(iv)
if the Issuer or any of its Subsidiaries shall purchase, redeem or buy back any depositary or other receipts or certificates representing Ordinary Stock, the provisions of paragraph (iii) above shall be applied in respect thereof in such manner and with such modifications (if any) as shall be determined in good faith by an Independent Financial Adviser; and
 
 
(v)
where a dividend or distribution is paid or made to Stockholders pursuant to any plan implemented by the Issuer for the purpose of enabling Stockholders to elect, or which may require Stockholders, to receive dividends or distributions in respect of the Ordinary Stock held by them from a person other than, or in addition to, the Issuer, such dividend or distribution shall for the purposes of Condition 4 be treated as a dividend or distribution made or paid to Stockholders by the Issuer, and the foregoing provisions of this definition and the provisions of Condition 4, including references to the Issuer paying or making a dividend, shall be construed accordingly, and any such determination shall be made on a gross basis and disregarding any withholding or deduction required to be made on account of tax, and disregarding any associated tax credit;
 
EEA Regulated Market” means a market as defined by Article 4.1(14) of Directive 2004/39/EC of the European Parliament and of the Council on markets on financial instruments;
 
Effective Date” means, in respect of Condition 4(e), the first date on which the ordinary shares or stock are traded ex-the relevant Dividend on the Primary Stock Exchange or, in the case of a purchase, redemption or buy back of Ordinary Stock (or any depositary or other receipts or certificates representing Ordinary Stock), the date on which such purchase, redemption or buy back is made;
 
Encumbrance” means any pledge, lien, option, security interest, claim, equity, trust, mortgage, charge, encumbrance or third party right or interest of any nature whatsoever and including for the avoidance of doubt any pre-emptive or similar right;
 
Event of Default” means any of the conditions, events or acts provided in Condition 12 to be Events of Default;
 

 
43

 

Exempt Reorganisation” means a Reorganisation where, immediately after completion of the relevant proceedings, the ordinary shares or stock or units or equivalent of Newco (or depositary or other receipts or certificates representing ordinary shares or stock or units or equivalent of Newco) are (i) admitted to trading on the Primary Stock Exchange or (ii) admitted to listing on such other regulated, regularly operating, recognised stock exchange or securities market as the Issuer or Newco may determine;
 
Extraordinary Resolution” has the meaning given to it in the Agency Deed;
 
Fair Market Value” means, with respect to any property on any date, the fair market value of that property as determined by an Independent Financial Adviser in good faith, provided that:
 
 
(i)
the Fair Market Value of any cash amount shall be the amount of such cash;
 
 
(ii)
where Ordinary Stock or Other Securities are publicly traded on a stock exchange or securities market of adequate liquidity (as determined in good faith by an Independent Financial Adviser), the Fair Market Value of such Ordinary Stock or Other Securities shall equal the arithmetic mean of the daily VWAP of such Ordinary Stock or Other Securities (or the arithmetic mean of the daily closing prices should daily VWAP not be available), during the period of five dealing days on the relevant stock exchange or securities market commencing on such date (or, if later, the first such dealing day such Ordinary Stock or Other Securities) or such shorter period as such Ordinary Stock or Other Securities are publicly traded;
 
 
(iii)
where Ordinary Stock or Other Securities are not publicly traded on a stock exchange or securities market of adequate liquidity (as aforesaid), the Fair Market Value of such Ordinary Stock or Other Securities shall be determined in good faith by an Independent Financial Adviser, on the basis of a commonly accepted market valuation method and taking account of such factors as it considers appropriate, including the market price per unit of Ordinary Stock, the dividend yield of a unit of Ordinary Stock, the volatility of such market price, prevailing interest rates and the terms of such Ordinary Stock or Other Securities, including as to the expiry date and exercise price (if any) thereof; and
 
 
(iv)
the Fair Market Value shall be determined on a gross basis and disregarding any withholding or deduction required to be made on account of tax, and disregarding any associated tax credit;
 
Floor Price” means €[ l ], subject to adjustment thereafter in accordance with Condition 4(e).  For the avoidance of doubt, the Floor Price shall not be subject to adjustment in respect of Ordinary Stock or Other Securities issued pursuant to or associated with the Liability Management Exercise and the Issuer Recapitalisation;
 
Group” means the Issuer and its subsidiaries (within the meaning of Section 155 of the Companies Act 1963) from time to time, subsidiary undertakings from time to time and any other entity in respect of which financial information is included from time to time in the consolidated annual accounts of the Issuer, and “Group Company” means any of them;
 

 
44

 

Holder” means each person in whose name a CCN is registered for the time being in the Register (being the Initial Holder on the Issue Date) and “Holders” shall be construed accordingly;
 
Independent Financial Adviser” means an independent financial institution of international repute appointed at its own expense by the Issuer and, for so long as the Initial Holder is a holder of 100 per cent. of the CCNs, which is approved in writing by the Initial Holder;
 
Initial Holder” means the Minister, and subsequently if transferred, any other State Entity which may from time to time be the Holder of the CCNs;
 
Interest Commencement Date” has the meaning given to such term in Condition 3(a);
 
Interest Payment Date” has the meaning given to such term in Condition 3(a);
 
Interest Period” has the meaning given to such term in Condition 3(a);
 
Issue Date” means [29] July 2011 or such other date agreed between the Issuer and the Initial Holder;
 
Issuer Recapitalisation” means the generation by the Issuer of Core Tier 1 Amount pursuant to any placement of Ordinary Stock with the State and a rights issue in respect of Ordinary Stock which is fully underwritten by the National Pension Reserve Fund Commission as set out in a prospectus of the Issuer dated 18 June 2011 (as supplemented);
 
Liability Management Exercise” means any purchase, repurchase, redemption or liability reduction exercise commenced by the Issuer or any member of the Group within six months of the Issue Date, in respect of any of the Group’s securities (other than units of Ordinary Stock and Other Securities) where such exercise has been approved by the Competent Authority including, but not limited to: (i) the exchange offers of the Issuer launched on 8 June 2011; (ii) the CAD138,721,000 Fixed/Floating Dated Subordinated Notes due September 2015 (ISIN: CA062786AA67); and (iii) the GBP75,000,000 13.375 per cent. Unsecured Perpetual Subordinated Bonds (ISIN: GB0000510312);
 
Maturity Date” means [30] July 2016;
 
Minister means the Minister for Finance of Ireland;
 
National Regulations” means the prevailing national banking and capital adequacy laws directly applicable to the Group and prevailing capital adequacy regulations promulgated by the Competent Authority and applicable to the Group;
 
New Conversion Condition” means, if by no later than seven Business Days following the occurrence of a Takeover Event where the Acquirer is an Approved Entity, the Issuer shall have entered into agreements and arrangements, to the satisfaction of the Initial Holder for so long as the Initial Holder is a holder of 100 per cent. of the CCNs, with the Approved Entity for delivery of the Approved Entity Shares upon the occurrence of a Conversion Event on terms mutatis mutandis identical to the provisions of Condition 4;
 

 
45

 

New Conversion Price” means, in respect of any Conversion Date falling on or after the Takeover Event Date, where the Takeover Event is a Qualifying Takeover Event, the greater of;
 
 
(i)
the Reference Market Price of the Approved Entity Shares on the Business Day prior to the date of the Conversion Notice (and where references in the definition of “Reference Market Price” and “VWAP” to “Ordinary Stock” shall be construed as a reference to the Approved Entity Shares and in the definition of “dealing day”, reference to the “Primary Stock Exchange” shall be to the relevant Recognised Stock Exchange); and
 
 
(ii)
the New Floor Price on the Business Day prior to such Conversion Event.
 
New Floor Price” means the amount determined in accordance with the following formula:
 
NFP    =     EFP   X       VWAPAES
VWAPOS
where:
 
NFP is the New Floor Price;
 
EFP” is the Floor Price in effect on the dealing day immediately prior to the Takeover Event Date;
 
VWAPAES” means the average of the VWAP of the Approved Entity Shares on each of the five dealing days ending on the dealing day prior to the closing date of the Takeover Event (and where references in the definition of “VWAP” to “Ordinary Stock” shall be construed as a reference to the Approved Entity Shares and in the definition of “dealing day”, references to the “Primary Stock Exchange”’ shall be to the relevant Recognised Stock Exchange); and
 
VWAPOS” is the average of the VWAP of the Ordinary Stock on each of the five dealing days ending on the dealing day immediately prior to the Takeover Event Date;
 
Non-Cash Dividend” means any Dividend which is not a Cash Dividend;
 
Non-Qualifying Takeover Event” means a Takeover Event that is not a Qualifying Takeover Event;
 
Non-Viability Event” means the earliest of the following:
 
 
(i)
the Competent Authority, in its absolute discretion, determining that Conversion of the CCNs, together with the conversion or write off of holders’ claims in respect of any Tier 1 Instruments or Tier 2 Instruments that, pursuant to their terms or by operation of law, are capable of being converted into equity or written off at that time, is, because customary measures to improve the Group’s capital adequacy are at the time inadequate or unfeasible, an essential requirement to prevent the Issuer from becoming insolvent, bankrupt or unable to pay its debts as they fall due, or from ceasing to carry on its business, or from failing to meet its minimum capital adequacy requirements, as determined by the Competent Authority; or
 

 
46

 

 
(ii)
by virtue of customary measures to improve the Group’s capital adequacy being at the time inadequate or unfeasible, the Issuer receiving an irrevocable commitment of extraordinary support from any State Entity (beyond customary transactions and arrangements in the ordinary course) that has, or imminently will have, the effect of improving the Group’s capital adequacy and without which, in the determination of the Competent Authority, the Issuer would become insolvent, bankrupt, unable to pay its debts as they fall due, or cease carrying on its business or fail to meet its minimum capital adequacy requirements, as determined by the Competent Authority;
 
Ordinary Stock” means ordinary stock of the Issuer of €[ l ] nominal value ([Bloomberg] Code: [ l ]) which are listed on the Irish Stock Exchange. The Ordinary Stock deliverable upon Conversion of the CCNs will be shares newly issued from the authorised capital of the Issuer. Ordinary Stock will rank pari passu with all other ordinary registered shares of the Issuer for any and all distributions payable on them on or after the Conversion Date;
 
Other Securities” means any equity securities including, without limitation, shares in the capital of the Issuer, or options, warrants or other rights to subscribe for or purchase or acquire shares in the capital of the Issuer other than the Ordinary Stock;
 
person” includes any individual, company, corporation, firm, partnership, joint venture, undertaking, association, organisation, trust, state or agency of a state (in each case whether or not being a separate legal entity);
 
Primary Stock Exchange” means the Irish Stock Exchange or, if at the relevant time the Ordinary Stock are not at that time listed and admitted to trading on the Irish Stock Exchange, the principal stock exchange or securities market on which the Ordinary Stock, if listed, are then listed, admitted to trading or quoted or accepted for dealing;
 
Qualifying CCNs” means securities issued directly or indirectly by the Issuer that (i) have terms materially as favourable to Holders as the CCNs prior to the Tax Event occurring, as determined in good faith by an Independent Financial Adviser and (ii) contain terms which in terms of quality of capital are at least equivalent to the terms of the CCNs prior to the Tax Event occurring, as determined by the Competent Authority in its absolute discretion;
 
Qualifying Takeover Event” means a Takeover Event where (i) the Acquirer is an Approved Entity and (ii) the New Conversion Condition is satisfied;
 
Rate of Interest” has the meaning given to such term in Condition 3(c);
 
Recognised Stock Exchange” means an EEA Regulated Market that is a recognised stock exchange for the purposes of Section 64 of the Taxes Consolidation Act 1997;
 
Record Date” has the meaning given to it in Condition 7(a)(ii);
 
Reference Amount” means 5 per cent. of the average of the VWAP of a unit of Ordinary Stock on each dealing day in the period of 5 dealing days ending on the dealing date immediately preceding the Effective Date provided that if on any such dealing day the VWAP shall have been based on a price cum-Dividend or cum-any other entitlement, the VWAP of a unit of Ordinary Stock on such dealing day shall be deemed to be an amount thereof reduced by an amount equal to the Fair Market Value
 

 
47

 

of any such Dividend or other entitlement per unit of Ordinary Stock as at the Effective Date relating to the relevant Dividend or entitlement;
 
Reference Market Price” means, in respect of a unit of Ordinary Stock at a particular date, the average of the daily VWAP of a unit of Ordinary Stock on each of the 30 consecutive dealing days ending on the dealing day immediately preceding such date (the “Reference Period”):
 
 
(i)
provided that:
 
 
(A)
if at any time during the Reference Period the VWAP shall have been based on a price ex-Dividend (or ex-any other entitlement) and during some other part of that Reference Period the VWAP shall have been based on a price cum-Dividend (or cum- any other entitlement), then:
 
 
(I)
if the Ordinary Stock to be issued or delivered (if applicable) do not rank for the Dividend (or entitlement) in question, the VWAP on the date(s) on which the Ordinary Stock shall have been based on a price cum-Dividend (or cum- any other entitlement) shall, for the purposes of this definition, be deemed to be the amount thereof reduced by an amount equal to the fair market value (as determined by an Independent Financial Adviser) of any such Dividend or entitlement per unit of Ordinary Stock as at the date of first public announcement relating to such Dividend or entitlement; or
 
 
(II)
if the Ordinary Stock to be issued or delivered (if applicable) do rank for the Dividend (or entitlement) in question, the VWAP on the date(s) on which the Ordinary Stock shall have been based on a price ex-Dividend (or ex-any other entitlement) shall, for the purposes of this definition, be deemed to be the amount thereof increased by an amount equal to the fair market value (as determined by an Independent Financial Adviser) of any such Dividend or entitlement per unit of Ordinary Stock as at the date of first public announcement relating to such Dividend or entitlement,
 
 
(B)
if on any of the dealing days in the Reference Period the VWAP shall have been based on a price cum-Dividend (or cum- any other entitlement) in respect of a Dividend (or other entitlement) which has been declared or announced but the Ordinary Stock to be issued or delivered do not rank for that Dividend (or other entitlement), the VWAP on each of such dates shall, for the purposes of this definition, be deemed to be the amount thereof reduced by an amount equal to the fair market value (as determined by an Independent Financial Adviser) of any such Dividend or entitlement per unit of Ordinary Stock as at the date of first public announcement relating to such Dividend or entitlement, and
 
 
(C)
if the VWAP of a unit of Ordinary Stock is not available on one or more of the dealing days in the Reference Period (disregarding for this purpose the proviso to the definition of VWAP), then the average of such VWAPs which are available in the Reference Period shall be used (subject to there being a daily VWAP available for a minimum
 

 
48

 

of two such days) and if only one, or no, such VWAP is available in the Reference Period, the Reference Market Price shall be determined in good faith by an Independent Financial Adviser appointed in good faith by the Issuer, and
 
Relevant Date” in respect of any payment on any CCN, means the date on which such payment first becomes due or (if any amount of the money payable is improperly withheld or refused) the date on which payment in full of the amount required to be paid is made or, in the case where presentation of the relevant Certificate is required pursuant to the Conditions, (if earlier) the date seven days after that on which notice is duly given to the Holders that, upon further presentation of the Certificate being made in accordance with the Conditions, such payment will be made, provided that payment is in fact made upon such presentation;
 
Reorganisation” means proceedings which effect the interposition of a limited liability company (“Newco”) between the Stockholders immediately prior to such proceedings (the “Existing Stockholders”) and the Issuer; provided that:
 
 
(i)
only ordinary shares or stock or units or equivalent of Newco (or depositary or other receipts or certificates representing ordinary shares or stock or units or equivalent of Newco) are issued to Existing Stockholders;
 
 
(ii)
immediately after completion of such proceedings the only holders of ordinary shares or stock or units or equivalent of Newco (or, as the case may be, the only holders of depositary or other receipts or certificates representing ordinary shares or stock or units or equivalent of Newco) are Existing Stockholders holding in the same proportions as immediately prior to completion of such proceedings;
 
 
(iii)
immediately after completion of such proceedings, Newco is (or one or more wholly-owned Subsidiaries of Newco are) the only Stockholder;
 
 
(iv)
all Subsidiaries immediately prior to such proceedings (other than Newco, if Newco is then a Subsidiary of the Issuer) are Subsidiaries of the Issuer (or of Newco) immediately after completion of such proceedings; and
 
 
(v)
immediately after completion of such proceedings, the Issuer (or Newco) holds, directly or indirectly, the same percentage of the ordinary share capital and equity share capital of those Subsidiaries as was held by the Issuer immediately prior to such proceedings;
 
RWA Amount” means, as at any date, the aggregate amount of all risk-weighted assets of the Issuer calculated on a consolidated basis pursuant to National Regulations, each applicable at such time, expressed in the Issuer’s reporting currency;
 
Semi-Annual Financial Report” means the consolidated financial accounts and disclosures of the Group in respect of a calendar semi-annual reporting period contained in a customary financial report published by the Group;
 
Semi-Annual Reporting Period” means six months ended 30 June and 31 December in each year or, if the Group amends its financial year end, such corresponding period as may be approved in writing by the Holders;
 

 
49

 

State Entities” means the Minister or his nominee, the National Pension Reserve Fund Commission, the National Treasury Management Agency, National Asset Management Agency, or any other entity or agency of or related to the Government of Ireland and “State Entity” shall be construed accordingly;
 
Stockholders” means the holders of Ordinary Stock for the time being (and “Stockholder” shall be construed accordingly);
 
Subsidiary” means a subsidiary within the meaning of Section 155 of the Companies Act 1963;
 
Takeover Event” shall occur if any person or persons acting in concert acquires control of the Issuer (other than as a result of an Exempt Reorganisation). For the purposes of the definition of “Takeover Event”, “acting in concert” has the meaning given to such term in the Irish Takeover Panel Act 1997 and “control” means the acquisition or holding of legal or beneficial ownership of more than 95 per cent. of the issued Ordinary Stock of the Issuer and the Ordinary Stock are not admitted to trading, or are no longer admitted to trading, as the case may be, on any Recognised Stock Exchange, and “controlled” shall be construed accordingly;
 
Takeover Event Date” means the date with effect from which the New Conversion Condition shall have been satisfied;
 
TARGET System” means the Trans-European Automated Real-Time Gross Settlement Express Transfer (known as TARGET2) System which was launched on 19 November 2007 or any successor thereto;
 
Tax Event” is deemed to have occurred if, as a result of a Tax Law Change, in making any payments on the CCNs, the Issuer has paid or will or would on the next payment date be required to pay Additional Amounts and the Issuer cannot avoid the foregoing by taking measures reasonably available to it;
 
Tax Law Change” means a change in or proposed change in, or amendment or proposed amendment to, the laws or regulations of Ireland including any treaty to which Ireland is a party, or any change in any generally published application or interpretation of such laws, including a decision of any court or tribunal, or any change in the generally published application or interpretation of such laws by any relevant tax authority or any generally published pronouncement by any tax authority, which change, amendment or pronouncement (x) (subject to (y)) becomes, or would become, effective on or after the Issue Date, or (y) in the case of a change or proposed change in law, if such change is enacted (or, in the case of a proposed change, is expected to be enacted) by the Oireachtas or by Statutory Instrument, on or after the Issue Date;
 
Trigger Ratio” means, at any time, 8.25 per cent.;
 
Tier 1 Capital” means any or all items constituting at the relevant time tier 1 capital under National Regulations (including items eligible as Tier 1 Capital as a result of grandfathering under Directive 2009/111/EC or CRD IV);
 
Tier 1 Instruments” means any and all shares, securities or other obligations issued by the Group, each of which shares, securities or other obligations qualify, or are issued in respect of a security that qualifies, as Tier 1 Capital of the Group (without regard to quantitative limits on such capital) on a consolidated or on an unconsolidated basis;
 

 
50

 

Tier 2 Capital” means any or all items constituting at the relevant time tier 2 capital under National Regulations (including items eligible as Tier 2 Capital as a result of grandfathering under Directive 2009/111/EC or CRD IV);
 
Tier 2 Instruments” means any and all securities or other obligations issued by the Group, each of which securities or other obligations qualify, or are issued in respect of a security that is eligible to qualify, as Tier 2 Capital of the Group on a consolidated or on an unconsolidated basis; and
 
VWAP” means, in respect of a unit of Ordinary Stock or Other Security, as the case may be, for any dealing day, the order book volume-weighted average price of a unit of Ordinary Stock or Other Security, as the case may be, published by or derived (in the case of a unit of Ordinary Stock) from the relevant Bloomberg page or (in the case of an Other Security) from the principal stock exchange or securities market on which such Other Securities are then listed or quoted or dealt in, if any or, in any such case, such other source as shall be determined in good faith to be appropriate by an Independent Financial Adviser on such dealing day, provided that if on any such dealing day such price is not available or cannot otherwise be determined as provided above, the VWAP of a unit of Ordinary Stock or Other Security in respect of such dealing day shall be the VWAP, determined as provided above, on the immediately preceding dealing day on which the same can be so determined or determined as an Independent Financial Adviser might otherwise determine in good faith to be appropriate.
 
 
16.2
References to any act or statute or any provision of any act or statute shall be deemed also to refer to any statutory modification or re-enactment thereof or any statutory instrument, order or regulation made thereunder or under such statutory modification or re-enactment.
 
 
16.3
Unless the context otherwise requires, references to (i) “principal” shall be deemed to include any premium payable in respect of the CCNs and all other amounts in the nature of principal payable pursuant to these Conditions or any amendment or supplement to it, (ii) “interest” shall be deemed to include any Accrued Conversion Interest and in any such case shall be deemed to include any Additional Amounts that may be payable under Condition 8 or any undertaking given in addition to or in substitution for it under the Agency Deed in respect of any such amount.
 
 
16.4
References to any issue or offer or grant to Stockholders or Existing Stockholders “as a class” or “by way of rights” shall be taken to be references to an issue or offer or grant to all or substantially all Stockholders or Existing Stockholders, as the case may be, other than Stockholders or Existing Stockholders, as the case may be, to whom, by reason of the laws of any territory or requirements of any recognised regulatory body or any other stock exchange or securities market in any territory or in connection with fractional entitlements, it is determined not to make such issue or offer or grant.
 
 
16.5
In making any calculation or determination of Current Market Price or VWAP, such adjustments (if any) shall be made as an Independent Financial Adviser determines in good faith to be appropriate to reflect any consolidation or sub-division of the Ordinary Stock or any issue of Ordinary Stock by way of capitalisation of profits or reserves, or any like or similar event.
 
 
16.6
For the purposes of Condition 4, (i) references to the “issue” of Ordinary Stock or Ordinary Stock being “issued” shall, unless otherwise expressly specified to be the case in respect of any of the provisions of Condition 4, include the delivery of Ordinary Stock, whether newly issued and allotted or previously existing or held by or
 

 
51

 

on behalf of the Issuer or any of its Subsidiaries, and (ii) Ordinary Stock held by or on behalf of the Issuer or any of its respective Subsidiaries shall not be considered as or treated as “in issue” or “issued” or entitled to receive the relevant Dividend, right or other entitlement.
 
 
16.7
References in these Conditions to “listing” or “listed” on the Irish Stock Exchange (or like or similar references) shall be construed as admission to the Official List of the Irish Stock Exchange and trading on its regulated market.
 
17.
Governing Law and Jurisdiction
 
 
(a)
Governing Law
 
The CCNs and any non-contractual obligations arising out of or in connection with them are governed by, and shall be construed in accordance with, the laws of Ireland.
 
 
(b)
Jurisdiction
 
Save as provided below, the courts of Ireland shall have exclusive jurisdiction to settle any disputes that may arise out of or in connection with any CCNs and accordingly any legal action or proceedings arising out of or in connection with any CCNs (“Proceedings”) may be brought in such courts. The Issuer submits to the jurisdiction of the courts of Ireland in respect of any such Proceedings and waives any objection to Proceedings in such courts on the ground of venue or on the ground that the Proceedings have been brought in an inconvenient forum. These submissions are made for the benefit of each of the Holders.
 

 
52

 
 
SCHEDULE 3
 
PART 1

 

CCN Sale Notice

Dated this [●] day of [●] 20[●]

To:       [Name of Investor]

Address:        [Registered Office]

For the Attention of:                                           [●]


Offer Agreement relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 between the Minister for Finance of Ireland and the Investors  (the “Offer Agreement”)

I refer to the Offer Agreement. Words and expressions defined in the Offer Agreement shall, unless expressly provided herein, have the same meaning in this CCN Sale Notice.

This is a CCN Sale Notice for the purposes of Clause 2.1 of the Offer Agreement. In accordance with Clause 2.1 of the Offer Agreement, I am directed by the Minister for Finance to offer to sell to you your Pro Rata Share of the CCNs at €[●] for each CCN, (being the CCN Sale Price) on [●] day of [●] 20[●] (the “Sale Date”) and invite you to apply in writing to the Minister for Finance by sending a CCN Acceptance Notice within [2/5] Business Days after the date of receipt of this notice to acquire your Pro Rata Share of the CCNs.  You will confirm your Pro Rata Share in the CCN Acceptance Notice.



Yours sincerely,



[●]
Department of Finance

 
53

 

SCHEDULE 3
 
PART 2
 



CCN Sale Acceptance Notice

Dated this [●] day of [●] 20[●]





[Name of Investor
Registered Office Address]


To:       Minister for Finance
Department of Finance
Government Buildings
Upper Merrion Street
Dublin 2
Ireland

Attention:


Offer Agreement relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 between the Minister for Finance of Ireland, and the Investors (the “Offer Agreement”)

We refer to the Offer Agreement.

Words and expressions defined in the Offer Agreement shall, unless expressly provided herein, have the same meaning in this CCN Sale Acceptance Notice.

We confirm that our Pro Rata Share is [●] per cent.

This is a CCN Sale Acceptance Notice for the purposes of Clause 2.1 of the Offer Agreement. In accordance with Clause 2.1 of the Offer Agreement, notice is hereby given to the Minister for Finance of our acceptance of his offer outlined in the CCN Sale Notice addressed to us dated [●], of which we acknowledge receipt.

We hereby agree to acquire and purchase our Pro Rata Share of the CCNs at €[●] for each CCN (being the CCN  Sale Price) at an aggregate price of €[●] for our entire Pro Rata Share on the Sale Date specified in the CCN Sale Notice dated [●] day of [●] 20[●].


Yours sincerely,



[Authorised Signatory(ies) of Investor]

 
54

 

SCHEDULE 4
 
PART 1
 



Stock Sale Notice2

Dated this [●] day of [●] 20[●]


To:      [Name of Investor]

Address:       [Registered Office]

For the Attention of:                                           [●]


Offer Agreement relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 between the Minister for Finance of Ireland and he Investors (the “Offer Agreement”)

I refer to the Offer Agreement. Words and expressions defined in the Offer Agreement shall, unless expressly provided herein, have the same meaning in this Stock Sale Notice.

This is a Stock Sale Notice for the purposes of Clause 2.4 of the Offer Agreement. In accordance with Clause 2.4 of the Offer Agreement, I am directed by the Minister for Finance to offer to sell to you your Pro Rata Share of the Converted Ordinary Stock at €[●] for each unit of Converted Ordinary Stock, (being the Stock Sale Price) on [●] day of [●] 20[●] (the “Sale Date”) and invite you to apply in writing to the Minister for Finance by sending a Stock Sale Acceptance Notice within [5] Business Days after the date of receipt of this notice to acquire your Pro Rata Share of the Converted Ordinary Stock.  You will confirm your Pro Rata Share in the Stock Sale Acceptance Notice.



Yours sincerely,



[●]
Department of Finance




__________________________
2
To be adapted for Approved Entity Shares, if applicable.

 
55

 

SCHEDULE 4
 
PART 2

 


Stock Sale Acceptance Notice

Dated this [●] day of [●] 20[●]





[Name of Investor
Registered Office Address]


To:       Minister for Finance
Department of Finance
Government Buildings
Upper Merrion Street
Dublin 2
Ireland

Attention:


Offer Agreement relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 between the Minister for Finance of Ireland and the Investors (the “Offer Agreement”)

We refer to the Offer Agreement.

Words and expressions defined in the Offer Agreement shall, unless expressly provided herein, have the same meaning in this Stock Sale Acceptance Notice.

We confirm that our Pro Rata Share is [●] per cent.

This is a Stock Sale Acceptance Notice for the purposes of Clause 2.4 of the Offer Agreement. In accordance with Clause 2.4 of the Offer Agreement, notice is hereby given to the Minister for Finance of our acceptance of his offer outlined in the Stock Sale Notice addressed to us dated [●], of which we acknowledge receipt.

We hereby agree to acquire and purchase our Pro Rata Share of the Converted Ordinary Stock at €[●] for each unit of Converted Ordinary Stock, (being the Stock Sale Price) at an aggregate price of €[●] for our entire Pro Rata Share on the Sale Date specified in the Stock Sale Notice dated [●] day of [●] 20[●].


Yours sincerely,



[Authorised Signatory(ies) of Investor]
 

 
56

 

SCHEDULE 5
 
PART 1
 



Bonus Stock Sale Notice

Dated this [●] day of [●] 20[●]


To:        [Name of Investor]

Address:       [Registered Office]

For the Attention of:       [●]


Offer Agreement relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 between the Minister for Finance of Ireland and the Investors (the “Offer Agreement”)

I refer to the Offer Agreement. Words and expressions defined in the Offer Agreement shall, unless expressly provided herein, have the same meaning in this Bonus Stock Sale Notice.

This is a Bonus Stock Sale Notice for the purposes of Clause 2.7 of the Offer Agreement. In accordance with Clause 2.7 of the Offer Agreement, I am directed by the Minister for Finance to offer to sell to you your Pro Rata Share of the 2009 Bonus Stock at €[●] for each unit of 2009 Bonus Stock, (being the Bonus Stock Sale Price) on [●] day of [●] 20[●] (the “Sale Date”) and invite you to apply in writing to the Minister for Finance by sending a Bonus Stock Acceptance Notice within [5] Business Days after the date of receipt of this notice to acquire your Pro Rata Share of the Bonus Stock.  You will confirm your Pro Rata Share in the Bonus Stock Sale Acceptance Notice.



Yours sincerely,



[●]
Department of Finance

 
57

 

SCHEDULE 5
 
PART 2
 



Bonus Stock Sale Acceptance Notice

Dated this [●] day of [●] 20[●]





[Name of Investor
Registered Office Address]


To:       Minister for Finance
Department of Finance
Government Buildings
Upper Merrion Street
Dublin 2
Ireland

Attention:


Offer Agreement relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 between the Minister for Finance of Ireland and the Investors (the “Offer Agreement”)

We refer to the Offer Agreement.

Words and expressions defined in the Offer Agreement shall, unless expressly provided herein, have the same meaning in this Bonus Stock Sale Acceptance Notice.

We confirm that our Pro Rata Share is [●] per cent.

This is a Bonus Stock Sale Acceptance Notice for the purposes of Clause 2.7 of the Offer Agreement. In accordance with Clause 2.7 of the Offer Agreement, notice is hereby given to the Minister for Finance of our acceptance of his offer outlined in the Bonus Stock Sale Notice addressed to us dated [●], of which we acknowledge receipt.

We hereby agree to acquire and purchase our Pro Rata Share of the 2009 Bonus Stock at €[●] for each unit of 2009 Bonus Stock, (being the Bonus Stock Sale Price) at an aggregate price of €[●] for our entire Pro Rata Share on the Sale Date specified in the Bonus Stock Sale Notice dated [●] day of [●] 20[●].


Yours sincerely,



[Authorised Signatory(ies) of Investor]

 
58

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)





SIGNED for and on behalf
of the MINISTER FOR FINANCE
by   John A. Moran                                                      


 
  /s/ John A. Moran
 
A person authorised by Section 15(4) of the Ministers and Secretaries Act 1924




 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)







SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ James Newman
 
Print name
Witness (Signature)
   
     
James Newman
   
Print name
   
     
Fitzwilton House, Wilton Place, Dublin 2
   
Print address
   





 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY CONTRAFUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
VARIABLE INSURANCE PRODUCTS FUND III: BALANCED PORTFOLIO
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY SECURITIES FUND: FIDELITY DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CAPITAL TRUST: FIDELITY VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   



 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY PURITAN TRUST: FIDELITY LOW-PRICED STOCK FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   




 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
KENNEDY-WILSON INVESTMENTS, LLC
by its authorised signatory
in the presence of:
 
/s/ Matthew Windisch
   
Authorised Signatory (Signature)
     
   
Matthew Windisch
/s/ Mark Martin
 
Print name
Witness (Signature)
   
     
Mark Martin
   
Print name
   
     
9701 Wilshire Blvd., Beverly Hills, CA 90212
   
Print address
   


 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
/s/ Wilbur L. Ross, Jr.
 
Manager (Signature)
 
Wilbur L. Ross, Jr.
   
/s/ Stephen J. Naughton
 
Witness (Signature)
 
Stephen J. Naughton
 
1166 Avenue of the Americas, 25th Floor
 
New York, New York 10036
 




SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
/s/ Wilbur L. Ross, Jr.
 
Manager (Signature)
 
Wilbur L. Ross, Jr.
   
/s/ Stephen J. Naughton
 
Witness (Signature)
 
Stephen J. Naughton
 
1166 Avenue of the Americas, 25th Floor
 
New York, New York 10036
 

 

 
 

 

(EXECUTION PAGE OF CCN OFFER AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS Master Co-Investment, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
/s/ Wilbur L. Ross, Jr.
 
Manager (Signature)
 
Wilbur L. Ross, Jr.
   
/s/ Stephen J. Naughton
 
Witness (Signature)
 
Stephen J. Naughton
 
1166 Avenue of the Americas, 25th Floor
 
New York, New York 10036
 




SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
/s/ Wilbur L. Ross, Jr.
 
Manager (Signature)
 
Wilbur L. Ross, Jr.
   
/s/ Stephen J. Naughton
 
Witness (Signature)
 
Stephen J. Naughton
 
1166 Avenue of the Americas, 25th Floor
 
New York, New York 10036
 


 
 

 

 (EXECUTION PAGE OF CCN OFFER AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
CAPITAL RESEARCH AND MANAGEMENT COMPANY
by its authorised signatory
in the presence of:
 
/s/ Michael J. Downer
   
Authorised Signatory (Signature)
     
   
Michael J. Downer, SVP and Secretary
/s/ Walt R. Burkley
 
Print name
Witness (Signature)
   
     
Walt R. Burkley
   
Print name
   
     
c/o 333 S. Hope Street, Los Angeles, CA 90071
   
Print address
   

EX-99 18 ex10.htm EXHIBIT 10 ex10.htm
Exhibit 10





THE GOVERNOR AND COMPANY OF THE BANK OF IRELAND


THE INVESTORS
















ISSUER AGREEMENT

relating to €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due 2016















William Fry
Solicitors
Fitzwilton House
Wilton Place
Dublin 2
www.williamfry.ie

© William Fry 2011

021444.0001.OMB

 
 

 

CONTENTS
1.
INTERPRETATION
3
     
2.
UNDERTAKINGS
6
     
3.
ACKNOWLEDGEMENTS
7
     
4.
REPRESENTATIONS AND WARRANTIES
7
     
5.
NOTICES
9
     
6.
ASSIGNMENT
10
     
7.
WAIVER
10
     
8.
ENTIRE AGREEMENT
10
     
9.
COUNTERPARTS
10
     
10.
GOVERNING LAW AND JURISDICTION
11
     
SCHEDULE 1  
  12
     
SCHEDULE 2
  16


 
2

 

This Agreement is made on                                     2011
 
BETWEEN:

 
THE GOVERNOR AND COMPANY OF THE
 
BANK OF IRELAND
 
a chartered corporation registered in Ireland
 
with registered no C-1
 
whose registered office is at
 
40 Mespil Road, Dublin 4, Ireland
 
(hereinafter called the "Issuer")
   
   
 
                   - and -
   
   
 
THE PERSONS WHOSE NAMES ARE
 
SET OUT IN SCHEDULE 1
 
(hereinafter called the “Investors”)


RECITALS:
 
A.
Under the note purchase agreement dated 8 July 2011 (the “Note Purchase Agreement”), the Issuer and the Minister have recorded certain arrangements agreed between them in relation to the issue of €1,000,000,000 (one billion euro) 10.00 per cent. Contingent Capital Tier 2 Notes due 2016 by the Issuer (the “CCNs”).
 
B.
The CCNs shall be issued in registered form by a definitive certificate or certificates pursuant to the Agency Deed.
 
C.
Each of the Investors has agreed to acquire units of Ordinary Stock in the capital of the Issuer under the terms of the Stock Purchase Agreement and Conditional Stock Purchase Agreement, as applicable.
 
D.
Condition 3(g)(iii) of the Conditions provides (among other things) that in certain circumstances the Issuer can solicit third party investors in respect of the CCNs.  The Issuer has agreed with the Investors that prior to soliciting any such third party investors, it will notify each of the Investors of its intention to do so and shall include each of the Investors in the negotiations to agree a potentially lower interest rate than the New Interest Rate and to find a purchaser of the CCNs.
 
E.
The Issuer and each of the Investors have entered into this Agreement to set out the arrangements between them in relation to the CCNs.
 
1.
Interpretation
 
1.1
In this Agreement, unless the context otherwise requires all terms defined in the Conditions shall have the same meanings when used herein. In this Agreement, the following words and expressions shall have the following meanings:
 
Agency Deed”, the agency deed to be entered into on or prior to the Issue Date by the Issuer with Citibank, N.A., London Branch as fiscal agent, calculation agent and registrar;
 
Associated Entity”, in respect of an Investor, any company or other entity controlled by that Investor or which controls that Investor or which is under common control with the Investor and any fund or partnership managed by any such company or entity and “Associated Entities” shall be construed accordingly;
 

 
3

 

"Business Day", a day (excluding Saturdays, Sundays and public holidays) on which banks are generally open for business in the City of Dublin and London;
 
"Central Bank", the Central Bank of Ireland;
 
Conditional Stock Purchase Agreement”, the agreement to be entered into on the date hereof between (among others) the Minister, the National Pensions Reserve Fund Commission and each of the Investors, providing (subject to certain conditions) for the purchase from the National Pensions Reserve Fund Commission of further Commission Stock (as defined therein);
 
"Conditions", the terms and conditions of the CCNs (as scheduled to the Agency Deed and as modified from time to time in accordance with their terms), being materially in the form of the draft terms and conditions set out in Schedule 2 to this Agreement, and any reference to a numbered "Condition" is to the corresponding numbered provision thereof;
 
Contracts”, the Note Purchase Agreement and the Agency Deed;
 
Deed of Undertaking”, the deed to be entered into on the date hereof between each of the Investors and the Issuer, providing (subject to certain conditions) for certain matters in connection with the transactions contemplated by this Agreement and the Stock Purchase Agreements;
 
Fully Diluted Ordinary Stock Capital”, shall have the meaning given to that term in the Deed of Undertaking;
 
"Group", the Issuer and its subsidiaries (within the meaning of Section 155 of the Companies Act 1963) from time to time, subsidiary undertakings from time to time and any other entity in respect of which financial information is included from time to time in the annual accounts of the Issuer;
 
Initial Proportion”, in respect of each Investor, the proportion of the Fully Diluted Ordinary Stock Capital held by it and its Associated Entities from time to time which is Sale Stock (as defined in the Stock Purchase Agreements) (including, for the avoidance of doubt, BoI Ordinary Stock acquired by way of rights issues, bonus issues and issues in lieu of dividend declared upon the Sale Stock (as defined in the Stock Purchase Agreements) and subsequently upon BoI Ordinary Stock so acquired, expressed as a percentage;
 
"Issue Date", such date as the Issuer and the Minister may agree, being not later than 29 July 2011;
 
Legal Reservations”:
 
 
(a)
the principle that equitable remedies are remedies which may be granted or refused at the discretion of the court, the limitation of enforcement by laws relating to bankruptcy, insolvency, court protection, liquidation, reorganisation, court scheme, moratoria, administration and other laws generally affecting the rights of creditors, the time barring of claims, the possibility that an undertaking to assume liability or to indemnify a person against non-payment of stamp duty may be void, defences of set-off or counterclaim and similar principles, rights and defences under the laws of any jurisdiction in which relevant obligations may have to be performed; and
 
 
(b)
any principles of the law limiting the obligations of any Investor;
 
Minister”, the Minister for Finance of Ireland of Upper Merrion Street, Dublin 2;
 
Offer Agreement”, the agreement to be entered into on the date hereof between (amongst others) the Minister and each of the Investors, providing for certain matters relating to the CCNs;
 

 
4

 

Party”, a party to this Agreement and “Parties” shall be construed accordingly;
 
Pro Rata Share”, in respect of an Investor, on any date, is a proportion equal to that Investor’s Initial Proportion on that date;
 
"Prospectus", the prospectus to be prepared in connection with the listing of the CCNs on the Stock Exchange;
 
"Prospectus Regulations", the Prospectus (Directive 2003/71/EC) Regulations 2005;
 
Specified Period”, the period commencing on the Issue Date and ending on the date on which a State Entity ceases to hold any of the CCNs;
 
"Stock Exchange", the Irish Stock Exchange;
 
Stock Purchase Agreement”, the stock purchase agreement to be entered into on the date of this Agreement between the Minister, the National Pensions Reserve Fund Commission and Fairfax Financial Institutions Limited;
 
Stock Purchase Agreements”, shall have the meaning given to that term in the Deed of Undertaking;
 
"Working Hours", 9.00 am to 5.00 pm on a Business Day.
 
1.2
In this Agreement, unless the context otherwise requires:
 
 
1.2.1
a reference to:
 
 
(a)
any party includes its successors in title and permitted assigns;
 
 
(b)
a "person" includes any individual, firm, body corporate, association or partnership, government or state or agency of a state, local authority or government body or any joint venture association or partnership (whether or not having a separate legal personality) and that person's personal representatives, successors or permitted assigns;
 
 
(c)
a "company" will be construed so as to include any company, corporation or body corporate, wherever and however incorporated or established;
 
 
(d)
a Clause, paragraph, or Schedule, unless otherwise specified, is a reference to a Clause, paragraph of or Schedule to this Agreement;
 
 
(e)
writing or similar expressions includes, unless otherwise specified, transmission by facsimile but excludes email;
 
 
(f)
the singular includes the plural and vice versa and references to one gender includes all genders;
 
 
(g)
"day" or a "Business Day" will mean a period of 24 (twenty-four) hours running from midnight to midnight;
 
 
(h)
a "month" will mean a calendar month;
 
 
(i)
times are to time in Ireland;
 
 
(j)
a reference to a "subsidiary undertaking" is to be construed in accordance with the European Communities (Companies: Group Accounts) Regulations 1992 of Ireland and a "subsidiary" or "holding company" is to be construed in accordance with Section 155 of the Companies Act 1963 of Ireland; and
 

 
5

 

 
(k)
any other document referred to in this Agreement is a reference to that document as amended, varied, novated or supplemented at any time.
 
 
1.2.2
a reference to a statute or statutory provision will be construed as a reference to the laws of Ireland unless otherwise specified and includes:
 
 
(a)
any subordinate legislation made under it including all regulations, by-laws, orders and codes made thereunder;
 
 
(b)
any repealed statute or statutory provision which it re-enacts (with or without modification); and
 
 
(c)
any statute or statutory provision which modifies, consolidates, re-enacts or supersedes it;
 
in each case, prior to the date of this Agreement.
 
 
1.2.3
any phrase introduced by the terms "including", "include" and "in particular" or any similar expression will be construed as illustrative and will not limit the sense of the words preceding those terms.
 
1.3
The table of contents and headings in this Agreement are inserted for convenience only, and they are to be ignored in the interpretation of this Agreement.
 
1.4
References in this Agreement to CCNs being or to be "listed on the Stock Exchange" shall be to CCNs being or to be listed on the official list (the "Official List") of the Stock Exchange, having obtained approval from the Central Bank in its capacity as competent authority for admission of the CCNs to trading on the Stock Exchange's regulated market for listed securities.
 
1.5
References in this Agreement to the "Prospectus Directive" are to Directive 2003/7l/EC of the European Parliament and of the Council and shall include the Prospectus (Directive 2003/7l/EC) Regulations 2005 and any other relevant implementing measures of Ireland as well as Commission Regulation (EC) No. 809/2004.
 
2.
Undertakings
 
The Issuer undertakes with each of the Investors as follows:
 
Contracts
 
2.1
That it will not agree to materially amend or modify: (i) the Note Purchase Agreement at any time prior to the Issue Date; and (ii) the Agency Deed (but for the avoidance of doubt excluding the Conditions) at any time during the Specified Period, without obtaining the prior written consent of each of the Investors and such consent not to be unreasonably withheld. For the avoidance of doubt, this Clause 2.1 shall not restrict the Issuers ability to exercise its other rights under the Contracts including, but not limited to, the termination of the appointment of an Agent in accordance with the terms of the Agency Deed.
 
Remarketing Option
 
2.2
That immediately, upon receipt of any notice from any Initial Holder under Condition 3(g)(iii) of any proposed Third Party Sale, it will send a copy of such notice to each of the Investors.
 
Pro Rata Share
 
2.3
That it will include each of the Investors in the negotiation process in relation to the price at which the CCNs might be sold, if the Issuer solicits third party investors in accordance with Condition 3(g).
 

 
6

 

2.4
That it will immediately upon receipt of a written request to do so confirm to each Investor that Investor’s Pro Rata Share in accordance with Clause 5 of this Agreement.
 
Agency Agreement
 
2.5
That it will furnish a certified copy of the Agency Deed to each of the Investors on the Issue Date.
 
3.
Acknowledgements
 
Investor Acknowledgements
 
3.1
Each Investor hereby acknowledges that, notwithstanding the Issuer’s rights under Condition 3(g)(iii):
 
 
3.1.1
pursuant to Condition 3(g)(iv), the Initial Holder has absolute discretion as to whether to sell the CCNs, to whom it may sell the CCNs and the terms of any such sale; and
 
 
3.1.2
pursuant to Condition 3(g)(v), the Issuer is obliged to (i) disclose to the Initial Holder the identity of the Investors (if any) solicited or to be solicited by the Issuer pursuant to Condition 3(g)(iii) and (ii) provide and/or disclose all such information necessary, as determined by the Initial Holder in its absolute discretion, to facilitate the effecting of a Third Party Sale.
 
Issuer Acknowledgements
 
3.2
The Issuer acknowledges that pursuant to the Offer Agreement each of the Investors has a right of first refusal in respect of its Pro Rata Share in the event of any solicitation for sale by the Minister or the Issuer of the CCNs.
 
4.
Representations and Warranties
 
4.1
Issuer Representations and Warranties
 
The Issuer represents and warrants to each of the Investors that:
 
 
4.1.1
Incorporation: it is duly incorporated under the laws of Ireland, with full power and authority to conduct its business, and is lawfully qualified to do business in those jurisdictions in which business is conducted by it;
 
 
4.1.2
Validity of Agreement and Contracts: this Agreement has been duly authorised, executed and delivered by it and constitutes, and the other Contracts, to which it is a party, have been duly authorised by it and on the Issue Date will constitute, valid, legally binding and enforceable obligations of the Issuer;
 
 
4.1.3
Validity of CCNs: the issue of the CCNs has been duly authorised by the Issuer and, when the Certificate is duly executed, authenticated and issued in accordance with the Agency Deed;
 
 
4.1.4
Compliance: the execution and delivery of this Agreement and the Contracts, the issue of the CCNs and any issue of Ordinary Stock as a result of the conversion of the CCNs (as contemplated by the Conditions), the carrying out by the Issuer of the other transactions contemplated by the Contracts and compliance by the Issuer with their terms do not, or as the case may be, will not (a) conflict with or result in a breach of any of the terms or provisions of, or constitute a default under, the constitutional documents of the Issuer, or (b) conflict with or result in a breach of any of the terms or provisions of, or constitute a default under, any indenture, trust deed, mortgage or other agreement or instrument to which the Issuer, or any member of the Group is a party or by which any of them is bound which conflict,
 

 
7

 

 
breach or default could reasonably be expected to be material in the context of the issue of the CCNs, or (c) infringe any existing applicable law or regulation of any government, governmental body or court, or (d) to the best knowledge and belief of the Issuer, infringe on or breach any judgment, order or decree of any government, governmental body or court;
 
 
4.1.5
Consents: no action or thing is required to be taken, fulfilled or done (including without limitation the obtaining of any consent or licence or the making of any filing or registration) for the issue of the CCNs and (other than as contemplated by and in accordance with the Conditions) any issue of Ordinary Stock as a result of the conversion of the CCNs, the carrying out of any other transactions contemplated by the Contracts or the compliance by the Issuer with the terms of the CCNs, as the case may be;
 
 
4.1.6
Prospectus: as at the date of publication of the Prospectus:
 
 
(a)
the Prospectus will contain all information which is material in the context of the listing of the CCNs (including all information required by applicable laws and the information which is necessary to enable investors to make an informed assessment of the assets and liabilities, financial position, profits and losses of the Issuer and of the rights attaching to the CCNs),
 
 
(b)
any statements relating to the Issuer contained in Prospectus are, in every material particular true and accurate and not misleading,
 
 
(c)
any opinions and intentions with regard to the Issuer expressed in the Prospectus are, honestly held, have been reached after considering all relevant circumstances and are based on reasonable assumptions,
 
 
(d)
there are no other facts in relation to the Issuer or the CCNs the omission of which shall, in the context of the listing of the CCNs, make any statement in the Prospectus misleading in any material respect,
 
 
(e)
all reasonable enquiries have been made by the Issuer to ascertain such facts and to verify the accuracy of all such information and statements; and
 
 
(f)
the Prospectus has been made available to the public in accordance with the Prospectus Directive;
 
 
4.1.7
Financial Statements:
 
 
(a)
the audited consolidated financial statements of the Group to be incorporated by reference in the Prospectus were prepared pursuant to the relevant laws of Ireland and in accordance with accounting principles required for the purposes of the Prospectus Directive consistently applied and give a true and fair view, in accordance with International Financial Reporting Standards, of the state of the Group's consolidated financial affairs as at the date they are made up to and of its consolidated profit for the financial year then ended, and
 
 
(b)
since the date of the last audited consolidated financial statements of the Group there has been no material adverse change to the financial condition or results of operations of the Group;
 
 
4.1.8
Litigation: there are no, nor have there been, any litigation, governmental or arbitration proceedings, including any which are pending or threatened of which the Issuer is aware, which may have, or have had during the 12 months prior to the date of this Agreement (or any date on which this warranty is deemed to be repeated), a significant effect on the Issuer's or the Group's consolidated financial
 

 
8

 

 
position or profitability or which are otherwise material in the context of the issue of the CCNs or any issue of Ordinary Stock as a result of the conversion of the CCNs (as contemplated by the Conditions);
 
 
4.1.9
Stamp Taxes: under the laws of Ireland in force at the date hereof, it is not necessary that this Agreement or any of the Contracts be filed, recorded or enrolled with any court or other authority in such jurisdiction or that any stamp duty, registration or similar tax be payable in relation to the issue of the CCNs or any of the Contracts;
 
 
4.1.10
Certified Copy Contracts: the certified copy of the Note Purchase Agreement which has been furnished to each of the Investors on or before the date of this Agreement is a true copy of the original and no amendments or modifications have been made to the terms of the Note Purchase Agreement.
 
4.2
Investors’ Representations and Warranties:
 
Each of the Investors represents in respect of itself only that this Agreement has been duly authorised, executed and delivered by it and constitutes its valid, legally binding and enforceable obligations of each Investor subject to any Legal Reservations.
 
4.3
Repetition
 
 
4.3.1
The representations and warranties in Clause 4.1 and 4.2 (other than those set out in Clause 4.1.6) above are given as at the date of this Agreement and shall be deemed to be repeated (a) on the Issue Date by reference to the facts and circumstances then existing, (b) as at the date of publication of the Prospectus and any supplement or amendment to the Prospectus, by reference to the facts and circumstances then existing and qualified, where relevant, by the contents of the Prospectus or any such supplement or amendment; and
 
 
4.3.2
The representations and warranties in Clause 4.1.6 shall be given as at the date of publication of the Prospectus and shall be deemed repeated (a) if later than the date of publication of the Prospectus, on the Issue Date by reference to the facts and circumstances then existing (b) as at the date of publication of any supplement or amendment to the Prospectus, by reference to the facts and circumstances then existing and qualified, where relevant, by the contents of any such supplement or amendment.
 
5.
Notices
 
5.1
Subject to Clause 5.2, any notice or other communication under this Agreement will only be effective if it is in writing.
 
5.2
Communication by email will not be effective under this Agreement.
 
5.3
Any notice or other communication given or made under this Agreement will be addressed as provided in Clause 5.5 and, if so addressed, will, in the absence of earlier receipt, be deemed to have been duly given or made as follows:
 
 
5.3.1
if sent by personal delivery, on delivery at the address of the relevant party;
 
 
5.3.2
if sent by pre-paid post, two (2) clear Business Days after the date of posting; or
 
 
5.3.3
if sent by facsimile, when transmitted.
 
5.4
Any notice or other communication given or made, or deemed to have been given or made, outside Working Hours will be deemed not to have been given or made until the start of the next period of Working Hours.
 

 
9

 

5.5
The relevant notice details for the parties hereto are:
 
 
5.5.1
if to the Issuer:
 
 
Address:
Head Office
40 Mespil Road
Dublin 4
 
 
Fax no.
+353 1 661 5671
 
 
Attention:
The Group Secretary
 
 
5.5.2
if to any of the Investors, to the address and fax number (if any) set out opposite that Investor’s name in Schedule 1, with copy to the person(s) if any specified in Schedule 1.
 
5.6
A party may notify the other parties of a change to its notice details. That notification will only be effective on:
 
 
5.6.1
any effective date specified in the notification; or
 
 
5.6.2
if no effective date is specified or the effective date specified is less than five (5) clear Business Days after the date when notice is received, the date falling five (5) clear Business Days after the notification has been received.
 
6.
Assignment
 
The Issuer may not may assign or transfer any of its respective rights, benefits or obligations under this Agreement without each Investor’s prior written consent.
 
7.
Waiver
 
A waiver by any Party or Parties of any breach of any of the terms, provisions or covenants of this Agreement or the acquiescence of any Party or Parties in any act (whether of commission or omission) which, but for such acquiescence, would be a breach as aforesaid shall not constitute a general waiver of such term, provision or covenant or of any subsequent act contrary thereto.  Any liability to any Party under the provisions of this Agreement may be released, compounded or compromised by such Party in its absolute discretion as regards any Party or Parties under such liability without in any way prejudicing its rights against any other Party or Parties under the same or a like liability, whether joint and several or otherwise.
 
8.
Entire Agreement
 
This Agreement (together with the Deed of Undertaking) contains the entire agreement between the Parties relating to the transactions provided to which the Issuer is a party for in this Agreement and supersedes all previous representations, arrangements, undertakings and agreements (if any) between the Parties in respect of such matters.  Each of the Parties acknowledges that in agreeing to enter into this Agreement it has not relied on any representation, warranty, undertaking, covenant, pre-contractual statement or understanding other than those contained in this Agreement and/or the Deed of Undertaking.
 
9.
Counterparts
 
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same document and any party to this Agreement may enter into this Agreement by executing a counterpart.
 

 
10

 

10.
Governing Law and Jurisdiction
 
10.1
This Agreement, and all non-contractual obligations arising in connection therewith, shall be governed by and construed in accordance with Irish law.
 
10.2
The courts of Ireland are to have jurisdiction to settle any disputes which may arise out of or in connection with this Agreement and accordingly any legal action or proceedings arising out of or in connection with this Agreement ("Proceedings") may be brought in such courts. The Issuer irrevocably submits to the jurisdiction of such courts and waives any objection to Proceedings in such courts whether on the ground of venue or on the ground that the Proceedings have been brought in an inconvenient forum. These submissions are made for the benefit of the Minister and shall not limit the right of any of them to take Proceedings in any other court of competent jurisdiction nor shall the taking of Proceedings in one or more jurisdictions preclude the taking of Proceedings in any other jurisdiction (whether concurrently or not).
 
IN WITNESS WHEREOF this Agreement has been entered as a deed into on the of this Agreement.
 

 
11

 

SCHEDULE 1
 
The Investors
 
Party
 
Address
 
Fax No.
         
Fairfax Financial Holdings Limited
 
 
95 Wellington Street West
Suite 800
Toronto
Ontario
Canada M5J 2N7
For the attention of:
Paul Rivett
Vice President and Chief Legal Officer
 
 
+1 416 367 4946
With a copy to:
 
 
 
William Fry
Fitzwilton House.
Wilton Place
Dublin 2
For the attention of:
Owen O’Connell
 
 
+353 1 639 5333
Fidelity Contrafund: Fidelity Advisor New Insights Fund
 
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Contrafund: Fidelity Contrafund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Variable Insurance Products Fund III: Balanced Portfolio
 
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 
 
 
12

 
 
Party
 
Address
 
Fax No.
         
Fidelity Advisor Series I: Fidelity Advisor Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+001 617 392 1605
Fidelity Securities Fund: Fidelity Dividend Growth Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Capital Trust: Fidelity Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
Fidelity Advisor Series I: Fidelity Advisor Value Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
Fidelity Puritan Trust: Fidelity Low-Priced Stock Fund
 
 
82 Devonshire Street, VI3H, Boston
MA 02109
USA
For the attention of:
Andrew Boyd
 
 
+ 001 617 392 1605
 
 
 
Kennedy-Wilson Investments, LLC
 
 
 
Kennedy-Wilson Investments LLC
c/o Matt Windisch
9701 Wilshire Boulevard, Suite 700
Beverly Hills
CA 90212
USA
 
 
+ 001 310 887 6459
 
 
13

 
 
 
Party
 
Address
 
Fax No.
         
With a copy to:
 
 
William McMorrow
(wmcmorrow@kennedywilson.com) or Mary Ricks
(mricks@kennedywilson.com)
 
   
WLR/GS Master Co-Investment L.P.
 
 
 
 
 
WLR Master Co-Investment GP, LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
 
+ 001 212 278 9821
 
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR Recovery Fund IV, L.P.
 
 
WLR Recovery Associates IV LLC
c c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001 212 278 9769
 
 
 
 
+ 001 212 278 9821
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR Recovery Fund V, L.P.
 
 
WLR Recovery Associates V LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+001 212 278 9769
 
 
 
 
+ 001 212 278 9821
 
 
14

 
 
Party
 
Address
 
Fax No.
         
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
WLR IV Parallel Esc, L.P.
 
 
WLR Recovery Associates IV LLC
c/o WL Ross & Co. LLC
1166 Avenue of the Americas
25th Floor
New York 10036
USA
For the attention of:
James B. Lockhart III
 
 
+ 001  212 278 9769
 
 
 
 
+ 001 212 278 9821
With a copy to:
 
Benjamin Gruder (BenGruder@invesco.com)
 
   
Capital Research and Management Company
 
333 South Hope St
Los Angeles
CA 90071
SA
For the attention of:
Michael Downer
 
 
+ 001 213 486 9041
 
 
 
 

 
15

 

SCHEDULE 2
 
Terms and Conditions
 
THE GOVERNOR AND COMPANY OF THE BANK OF IRELAND
 
TERMS AND CONDITIONS OF THE CONTINGENT CAPITAL TIER 2 NOTES
 
The following (excluding this paragraph) is the text of the terms and conditions (the “Conditions”) of the CCNs which (subject to modification) shall be endorsed on the Certificates relating to the CCNs.
 
The €1,000,000,000 10.00 per cent. Contingent Capital Tier 2 Notes due [30] July 20161 (“CCNs”) issued by The Governor and Company of the Bank of Ireland (the “Issuer”), which expression shall in these Conditions include any further CCNs issued pursuant to Condition 10 and forming a single series with the CCNs, are subject to these Conditions and are issued pursuant to an agency deed dated on or about the Issue Date (the “Agency Deed”) made between the Issuer and [Citibank N.A., London Branch] as fiscal agent (the “Fiscal Agent”), calculation agent (the “Calculation Agent”) and registrar (the “Registrar”) (together with any other agent or agents appointed from time to time with respect to the CCNs, the “CCN Agents” and each a “CCN Agent”). Copies of the Agency Deed will be available during usual business hours at the specified offices of the Fiscal Agent.
 
The Holders are entitled to the benefit of, are bound by, and are deemed to have notice of those provisions applicable to them of the Agency Deed.
 
1.
Form, Denomination and Title
 
The CCNs are issued in definitive registered form, serially numbered, in denominations of €100,000 and integral multiples of €1,000 in excess thereof.
 
The CCNs are represented by a definitive registered certificate or, as the case may be, definitive registered certificates (each, a “Certificate”) and, save as provided in these Conditions, each Certificate shall represent the entire holding of CCNs by the same Holder.
 
Title to the CCNs shall pass by registration in the register that the Issuer shall procure to be kept by the Registrar in accordance with the provisions of the Agency Deed (the “Register”).
 
2.
Status and Subordination of the CCNs
 
 
(a)
Status
 
The CCNs constitute direct, unsecured and subordinated obligations of the Issuer and rank pari passu and without any preference among themselves. The rights and claims of the Holders are subordinated as described in Condition 2(b).
 
 
(b)
Subordination
 
Subject as provided below, in the event of an order being made, or an effective resolution being passed, for the liquidation, dissolution or winding-up of the Issuer by reason of insolvency, bankruptcy or otherwise, the rights and claims of the Holders against the Issuer in respect of or arising under (including any damages awarded for breach of any obligation under) the CCNs shall, subject to any obligations which are mandatorily preferred by law, rank (A) junior to the claims of all holders of unsubordinated obligations of the Issuer, (B) pari passu with the claims of holders of all other dated subordinated obligations of the Issuer which qualify as consolidated
 
_______________________
1           Assumes an issue date of 29 July 2011.
 

 
16

 

Tier 2 Capital of the Group for regulatory capital purposes, and (C) senior to the claims of holders of all other subordinated obligations of the Issuer expressed to rank junior to the subordinated obligations of the Issuer including any subordinated obligations of the Issuer which qualify as Tier 1 Capital of the Group for regulatory purposes or which are expressed to rank junior to the CCNs.
 
3.
Interest
 
 
(a)
Interest Payment Dates
 
Each CCN bears interest on its principal amount from time to time from (and including) the Issue Date (the “Interest Commencement Date”) and interest will be payable in arrears at the Rate of Interest (as defined below) on [29] July in each year (each an “Interest Payment Date”) up to (but excluding) the Maturity Date in accordance with Condition 7.
 
If any Interest Payment Date falls on a day which is not a Business Day, such Interest Payment Date shall be postponed to the next day which is a Business Day unless it would then fall into the next calendar month, in which event the Interest Payment Date shall be brought forward to the immediately preceding Business Day.
 
The period from and including the Interest Commencement Date to (but excluding) the first Interest Payment Date, and each successive period from and including an Interest Payment Date to (but excluding) the next succeeding Interest Payment Date, or if earlier, the Maturity Date or the Conversion Date is called an “Interest Period”.
 
 
(b)
Interest Accrual
 
Interest accrues on each CCN from day to day from (and including) the Interest Commencement Date to (but excluding) the date on which such CCN has been redeemed in full. Each CCN will cease to bear interest from and including the due date for redemption unless, upon due presentation of the relevant Certificate, payment of the principal in respect of such CCN is improperly withheld or refused or unless default is otherwise made in respect of payment. In such event, interest will continue to accrue until whichever is the earlier of:
 
 
(i)
the date upon which all amounts due in respect of such CCN has been paid;
 
 
(ii)
five days after the date on which the full amount of the moneys in respect of such CCN has been received by the Fiscal Agent and notice to that effect has been given to the Holders; and
 
 
(iii)
in the case of a Conversion (as defined below), the Conversion Date.
 
 
(c)
Fixed Rate of Interest
 
Subject to Condition 3(g), interest is payable on each Interest Payment Date at a rate of 10.00 per cent. per annum (the “Rate of Interest”) and shall be calculated by the Calculation Agent in accordance with the Agency Deed on each Interest Payment Date in respect of each CCN.
 
 
(d)
Calculations
 
If interest is required to be calculated for a period other than a complete Interest Period, the day count fraction used will be the actual number of days in the relevant
 

 
17

 

period divided by the actual number of days in the Interest Period in which such payment falls (including the first such day but excluding the last).
 
 
(e)
Notifications to be Final
 
All notifications, opinions, determinations, certificates, calculations, quotations and decisions given, expressed, made or obtained for the purposes of the provisions of these Conditions by the Calculation Agent will, in the absence of wilful default, bad faith or manifest error, be binding on the Issuer, the Fiscal Agent and the Holders and in the absence of wilful default, bad faith or manifest error, no liability to the Issuer, the Fiscal Agent or the Holders shall attach to the Calculation Agent in connection with  exercise or non-exercise by it of its powers, duties and discretions under these Conditions.
 
 
(f)
No Deferral
 
The Issuer shall not be entitled to defer or cancel any payments of interest or any other amounts payable in respect of the CCNs.
 
 
(g)
Remarketing Option
 
 
(i)
For as long as the Initial Holder is Holder of 100 per cent. of the CCNs, the Initial Holder may, at any time, increase the Rate of Interest on the CCNs (such increased rate, the “New Interest Rate”) as determined by an independent investment bank appointed by the Initial Holder (the “Remarketing Agent”) but with effect only from the date that the CCNs are sold by the Initial Holder to any other person other than any State Entity (a “Third Party Sale”).
 
 
(ii)
For the purposes of this Condition 3(g), the New Interest Rate will not exceed 18.00 per cent. per annum.
 
 
(iii)
The Initial Holder will provide at least 15 Business Days notice in writing to the Issuer of any proposed Third Party Sale or such longer period as may be approved in writing by the Initial Holder. During such period, the Issuer may solicit other third party investors, at a potentially lower interest rate than the rate described in Condition 3(g)(ii), to whom the entire principal amount of the CCNs may be sold at an equivalent or higher price than the Initial Holder would receive for any proposed Third Party Sale.
 
 
(iv)
Notwithstanding any other provision of these Conditions or the Agency Deed to the contrary, the Initial Holder shall have absolute discretion as to whether to sell the CCNs, to whom it may sell the CCNs and the terms of any such sale.
 
 
(v)
The Issuer shall, if required by the Initial Holder: (a) disclose to the Initial Holder the identity of any third party investors solicited or to be solicited by the Issuer pursuant to Condition 3(g)(iii) and (b) provide and/or disclose all such information necessary, as determined by the Initial Holder in its absolute discretion, to facilitate the effecting of a Third Party Sale.
 
 
(h)
Maintenance of Agents
 
The Issuer shall ensure that, so long as any of the CCNs remain outstanding, there shall at all times be a Calculation Agent and a Fiscal Agent having its office in a
 

 
18

 

European city (other than Ireland) and not operating through a branch in Ireland, and that, if the Issuer or the Fiscal Agent would be required to withhold or deduct tax in respect of payments on the CCNs, the Issuer undertakes that it will ensure that it maintains a Fiscal Agent in a member state of the European Union (other than Ireland) that will not be obliged to withhold or deduct tax pursuant to European Council Directive 2003/48/EC on the taxation of savings or any law implementing or complying with, or introduced in order to confirm to, such Directive.
 
4.
Conversion
 
 
(a)
Conversion upon a Conversion Event
 
 
(i)
If a Conversion Event shall occur at any time while the CCNs are outstanding, each CCN shall, subject to and as provided in this Condition 4, be immediately and mandatorily redeemed as of the Conversion Date and settled (such redemption and settlement being the “Conversion” and the term “converted” shall be construed accordingly) by the allotment, issue and delivery by the Issuer of fully paid Ordinary Stock to the Holders on the date specified in the Conversion Notice (as defined below), which date shall be no later than 20 Business Days following the Conversion Date (the “Conversion Settlement Date”).  Subject to Condition 4(c), receipt by the Holders of the Ordinary Stock and Accrued Conversion Interest (if any) shall be a good and complete discharge of the Issuer’s obligations in respect of the CCNs.
 
 
(ii)
As soon as reasonably practicable following the occurrence of the Conversion Event, the Issuer shall give notice thereof to Holders (the “Conversion Notice”) in accordance with Condition 13. The Conversion Notice shall specify the circumstances giving rise to the Conversion Event, the Conversion Price and the Conversion Settlement Date.
 
 
(iii)
If a Conversion Event occurs, the CCNs will be converted in whole and not in part as provided in accordance with this Condition 4(a). CCNs so converted shall be automatically cancelled by the Issuer and may not be held, reissued or resold.
 
 
(iv)
Except on the occurrence of a Conversion Event, the CCNs are not convertible into Ordinary Stock at the option of Holders at any time and are not redeemable in cash as a result of a Conversion Event.
 
 
(v)
No Conversion Notice shall be given and no Conversion shall occur following a Capital Deficiency Event if, notwithstanding the Capital Ratio being below the Trigger Ratio, the Competent Authority, at the request of the Issuer, has agreed, in its absolute discretion, that a Conversion shall not occur because it is satisfied that actions, circumstances or events have had, or imminently will have during the next 90 days following such Capital Deficiency Event, the effect of restoring the Capital Ratio to a level above the Trigger Ratio that the Competent Authority deems to be adequate at such time.
 
 
(vi)
Notwithstanding Condition 4(a)(v), a Conversion Event will immediately occur if the Competent Authority determines, in its absolute discretion, that at any time after agreeing under Condition 4(a)(v) that no Conversion Event shall occur, the Issuer will not be able to restore the Capital Ratio to a level above the Trigger Ratio that the Competent Authority deems to be adequate at such time.
 

 
19

 

 
(b)
Accrued Conversion Interest
 
 
(i)
Upon Conversion, Accrued Conversion Interest shall become due and payable on the Conversion Date and the Issuer shall pay to the Holders the Accrued Conversion Interest (if any) in respect of the CCNs on the Conversion Settlement Date.
 
 
(ii)
Payment of any Accrued Conversion Interest will be made in cash by transfer to an account with a bank in a city in which banks have access to the TARGET System, as specified by the relevant Holder.
 
 
(c)
Conversion Price
 
 
(i)
Upon Conversion, each Holder shall be deemed to have accepted the conversion of its holding of CCNs into Ordinary Stock at the Conversion Price and that the Issuer shall effect such conversion on behalf of such Holder. Such Ordinary Stock will be deemed to be credited as fully paid up and allotted, issued and delivered as of the Conversion Date, whereupon each Holder shall cease as a matter of Irish law to be treated for all purposes under Irish law as a Holder and shall instead as of such date be treated for all purposes under Irish law as a Stockholder.
 
 
(ii)
The Issuer shall, not later than the Conversion Settlement Date, allot and issue or deliver such number of units of Ordinary Stock to the Holders in respect of each CCN as is determined by dividing the principal amount of such CCN by the Conversion Price in effect on the Conversion Date.
 
 
(iii)
The Conversion Price shall be subject to adjustment in the circumstances provided in Condition 4(e) for the adjustment of the Floor Price (with such modifications and amendments as an Independent Financial Adviser acting in good faith shall determine to be appropriate) and the Issuer shall give notice to Holders of the New Floor Price and of any such modifications and amendments thereafter.
 
 
(d)
Conversion on a Takeover Event
 
 
(i)
If a Qualifying Takeover Event shall occur then the CCNs shall, where the Conversion Date falls on or after the Takeover Event Date, be convertible into Approved Entity Shares upon the occurrence of a Conversion Event, mutatis mutandis as provided in accordance with this Condition 4, at a Conversion Price that shall be the New Conversion Price.
 
 
(ii)
The New Conversion Price shall be subject to adjustment in the circumstances provided in Condition 4(e) for the adjustment of the Floor Price (if necessary with such modifications and amendments as an Independent Financial Adviser acting in good faith shall determine to be appropriate) and the Issuer shall give notice to Holders of the New Conversion Price and of any such modifications and amendments thereafter.
 
 
(iii)
If a Non-Qualifying Takeover Event shall occur then, with effect from the occurrence of such Takeover Event and unless a Conversion Event shall have occurred prior to such date, any outstanding CCNs shall remain the obligation of the Issuer and shall, upon the occurrence of a Conversion Event, be convertible into Ordinary Stock in accordance with this Condition 4 but shall
 

 
20

 

not be convertible into Approved Entity Shares at any time notwithstanding that a Conversion Event may occur subsequently.
 
 
(iv)
In the case of a Qualifying Takeover Event:
 
 
(1)
the Issuer shall, on or prior to the Takeover Event Date, enter into such agreements and arrangements, (which may include deeds supplemental to these Conditions and amendments and modifications to these Conditions) as may be required to ensure that, with effect from the Takeover Event Date, the CCNs will be convertible into Approved Entity Shares of the Approved Entity, mutatis mutandis in accordance with, and subject to, this Condition 4 (as may be so supplemented, amended or modified) at a price equal to the New Conversion Price and that subject to such Conversion the CCNs shall remain the obligations of the Issuer; and
 
 
(2)
the Issuer shall, where the Conversion Date falls on or after the Takeover Event Date, procure the allotment and issue and/or delivery of the relevant number of Approved Entity Shares in the manner provided in this Condition 4, as may be amended or modified as provided above.
 
 
(v)
Within 10 Business Days following the occurrence of a Takeover Event, the Issuer shall give notice thereof in accordance with Condition 13 to the Holders (a “Takeover Event Notice”), which shall specify.
 
 
(1)
the identity of the Acquirer;
 
 
(2)
whether the Takeover Event is a Qualifying Takeover Event or a Non-Qualifying Takeover Event;
 
 
(3)
in the case of a Qualifying Takeover Event, if determined at such time, the New Conversion Price; and
 
 
(4)
in the case of a Qualifying Takeover Event, the Takeover Event Date.
 
 
(e)
Adjustments to the Floor Price
 
Upon the happening of any of the events described below, the Floor Price shall be adjusted, unless, for as long as the Initial Holder is a holder of 100 per cent. of the CCNs, the Initial Holder within six months of the Issue Date agrees that no adjustment is required, as follows:
 
 
(i)
Increase of share capital by means of capitalisation of reserves, profits or premia by distribution of Ordinary Stock, or division or consolidation of Ordinary Stock
 
Subject to Condition 4(f), in the event of a change in the Issuer’s share capital as a result of the capitalisation of reserves, profits or premia by means of the distribution of Ordinary Stock or as a result of the division or consolidation of the Ordinary Stock, the Floor Price shall be adjusted by multiplying the Floor Price in force immediately prior to such change by the result of the following formula:
 
Nold / Nnew
 

 
21

 

where:
 
 
Nold
is the number of units of Ordinary Stock existing before the change in share capital; and
 
 
Nnew
is the number of units of Ordinary Stock existing after the change in share capital;
 
provided, however, that no such adjustment shall be made if Ordinary Stock are issued in lieu of the whole or any part of a Cash Dividend, or another cash distribution made in lieu of a dividend, which the Stockholders concerned would or could otherwise have received. Such adjustment shall become effective on the date on which such Ordinary Stock are traded ex-the relevant entitlement on the Primary Stock Exchange.
 
 
(ii)
Issues of Ordinary Stock or Other Securities to Stockholders by way of conferring subscription or purchase rights
 
Subject to Condition 4(f), if (a) the Issuer issues or grants to Stockholders any rights or options, warrants or other rights to subscribe for or acquire Ordinary Stock, Other Securities or securities convertible or exchangeable into Ordinary Stock or Other Securities or (b) any third party, with the agreement of the Issuer, issues to holders of Ordinary Stock any rights, options or warrants to purchase any Ordinary Stock, Other Securities or securities convertible or exchangeable into Ordinary Stock or Other Securities (the rights referred to in (a) and (b) collectively and individually being the “Purchase Rights”), the Floor Price shall be adjusted by multiplying the Floor Price in force immediately prior to such issue or grant by the result of the following formula:
 
(Pcum – R) / Pcum
 
where:
 
 
Pcum
is the VWAP of one unit of Ordinary Stock on whichever is the later of (x) the last dealing day immediately preceding the first date on which the Ordinary Stock is first traded ex-the relevant Purchase Rights on the Primary Stock Exchange or (y) the dealing day when the price for the relevant Purchase Rights is announced, or if the day the subscription or purchase price is announced is not a dealing day, the next following dealing day; and
 
 
R
is the value of the relevant Purchase Rights relating to one unit of Ordinary Stock or Other Security, such value to be calculated as follows:
 
(1)       if the Purchase Rights relate to Ordinary Stock
 
R = Pcum – TERP
 
where:
 
TERP     = (Nold x Pcum + Nnew x (Prights + Div)) / (Nold + Nnew)
 
and:
 

 
22

 

TERP   is the theoretical ex-rights price; and
 
 
Nold
is the number of units of Ordinary Stock existing before the change in share capital; and
 
 
Nnew
is the number of units of Ordinary Stock being newly issued; and
 
 
Prights
is the price at which one new unit of Ordinary Stock can be subscribed, exercised or purchased for; and
 
 
Div
is the amount (in euro) by which the dividend entitlement per unit of Ordinary Stock exceeds the dividend entitlement per new unit of Ordinary Stock, (x) if dividends have already been proposed to the general meeting of shareholders but not yet paid, based on the proposed dividend amount, or (y) if dividends have not yet been proposed based on the last paid dividend;
 
provided, however, that no such adjustment shall be made if the subscription or purchase price at which one new unit of Ordinary Stock can be subscribed or purchased is at least 95 per cent. of Pcum (as defined above);
 
 
(2)
if the Purchase Rights relate to Other Securities or to securities convertible or exchangeable into Ordinary Stock or Other Securities and where such Purchase Rights, or Other Securities are traded on a regulated stock exchange in the European Union, the United States of America, Canada or Japan:
 
R = Nrights x Prights
 
where:
 
 
Nrights
is the number of Purchase Rights granted per unit of Ordinary Stock; and
 
 
Prights
is the average of the last paid prices on the Primary Stock Exchange (in euro) (or, if no dealing is recorded, the arithmetic mean of the bid and offered prices) on a spot basis of one Purchase Right on each dealing day during the period the Purchase Rights are traded or, if such period is longer than ten dealing days, the arithmetic average of the last paid prices (or, if no dealing is recorded, the arithmetic mean of the bid and offered prices) on a spot basis on the first ten such dealing days; or
 
 
(3)
in all other cases where neither of the previous paragraphs (1) or (2) is applicable:
 
R will be determined by an Independent Financial Adviser.
 
Such adjustment shall become effective:
 

 
23

 

 
(i)
where the provisions of Condition 4(e)(ii)(1) apply, on the date on which the Ordinary Stock are traded ex-Purchase Rights on the Primary Stock Exchange or, if the subscription or exercise price is announced only at a later time, one dealing day after the announcement of the price of the Purchase Right;
 
 
(ii)
where the provisions of Condition 4(e)(ii)(2) apply, five dealing days after (x) the end of the subscription or purchase period or (y) the tenth day of the subscription or purchase period, whichever is the sooner; and
 
 
(iii)
where the provisions of Condition 4(e)(ii)(3) apply, on the date determined by an Independent Financial Adviser.
 
 
(iii)
Capital Distributions
 
Subject to Condition 4(f), if and whenever any Capital Distribution shall be made or paid to Stockholders, the Floor Price shall be adjusted by multiplying the Floor Price in force immediately prior to the Effective Date by the following fraction:
 
(Pcum – D) / Pcum
 
where:
 
 
Pcum
is the VWAP of one unit of Ordinary Stock on whichever is the later of (x) the last dealing day immediately preceding the Effective Date or (y) the dealing day when the relevant Dividend is announced (or, if the day on which the amount of the relevant Dividend is announced is not a dealing day, the next following dealing day); and
 
 
D
is the portion of the Fair Market Value of the aggregate Capital Distribution attributable to one unit of Ordinary Stock, with such portion being determined by dividing the Fair Market Value of the aggregate Capital Distribution on the Effective Date by the number of units of Ordinary Stock entitled to receive the relevant Dividend (or, in the case of a purchase, redemption or buy back of Ordinary Stock (or any depositary or other receipts or certificates representing Ordinary Stock) by or on behalf of the Issuer or any Subsidiary of the Issuer, by the number of units of Ordinary Stock in issue immediately following such purchase, redemption or buy back, and treating as not being in issue any Ordinary Stock (or any Ordinary Stock represented by depositary or other receipts or certificates) so purchased, redeemed or bought back).
 
Such adjustment shall become effective on the Effective Date or, if later, the first date upon which the Fair Market Value of the relevant Capital Distribution is capable of being determined as provided herein.
 
 
(iv)
Non-Cash Dividends
 
Subject to Condition 4(f), in respect of a Non-Cash Dividend, the Floor Price shall be adjusted as follows:
 

 
24

 

 
(1)
where the Non-Cash Dividend in question (x) consists of securities that are traded on a regulated stock exchange in the European Union, the United States of America, Canada or Japan or (y) has otherwise a value which is determinable by reference to a stock exchange quotation or otherwise, by multiplying the Floor Price in force immediately prior to such Non-Cash Dividend by the result of the following formula:
 
(Pcum – D) / Pcum
 
where:
 
 
Pcum
is the VWAP of one unit of Ordinary Stock on whichever is the later of (x) the last dealing day preceding the date on which the Ordinary Stock is first traded ex-the relevant Non-Cash Dividend on the Primary Stock Exchange or (y) the dealing day when the amount of the relevant Non-Cash Dividend is announced (or, if the day on which the amount of the relevant Non-Cash Dividend is announced is not a dealing day, the next following dealing day); and
 
 
D
is the portion of the Fair Market Value of the relevant Non-Cash Dividend (in euro) on the dealing day immediately following the date in respect of which Pcum (as defined above) has been determined; and
 
 
(2)
in all other cases, by multiplying the Floor Price in force immediately prior to such issue or distribution by the result of the following formula:
 
Pafter / Pbefore
 
where:
 
 
Pafter
is the arithmetic average of the VWAP of a unit of Ordinary Stock on the first five consecutive dealing days starting on the dealing day immediately following the first dealing day on which the Ordinary Stock are traded ex-the relevant Non-Cash Dividend (the “Distribution Date”); and
 
 
Pbefore
is arithmetic average of the VWAP of a unit of Ordinary Stock on the five consecutive dealing days ending on the dealing day immediately preceding the Distribution Date,
 
as determined by an Independent Financial Adviser.
 
Such adjustment shall become effective:
 
 
(i)
where the provisions of Condition 4(e)(iv)(1) apply, on the date on which the relevant Non-Cash Dividend is made; and
 
 
(ii)
where the provisions of Condition 4(e)(iv)(2) apply, five dealing days after the Distribution Date.
 

 
25

 
 
 
(v)
Other Events
 
If the Issuer determines that, notwithstanding paragraphs (i) to (iv) of this Condition 4(e), an adjustment should be made to the Floor Price as a result of one or more of the events or circumstances not referred to in this Condition 4(e) or circumstances have arisen which might have an adverse effect on the right of the Holders upon Conversion of the CCNs and no adjustment of the Floor Price under this Condition 4(e) would otherwise arise, the Issuer shall engage the advice or services of an Independent Financial Adviser to determine as soon as practicable what adjustment, if any, to the Floor Price or amendment, if any, to the terms of this Condition 4 is fair and reasonable to take into account thereof and the date on which such adjustment should take effect.  The Independent Financial Adviser shall have no responsibility to make any enquiries as to whether or not any event has occurred which might require an adjustment to the Floor Price or amendment, if any, to the terms of this Condition 4.
 
Notwithstanding the foregoing provisions of this Condition 4(e)(v):
 
 
(1)
where the events or circumstances giving rise to any adjustment pursuant to this Condition 4(e) have already resulted or will result in an adjustment to the Floor Price or where the events or circumstances giving rise to any adjustment arise by virtue of any other events or circumstances which have already given or will give rise to an adjustment to the Floor Price or where more than one event which gives rise to an adjustment to the Floor Price occurs within such a short period of time that, in the opinion of the Issuer, a modification to the operation of the adjustment provisions is required to give the intended result, such modification shall be made to the operation of the adjustment provisions as may be determined in good faith by an Independent Financial Adviser to be in its opinion appropriate to give the intended result;
 
 
(2)
such modification shall be made to the operation of the CCNs as may be determined in good faith by an Independent Financial Adviser to be in its opinion appropriate (i) to ensure that an adjustment to the Floor Price or the economic effect thereof shall not be taken into account more than once and (ii) to ensure that the economic effect of a Dividend is not taken into account more than once;
 
 
(3)
for the avoidance of doubt, the issue of Ordinary Stock upon a Conversion or upon any conversion or exchange in respect of any Other Securities or the exercise of any other options, warrants or other rights shall not result in an adjustment to the Floor Price; and
 
 
(4)
at any time when the Ordinary Stock are not admitted to trading on a Recognised Stock Exchange, the Floor Price shall be adjusted as provided above save that for the purposes thereof the Current Market Price, the VWAP of a unit of Ordinary Stock and the date upon which any adjustment becomes effective shall be determined in good faith by an Independent Financial Adviser in such manner as it considers appropriate to ensure that an adjustment to the Floor Price is made which gives the intended same result as if the Ordinary Stock we so admitted to trading.
 

 
26

 

Notice of any adjustments to the Floor Price pursuant to this Condition 4(e)(v) shall be given by the Issuer in accordance with Condition 13 to Holders promptly after the determination thereof.
 
The Floor Price shall not in any event be reduced to below the prevailing nominal value of the Ordinary Stock at the effective date of such adjustment. The Issuer shall not take any action, and procure that no action is taken, that would otherwise result in an adjustment to the Floor Price to an amount below such nominal value.
 
 
(f)
Events not Giving Rise to Adjustments
 
Notwithstanding the provisions of Condition 4(e), no adjustment to the Floor Price will be made:
 
 
(i)
as a result of any issue or distribution of new Ordinary Stock or Other Securities if the pre-emptive right in respect thereof has been validly excluded by a non-routine resolution of the general meeting of Stockholders unless a pre-emptive right in respect thereof is granted indirectly to the Stockholders by a third party with the agreement of the Issuer. For the purpose of these Conditions, the annual disapplication of pre-emption rights conferred by way of special resolution proposed at each annual general meeting of the Issuer shall not constitute a non-routine resolution; or
 
 
(ii)
as a result of any public issue of bonds convertible into Ordinary Stock or bonds with options to subscribe for Ordinary Stock, such issue being in connection with a conditional increase of the share capital of the Issuer, irrespective of whether in respect of such issue the advance subscription rights to acquire such bonds have been excluded or not, unless advance subscription rights have been granted and are traded on the Primary Stock Exchange; or
 
 
(iii)
if, as a result of any Non-Cash Dividend by the Issuer, the Issuer sells any share, right, warrant or other security representing the same (an “Interest”) in any of its subsidiaries to holders of the Ordinary Stock at fair value, and for this purpose:
 
 
(1)
where such Interest is listed on, traded on, or dealt in any stock exchange, the fair value of such Interest shall be at least 95 per cent. of the average of the last paid prices therefor on such stock exchange (or, if more than one, the principal such stock exchange) on each of the ten dealing days commencing on the twentieth dealing day before the day on which the Issuer officially announces the terms and conditions for such sale, as determined by an Independent Financial Adviser; and
 
 
(2)
where such Interest is not so listed, traded or dealt in, the fair value of such Interest shall be at least 95 per cent. of the Fair Market Value thereof; or
 
 
(iv)
if an increase in the Floor Price would result from such adjustment, except in case of an exchange of the Ordinary Stock for Other Securities or a consolidation of Ordinary Stock.
 

 
27

 
 
 
(g)
Decision of an Independent Financial Adviser
 
 
(i)
If any doubt shall arise as to whether an adjustment falls to be made to the Floor Price or the Conversion Price or as to the appropriate adjustment to the Floor Price, and following consultation between the Issuer and an Independent Financial Adviser, a written opinion of such Independent Financial Adviser in respect thereof shall be conclusive and binding on the Issuer and the Holders, save in the case of manifest error.
 
 
(ii)
If the Independent Financial Adviser does not at any time for any reason make any determination or calculate any adjustment in the circumstances provided for in this Condition 4 then the Holders shall, at the expense of the Issuer, be entitled to appoint an agent to do so, and such determination or calculation shall be deemed to have been made by the Independent Financial Adviser. In doing so, the Holders’ agent shall apply the foregoing provisions of Condition 4, with any necessary consequential amendments, to the extent that, in its opinion, it can do so, and in all other respects it shall do so in such manner as it shall deem fair and reasonable in all the circumstances.
 
 
(h)
Share Option Schemes
 
No adjustment will be made to the Floor Price if Ordinary Stock or Other Securities (including pre-emptive rights, options or warrants in relation to Ordinary Stock or Other Securities) are issued, offered or granted to, or for the benefit of, directors or employees, or former directors or employees, of the Issuer or any of its Subsidiaries or any associated company or to trustees to be held for the benefit of any such person in any such case pursuant to any employee share or option scheme which, if required, has been approved by Stockholders.
 
 
(i)
Rounding Down
 
On any adjustment, the resultant Floor Price, if a number that is of more decimal places than the initial Floor Price, shall be rounded to such decimal place. No adjustment shall be made to the Floor Price where such adjustment (rounded down if applicable) would be less than one per cent. of the Floor Price then in effect. Any adjustment not required to be made, and/or any amount by which the Floor Price has been rounded down, shall be carried forward and taken into account in any subsequent adjustment, and such subsequent adjustment shall be made on the basis that the adjustment not required to be made had been made at the relevant time and/or, as the case may be, that the relevant rounding down had not been made.
 
 
(j)
No other Conversion Events
 
Other than a Conversion in accordance with this Condition 4, the CCNs are not subject to any other conversion event. In particular, the CCNs are not convertible into Ordinary Stock at the option of the Holders.
 
 
(k)
Procedure for Settlement and Delivery of Ordinary Stock on Conversion
 
Ordinary Stock to be issued upon a Conversion in respect of the CCNs shall be allotted, issued and delivered subject to and as provided in these Conditions and in the Agency Deed.
 

 
28

 
 
 
(l)
Fractions
 
Fractions of Ordinary Stock will not be issued or delivered pursuant to the Conditions upon a Conversion and no cash payment will be made in lieu thereof.
 
 
(m)
Delivery of Ordinary Stock
 
 
(i)
The Issuer shall, on or prior to the Conversion Settlement Date, allot and issue or deliver to the Holders such number of units of Ordinary Stock as is required to satisfy in full the Issuer’s obligation to deliver Ordinary Stock in respect of the Conversion of the aggregate amount of CCNs as at the Conversion Date. Receipt by the Holders of such Ordinary Stock and Accrued Conversion Interest (if any) shall be a good and complete discharge of the Issuer’s obligations in respect of the CCNs.
 
 
(ii)
In order to obtain delivery of the relevant Ordinary Stock upon a Conversion, the relevant Holder must deliver the relevant Certificates representing the CCNs held by it to the specified office of the Registrar prior to the Conversion Settlement Date.
 
 
(iii)
The Issuer shall procure that Ordinary Stock to be created, issued and delivered following a Conversion Event will be delivered to the Holders in uncertificated form through CREST, unless at the relevant time the Ordinary Stock are not a participating security in CREST or the relevant holder elects to receive the Ordinary Stock in certificated registered form.  Where the Ordinary Stock are to be delivered through CREST, they will be delivered to an account specified by the relevant Holder prior to the Conversion Settlement Date. Where the Ordinary Stock are to be delivered in certificated form, a certificate in respect thereof will be dispatched by mail free of charge (but uninsured and at the risk of the recipient) to the relevant Holder or prior to the Conversion Settlement Date.
 
 
(n)
Taxes and Duties
 
 
(i)
A Holder must pay any taxes and capital, stamp, issue and registration and transfer taxes or duties arising on Conversion (other than any taxes and capital, stamp, issue and registration and transfer taxes or other duties payable in Ireland in respect of the issue and delivery of the Ordinary Stock delivered pursuant to these Conditions which shall be paid by the Issuer) and such Holder must pay all, if any, taxes arising by reference to any disposal or deemed disposal of a CCN or interest therein.
 
 
(ii)
If the Issuer shall fail to pay any taxes or capital, stamp, issue, registration and transfer taxes or other duties payable in Ireland for which it is responsible as provided in Condition 4(n)(i) above, any Holder shall be entitled (but shall not be obliged) to tender and pay the same and the Issuer, as a separate and independent stipulation, covenants to reimburse and indemnify on an after tax basis such Holder in respect of any payment thereof and any penalties payable in respect thereof.
 
 
(o)
Ordinary Stock
 
The Ordinary Stock issued or delivered on Conversion will be fully paid and non-assessable, free from any Encumbrance and will in all respects rank pari passu with the fully paid Ordinary Stock in issue on the Conversion Settlement Date except in
 

 
29

 

any such case for any right excluded by mandatory provisions of applicable law, and except that the Ordinary Stock so issued or delivered will not rank for (or, as the case may be, the relevant Holder shall not be entitled to receive) any rights, distributions or payments the record date or other due date for the establishment of entitlement for which falls prior to the Conversion Settlement Date.
 
5.
Covenants
 
For so long as any CCN remains outstanding, the Issuer shall (in each case save with the prior written approval of the Holders):
 
 
(a)
not make any issue, grant, reorganisation, capitalisation or distribution or take or omit to take any other action if the effect thereof would be (or is reasonably foreseeable to be) that a unit of Ordinary Stock cannot be legally issued as fully paid and free from any Encumbrance on the Conversion of each CCN;
 
 
(b)
(other than in connection with a Reorganisation or a Liability Management Exercise) not issue or pay up any Ordinary Stock or Other Securities, in either case by way of capitalisation of profits or reserves, other than:
 
 
(i)
by the issue of fully paid Ordinary Stock or Other Securities to Stockholders and other holders of shares in the capital of the Issuer which, by their terms, entitle the holders thereof to receive Ordinary Stock or Other Securities on a capitalisation of profits or reserves; or
 
 
(ii)
by the issue of Ordinary Stock paid up in full (in accordance with applicable law) and issued wholly, ignoring fractional entitlements, in lieu of the whole or part of a Dividend in cash (excluding, for the avoidance of doubt, the issue of Ordinary Stock in respect of hybrid capital instruments where there is an alternative coupon settlement mechanism); or
 
 
(iii)
by the issue of fully paid Other Securities to the holders of Ordinary Stock or Other Securities which, by their terms, entitle the holders thereof to receive Other Securities (excluding, for the avoidance of doubt, the issue of Ordinary Stock in respect of hybrid capital instruments where there is an alternative coupon settlement mechanism); or
 
 
(iv)
by the issue of Ordinary Stock or Other Securities to, or for the benefit of, any employee or former employee, director or executive holding or formerly holding executive office of Issuer or any of its Subsidiaries or any associated company or totrustees or nominees to be held for the benefit of any such person, in any such case pursuant to an employee, director or executive share or option scheme whether for all employees, directors, or executives or any one or more of them,
 
unless, in any such case, the same constitutes a Dividend or otherwise gives rise (or would, but for the provisions of Condition 4(i) relating to roundings and minimum adjustments or the carry forward of adjustments, give rise) to an adjustment to the Floor Price and unless, if the Floor Price would otherwise be reduced to below the prevailing nominal value of the Ordinary Stock at the effective date of such adjustment, gives rise to an adjustment to the nominal value of the Ordinary Stock to reflect the Floor Price so reduced;
 
 
(c)
not modify the rights attaching to the Ordinary Stock with respect to voting, dividends or liquidation but so that nothing in this Condition 5(b) shall prevent:

 
30

 
 
 
(i)
any consolidation, reclassification or subdivision of the Ordinary Stock; or
 
 
(ii)
any modification of such rights which is not materially prejudicial to the interests of the Holders as determined in good faith by an Independent Financial Adviser;
 
 
(d)
procure that no Ordinary Stock or Other Securities issued without rights to convert into, or exchange or subscribe for, Ordinary Stock shall subsequently be granted such rights and that at no time shall there be in issue Ordinary Stock of differing nominal values unless the same gives rise (or would, but for the provisions of Condition 4(i) relating to roundings and minimum adjustments or the carry forward of adjustments, give rise) to an adjustment to the Floor Price and that at no time shall there be in issue Ordinary Stock or Other Securities of differing nominal values, save where such Ordinary Stock or Other Securities have the same economic rights;
 
 
(e)
not reduce its issued ordinary share capital, share premium account, capital redemption reserve, or any uncalled liability in respect thereof, or any non-distributable reserves, except where the reduction is permitted by applicable law and results in (or would, but for the provisions of Condition 4(i) relating to roundings or the carry forward of adjustments, result in) an adjustment to the Floor Price or is otherwise taken into account for the purposes of determining whether or not such an adjustment should be made, provided that, for the avoidance of doubt, this Condition 5(e) shall not operate to restrict the Issuer from reducing its preference share capital and share premium amounts in respect of its preference share capital;
 
 
(f)
issue, allot and/or deliver Ordinary Stock upon Conversion subject to and as provided in Condition 4;
 
 
(g)
use all reasonable endeavours to ensure that any Ordinary Stock issued upon a Conversion Event will, as soon as is practicable, be admitted to the Official List of the Irish Stock Exchange and trading on its regulated market or will be listed, quoted or dealt in, as soon as is practicable, on any other stock exchange or securities market on which the Ordinary Stock are then listed or quoted or dealt in;
 
 
(h)
use all reasonable endeavours to ensure that its issued and outstanding Ordinary Stock continue to be admitted to the Official List of the Irish Stock Exchange and trading on its regulated market, or listed, admitted to trading, quoted or dealt in on such other principal stock exchange or securities market on which the Ordinary Stock are currently listed, admitted to trading or quoted or dealt in;
 
 
(i)
in the event of a Reorganisation, take (or shall procure that there is taken) all necessary action to ensure that, immediately after completion of the relevant proceedings, such amendments are made to these Conditions as are necessary to ensure that the CCNs may be converted into or exchanged for ordinary shares or stock or units or the equivalent in Newco mutatis mutandis in accordance with and subject to these Conditions and the ordinary shares or stock or units or the equivalent of Newco are listed and admitted to trading on a Recognised Stock Exchange;
 
 
(j)
if an offer is made to all (or a majority) of the holders of the Ordinary Stock other than the offeror and/or any associates of the offeror to acquire all or a majority of the issued ordinary share capital of the Issuer, or if a scheme (other than a Reorganisation) or merger is proposed with regard to such acquisition or merger with the undertaking of the Issuer, give notice in writing of such offer or scheme or merger to the Holders, in their capacity as the Holders, as soon as practicable upon becoming aware of such offer;
 

 
31

 

 
(k)
give notice in writing to the Holders, in their capacity as the Holders, if an offer is made to all (or a majority) of the holders of the Ordinary Stock other than the offeror and/or any associate of the offeror to acquire all or a majority of the issued ordinary share capital of the Issuer or if any person proposes a scheme or merger with regard to such acquisition or merger with the undertaking of the Issuer and such offer or scheme or merger having become or been declared unconditional in all respects, the right to cast more than 50 per cent. of the votes which may ordinarily be cast on a poll at a general meeting of the Issuer has or will become unconditionally vested in the offeror and/or an associate. Such notice shall specify all information relevant to Holders concerning such offer or scheme or merger;
 
 
(l)
notwithstanding that no voting rights shall attach to the CCNs in respect of the Ordinary Stock, provide to the Holders, in their capacity as Holders, notice of every general meeting of the Stockholders of the Issuer and a copy of every circular or like document sent out by the Issuer to the Stockholders;
 
 
(m)
for so long as the CCNs are listed and freely transferable, from time to time on request and at its own expense, do and execute or procure to be done and executed all necessary acts, deeds, documents and things in a form satisfactory to a Holder that such Holder reasonably considers necessary to effect and/or facilitate the transfer of any of the CCNs and their registration in the name of the transferee in the Register;
 
 
(n)
where the provisions of Condition 4 require or provide for a determination by an Independent Financial Adviser, use all reasonable endeavours promptly to appoint such person for such purpose;
 
 
(o)
at all times keep available for issue, free from pre-emptive or other preferential rights, a sufficient number of units of Ordinary Stock to enable the conversion of the CCNs, and any other rights of subscription and exchange for Ordinary Stock arising pursuant to the CCNs, to be satisfied in full;
 
 
(p)
not take any action, and procure that no action is taken, that would result in an adjustment to the Floor Price to below the prevailing nominal value of the Ordinary Stock at the effective date of such adjustment;
 
 
(q)
provide to the Competent Authority the Core Tier 1 Ratio and CET1 Ratio, as applicable, on an ad hoc or ongoing basis as requested by the Competent Authority and the Issuer will publish the Core Tier 1 Ratio and CET1 Ratio, as applicable, in respect of any Semi-Annual Reporting Period or as otherwise required to be publically disclosed by the Issuer;
 
 
(r)
obtain prior written approval from the Competent Authority for any distributions proposed by the Issuer in respect of any profit generated or other fair value movements as a consequence of the accounting treatment of the CCNs in the Issuer’s shareholder funds;
 
 
(s)
maintain a listing of the CCNs on the Irish Stock Exchange, or failing that, any other Recognised Stock Exchange; and
 
 
(t)
immediately give notice in writing to the Holders of the occurrence of any Conversion Event or Takeover Event or any Event of Default or any matter it concludes is likely to give rise to a Conversion Event or Takeover Event or Event of Default immediately upon becoming aware thereof and without waiting for the Holders to take any further action.
 

 
32

 

6.
Redemption and Cancellation
 
 
(a)
Redemption at Maturity
 
Unless previously converted as provided in these Conditions, each CCN will only be redeemed at its principal amount, together with accrued interest, on the Maturity Date.
 
 
(b)
No other redemption, purchase, or buy back
 
None of the Issuer nor any of its Subsidiaries nor any other Group Company shall purchase, redeem, buy back or otherwise acquire any of the CCNs prior to the Maturity Date.
 
 
(c)
Cancellation
 
All CCNs redeemed by the Issuer pursuant to this Condition 6 will forthwith be cancelled.
 
7.
Payments
 
 
(a)
Payments in respect of CCNs
 
 
(i)
Payments of principal to be made to Holders in respect of CCNs and payments of accrued interest payable on a redemption of CCNs (other than on an Interest Payment Date) and payment of any Accrued Conversion Interest that is to be paid in accordance with this Condition 7 shall, in each case, be made against presentation and surrender of the relevant Certificates at the specified office of any of the CCN Agents or of the Registrar.
 
 
(ii)
Payments of interest to be made to Holders in respect of CCNs due on an Interest Payment Date shall be paid to the person shown on the Register at the close of business on the fifteenth day before the Relevant Date for payment thereof (the “Record Date”).
 
 
(iii)
Payments of any other amounts in respect of CCNs other than as referred to in (i) and (ii) will be made as provided in these Conditions.
 
 
(b)
Payments subject to Fiscal Laws
 
All payments are subject in all cases to any applicable fiscal or other laws, regulations and directives in the place of payment, but without prejudice to the provisions of Condition 8. No commission or expenses shall be charged to the Holders in respect of such payments.
 
 
(c)
Method of Payment
 
Payments of principal and interest will be made by credit or transfer in euro to the account specified in the Register.
 
 
(d)
Non-Business Days
 
If any date for payment in respect of any CCNs is not a Business Day, the Holder shall not be entitled to payment until the next following Business Day nor to any interest or other sum in respect of such postponed payment.
 

 
33

 

8.
Taxation
 
All payments of principal, premium (if any) and/or interest to the Holders by or on behalf of the Issuer in respect of the CCNs shall be made without withholding or deduction for or on account of any present or future tax, duty, assessment or governmental charge of whatsoever nature imposed, levied, collected, withheld or assessed by or on behalf of Ireland or any authority thereof or therein having power to tax, unless such withholding or deduction is required by law. In that event, the Issuer shall pay such additional amounts (“Additional Amounts”) as will result (after such withholding or deduction) in receipt by the Holders of the sums which would have been receivable (in the absence of such withholding or deduction) from it in respect of their CCNs; except that no such Additional Amounts shall be payable with respect to any CCN:
 
 
(a)
to, or to a third party on behalf of, a Holder if such withholding or deduction may be avoided by complying with any statutory requirement or by making a declaration of non-residence or other similar claim for exemption to any authority of or in Ireland, unless such Holder proves that he is not entitled so to comply or to make such declaration or claim; or
 
 
(b)
to, or to a third party on behalf of, a Holder that is a partnership, or a holder that is not the sole beneficial owner of the CCN, or which holds the CCN in a fiduciary capacity, to the extent that any of the members of the partnership, the beneficial owner or the settlor or beneficiary with respect to the fiduciary would not have been entitled to the payment of an additional amount had each of the members of the partnership, the beneficial owner, settlor or beneficiary (as the case may be) received directly his beneficial or distributive share of the payment; or
 
 
(c)
(where presentation and surrender is required pursuant to these Conditions) presented for payment more than 30 days after the Relevant Date except to the extent that the Holder thereof would have been entitled to such Additional Amounts on presenting the same for payment at the expiry of such period of 30 days; or
 
 
(d)
where such withholding or deduction is imposed on a payment to an individual and is required to be made pursuant to European Council Directive 2003/48/EC on the taxation of savings income or any law implementing or complying with, or introduced in order to conform to, such Directive; or
 
 
(e)
(where presentation and surrender is required pursuant to these Conditions) in respect of any CCN presented for payment by or on behalf of a Holder who would have been able to avoid such withholding or deduction by presenting the relevant CCN to another Fiscal Agent in a member state of the European Union; or
 
 
(f)
where such withholding or deduction arises by reason of the Holder having some connection with Ireland other than the mere holding or ownership of the CCNs.
 
9.
Variation following Tax Event
 
 
(a)
Tax Event
 
If a Tax Event has occurred and is continuing, the Issuer may, subject to Condition 9(b), at any time upon not less than 30 nor more than 60 days’ notice to the Holders in accordance with Condition 13, without any requirement for the consent of approval of the Holders, vary the terms of the CCNs so that they remain or, as appropriate, become, Qualifying CCNs.  In connection with any variation in accordance with this Condition 9, the Issuer shall comply with the rules of any stock exchange on which
 

 
34

 

the CCNs are for the time being listed or admitted to trading.  For the avoidance of doubt, a variation under this Condition 9 may include a substitution of the Issuer.
 
 
(b)
Conditions to Variation
 
Any variation of the terms of the CCNs in accordance with this Condition 9 shall be solely for the purposes of curing a Tax Event and shall be subject to (i) the provisions of Condition 14(b) and (ii) for so long as the Initial Holder is a holder of 100 per cent of the CCNs, such variation being approved in writing by the Initial Holder.
 
10.
Replacement of Certificates
 
If a Certificate is lost, stolen, mutilated, defaced or destroyed, it may be replaced, subject to applicable laws, regulations and stock exchange or other relevant authority regulations, at the specified office of the Registrar, or such other CCN Agent as may from time to time be designated by the Issuer for the purpose and notice of whose designation is given to Holders, on payment by the claimant of the fees and costs incurred in connection therewith and on such terms as to evidence, security and indemnity (which may provide, inter alia, that if the allegedly lost, stolen or destroyed Certificate is subsequently presented for payment there shall be paid to the Issuer on demand the amount payable by the Issuer in respect of such Certificates) and otherwise as the Issuer and/or CCN Agent may reasonably require. Mutilated or defaced CCNs or Certificates must be surrendered before replacements will be issued.
 
11.
Further Issues
 
The Issuer may, from time to time, without the consent of the Holders, create and issue further securities either having the same terms and conditions as the CCNs in all respects (or in all respects except for the first payment of interest on them) and so that such further issue shall be consolidated and form a single series with the outstanding securities of any series (including the CCNs) or upon such terms as the Issuer may determine at the time of their issue. References in these Conditions to the CCNs include (unless the context requires otherwise) any other securities issued pursuant to these Conditions and forming a single series with the CCNs.
 
12.
Event of Default
 
If, for so long as the CCNs have not converted, (a) there is default for more than 7 days in the payment of any principal or for more than 14 days in the payment of any interest in respect of the CCNs or any of them when and as the same are due for payment or (b) if proceedings have been instituted for the winding up or liquidation of the Issuer (each an “Event of Default”), the Holders of 25 per cent of the aggregate principal amount of the CCNs for the time being outstanding may, in their absolute discretion, institute proceedings for the winding-up or liquidation of the Issuer (in the case of (a) above) and each Holder may prove and/or claim in the winding up or liquidation of the Issuer for such payment but may not take any other action with respect to such default.
 
13.
Notices
 
A notice may be given by the Issuer to any Holder of CCNs by sending it by post to such Holder at its address in the Register. Service of such notice shall be deemed to have been effected by properly addressing, prepaying and posting a letter by post containing the notice and shall be deemed to have been given on the second Business Day after the date of posting.
 
A notice may be given by the Issuer to joint holders of the CCNs by giving notice to the joint holder first named in the Register.
 

 
35

 

A notice may be given by the Issuer, to the extent permitted by the Irish Stock Exchange (if and for so long as the CCNs are listed on the Irish Stock Exchange) and by law, by electronic communication if so requested or authorised by the Holders, the Holders having notified the Issuer of an e-mail address to which the Issuer may send electronic communications and having agreed to receive notices and other documents from the Issuer by electronic communication. If a Holder notifies the Issuer of an e-mail address, the Issuer may send the Holder the notice or other document by publishing the notice or other document on a website and notifying the Holder by e-mail that the notice or other document has been published on the website.  The Issuer must also specify the address of the website on which it has been published, the place on the website where the notice may be accessed and how it may be accessed, and where the notice in question is a notice of a meeting, the notice must continue to be published on that website throughout the period beginning with the date of that notification and ending on the conclusion of that meeting, save that if the notice is published for part only of that period the failure to publish the notice throughout that period shall not invalidate the proceedings of a meeting where such failure is wholly attributable to circumstances which it would not be reasonable to have expected the Issuer to prevent or avoid.
 
In addition, if and for so long as the CCNs are listed on the Irish Stock Exchange or any other Recognised Stock Exchange, notices shall be given in accordance with any requirement of such exchange.
 
Any notice or notification (however expressed) to be given to the Issuer by any Holder shall be effected by properly addressing, prepaying and posting a letter by registered post containing the notice and shall be deemed to have been given on the second Business Day after the date of posting.
 
14.
Meetings of Holders, Modification and Consent
 
 
(a)
Meetings of Holders
 
The Agency Deed contains provisions for convening meetings of Holders to consider any matter affecting their interests, including the sanctioning by Extraordinary Resolution of a modification of any of these Conditions or any provisions of the Agency Deed. Such a meeting may be convened by Holders holding not less than 10 per cent. in aggregate principal amount of the CCNs for the time being outstanding. The quorum for any meeting convened to consider an Extraordinary Resolution shall be one or more persons holding or representing a clear majority in aggregate principal amount of the CCNs for the time being outstanding, or at any adjourned meeting one or more persons being or representing Holders whatever the aggregate principal amount of the CCNs held or represented, unless the business of such meeting includes consideration of proposals, inter alia, (i) to amend the provisions for redemption of the CCNs or any date for payment of interest on the CCNs, (ii) to reduce or cancel the principal amount of the CCNs, (iii) to reduce the rate of interest in respect of the CCNs or to vary the method or basis of calculating the rate or amount of interest or the basis for calculating the amounts of any interest in respect of the CCNs, (iv) to vary any method of, or basis for, calculating the amounts payable on redemption of the CCNs, (v) to vary the currency of payment or denomination of the CCNs, (vi) to modify the provisions concerning the quorum required at any meeting of Holders or the majority required to pass the Extraordinary Resolution, or (vii) to amend or modify the provisions relating to the Conversion Event, in which case the necessary quorum shall be such person or persons holding or representing not less than 75 per cent., or at any adjourned meeting not less than 25 per cent., in aggregate principal amount of the CCNs for the time being outstanding. Any Extraordinary Resolution duly passed shall be binding on Holders (whether or not they were present at the meeting at which such resolution was passed).
 

 
36

 

A resolution in writing signed by or on behalf of the Holder or Holders of not less than 75 per cent. in aggregate principal amount of the CCNs outstanding shall for all purposes be as valid and effective as an Extraordinary Resolution passed at a meeting of Holders duly convened and held. Such a resolution in writing may be contained in one document or several documents in the same form, each signed by or on behalf of one or more Holders.
 
 
(b)
Modification
 
No modification to these Conditions or any other provisions of the Agency Deed (whether pursuant to this Condition 14 or otherwise) shall become effective unless the Issuer shall have received written approval from the Competent Authority (provided that, at the relevant time, there is a requirement to obtain such approval).
 
The Issuer may, in accordance with Condition 9, without the consent or approval of the Holders, make such modifications or variations to the terms of the CCNs and Agency Deed as it considers necessary or desirable to give effect to the provisions of Condition 9, provided that such modifications or variations are not materially prejudicial to the interests of the Holders, as determined in good faith by an Independent Financial Adviser, and provided that such modifications or variations do not modify or vary any of the terms of the CCNs as contemplated by Condition 14(a)(i) to (vii) above.
 
 
(c)
Consent
 
Where these Conditions require the prior consent or approval of the Holders, such consent or approval shall for all purposes be deemed to be valid and effective if in writing signed by or on behalf of the Holder or Holders of in excess of 50.00 per cent. in aggregate principal amount of the CCNs outstanding or if given by way of an Extraordinary Resolution.
 
15.
Transfers of CCNs
 
 
(a)
Transfer of CCNs
 
One or more CCNs may be transferred upon the surrender (at the specified office of the Registrar) of the Certificate representing such CCNs to be transferred, together with the form of transfer endorsed on such Certificate (or another form of transfer substantially in the same form and containing the same representations and certifications (if any), unless otherwise agreed by the Issuer), duly completed and executed and any other evidence as the Registrar may reasonably require. A new Certificate shall be issued to the transferee in respect of the CCNs the subject of the relevant transfer and, in the case of a transfer of part only of a holding of CCNs represented by one Certificate, a new Certificate in respect of the balance of the CCNs not transferred shall be issued to the transferor. In the case of a transfer of CCNs to a person who is already a Holder, a new Certificate representing the enlarged holding may be issued but only against surrender of the Certificate representing the existing holding of such person. All transfers of CCNs and entries on the Register will be made subject to the detailed regulations concerning transfers of CCNs scheduled to the Agency Deed. The regulations may be changed by the Issuer, with the prior written approval of the Registrar. A copy of the current regulations will be made available by the Registrar to any Holder upon request.
 

 
37

 

 
(b)
Delivery of New Certificates
 
Each new Certificate to be issued pursuant to Condition 15(a) shall be available for delivery within three Business Days of receipt of the form of transfer and surrender of the relevant Certificate.  Delivery of new Certificate(s) shall be made at the specified office of the Registrar to whom delivery and surrender of such form of transfer and Certificate or, as the case may be, surrender of such Certificate, shall have been made or, at the option of the relevant Holder and as specified in the relevant form of transfer or otherwise in writing, be mailed by uninsured post at the risk of the Holder entitled to the new Certificate to such address as may be so specified, unless such Holder requests otherwise and pays in advance to the relevant Registrar the costs of such other method of delivery and/or such insurance as it may specify.
 
 
(c)
Transfers Free of Charge
 
Transfers of CCNs and the issue of new Certificates on transfer shall be effected without charge by or on behalf of the Issuer or the Registrar, but upon payment by the transferee of any tax or other governmental charges that may be imposed in relation to it (or the giving of such indemnity as the Registrar may require).
 
16.
Definitions and Interpretation
 
 
16.1
The following capitalised terms shall have the following meanings:
 
Accrued Conversion Interest” means, upon Conversion of the CCNs, interest accrued on the CCNs, if any, from (and including) the Interest Payment Date immediately preceding the Conversion Date (or, if none, from the Issue Date) to (but excluding) the Conversion Date;
 
Acquirer” means the person which, following a Takeover Event, controls the Issuer;
 
Additional Amounts has the meaning given to it in Condition 8;
 
Approved Entity” means a body corporate (other than a State Entity) which: (i) for so long as the Initial Holder is a holder of 100 per cent. of the CCNs is (a) approved in writing by the Initial Holder and (b) on the occurrence of the Takeover Event, has in issue Approved Entity Shares; or (ii) where the Initial Holder is not the sole holder of 100 per cent. of the CCNs, on the occurrence of the Takeover Event, has in issue Approved Entity Shares. On and after the date of a Takeover Event, references herein to “Ordinary Stock” shall be read as references to “Approved Entity Shares”;
 
Approved Entity Shares means ordinary shares or stock in the capital of the Approved Entity which constitute equity share capital or the equivalent which, unless otherwise agreed in writing by the Holders at such time, is listed and admitted to trading on a Recognised Stock Exchange. In relation to any Conversion in respect of which the Conversion Date falls on or after the Takeover Event Date, where the Takeover Event is a Qualifying Takeover Event, references herein to “Ordinary Stock” shall be deemed to be references to “Approved Entity Shares”;
 
Business Day” means a day on which the TARGET system is operating;
 
Capital Deficiency Event” means the occurrence of (i) the Issuer giving notice to the Holders that the relevant Capital Ratio is below the Trigger Ratio, or (ii) the Competent Authority notifying the Issuer that it has determined, in its absolute discretion, that the Group’s financial and solvency condition is deteriorating in such a
 

 
38

 

way that the relevant Capital Ratio is likely to be below the Trigger Ratio in the short term;
 
Capital Distribution” means:
 
 
(i)
any Dividend which is expressed by the Issuer or declared by the board of directors of the Issuer to be a capital distribution, extraordinary dividend, extraordinary distribution, special dividend or return of value to Stockholders or any analogous or similar term, in which case the Capital Distribution for the purpose of these Conditions shall be the Fair Market Value of such Dividend; or
 
 
(ii)
any Cash Dividend (the “Relevant Dividend”) paid or made in respect of a fiscal year of the Issuer (the “Relevant Fiscal Year”) if the sum of:
 
 
(a)
the Fair Market Value of the Relevant Dividend per unit of Ordinary Stock; and
 
 
(b)
the aggregate of the Fair Market Value per unit of Ordinary Stock of any other Cash Dividend or Cash Dividends per unit of Ordinary Stock paid or made in respect of the Relevant Fiscal Year (disregarding for such purposes any amount previously determined to be a Capital Distribution in respect of the Relevant Fiscal Year),
 
such sum being the “Current Year’s Dividend”, exceeds the Reference Amount, and in such case the amount of the relevant Capital Distribution shall be the lesser of (i) the amount by which the Current Year’s Dividend exceeds the Reference Amount and (ii) the Fair Market Value of the Relevant Dividend;
 
Capital Ratio” means, prior to the CRD IV Implementation Date, the Core Tier 1 Ratio and, on or after the CRD IV Implementation Date, the CET1 Ratio;
 
Cash Dividend” means (i) any Dividend which is to be paid or made in cash (in whatever currency) and (ii) any Dividend determined to be a Cash Dividend pursuant to paragraph (i) of the definition of Dividend:
 
CET1 Amount” means, at any time, as calculated by the Issuer on a consolidated basis and expressed in the Group’s reporting currency, the sum of all amounts (whether positive or negative) of Common Equity Tier 1 Capital of the Group as at such time. For the avoidance of doubt, CET1 Amount includes any capital instruments injected at any time by the Initial Holder or any other State Entity to strengthen the capital base of the Group and deemed by the Competent Authority to be eligible to count previously towards Core Tier 1 Amount;
 
CET1 Ratio” means, in respect of any Semi-Annual Reporting Period, the ratio (expressed as a percentage) of the CET1 Amount divided by the RWA Amount, as at the date of the financial statements contained in the relevant Semi-Annual Financial Report, as calculated by the Issuer and appearing in its relevant Semi-Annual Financial Report;
 
Common Equity Tier 1 Capital” means all items that constitute common equity tier 1 capital, or deductions from and any other adjustments to common equity tier 1 capital, in each case within the meaning of these terms or equivalent in the CRD IV and as implemented, where necessary, in Ireland through legislation.  For the
 

 
39

 

avoidance of doubt the Common Equity Tier 1 Capital will be calculated taking into account the phase-in of deductions and other adjustments pursuant to CRD IV;
 
Competent Authority” means the Central Bank of Ireland or any subsequent entity acting in that capacity as the lead regulator of the Issuer;
 
Conversion” and “converted” shall have the meaning given to such terms in Condition 4(a);
 
Conversion Date” means the date upon which a Conversion Event occurs;
 
Conversion Event” means the occurrence of a Capital Deficiency Event or Non-Viability Event;
 
Conversion Notice has the meaning given to it in Condition 4(a)(ii);
 
Conversion Price” means: (i) at any time when the Ordinary Stock are admitted to trading on a Recognised Stock Exchange, in respect of any Conversion Date, the greater of:
 
 
(a)
the VWAP of a unit of Ordinary Stock of the Issuer over the 30 Business Days prior to the date of the relevant Conversion Event, and
 
 
(b)
the Floor Price of unit of Ordinary Stock on the date of the relevant Conversion Event (being, at the Issue Date, €[ l ]),
 
or (ii) at any time when the Ordinary Stock are not admitted to trading on a Recognised Stock Exchange, the Floor Price;
 
Conversion Settlement Date” shall have the meaning given to such terms in Condition 4(a)(i);
 
Core Tier 1 Amount” means, if at any time, as calculated by the Issuer on a consolidated basis and expressed in the Group’s reporting currency, the aggregate amount of capital elements prescribed by the European Banking Authority in the “Supporting Document 2: Capital Definition Criteria” published on the 8 April 2011 and released to be the benchmark to be used in the 2011 EU-wide stress test for the purpose of computing the “Core Tier 1 including existing government support measures (CT1)” as at such time. For the avoidance of doubt, Core Tier 1 Amount includes any capital instruments injected at any time by the Initial Holder or any other State Entity to strengthen the capital base of the Group and deemed by the Competent Authority to be eligible to count towards Core Tier 1 Amount;
 
Core Tier 1 Ratio” means, in respect of any Semi-Annual Reporting Period, the ratio (expressed as a percentage) of the Core Tier 1 Amount divided by the RWA Amount, as at the date of the financial statements contained in the Semi-Annual Reporting Period, as calculated by the Issuer and appearing in its relevant Semi-Annual Financial Report as “Core Tier 1 Ratio” or such other term having the same meaning;
 
CRD IV” means a proposal for a Directive of the European Parliament and of the Council which will amend Directives 2006/48/EC and 2006/49/EC, principally in order to implement in the EU, the reforms agreed by the Basel Committee on Banking Supervision in December 2010 (Basel III), including reforms to the definition of capital and counterparty credit risk and the introduction of a leverage ratio and liquidity requirements;
 

 
40

 

CRD IV Implementation Date” means the first date on which the Group is required to comply with the capital adequacy standards adopted and implemented in the European Union through the CRD IV as amended and as implemented, where necessary, in Ireland through legislation. Such date can be when the Minister chooses to transpose the requirements of CRD IV into Irish law or when the deadline for transposition has been reached, whichever is earlier;
 
Current Market Price” means, in respect of unit of Ordinary Stock  at a particular date, the average of the daily VWAP of a unit of Ordinary Stock on each of the five consecutive dealing days ending on the dealing day immediately preceding such date; provided that, if the VWAP of a unit of Ordinary Stock is not available on one or more of the said five dealing days (disregarding for this purpose the proviso to the definition of VWAP), then the average of such VWAPs which are available in that five-dealing-day period shall be used (subject to there being a daily VWAP available for a minimum of two such days) and if only one, or no, such VWAP is available in the relevant period, the Current Market Price shall be determined in good faith by an Independent Financial Adviser;
 
dealing day” means a day on which the Primary Stock Exchange or relevant stock exchange or securities market is open for business and on which Ordinary Stock or Other Securities may be dealt in (other than a day on which the Primary Stock Exchange or relevant stock exchange or securities market is scheduled to or does close prior to its regular weekday closing time);
 
Dividend” means any dividend or distribution in respect of the Ordinary Stock to Stockholders whether of cash, assets or other property, and however described and whether payable out of share premium account, profits, retained earnings or any other capital or revenue reserve or account, and including a distribution or payment to holders upon or in connection with a reduction of capital, provided that:
 
 
(i)
where a Dividend in cash is announced which is to be, or may at the election of a Stockholder or Stockholders be, satisfied by the issue or delivery of Ordinary Stock or other property or assets, then the Dividend in question shall be treated as a Cash Dividend of an amount equal to the greater of (i) the Fair Market Value of such cash amount and (ii) the Current Market Price of such Ordinary Stock as at the first date on which the Ordinary Stock are traded ex-the relevant Dividend on the Primary Stock Exchange or, as the case may be, the Fair Market Value of such other property or assets as at the date of the first public announcement of such Dividend on the Primary Stock Exchange or, if later, the date on which the number of units of Ordinary Stock (or amount of such other property or assets, as the case may be) which may be issued or delivered is determined;
 
 
(ii)
any issue of Ordinary Stock falling within Condition 4(e)(i) or Condition 4(e)(ii) shall be disregarded;
 
 
(iii)
a purchase or redemption or buy back of share capital of the Issuer by or on behalf of the Issuer or any of its Subsidiaries shall not constitute a Dividend unless, in the case of a purchase or redemption or buy back of Ordinary Stock by or on behalf of the Issuer or any of its Subsidiaries, the VWAP per unit of Ordinary Stock (before expenses) on any one day (a “Specified Share Day”) in respect of such purchases or redemptions or buy backs exceeds by more than 5 per cent. the average of the daily VWAP of a unit of Ordinary Stock on the five dealing days immediately preceding the Specified Share Day or, where an announcement (excluding, for the avoidance of doubt for these
 

 
41

 

purposes, any general authority for such purchases, redemptions or buy backs approved by a general meeting of Stockholders or any notice convening such a meeting of Stockholders) has been made of the intention to purchase, redeem or buy back Ordinary Stock at some future date at a specified price or where a tender offer is made, on the five dealing days immediately preceding the date of such announcement or the date of first public announcement of such tender offer (and regardless of whether or not a price per unit of Ordinary Stock, a minimum price per unit of Ordinary Stock or a price range or formula for the determination thereof is or is not announced at such time), as the case may be, in which case such purchase, redemption or buy back shall be deemed to constitute a Dividend in euro in an amount equal to the amount by which the aggregate price paid (before expenses) in respect of such Ordinary Stock purchased, redeemed or bought back by the Issuer or, as the case may be, any of its Subsidiaries exceeds the product of (i) 105 per cent. of the daily VWAP of a unit of Ordinary Stock determined as aforesaid and (ii) the number of units of Ordinary Stock so purchased, redeemed or bought back;
 
 
(iv)
if the Issuer or any of its Subsidiaries shall purchase, redeem or buy back any depositary or other receipts or certificates representing Ordinary Stock, the provisions of paragraph (iii) above shall be applied in respect thereof in such manner and with such modifications (if any) as shall be determined in good faith by an Independent Financial Adviser; and
 
 
(v)
where a dividend or distribution is paid or made to Stockholders pursuant to any plan implemented by the Issuer for the purpose of enabling Stockholders to elect, or which may require Stockholders, to receive dividends or distributions in respect of the Ordinary Stock held by them from a person other than, or in addition to, the Issuer, such dividend or distribution shall for the purposes of Condition 4 be treated as a dividend or distribution made or paid to Stockholders by the Issuer, and the foregoing provisions of this definition and the provisions of Condition 4, including references to the Issuer paying or making a dividend, shall be construed accordingly, and any such determination shall be made on a gross basis and disregarding any withholding or deduction required to be made on account of tax, and disregarding any associated tax credit;
 
EEA Regulated Market means a market as defined by Article 4.1(14) of Directive 2004/39/EC of the European Parliament and of the Council on markets on financial instruments;
 
Effective Date” means, in respect of Condition 4(e), the first date on which the ordinary shares or stock are traded ex-the relevant Dividend on the Primary Stock Exchange or, in the case of a purchase, redemption or buy back of Ordinary Stock (or any depositary or other receipts or certificates representing Ordinary Stock), the date on which such purchase, redemption or buy back is made;
 
Encumbrance” means any pledge, lien, option, security interest, claim, equity, trust, mortgage, charge, encumbrance or third party right or interest of any nature whatsoever and including for the avoidance of doubt any pre-emptive or similar right;
 
Event of Default” means any of the conditions, events or acts provided in Condition 12 to be Events of Default;
 

 
42

 

Exempt Reorganisation” means a Reorganisation where, immediately after completion of the relevant proceedings, the ordinary shares or stock or units or equivalent of Newco (or depositary or other receipts or certificates representing ordinary shares or stock or units or equivalent of Newco) are (i) admitted to trading on the Primary Stock Exchange or (ii) admitted to listing on such other regulated, regularly operating, recognised stock exchange or securities market as the Issuer or Newco may determine;
 
Extraordinary Resolution” has the meaning given to it in the Agency Deed;
 
Fair Market Value” means, with respect to any property on any date, the fair market value of that property as determined by an Independent Financial Adviser in good faith, provided that:
 
 
 
(i)
the Fair Market Value of any cash amount shall be the amount of such cash;
 
 
(ii)
where Ordinary Stock or Other Securities are publicly traded on a stock exchange or securities market of adequate liquidity (as determined in good faith by an Independent Financial Adviser), the Fair Market Value of such Ordinary Stock or Other Securities shall equal the arithmetic mean of the daily VWAP of such Ordinary Stock or Other Securities (or the arithmetic mean of the daily closing prices should daily VWAP not be available), during the period of five dealing days on the relevant stock exchange or securities market commencing on such date (or, if later, the first such dealing day such Ordinary Stock or Other Securities) or such shorter period as such Ordinary Stock or Other Securities are publicly traded;
 
 
(iii)
where Ordinary Stock or Other Securities are not publicly traded on a stock exchange or securities market of adequate liquidity (as aforesaid), the Fair Market Value of such Ordinary Stock or Other Securities shall be determined in good faith by an Independent Financial Adviser, on the basis of a commonly accepted market valuation method and taking account of such factors as it considers appropriate, including the market price per unit of Ordinary Stock, the dividend yield of a unit of Ordinary Stock, the volatility of such market price, prevailing interest rates and the terms of such Ordinary Stock or Other Securities, including as to the expiry date and exercise price (if any) thereof; and
 
 
(iv)
the Fair Market Value shall be determined on a gross basis and disregarding any withholding or deduction required to be made on account of tax, and disregarding any associated tax credit;
 
Floor Price” means €[ l ], subject to adjustment thereafter in accordance with Condition 4(e).  For the avoidance of doubt, the Floor Price shall not be subject to adjustment in respect of Ordinary Stock or Other Securities issued pursuant to or associated with the Liability Management Exercise and the Issuer Recapitalisation;
 
Group” means the Issuer and its subsidiaries (within the meaning of Section 155 of the Companies Act 1963) from time to time, subsidiary undertakings from time to time and any other entity in respect of which financial information is included from time to time in the consolidated annual accounts of the Issuer, and “Group Company” means any of them;
 

 
43

 

Holder” means each person in whose name a CCN is registered for the time being in the Register (being the Initial Holder on the Issue Date) and “Holders” shall be construed accordingly;
 
Independent Financial Adviser” means an independent financial institution of international repute appointed at its own expense by the Issuer and, for so long as the Initial Holder is a holder of 100 per cent. of the CCNs, which is approved in writing by the Initial Holder;
 
Initial Holder” means the Minister, and subsequently if transferred, any other State Entity which may from time to time be the Holder of the CCNs;
 
Interest Commencement Date” has the meaning given to such term in Condition 3(a);
 
Interest Payment Date” has the meaning given to such term in Condition 3(a);
 
Interest Period” has the meaning given to such term in Condition 3(a);
 
Issue Date” means [29] July 2011 or such other date agreed between the Issuer and the Initial Holder;
 
Issuer Recapitalisation” means the generation by the Issuer of Core Tier 1 Amount pursuant to any placement of Ordinary Stock with the State and a rights issue in respect of Ordinary Stock which is fully underwritten by the National Pension Reserve Fund Commission as set out in a prospectus of the Issuer dated 18 June 2011 (as supplemented);
 
Liability Management Exercise” means any purchase, repurchase, redemption or liability reduction exercise commenced by the Issuer or any member of the Group within six months of the Issue Date, in respect of any of the Group’s securities (other than units of Ordinary Stock and Other Securities) where such exercise has been approved by the Competent Authority including, but not limited to: (i) the exchange offers of the Issuer launched on 8 June 2011; (ii) the CAD138,721,000 Fixed/Floating Dated Subordinated Notes due September 2015 (ISIN: CA062786AA67); and (iii) the GBP75,000,000 13.375 per cent. Unsecured Perpetual Subordinated Bonds (ISIN: GB0000510312);
 
Maturity Date” means [30] July 2016;
 
Minister means the Minister for Finance of Ireland;
 
National Regulations” means the prevailing national banking and capital adequacy laws directly applicable to the Group and prevailing capital adequacy regulations promulgated by the Competent Authority and applicable to the Group;
 
New Conversion Condition” means, if by no later than seven Business Days following the occurrence of a Takeover Event where the Acquirer is an Approved Entity, the Issuer shall have entered into agreements and arrangements, to the satisfaction of the Initial Holder for so long as the Initial Holder is a holder of 100 per cent. of the CCNs, with the Approved Entity for delivery of the Approved Entity Shares upon the occurrence of a Conversion Event on terms mutatis mutandis identical to the provisions of Condition 4;
 

 
44

 

New Conversion Price” means, in respect of any Conversion Date falling on or after the Takeover Event Date, where the Takeover Event is a Qualifying Takeover Event, the greater of;
 
 
(i)
any Dividend which is expressed by the Issuer or declared by the board of directors of the Issuer to be a capital distribution, extraordinary dividend, extraordinary distribution, special dividend or return of value to Stockholders or any analogous or similar term, in which case the Capital Distribution for the purpose of these Conditions shall be the Fair Market Value of such Dividend; or
 
 
(ii)
any Cash Dividend (the “Relevant Dividend”) paid or made in respect of a fiscal year of the Issuer (the “Relevant Fiscal Year”) if the sum of:
 
New Floor Price means the amount determined in accordance with the following formula:
 
NFP    =     EFP   X       VWAPAES
VWAPOS
where:
 
NFP is the New Floor Price;
 
EFP is the Floor Price in effect on the dealing day immediately prior to the Takeover Event Date;
 
VWAPAES means the average of the VWAP of the Approved Entity Shares on each of the five dealing days ending on the dealing day prior to the closing date of the Takeover Event (and where references in the definition of “VWAP” to “Ordinary Stock” shall be construed as a reference to the Approved Entity Shares and in the definition of “dealing day”, references to the “Primary Stock Exchange”’ shall be to the relevant Recognised Stock Exchange); and
 
VWAPOS is the average of the VWAP of the Ordinary Stock on each of the five dealing days ending on the dealing day immediately prior to the Takeover Event Date;
 
Non-Cash Dividend” means any Dividend which is not a Cash Dividend;
 
Non-Qualifying Takeover Event” means a Takeover Event that is not a Qualifying Takeover Event;
 
Non-Viability Event” means the earliest of the following:
 
 
(i)
the Competent Authority, in its absolute discretion, determining that Conversion of the CCNs, together with the conversion or write off of holders’ claims in respect of any Tier 1 Instruments or Tier 2 Instruments that, pursuant to their terms or by operation of law, are capable of being converted into equity or written off at that time, is, because customary measures to improve the Group’s capital adequacy are at the time inadequate or unfeasible, an essential requirement to prevent the Issuer from becoming insolvent, bankrupt or unable to pay its debts as they fall due, or from ceasing to carry on its business, or from failing to meet its minimum capital adequacy requirements, as determined by the Competent Authority; or
 

 
45

 

 
(ii)
by virtue of customary measures to improve the Group’s capital adequacy being at the time inadequate or unfeasible, the Issuer receiving an irrevocable commitment of extraordinary support from any State Entity (beyond customary transactions and arrangements in the ordinary course) that has, or imminently will have, the effect of improving the Group’s capital adequacy and without which, in the determination of the Competent Authority, the Issuer would become insolvent, bankrupt, unable to pay its debts as they fall due, or cease carrying on its business or fail to meet its minimum capital adequacy requirements, as determined by the Competent Authority;
 
Ordinary Stock” means ordinary stock of the Issuer of €[ l ] nominal value ([Bloomberg] Code: [ l ]) which are listed on the Irish Stock Exchange. The Ordinary Stock deliverable upon Conversion of the CCNs will be shares newly issued from the authorised capital of the Issuer. Ordinary Stock will rank pari passu with all other ordinary registered shares of the Issuer for any and all distributions payable on them on or after the Conversion Date;
 
Other Securities” means any equity securities including, without limitation, shares in the capital of the Issuer, or options, warrants or other rights to subscribe for or purchase or acquire shares in the capital of the Issuer other than the Ordinary Stock;
 
person” includes any individual, company, corporation, firm, partnership, joint venture, undertaking, association, organisation, trust, state or agency of a state (in each case whether or not being a separate legal entity);
 
Primary Stock Exchange” means the Irish Stock Exchange or, if at the relevant time the Ordinary Stock are not at that time listed and admitted to trading on the Irish Stock Exchange, the principal stock exchange or securities market on which the Ordinary Stock, if listed, are then listed, admitted to trading or quoted or accepted for dealing;
 
Qualifying CCNs” means securities issued directly or indirectly by the Issuer that (i) have terms materially as favourable to Holders as the CCNs prior to the Tax Event occurring, as determined in good faith by an Independent Financial Adviser and (ii) contain terms which in terms of quality of capital are at least equivalent to the terms of the CCNs prior to the Tax Event occurring, as determined by the Competent Authority in its absolute discretion;
 
Qualifying Takeover Event” means a Takeover Event where (i) the Acquirer is an Approved Entity and (ii) the New Conversion Condition is satisfied;
 
Rate of Interest” has the meaning given to such term in Condition 3(c);
 
Recognised Stock Exchange” means an EEA Regulated Market that is a recognised stock exchange for the purposes of Section 64 of the Taxes Consolidation Act 1997;
 
Record Date” has the meaning given to it in Condition 7(a)(ii);
 
Reference Amount means 5 per cent. of the average of the VWAP of a unit of Ordinary Stock on each dealing day in the period of 5 dealing days ending on the dealing date immediately preceding the Effective Date provided that if on any such dealing day the VWAP shall have been based on a price cum-Dividend or cum-any other entitlement, the VWAP of a unit of Ordinary Stock on such dealing day shall be deemed to be an amount thereof reduced by an amount equal to the Fair Market Value
 

 
46

 

of any such Dividend or other entitlement per unit of Ordinary Stock as at the Effective Date relating to the relevant Dividend or entitlement;
 
Reference Market Price means, in respect of a unit of Ordinary Stock at a particular date, the average of the daily VWAP of a unit of Ordinary Stock on each of the 30 consecutive dealing days ending on the dealing day immediately preceding such date (the “Reference Period):
 
 
(i)
provided that:
 
 
(A)
if at any time during the Reference Period the VWAP shall have been based on a price ex-Dividend (or ex-any other entitlement) and during some other part of that Reference Period the VWAP shall have been based on a price cum-Dividend (or cum- any other entitlement), then:
 
 
(I)
if the Ordinary Stock to be issued or delivered (if applicable) do not rank for the Dividend (or entitlement) in question, the VWAP on the date(s) on which the Ordinary Stock shall have been based on a price cum-Dividend (or cum- any other entitlement) shall, for the purposes of this definition, be deemed to be the amount thereof reduced by an amount equal to the fair market value (as determined by an Independent Financial Adviser) of any such Dividend or entitlement per unit of Ordinary Stock as at the date of first public announcement relating to such Dividend or entitlement; or
 
 
(II)
if the Ordinary Stock to be issued or delivered (if applicable) do rank for the Dividend (or entitlement) in question, the VWAP on the date(s) on which the Ordinary Stock shall have been based on a price ex-Dividend (or ex-any other entitlement) shall, for the purposes of this definition, be deemed to be the amount thereof increased by an amount equal to the fair market value (as determined by an Independent Financial Adviser) of any such Dividend or entitlement per unit of Ordinary Stock as at the date of first public announcement relating to such Dividend or entitlement,
 
 
(B)
if on any of the dealing days in the Reference Period the VWAP shall have been based on a price cum-Dividend (or cum- any other entitlement) in respect of a Dividend (or other entitlement) which has been declared or announced but the Ordinary Stock to be issued or delivered do not rank for that Dividend (or other entitlement), the VWAP on each of such dates shall, for the purposes of this definition, be deemed to be the amount thereof reduced by an amount equal to the fair market value (as determined by an Independent Financial Adviser) of any such Dividend or entitlement per unit of Ordinary Stock as at the date of first public announcement relating to such Dividend or entitlement, and
 
 
(C)
if the VWAP of a unit of Ordinary Stock is not available on one or more of the dealing days in the Reference Period (disregarding for this purpose the proviso to the definition of VWAP), then the average of such VWAPs which are available in the Reference Period shall be used (subject to there being a daily VWAP available for a minimum
 
 
47

 
 
 
 
of two such days) and if only one, or no, such VWAP is available in the Reference Period, the Reference Market Price shall be determined in good faith by an Independent Financial Adviser appointed in good faith by the Issuer, and
 
Relevant Date” in respect of any payment on any CCN, means the date on which such payment first becomes due or (if any amount of the money payable is improperly withheld or refused) the date on which payment in full of the amount required to be paid is made or, in the case where presentation of the relevant Certificate is required pursuant to the Conditions, (if earlier) the date seven days after that on which notice is duly given to the Holders that, upon further presentation of the Certificate being made in accordance with the Conditions, such payment will be made, provided that payment is in fact made upon such presentation;
 
Reorganisation” means proceedings which effect the interposition of a limited liability company (“Newco”) between the Stockholders immediately prior to such proceedings (the “Existing Stockholders”) and the Issuer; provided that:
 
 
(i)
only ordinary shares or stock or units or equivalent of Newco (or depositary or other receipts or certificates representing ordinary shares or stock or units or equivalent of Newco) are issued to Existing Stockholders;
 
 
(ii)
immediately after completion of such proceedings the only holders of ordinary shares or stock or units or equivalent of Newco (or, as the case may be, the only holders of depositary or other receipts or certificates representing ordinary shares or stock or units or equivalent of Newco) are Existing Stockholders holding in the same proportions as immediately prior to completion of such proceedings;
 
 
(iii)
immediately after completion of such proceedings, Newco is (or one or more wholly-owned Subsidiaries of Newco are) the only Stockholder;
 
 
(iv)
all Subsidiaries immediately prior to such proceedings (other than Newco, if Newco is then a Subsidiary of the Issuer) are Subsidiaries of the Issuer (or of Newco) immediately after completion of such proceedings; and
 
 
(v)
immediately after completion of such proceedings, the Issuer (or Newco) holds, directly or indirectly, the same percentage of the ordinary share capital and equity share capital of those Subsidiaries as was held by the Issuer immediately prior to such proceedings;
 
RWA Amount” means, as at any date, the aggregate amount of all risk-weighted assets of the Issuer calculated on a consolidated basis pursuant to National Regulations, each applicable at such time, expressed in the Issuer’s reporting currency;
 
Semi-Annual Financial Report” means the consolidated financial accounts and disclosures of the Group in respect of a calendar semi-annual reporting period contained in a customary financial report published by the Group;
 
Semi-Annual Reporting Period” means six months ended 30 June and 31 December in each year or, if the Group amends its financial year end, such corresponding period as may be approved in writing by the Holders;
 
 
48

 
 
State Entities” means the Minister or his nominee, the National Pension Reserve Fund Commission, the National Treasury Management Agency, National Asset Management Agency, or any other entity or agency of or related to the Government of Ireland and “State Entity” shall be construed accordingly;
 
Stockholders” means the holders of Ordinary Stock for the time being (and “Stockholder” shall be construed accordingly);
 
Subsidiary” means a subsidiary within the meaning of Section 155 of the Companies Act 1963;
 
Takeover Event” shall occur if any person or persons acting in concert acquires control of the Issuer (other than as a result of an Exempt Reorganisation). For the purposes of the definition of “Takeover Event”, “acting in concert” has the meaning given to such term in the Irish Takeover Panel Act 1997 and “control” means the acquisition or holding of legal or beneficial ownership of more than 95 per cent. of the issued Ordinary Stock of the Issuer and the Ordinary Stock are not admitted to trading, or are no longer admitted to trading, as the case may be, on any Recognised Stock Exchange, and “controlled” shall be construed accordingly;
 
Takeover Event Date means the date with effect from which the New Conversion Condition shall have been satisfied;
 
TARGET System” means the Trans-European Automated Real-Time Gross Settlement Express Transfer (known as TARGET2) System which was launched on 19 November 2007 or any successor thereto;
 
Tax Event” is deemed to have occurred if, as a result of a Tax Law Change, in making any payments on the CCNs, the Issuer has paid or will or would on the next payment date be required to pay Additional Amounts and the Issuer cannot avoid the foregoing by taking measures reasonably available to it;
 
Tax Law Change” means a change in or proposed change in, or amendment or proposed amendment to, the laws or regulations of Ireland including any treaty to which Ireland is a party, or any change in any generally published application or interpretation of such laws, including a decision of any court or tribunal, or any change in the generally published application or interpretation of such laws by any relevant tax authority or any generally published pronouncement by any tax authority, which change, amendment or pronouncement (x) (subject to (y)) becomes, or would become, effective on or after the Issue Date, or (y) in the case of a change or proposed change in law, if such change is enacted (or, in the case of a proposed change, is expected to be enacted) by the Oireachtas or by Statutory Instrument, on or after the Issue Date;
 
Trigger Ratio” means, at any time, 8.25 per cent.;
 
Tier 1 Capital” means any or all items constituting at the relevant time tier 1 capital under National Regulations (including items eligible as Tier 1 Capital as a result of grandfathering under Directive 2009/111/EC or CRD IV);
 
Tier 1 Instruments” means any and all shares, securities or other obligations issued by the Group, each of which shares, securities or other obligations qualify, or are issued in respect of a security that qualifies, as Tier 1 Capital of the Group (without regard to quantitative limits on such capital) on a consolidated or on an unconsolidated basis;
 
 
49

 
 
Tier 2 Capital” means any or all items constituting at the relevant time tier 2 capital under National Regulations (including items eligible as Tier 2 Capital as a result of grandfathering under Directive 2009/111/EC or CRD IV);
 
Tier 2 Instruments” means any and all securities or other obligations issued by the Group, each of which securities or other obligations qualify, or are issued in respect of a security that is eligible to qualify, as Tier 2 Capital of the Group on a consolidated or on an unconsolidated basis; and
 
VWAP” means, in respect of a unit of Ordinary Stock or Other Security, as the case may be, for any dealing day, the order book volume-weighted average price of a unit of Ordinary Stock or Other Security, as the case may be, published by or derived (in the case of a unit of Ordinary Stock) from the relevant Bloomberg page or (in the case of an Other Security) from the principal stock exchange or securities market on which such Other Securities are then listed or quoted or dealt in, if any or, in any such case, such other source as shall be determined in good faith to be appropriate by an Independent Financial Adviser on such dealing day, provided that if on any such dealing day such price is not available or cannot otherwise be determined as provided above, the VWAP of a unit of Ordinary Stock or Other Security in respect of such dealing day shall be the VWAP, determined as provided above, on the immediately preceding dealing day on which the same can be so determined or determined as an Independent Financial Adviser might otherwise determine in good faith to be appropriate.
 
 
16.2
References to any act or statute or any provision of any act or statute shall be deemed also to refer to any statutory modification or re-enactment thereof or any statutory instrument, order or regulation made thereunder or under such statutory modification or re-enactment.
 
 
16.3
Unless the context otherwise requires, references to (i) “principal” shall be deemed to include any premium payable in respect of the CCNs and all other amounts in the nature of principal payable pursuant to these Conditions or any amendment or supplement to it, (ii) “interest” shall be deemed to include any Accrued Conversion Interest and in any such case shall be deemed to include any Additional Amounts that may be payable under Condition 8 or any undertaking given in addition to or in substitution for it under the Agency Deed in respect of any such amount.
 
 
16.4
References to any issue or offer or grant to Stockholders or Existing Stockholders “as a class” or “by way of rights” shall be taken to be references to an issue or offer or grant to all or substantially all Stockholders or Existing Stockholders, as the case may be, other than Stockholders or Existing Stockholders, as the case may be, to whom, by reason of the laws of any territory or requirements of any recognised regulatory body or any other stock exchange or securities market in any territory or in connection with fractional entitlements, it is determined not to make such issue or offer or grant.
 
 
16.5
In making any calculation or determination of Current Market Price or VWAP, such adjustments (if any) shall be made as an Independent Financial Adviser determines in good faith to be appropriate to reflect any consolidation or sub-division of the Ordinary Stock or any issue of Ordinary Stock by way of capitalisation of profits or reserves, or any like or similar event.
 
 
16.6
For the purposes of Condition 4, (i) references to the “issue” of Ordinary Stock or Ordinary Stock being “issued” shall, unless otherwise expressly specified to be the case in respect of any of the provisions of Condition 4, include the delivery of Ordinary Stock, whether newly issued and allotted or previously existing or held by or
 
 
50

 
 
 
 
For the purposes of Condition 4, (i) references to the “issue” of Ordinary Stock or Ordinary Stock being “issued” shall, unless otherwise expressly specified to be the case in respect of any of the provisions of Condition 4, include the delivery of Ordinary Stock, whether newly issued and allotted or previously existing or held by or on behalf of the Issuer or any of its Subsidiaries, and (ii) Ordinary Stock held by or on behalf of the Issuer or any of its respective Subsidiaries shall not be considered as or treated as “in issue” or “issued” or entitled to receive the relevant Dividend, right or other entitlement.
 
 
16.7
References in these Conditions to “listing” or “listed” on the Irish Stock Exchange (or like or similar references) shall be construed as admission to the Official List of the Irish Stock Exchange and trading on its regulated market.
 
17.
Governing Law and Jurisdiction
 
 
(a)
Governing Law
 
The CCNs and any non-contractual obligations arising out of or in connection with them are governed by, and shall be construed in accordance with, the laws of Ireland.
 
 
(b)
Jurisdiction
 
Save as provided below, the courts of Ireland shall have exclusive jurisdiction to settle any disputes that may arise out of or in connection with any CCNs and accordingly any legal action or proceedings arising out of or in connection with any CCNs (“Proceedings”) may be brought in such courts. The Issuer submits to the jurisdiction of the courts of Ireland in respect of any such Proceedings and waives any objection to Proceedings in such courts on the ground of venue or on the ground that the Proceedings have been brought in an inconvenient forum. These submissions are made for the benefit of each of the Holders.
 

 
51

 
 
(EXECUTION PAGE OF ISSUER AGREEMENT)



The Seal of
THE GOVERNOR AND COMPANY
OF THE BANK OF IRELAND
was affixed in the presence of:

  /s/ John O'Donovan
 
Director/Secretary/Authorised Signatory
   
   
  /s/ Richie Boucher
 
Director/Secretary/Authorised Signatory





 
52

 

(EXECUTION PAGE OF ISSUER AGREEMENT)







SIGNED and DELIVERED AS A DEED
on behalf of
FAIRFAX FINANCIAL HOLDINGS LIMITED
by its authorised signatory
in the presence of:
 
/s/ Paul Rivett
   
Authorised Signatory (Signature)
     
   
Paul Rivett
/s/ James Newman
 
Print name
Witness (Signature)
   
     
James Newman
   
Print name
   
     
Fitzwilton House, Wilton Place, Dublin 2
   
Print address
   





 
 

 

(EXECUTION PAGE OF ISSUER AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CONTRAFUND: FIDELITY CONTRAFUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
VARIABLE INSURANCE PRODUCTS FUND III: BALANCED PORTFOLIO
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


 
 

 

(EXECUTION PAGE OF ISSUER AGREEMENT)

SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY SECURITIES FUND: FIDELITY DIVIDEND GROWTH FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY CAPITAL TRUST: FIDELITY VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   



 
 

 

(EXECUTION PAGE OF ISSUER AGREEMENT)


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY ADVISOR SERIES I: FIDELITY ADVISOR VALUE FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   


SIGNED and DELIVERED AS A DEED
on behalf of
FIDELITY PURITAN TRUST: FIDELITY LOW-PRICED STOCK FUND
by its authorised signatory
in the presence of:
 
/s/ Jeffrey Christian
   
Authorised Signatory (Signature)
     
   
Jeffrey Christian, Deputy Treasurer
/s/ Suzanne Joyce
 
Print name
Witness (Signature)
   
     
Suzanne Joyce
   
Print name
   
     
82 Devonshire St., V13F, Boston, MA 02109
   
Print address
   




 
 

 

(EXECUTION PAGE OF ISSUER AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
KENNEDY-WILSON INVESTMENTS, LLC
by its authorised signatory
in the presence of:
 
/s/ Matthew Windisch
   
Authorised Signatory (Signature)
     
   
Matthew Windisch
/s/ Mark Martin
 
Print name
Witness (Signature)
   
     
Mark Martin
   
Print name
   
     
9701 Wilshire Blvd., Beverly Hills, CA 90212
   
Print address
   
 

 
 

 

(EXECUTION PAGE OF ISSUER AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund IV, L.P.
by WLR Recovery Associates IV LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   




SIGNED and DELIVERED AS A DEED
on behalf of
WLR Recovery Fund V, L.P.
by WLR Recovery Associates V LLC
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   


 
 
 

 

(EXECUTION PAGE OF ISSUER AGREEMENT)



SIGNED and DELIVERED AS A DEED
on behalf of
WLR/GS Master Co-Investment, L.P.
by WLR Master Co-Investment GP, L.P.
its General Partner
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   



SIGNED and DELIVERED AS A DEED
on behalf of
WLR IV Parallel ESC, L.P.
by WLR Recovery Associates IV LLC
its attorney-in-fact
by WL Ross Group, L.P.
its Managing Member
by El Vedado LLC
its General Partner
by its authorized signatory
in the presence of:
 
/s/ Wilbur L. Ross, Jr.
   
Manager (Signature)
   
Wilbur L. Ross, Jr.
     
/s/ Stephen J. Naughton
   
Witness (Signature)
   
Stephen J. Naughton
   
1166 Avenue of the Americas, 25th Floor
   
New York, New York 10036
   

 
 

 
 
(EXECUTION PAGE OF ISSUER AGREEMENT)

 
 
SIGNED and DELIVERED AS A DEED
on behalf of
CAPITAL RESEARCH AND MANAGEMENT COMPANY
by its authorised signatory
in the presence of:
 
/s/ Michael J. Downer
   
Authorised Signatory (Signature)
     
   
Michael J. Downer, SVP and Secretary
/s/ Walt R. Burkley
 
Print name
Witness (Signature)
   
     
Walt R. Burkley
   
Print name
   
     
c/o 333 S. Hope Street, Los Angeles, CA 90071
   
Print address
   

EX-99 19 ex11.htm EXHIBIT 11 ex11.htm
Exhibit 11

EXECUTION COPY

 

 

 

 

 

 

 




PARALLEL INVESTMENT AGREEMENT
 
by and between
 
WLR RECOVERY ASSOCIATES IV LLC
 
and
 
INVESCO WLR IV ASSOCIATES LLC

 


 


 
Dated May 30, 2008
 

 
(Effective as of December 6, 2007)
 

 
 

 
 
This PARALLEL INVESTMENT AGREEMENT, dated May 30, 2008, but intended to be effective as of December 6, 2007 (this “Agreement”), is entered by and between WLR RECOVERY ASSOCIATES IV LLC, a Delaware limited liability company (the “Fund GP”), and INVESCO WLR IV Associates LLC, a Delaware limited liability company (the “ESC GP”).
 
WHEREAS, the Fund GP and the ESC GP are the general partners of, respectively, WLR Recovery Fund IV, L.P. a Delaware limited partnership (the “Fund”), and WLR IV Parallel ESC, L.P., a Delaware limited partnership (the “ESC”);
 
WHEREAS, the Fund has been established to make investments in the securities and obligations of domestic and foreign companies that are experiencing significant financial or business difficulties, including companies involved in bankruptcy or other reorganization and liquidation proceedings;
 
WHEREAS, the ESC has been established to allow employees of INVESCO PLC to make investments on a pro rata and parallel basis with the Fund;
 
WHEREAS, (i)  the parties desire that the ESC act as parallel vehicle of the Fund, as provided in Section 6.08 of the Amended and Restated Limited Partnership Agreement of the Fund dated as of September 25, 2007 (as amended and restated from time to time, the “Fund Partnership Agreement”); and (ii) the ESC desires to support the activities of the Fund by delegating, to the maximum extent permitted by law, to the Fund GP, the power and authority to act on behalf of the ESC, all on the terms and subject to the conditions specified herein and in the Amended and Restated Limited Partnership Agreement of the ESC dated as of December 6, 2007 (as amended and restated from time to time, the “ESC Partnership Agreement”); and
 
WHEREAS, capitalized terms used herein and not defined herein have the respective meanings set forth in the Fund Partnership Agreement.
 
NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration the receipt and adequacy of which are acknowledged, the parties hereto agree as follows:
 
ARTICLE I
INVESTMENT ARRANGEMENTS
 
Section 1.1             Investment by the ESC.
 
(a)        During the term of the Fund, to the maximum extent practicable, the ESC shall  invest on a pro rata basis (based upon the capital available for investments of the ESC and the undrawn commitments of the Fund) with, and on the same terms and conditions of the Fund in each Portfolio Investment including, without limitation, any Follow-on Investment made by the Fund.
 
(b)        If the Fund GP so determines, the ESC shall sell or dispose of securities purchased pursuant to Section 2.1(a) hereof at the same time, and on the same terms and conditions, as the Fund.
 

 
 

 

Section 1.2             Expenses.  The ESC shall bear and pay out of its capital contributions (i) its pro rata share of Organizational Expenses and (ii) its pro rata share of operating expenses in accordance with Section 5.02 of the ESC Partnership Agreement.
 

ARTICLE II
INVESTMENT PROCESS
 
Section 2.1             Investment Decisions.  To the maximum extent permitted by law, all decisions relating to the acquisition and disposition of Portfolio Investments by the ESC and any other decisions in connection therewith shall be delegated to the Fund GP, provided, however, that the ESC GP shall remain responsible for the management and control of the Partnership.
 
Section 2.2             Power of Attorney.
 
(a)        Appointment.  The ESC GP hereby constitutes and appoints the Fund GP as the true and lawful representative and attorney-in-fact of the ESC to:
 
(i)           investigate, select, negotiate, structure, purchase, invest in, hold, pledge, exchange, transfer and sell or otherwise dispose of Portfolio Investments and temporary investments;
 
(ii)           monitor the performance of Portfolio Investments and temporary investments, designate members of the board of directors of Portfolio Companies or obtain equivalent representation, exercise all rights, powers, privileges and other incidents of ownership or possession with respect to Portfolio Investments and temporary investments and to take whatever action, including steps to influence key management decisions of Portfolio Companies and voting shares of capital stock or other ownership interests issued by such Portfolio Companies as may be necessary or advisable as determined by the Fund GP in its discretion;
 
(iii)           open, maintain and close bank accounts and draw checks or other orders for the payment of money and open, maintain and close brokerage, money market fund and similar accounts;
 
(iv)           hire, for usual and customary payments and expenses, consultants, brokers, attorneys, accountants and such other agents for the ESC as it may deem necessary or advisable, and authorize any such agent to act for and on behalf of the ESC; and
 
(v)           take any and all other actions which are determined by the Fund GP to be necessary, convenient or incidental to the Investment Agenda.
 
(b)        Irrevocable.  The foregoing grant of authority is a special power of attorney coupled with an interest in favor of the Fund GP and as such shall be irrevocable and shall survive the merger, dissolution or other termination of the existence of the ESC GP.
 
(c)        No control of the ESC. The Fund GP shall for all purposes herein be deemed to be an independent contractor with respect to the ESC.  Except as expressly provided in this
 

 
 

 

Agreement, the Fund GP shall have no right or power to participate in the management or affairs of the ESC.  The exercise by the Fund GP of any right conferred herein shall not be construed to constitute participation by the Fund GP in the control of the business of the ESC so as to make the Fund GP liable as a general partner for the debts and obligations of the ESC for purposes of the Delaware Act.
 
ARTICLE III
BOOKS AND RECORDS
 
At all times during the term of this Agreement, the parties shall maintain at their respective principal places of business a complete and accurate set of files, books and records of all business activities and operations conducted by each of them in connection with this Agreement.  Each party shall have the right during normal business hours to examine such books and records.
 
ARTICLE IV
TERM

 
This Agreement shall terminate when the Fund dissolves and terminates.  This Agreement may not be earlier terminated, and may not be extended, amended or modified, without the prior written consent of both parties.  The ESC’s obligation to invest with the Fund shall be suspended if the Fund's investment activities are suspended in accordance with Section 8.06(a) of the Fund Partnership Agreement, provided, however, that the ESC's obligation to invest with the Fund shall re-start if the conditions set forth in Section 8.06(c) of the Fund Partnership Agreement are satisfied.
 
ARTICLE V
INDEMNIFICATION
 
The ESC shall bear and be liable to pay its pro rata share of indemnification obligations to the Indemnified Parties in accordance with Article XVIII of the Fund Partnership Agreement.
 
ARTICLE VI
MISCELLANEOUS
 
Section 6.1             Notice.  Any notice or demand required or permitted to be given or made to or upon any party hereto pursuant to any provision of this Agreement shall be deemed to have been duly given or made for all purposes if (i) in writing and delivered by hand against receipt, or sent by certified or registered mail, postage prepaid, return receipt requested, or (ii) sent by telegram, electronic mail, telecopy, or other electronic means, to such party at the following address:
 
To the Fund GP at:
 
WLR Recovery Associates IV LLC
c/o WL Ross & Co. LLC

 
 

 

1166 Avenue of the Americas, 27th floor
New York, New York  10036
Attention: Chief Financial Officer
Telephone: 212-826-1100
Telecopy: 212-317-4892
email: mgibbons@wlross.com

 
To the ESC GP at:
 
INVESCO WLR IV Associates LLC
c/o INVESCO Private Capital, Inc.
1166 Avenue of the Americas, 27th floor
New York, New York  10036
Attention:  Benjamin Gruder
Telephone:  212-278-9821
Telecopy:  212-278-9811
email: Ben_Gruder@invesco.com

or such other address as any party hereto may at any time, or from time to time, direct by notice given to the other party in accordance with this Section 6.1. The date of giving or making of any such notice or demand shall be the earlier of the date of actual receipt, or five business days after such notice or demand is sent, or, if sent in accordance with clause (ii), the next business day following the day such notice or demand is actually transmitted.
 
Section 6.2             Entire Agreement.  This Agreement contains, and is intended as, a complete statement of all of the terms of the arrangements between the parties with respect to the matters provided for, supersedes any previous agreements and understandings between the parties with respect to those matters, and cannot be changed or terminated orally.
 
Section 6.3             Waiver.  Any party may waive compliance by another with any of the provisions of this Agreement. No waiver of any provision shall be construed as a waiver of any other provision. Any waiver must be in writing and must be signed by the party waiving any provision hereof.
 
Section 6.4             Remedies.  Each of the parties acknowledges that the subject matter of this Agreement is of a special, unique and extraordinary character, and that any violation of this Agreement by any party to this Agreement would be likely to be highly injurious to the other party.  Each of the parties agrees that if either party defaults in the performance of its obligations under this Agreement, the other party shall be entitled, in addition to any other remedies that it may have, to enforce this Agreement by a decree of specific performance in a court of competent jurisdiction requiring such party to perform its obligations under this Agreement.
 
Section 6.5             Separability.  If any provision of this Agreement shall be held to be invalid or unenforceable by any court of competent jurisdiction, the balance of this Agreement shall remain in effect.
 

 
 

 

Section 6.6             Counterparts. This Agreement or any amendment hereto may be signed in any number of counterparts, each of which shall be an original, but all of which taken together shall constitute one agreement (or amendment, as the case may be).
 
Section 6.7             Further Assurances.  Each of the Fund and the ESC will take such further actions as may be necessary and appropriate to effectuate the terms of this Agreement.
 
Section 6.8             Assignment.  None of the provisions of this Agreement shall be for the benefit of or enforceable by any creditor of the Fund or the ESC or any other third party.  This Agreement and the rights and obligations hereunder may not be assigned without the prior written consent of the other party.
 
Section 6.9             Headings.  Captions in this Agreement are for convenience only and do not define or limit any term of this Agreement.
 
Section 6.10           Governing Law.  This Agreement shall be governed by and construed in accordance with the internal laws of the state of Delaware (without regard to conflict of laws principles).
 

 

 

 

 
[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]
 

 
 

 


 
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivery by their respective duly authorized officers as of the date first above written.
 

 

 
WLR RECOVERY ASSOCIATES IV LLC, on its behalf an on behalf of WLR Recovery Fund IV, L.P.
       
 
By:  
WL Ross Group, L.P., its managing member
       
   
By:  
El Vedado LLC, its general partner
       
   
By:
/s/ Michael J. Gibbons
     
Name: Michael J. Gibbons
     
Title: Manager
       
       
       
 
INVESCO WLR IV ASSOCIATES LLC, on its behalf and on behalf of WLR IV Parallel ESC, L.P.
   
 
By:
INVESCO Private Capital Inc., its managing member
       
 
By:  
/s/ Benjamin Gruder
   
Name:  
Benjamin Gruder
   
Title:
Assistant Secretary